|
Name |
Accession |
Description |
Interval |
E-value |
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
73-1981 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 1158.95 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVvNEQGKGEQRIDAYQPFVIQHD 152
Cdd:PRK12316 51 RLSYAQQRMWFLWQLEPQSGAYNLPSAVRLNGPLDRQALERAFASLVQRHETLRTVFP-RGADDSLAQVPLDRPLEVEFE 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:PRK12316 130 DCSGLPEAEQEARLRDEAQRESLQPFDLCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEFSRFYSAYATGA 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PYPVETTQLNYIDYAHWfnSDSFLDYHNEFK--PFWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKR 310
Cdd:PRK12316 210 EPGLPALPIQYADYALW--QRSWLEAGEQERqlEYWRAQLGEEHPVLELPTDHPRPAVPSYRGSRYEFSIDPALAEALRG 287
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 311 LCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLS 390
Cdd:PRK12316 288 TARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRAEVEGLIGFFVNTQVLRSVFDGRTRVATLLAGVKDTVLG 367
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 391 AFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQ---AKVDFNDLIPGCDAAEETSPVLPAKTDISVKVTELMGEVRLD 467
Cdd:PRK12316 368 AQAHQDLPFERLVEALKVERSLSHSPLFQVMYNHQplvADIEALDTVAGLEFGQLEWKSRTTQFDLTLDTYEKGGRLHAA 447
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 468 WLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQpQLTVTDVIEAVAQRDPQ 547
Cdd:PRK12316 448 LTYATDLFEARTVERMARHWQNLLRGMVENPQARVDELPMLDAEERGQLVEGWNATAAEYPL-QRGVHRLFEEQVERTPE 526
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 548 QLAIAFdGEprtDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRH 627
Cdd:PRK12316 527 APALAF-GE---ETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILKAGGAYVPLDPEYPAERLAY 602
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 628 IITDANLSVILG--GDGQQLAQWSAEQRIDLTDPAVveqWQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:PRK12316 603 MLEDSGVQLLLSqsHLGRKLPLAAGVQVLDLDRPAA---WLEGYSEENPGTELNPENLAYVIYTSGSTGKPKGAGNRHRA 679
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDR-------AIMQAEQAGATHLIlPTALM 778
Cdd:PRK12316 680 LSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHrdpaklvELINREGVDTLHFV-PSMLQ 758
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 779 SIL---DPEQVNGIQAIGMGGEACPNAVVENWADKV---ALYNMYGPTECT--VTALSTRLRKGQPVTIGKPLIHIQALI 850
Cdd:PRK12316 759 AFLqdeDVASCTSLRRIVCSGEALPADAQEQVFAKLpqaGLYNLYGPTEAAidVTHWTCVEEGGDSVPIGRPIANLACYI 838
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 851 LDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndVNNAGQGAatlRIYRTGDKARLLNNGDYEYCGRID 930
Cdd:PRK12316 839 LDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFV------PSPFVAGE---RMYRTGDLARYRADGVIEYAGRID 909
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 931 EQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAqvgSRPALVAYaTVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLL 1010
Cdd:PRK12316 910 HQVKLRGLRIELGEIEARLLEH-PWVREAAVLAV---DGKQLVGY-VVLESEGGDWREALKAHLAASLPEYMVPAQWLAL 984
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1011 EDMPLTPNGKLDMKQLPPVLEANESDGEA--DNPLEADVLAIWRSVLNT-PLGVEDDFFRLGGDSILSIQLTTRLRSAGY 1087
Cdd:PRK12316 985 ERLPLTPNGKLDRKALPAPEASVAQQGYVapRNALERTLAAIWQDVLGVeRVGLDDNFFELGGDSIVSIQVVSRARQAGI 1064
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1088 ACTVKDVFEAKSVRRLCRVLaqnNRDTGTVAEQGTLEGEFALLPIQRWFMEQSLARPEHWNQAAMIQLPE-VDTERLVTM 1166
Cdd:PRK12316 1065 QLSPRDLFQHQTIRSLALVA---KAGQATAADQGPASGEVALAPVQRWFFEQAIPQRQHWNQSLLLQARQpLDPDRLGRA 1141
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1167 LQALMAQHDALRLGCD--AEGQRYLADVPCpALSTLDYRQLGDDG-LQQAFTALQSEFDPAQGRTMACALVrHHPQADTA 1243
Cdd:PRK12316 1142 LERLVAHHDALRLRFReeDGGWQQAYAAPQ-AGEVLWQRQAASEEeLLALCEEAQRSLDLEQGPLLRALLV-DMADGSQR 1219
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1244 LFLAFHHLVIDAVSWRILVDDLERLY--LGEPLLPKTSSYRQWGAALQHYATQHAEQLTYWQAQEDGVDLTalLAAKDPQ 1321
Cdd:PRK12316 1220 LLLVIHHLVVDGVSWRILLEDLQRAYadLDADLPARTSSYQAWARRLHEHAGARAEELDYWQAQLEDAPHE--LPCENPD 1297
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1322 G-----HASAAILTLDAKTTGQLVSEANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREAIDPTLDVSRTVGW 1396
Cdd:PRK12316 1298 GalenrHERKLELRLDAERTRQLLQEAPAAYRTQVNDLLLTALARVTCRWSGQASVLVQLEGHGREDLFEDIDLSRTVGW 1377
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1397 FTSTYPVCLQDKPDWASLIQSSKEQLRQVPDKGVGFNPLRYHHPQGNSLTLSP-----IVFNYLGL---SVQAAGTWRPV 1468
Cdd:PRK12316 1378 FTSLFPVRLTPAADLGESIKAIKEQLRAVPDKGIGYGLLRYLAGEEAAARLAAlpqprITFNYLGQfdrQFDEAALFVPA 1457
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1469 DVAPGCCVSPGNKPAEVISLHGGITGGQLTL-----RQVgcLNQRDSERLMTRLTENLRALTEACLTQLSHGVvfTPSDF 1543
Cdd:PRK12316 1458 TESAGAAQDPCAPLANWLSIEGQVYGGELSLhwsfsREM--FAEATVQRLADDYARELQALIEHCCDERNRGV--TPSDF 1533
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1544 PAVNLSQTQLDSLSQRYD-IDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHvLDVEGYRQAWQRQIQRFPALRAA 1622
Cdd:PRK12316 1534 PLAGLSQAQLDALPLPAGeIADIYPLSPMQQGMLFHSLYEQEAGDYINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSG 1612
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1623 ---LESECASIQVIVKQADLPFYYQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVI 1699
Cdd:PRK12316 1613 flwQDGLEQPLQVIHKQVELPFAELDWRGREDLGQALDALAQAERQKGFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILM 1692
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1700 DGWSGPQLLGAVHRDYQtlmqgqvlmhGDAPAIQVDRaYVDYARHAVAQ-QSAVDAFWQQRQSLLAQTNDVSMLFAAAGK 1778
Cdd:PRK12316 1693 DGWSNAQLLGEVLQRYA----------GQPVAAPGGR-YRDYIAWLQRQdAAASEAFWKEQLAALEEPTRLAQAARTEDG 1761
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1779 RADLSQHLTQIEPQVTsvslnekdqATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSV 1858
Cdd:PRK12316 1762 QVGYGDHQQLLDPAQT---------RALAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAELPGIEQQI 1832
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1859 GLYINSLPLALSWQQPVSLQQHLVQLQNELMAMNQHATQSL--IALTAGR--SRLFNSLFIYENYPDAKA-EQGQraddP 1933
Cdd:PRK12316 1833 GLFINTLPVIAAPRPDQSVADWLQEVQALNLALREHEHTPLydIQRWAGQggEALFDSLLVFENYPVAEAlKQGA----P 1908
|
1930 1940 1950 1960
....*....|....*....|....*....|....*....|....*...
gi 499404635 1934 HRLYPEFSAAYEKVEMPLNLVVrEQSGCMLLRFEFDADALDSAQARRV 1981
Cdd:PRK12316 1909 AGLVFGRVSNHEQTNYPLTLAV-TLGETLSLQYSYDRGHFDAAAIERL 1955
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
41-1981 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 1117.16 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 41 RTIKENKD--AIVRCLTAQQAFERPITPQNA--TSGPLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFD 116
Cdd:PRK12467 1082 RTLFEHQTlaGFAQAVAAQQQGAQPALPDVDrdQPLPLSYAQERQWFLWQLEPGSAAYHIPQALRLKGPLDIEALERSFD 1161
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 117 ALAQRHASLRTRFVVNEqGKGEQRIDAYQPFVIQHDdfSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSER 196
Cdd:PRK12467 1162 ALVARHESLRTTFVQED-GRTRQVIHPVGSLTLEEP--LLLAADKDEAQLKVYVEAEARQPFDLEQGPLLRVGLLRLAAD 1238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 197 THVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQPYPVETTQLNYIDYAHWfnSDSFLDYHNEFK--PFWVERLTGIP 274
Cdd:PRK12467 1239 EHVLVLTLHHIVSDGWSMQVLVDELVALYAAYSQGQSLQLPALPIQYADYAVW--QRQWMDAGERARqlAYWKAQLGGEQ 1316
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 275 EVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDI 354
Cdd:PRK12467 1317 PVLELPTDRPRPAVQSHRGARLAFELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAET 1396
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 355 EDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQaKVDFNDL- 433
Cdd:PRK12467 1397 EGLIGFFVNTQVLRAEVDGQASFQQLLQQVKQAALEAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQ-RDDHQAQa 1475
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 434 -IPGCDAAEETSPVLPAKTDISVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDR 512
Cdd:PRK12467 1476 qLPGLSVESLSWESQTAQFDLTLDTYESSEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDEAE 1555
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 513 FAAVLAETQQLPRSYPqPQLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVL 592
Cdd:PRK12467 1556 RRQILEGWNATHTGYP-LARLVHQLIEDQAAATPEAVALVFGEQ----ELTYGELNRRANRLAHRLIALGVGPEVLVGIA 1630
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 593 AKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVIlggdgqqLAQWSAEQRIDLTD---PAVVEQWQDLP 669
Cdd:PRK12467 1631 VERSLEMVVGLLAILKAGGAYVPLDPEYPRERLAYMIEDSGIELL-------LTQSHLQARLPLPDglrSLVLDQEDDWL 1703
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 670 GDQPPAIPRHA---QQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSS 746
Cdd:PRK12467 1704 EGYSDSNPAVNlapQNLAYVIYTSGSTGRPKGAGNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFDVSVWELFWPLIN 1783
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 747 GGTLAFGEPN-----DRAIMQAEQAGATHL-ILPTALMSILD-PEQVNG---IQAIGMGGEACPNAVVENWADK---VAL 813
Cdd:PRK12467 1784 GARLVIAPPGahrdpEQLIQLIERQQVTTLhFVPSMLQQLLQmDEQVEHplsLRRVVCGGEALEVEALRPWLERlpdTGL 1863
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 814 YNMYGPTECTVTALSTRLRKGQP-----VTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF 888
Cdd:PRK12467 1864 FNLYGPTETAVDVTHWTCRRKDLegrdsVPIGQPIANLSTYILDASLNPVPIGVAGELYLGGVGLARGYLNRPALTAERF 1943
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 889 ehiTLNDVNNAGQgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGS 968
Cdd:PRK12467 1944 ---VADPFGTVGS-----RLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLREQ-GGVREAVVIAQDGAN 2014
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 969 RPALVAYaTVKADSSTPEPA---AVLIDVAK-----YLPEYMVPFRLMLLEDMPLTPNGKLDMKQLpPVLEANESDGEAD 1040
Cdd:PRK12467 2015 GKQLVAY-VVPTDPGLVDDDeaqVALRAILKnhlkaSLPEYMVPAHLVFLARMPLTPNGKLDRKAL-PAPDASELQQAYV 2092
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1041 NP---LEADVLAIWRSVLNTP-LGVEDDFFRLGGDSILSIQLTTRLRSAGYACTVKDVFEAKSVRRLCRVlAQNNrDTGT 1116
Cdd:PRK12467 2093 APqseLEQRLAAIWQDVLGLEqVGLHDNFFELGGDSIISIQVVSRARQAGIRFTPKDLFQHQTVQSLAAV-AQEG-DGTV 2170
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1117 VAEQGTLEGEFALLPIQRWFMEQSLARPEHWNQAAMIQLPE-VDTERLVTMLQALMAQHDALRLGCDAEGQRYLA---DV 1192
Cdd:PRK12467 2171 SIDQGPVTGDLPLLPIQQMFFADDIPERHHWNQSVLLEPREaLDAELLEAALQALLVHHDALRLGFVQEDGGWSAmhrAP 2250
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1193 PCPALSTLDYRQLGDDG-LQQAFTALQSEFDPAQGRTMAcALVRHHPQADTALFLAFHHLVIDAVSWRILVDDLE----R 1267
Cdd:PRK12467 2251 EQERRPLLWQVVVADKEeLEALCEQAQRSLDLEEGPLLR-AVLATLPDGSQRLLLVIHHLVVDGVSWRILLEDLQtayrQ 2329
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1268 LYLGEPL-LP-KTSSYRQWGAALQHYATQH--AEQLTYWQAQEDGVdlTALLAAKDPQG-----HASAAILTLDAKTTGQ 1338
Cdd:PRK12467 2330 LQGGQPVkLPaKTSAFKAWAERLQTYAASAalADELGYWQAQLQGA--STELPCDHPQGglqrrHAASVTTHLDSEWTRR 2407
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1339 LVSEANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREAIDPTLDVSRTVGWFTSTYPVCLQDKPDWASLIQSS 1418
Cdd:PRK12467 2408 LLQEAPAAYRTQVNDLLLTALARVIARWTGQASTLIQLEGHGREDLFDEIDLTRTVGWFTSLYPVKLSPTASLATSIKTI 2487
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1419 KEQLRQVPDKGVGFNPLRYHHPQGNSLTLSP-----IVFNYLG-----LSVQAAGTWRPVDVAPGCCVSPGNKPAEVISL 1488
Cdd:PRK12467 2488 KEQLRAVPNKGLGFGVLRYLGSEAARQTLQAlpvprITFNYLGqfdgsFDAEKQALFVPSGEFSGAEQSEEAPLGNWLSI 2567
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1489 HGGITGGQLTLRQVGClNQRDSERLMTRLT----ENLRALTEACLTQLSHGVvfTPSDFPAVNLSQTQLDSLS-QRYDID 1563
Cdd:PRK12467 2568 NGQVYGGELNLGWTFS-QEMFDEATIQRLAdayaEELRALIEHCCSNDQRGV--TPSDFPLAGLSQEQLDRLPvAVGDIE 2644
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1564 TLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRyAHVLDVEGYRQAWQRQIQRFPALRAALESECA---SIQVIVKQADLP 1640
Cdd:PRK12467 2645 DIYPLSPMQQGMLFHTLYEGGAGDYINQMRVD-VEGLDVERFRTAWQAVIDRHEILRSGFLWDGEleePLQVVYKQARLP 2723
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1641 FYYQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQtlmq 1720
Cdd:PRK12467 2724 FSRLDWRDRADLEQALDALAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVLQRYF---- 2799
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1721 gqvlmhGDAPAIQVDRaYVDYARHAVAQQSAV-DAFWQQRQSLLAQTNDVSMLFAAA-----GKRADLSQHltqiepqvt 1794
Cdd:PRK12467 2800 ------GQPPPAREGR-YRDYIAWLQAQDAEAsEAFWKEQLAALEEPTRLARALYPApaeavAGHGAHYLH--------- 2863
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1795 svsLNEKDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSVGLYINSLPLALSWQQP 1874
Cdd:PRK12467 2864 ---LDATQTRQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAQLRGAEQQLGLFINTLPVIASPRAE 2940
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1875 VSLQQHLVQLQNELMAMNQHATQSL--IALTAGR--SRLFNSLFIYENYP-DAKAEQGQraddPHRLYPEFSAAYEKVEM 1949
Cdd:PRK12467 2941 QTVSDWLQQVQAQNLALREFEHTPLadIQRWAGQggEALFDSILVFENYPiSEALKQGA----PSGLRFGAVSSREQTNY 3016
|
2010 2020 2030
....*....|....*....|....*....|...
gi 499404635 1950 PLNLVVReqSGCML-LRFEFDADALDSAQARRV 1981
Cdd:PRK12467 3017 PLTLAVG--LGDTLeLEFSYDRQHFDAAAIERL 3047
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
56-2000 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 1045.70 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 56 AQQAFERPITPQNATSG---PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVvn 132
Cdd:PRK12316 2584 ESGQTSRAPVLQKVTRVqplPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHETLRTRFV-- 2661
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 133 eqGKGEQRIDAYQPfVIQHDDFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGW 212
Cdd:PRK12316 2662 --EVGEQTRQVILP-NMSLRIVLEDCAGVADAAIRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHHIVSDGW 2738
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 213 SVKNLFADFKPAFLACQNCQPYPVETTQLNYIDYAHWFNSDSFLDYHNEFKPFWVERLTGIPEVHSLPLDKPRPAHQNSG 292
Cdd:PRK12316 2739 SMQVMVDELVQAYAGARRGEQPTLPPLPLQYADYAAWQRAWMDSGEGARQLDYWRERLGGEQPVLELPLDRPRPALQSHR 2818
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 293 GEVIFSAINNDLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQ 372
Cdd:PRK12316 2819 GARLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRAETERLIGFFVNTQVLRAQVD 2898
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 373 DSQNFVDYLQYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVDFNDLIPGCDAAEETSPVLPAKTD 452
Cdd:PRK12316 2899 AQLAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNHQSGERAAAQLPGLHIESFAWDGAATQFD 2978
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 453 ISVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQpQL 532
Cdd:PRK12316 2979 LALDTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQLLEAWNATAAEYPL-ER 3057
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK12316 3058 GVHRLFEEQVERTPDAVALAFGEQ----RLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGLLAILKAGGA 3133
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDANLSVILGGDGQQLAQWSAEQRIDltdpavVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGS 692
Cdd:PRK12316 3134 YVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGVQVLD------LDRGDENYAEANPAIRTMPENLAYVIYTSGS 3207
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 693 TGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQA--EQAGATH 770
Cdd:PRK12316 3208 TGKPKGVGIRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDWRDPALlvELINSEG 3287
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 771 LILPTALMSIL-------DPEQVNGIQAIGMGGEACPNAVVENWADKVALYNMYGPTECTVTALSTRLRKGQPVT--IGK 841
Cdd:PRK12316 3288 VDVLHAYPSMLqafleeeDAHRCTSLKRIVCGGEALPADLQQQVFAGLPLYNLYGPTEATITVTHWQCVEEGKDAvpIGR 3367
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 842 PLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndvnnAGQGAATLRIYRTGDKARLLNNG 921
Cdd:PRK12316 3368 PIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFV---------PDPFVPGERLYRTGDLARYRADG 3438
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 922 DYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIvAQVGSRpaLVAYaTVKADSSTPEPAAVLIDVAKYLPEY 1001
Cdd:PRK12316 3439 VIEYIGRVDHQVKIRGFRIELGEIEARLLEH-PWVREAVVL-AVDGRQ--LVAY-VVPEDEAGDLREALKAHLKASLPEY 3513
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1002 MVPFRLMLLEDMPLTPNGKLDMKQLPPVLEANESDG--EADNPLEADVLAIWRSVLNTP-LGVEDDFFRLGGDSILSIQL 1078
Cdd:PRK12316 3514 MVPAHLLFLERMPLTPNGKLDRKALPRPDAALLQQDyvAPVNELERRLAAIWADVLKLEqVGLTDNFFELGGDSIISLQV 3593
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1079 TTRLRSAGYACTVKDVFEAKSVRRLCRVLaqnNRDTGTVAEQGTLEGEFALLPIQRWFMEQSLARPEHWNQAAMIQLPEV 1158
Cdd:PRK12316 3594 VSRARQAGIRFTPKDLFQHQTIQGLARVA---RVGGGVAVDQGPVSGETLLLPIQQQFFEEPVPERHHWNQSLLLKPREA 3670
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1159 -DTERLVTMLQALMAQHDALRLGCDAEGQRYLAD-VPCPALSTLDYRQLGDDG--LQQAFTALQSEFDPAQGRTMACALV 1234
Cdd:PRK12316 3671 lDAAALEAALQALVEHHDALRLRFVEDAGGWTAEhLPVELGGALLWRAELDDAeeLERLGEEAQRSLDLADGPLLRALLA 3750
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1235 RhHPQADTALFLAFHHLVIDAVSWRILVDDLERLY----LGEPL-LP-KTSSYRQWGAALQHYATQHA--EQLTYWQAQE 1306
Cdd:PRK12316 3751 T-LADGSQRLLLVIHHLVVDGVSWRILLEDLQQAYqqllQGEAPrLPaKTSSFKAWAERLQEHARGEAlkAELAYWQEQL 3829
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1307 DGVdlTALLAAKDPQG-----HASAAILTLDAKTTGQLVSEANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGR 1381
Cdd:PRK12316 3830 QGV--SSELPCDHPQGalqnrHAASVQTRLDRELTRRLLQQAPAAYRTQVNDLLLTALARVVCRWTGEASALVQLEGHGR 3907
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1382 EAIDPTLDVSRTVGWFTSTYPVCLQDKPDWASLIQSSKEQLRQVPDKGVGFNPLRYHHPQGNSLTLSP-----IVFNYLG 1456
Cdd:PRK12316 3908 EDLFADIDLSRTVGWFTSLFPVRLSPVEDLGASIKAIKEQLRAIPNKGIGFGLLRYLGDEESRRTLAGlpvprITFNYLG 3987
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1457 L----SVQAAGTWRPVDVAPGCCVSPGNKPAEVISLHGGITGGQLTLrQVGCLNQRDSERLMTRLTEN----LRALTEAC 1528
Cdd:PRK12316 3988 QfdgsFDEEMALFVPAGESAGAEQSPDAPLDNWLSLNGRVYGGELSL-DWTFSREMFEEATIQRLADDyaaeLTALVEHC 4066
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1529 LTQLSHGVvfTPSDFPAVNLSQTQLDSLS-QRYDIDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRyAHVLDVEGYRQ 1607
Cdd:PRK12316 4067 CDAERHGV--TPSDFPLAGLDQARLDALPlPLGEIEDIYPLSPMQQGMLFHSLYEQEAGDYINQMRVD-VQGLDVERFRA 4143
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1608 AWQRQIQRFPALRAALESECAS---IQVIVKQADLPFYYQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLG 1684
Cdd:PRK12316 4144 AWQAALDRHDVLRSGFVWQGELgrpLQVVHKQVSLPFAELDWRGRADLQAALDALAAAERERGFDLQRAPLLRLVLVRTA 4223
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1685 EQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQtlmqgqvlmhGDAPAIQVDRaYVDYARHAVAQQSAV-DAFWQQRQSLL 1763
Cdd:PRK12316 4224 EGRHHLIYTNHHILMDGWSNSQLLGEVLERYS----------GRPPAQPGGR-YRDYIAWLQRQDAAAsEAFWREQLAAL 4292
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1764 AQTNDVSMLFAAAGKR--ADLSQHLTQIEPQVTsvslnekdqATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVG 1841
Cdd:PRK12316 4293 DEPTRLAQAIARADLRsaNGYGEHVRELDATAT---------ARLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFG 4363
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1842 NVLSGRESPVEDVASSVGLYINSLPLALSWQQPVSLQQHLVQLQNELMAMNQHATQSLIALT----AGRSRLFNSLFIYE 1917
Cdd:PRK12316 4364 ATVAGRPAELPGIEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQNLALREHEHTPLYEIQrwagQGGEALFDSLLVFE 4443
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1918 NYPDAKAEQGQRADDphrLYPEFSAAYEKVEMPLNLVVrEQSGCMLLRFEFDADALDSAQARRVLMRWHDEVVALVnSVP 1997
Cdd:PRK12316 4444 NYPVSEALQQGAPGG---LRFGEVTNHEQTNYPLTLAV-GLGETLSLQFSYDRGHFDAATIERLARHLTNLLEAMA-EDP 4518
|
...
gi 499404635 1998 QQP 2000
Cdd:PRK12316 4519 QRR 4521
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
73-1920 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 966.17 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVvNEQGKGEQRIDAYQPFVIQHD 152
Cdd:PRK05691 1730 PLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFP-SVDGVPVQQVAEDSGLRMDWQ 1808
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVkNLFA----DFKPAFLAC 228
Cdd:PRK05691 1809 DFSALPADARQQRLQQLADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWAM-DIFArelgALYEAFLDD 1887
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 229 QncqPYPVETTQLNYIDYA----HWFNS---DSFLDYhnefkpfWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAIN 301
Cdd:PRK05691 1888 R---ESPLEPLPVQYLDYSvwqrQWLESgerQRQLDY-------WKAQLGNEHPLLELPADRPRPPVQSHRGELYRFDLS 1957
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 302 NDLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYL 381
Cdd:PRK05691 1958 PELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRIRPESEGLIGAFLNTQVLRCQLDGQMSVSELL 2037
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 382 QYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQ------------AKVDF--NDlipgcdaAEETspvl 447
Cdd:PRK05691 2038 EQVRQTVIEGQSHQDLPFDHLVEALQPPRSAAYNPLFQVMCNVQrwefqqsrqlagMTVEYlvND-------ARAT---- 2106
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 448 paKTDISVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSY 527
Cdd:PRK05691 2107 --KFDLNLEVTDLDGRLGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRLAELPLLAAAEQQQLLDSLAGEAGEA 2184
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 528 PQPQlTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIW 607
Cdd:PRK05691 2185 RLDQ-TLHGLFAAQAARTPQAPALTFAGQ----TLSYAELDARANRLARALRERGVGPQVRVGLALERSLEMVVGLLAIL 2259
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 608 KAGAAYVPLDPDYPPERLRHIITDANLSVILGGDG---------QQLAQWSAEQridltDPAVVEqwqDLPGDQPPAI-- 676
Cdd:PRK05691 2260 KAGGAYVPLDPEYPLERLHYMIEDSGIGLLLSDRAlfealgelpAGVARWCLED-----DAAALA---AYSDAPLPFLsl 2331
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 677 PRHaqqLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGtlafgepn 756
Cdd:PRK05691 2332 PQH---QAYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFDAASERLLVPLLCGA-------- 2400
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 757 dRAIMQAE-QAGATHL--ILPTALMSILDPEQVNGIQ------------AIGM---GGEACPNavvENWADKVA------ 812
Cdd:PRK05691 2401 -RVVLRAQgQWGAEEIcqLIREQQVSILGFTPSYGSQlaqwlagqgeqlPVRMcitGGEALTG---EHLQRIRQafapql 2476
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 813 LYNMYGPTECTVTALST----RLRKGQ-PVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASR 887
Cdd:PRK05691 2477 FFNAYGPTETVVMPLAClapeQLEEGAaSVPIGRVVGARVAYILDADLALVPQGATGELYVGGAGLAQGYHDRPGLTAER 2556
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 888 FehitLNDVNNAGQGaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVG 967
Cdd:PRK05691 2557 F----VADPFAADGG----RLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLE-HPAVREAVVLALDTP 2627
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 968 SRPALVAYATVKADSSTPEPAAVLIDVAK-----YLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP-PVLEANESDGEA-D 1040
Cdd:PRK05691 2628 SGKQLAGYLVSAVAGQDDEAQAALREALKahlkqQLPDYMVPAHLILLDSLPLTANGKLDRRALPaPDPELNRQAYQApR 2707
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1041 NPLEADVLAIWRSVLNTP-LGVEDDFFRLGGDSILSIQLTTRLRSAGYACTVKDVFEAKSVRRLCRVLaqnNRDTGTVAE 1119
Cdd:PRK05691 2708 SELEQQLAQIWREVLNVErVGLGDNFFELGGDSILSIQVVSRARQLGIHFSPRDLFQHQTVQTLAAVA---THSEAAQAE 2784
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1120 QGTLEGEFALLPIQRWFMEQSLARPEHWNQAAMIQ-LPEVDTERLVTMLQALMAQHDALRLGCDAEGQRYLADvpcpals 1198
Cdd:PRK05691 2785 QGPLQGASGLTPIQHWFFDSPVPQPQHWNQALLLEpRQALDPALLEQALQALVEHHDALRLRFSQADGRWQAE------- 2857
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1199 tldYRQLGDDGL------------QQAFTALQSEFDPAQGRTMACALVRHhPQADTALFLAFHHLVIDAVSWRILVDDLE 1266
Cdd:PRK05691 2858 ---YRAVTAQELlwqvtvadfaecAALFADAQRSLDLQQGPLLRALLVDG-PQGQQRLLLAIHHLVVDGVSWRVLLEDLQ 2933
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1267 RLY------LGEPLLPKTSSYRQWGAALQHYATQHA--EQLTYWQAQEDGVDltALLAAKDPQG-----HASAAILTLDA 1333
Cdd:PRK05691 2934 ALYrqlsagAEPALPAKTSAFRDWAARLQAYAGSESlrEELGWWQAQLGGPR--AELPCDRPQGgnlnrHAQTVSVRLDA 3011
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1334 KTTGQLVSEANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREAIDPTLDVSRTVGWFTSTYPVCLQ----DKP 1409
Cdd:PRK05691 3012 ERTRQLLQQAPAAYRTQVNDLLLTALARVLCRWSGQPSVLVQLEGHGREALFDDIDLTRSVGWFTSAYPLRLTpapgDDA 3091
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1410 DWASLIQSSKEQLRQVPDKGVGFNPLRY-----HHPQGNSLTLSPIVFNYLG---LSVQAAGTWRPVDVAPGCCVSPGNK 1481
Cdd:PRK05691 3092 ARGESIKAIKEQLRAVPHKGLGYGVLRYladaaVREAMAALPQAPITFNYLGqfdQSFASDALFRPLDEPAGPAHDPDAP 3171
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1482 PAEVISLHGGITGGQLTLRQVGCLNQRDS---ERLMTRLTENLRALTEACLTQLSHGvvFTPSDFPAVNLSQTQLDSLS- 1557
Cdd:PRK05691 3172 LPNELSVDGQVYGGELVLRWTYSAERYDEqtiAELAEAYLAELQALIAHCLADGAGG--LTPSDFPLAQLTQAQLDALPv 3249
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1558 QRYDIDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL--ESECASIQVIVK 1635
Cdd:PRK05691 3250 PAAEIEDVYPLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFswNAGETMLQVIHK 3329
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1636 QADLPFYYQDL--MQDADPLAVIERYRQQDLRTGFD-LSQPPL-LRIacFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAV 1711
Cdd:PRK05691 3330 PGRTPIDYLDWrgLPEDGQEQRLQALHKQEREAGFDlLNQPPFhLRL--IRVDEARYWFMMSNHHILIDAWCRSLLMNDF 3407
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1712 HRDYQTLMQGQVLMHGDAPaiqvdrAYVDYARhavaqqsavdafWQQRQSLLA-----QTN--DVSMLFAAAGKRADLSQ 1784
Cdd:PRK05691 3408 FEIYTALGEGREAQLPVPP------RYRDYIG------------WLQRQDLAQarqwwQDNlrGFERPTPIPSDRPFLRE 3469
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1785 HLTQIEPQVTS---VSLNEKDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSVGLY 1861
Cdd:PRK05691 3470 HAGDSGGMVVGdcyTRLDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPVSMPQMQRTVGLF 3549
|
1930 1940 1950 1960 1970 1980
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 1862 INSLPLALSW---QQPVSLQQHLVQLQNELMAMNQHATQSLIA------LTAGRSrLFNSLFIYENYP 1920
Cdd:PRK05691 3550 INSIALRVQLpaaGQRCSVRQWLQGLLDSNMELREYEYLPLVAiqecseLPKGQP-LFDSLFVFENAP 3616
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
55-1333 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 806.77 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 55 TAQQAFERPITPQNATSGPLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVnEQ 134
Cdd:COG1020 1 AAAAAAAALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRT-RA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 135 GKGEQRIDAYQPFVIQHDDFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSV 214
Cdd:COG1020 80 GRPVQVIQPVVAAPLPVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSD 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 215 KNLFADFKPAFLACQNCQPYPVETTQLNYIDYAHWFNSDSFLDYHNEFKPFWVERLTGIPEVHSLPLDKPRPAHQNSGGE 294
Cdd:COG1020 160 GLLLAELLRLYLAAYAGAPLPLPPLPIQYADYALWQREWLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPAVQSYRGA 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 295 VIFSAINNDLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDS 374
Cdd:COG1020 240 RVSFRLPAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSGD 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 375 QNFVDYLQYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQaKVDFNDL-IPGCDAAEETSPVLPAKTDI 453
Cdd:COG1020 320 PSFAELLARVRETLLAAYAHQDLPFERLVEELQPERDLSRNPLFQVMFVLQ-NAPADELeLPGLTLEPLELDSGTAKFDL 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 454 SVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQPQlT 533
Cdd:COG1020 399 TLTVVETGDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAEWNATAAPYPADA-T 477
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 534 VTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAY 613
Cdd:COG1020 478 LHELFEAQAARTPDAVAVVFGDQ----SLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAY 553
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 614 VPLDPDYPPERLRHIITDANLSVILGGDG--QQLAQWSAeQRIDLTDPAVVEQwqdlpGDQPPAIPRHAQQLAQVIYTSG 691
Cdd:COG1020 554 VPLDPAYPAERLAYMLEDAGARLVLTQSAlaARLPELGV-PVLALDALALAAE-----PATNPPVPVTPDDLAYVIYTSG 627
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 692 STGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQA-----EQA 766
Cdd:COG1020 628 STGRPKGVMVEHRALVNLLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAAlaellARH 707
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 767 GATHLILPTALMSIL---DPEQVNGIQAIGMGGEACPNAVVENWADK---VALYNMYGPTECTVTALSTRLRKGQ----P 836
Cdd:COG1020 708 RVTVLNLTPSLLRALldaAPEALPSLRLVLVGGEALPPELVRRWRARlpgARLVNLYGPTETTVDSTYYEVTPPDadggS 787
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 837 VTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehITlNDVNNAGQgaatlRIYRTGDKAR 916
Cdd:COG1020 788 VPIGRPIANTRVYVLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERF--VA-DPFGFPGA-----RLYRTGDLAR 859
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 917 LLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIDVAK 996
Cdd:COG1020 860 WLPDGNLEFLGRADDQVKIRGFRIELGEIEAALLQ-HPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAALLRLALAL 938
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 997 YLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEANESDGEADNPLEADVLA--IWRSVLNTPLGVEDDFFRLGGDSIL 1074
Cdd:COG1020 939 LLPPYMVPAAVVLLLPLPLTGNGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAalALLLLLVVVVGDDDFFFFGGGLGLL 1018
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1075 SIQLTTRLRSAGYACTVKDVF-------EAKSVRRLCRVLAQNNRDTGTVAEQGTLEGEFALLPIQRWFMEQSLARPEHW 1147
Cdd:COG1020 1019 LLLALARAARLLLLLLLLLLLflaaaaaAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLAL 1098
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1148 NQAAMIQLPEVDTERLVTMLQALMAQHDALRLGCDAEGQRYLADVPCPALSTLDYRQLGDDGLQQAFTALQSEFDPAQGR 1227
Cdd:COG1020 1099 LLLLLLLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLLLLA 1178
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1228 TMACALVRHHPQADTALFLAFHHLVIDAVSWRILVDDLERLYLGEPLLPKTSSYRQWGAALQHYATQHAEQLTYWQAQED 1307
Cdd:COG1020 1179 LLLLALLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLAAAAAALLALALLLALLALAALLALAALAALAAA 1258
|
1290 1300
....*....|....*....|....*.
gi 499404635 1308 GVDLTALLAAKDPQGHASAAILTLDA 1333
Cdd:COG1020 1259 LLALALALLALALLLLALALLLPALA 1284
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
73-1305 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 715.78 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKgEQRIDAYQPFVIQHD 152
Cdd:PRK12467 51 PLSYAQERQWFLWQLDPDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQDEEGF-RQVIDASLSLTIPLD 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLA-CQNC 231
Cdd:PRK12467 130 DLANEQGRARESQIEAYINEEVARPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAySQGR 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 232 QPyPVETTQLNYIDYAHWfnSDSFLDYHNEFKP--FWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFK 309
Cdd:PRK12467 210 EP-SLPALPIQYADYAIW--QRSWLEAGERERQlaYWQEQLGGEHTVLELPTDRPRPAVPSYRGARLRVDLPQALSAGLK 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 310 RLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDL 389
Cdd:PRK12467 287 ALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNRVETERLIGFFVNTQVLKAEVDPQASFLELLQQVKRTAL 366
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 390 SAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQ--AKVDFNDL---IPGCDAAEETSPVLPAKTDISVKVTELMGEV 464
Cdd:PRK12467 367 GAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQntATGGRDREgaqLPGLTVEELSWARHTAQFDLALDTYESAQGL 446
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 465 RLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQPqlTVTDVIEAVAQR 544
Cdd:PRK12467 447 WAAFTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERARELVRWNAPATEYAPD--CVHQLIEAQARQ 524
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 545 DPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPER 624
Cdd:PRK12467 525 HPERPALVFGEQ----VLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQDR 600
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 625 LRHIITDANLSVILgGDGQQLAQW---SAEQRIDLTDPAvvEQWQDLPGDQPPaIPRHAQQLAQVIYTSGSTGLPKGVMI 701
Cdd:PRK12467 601 LAYMLDDSGVRLLL-TQSHLLAQLpvpAGLRSLCLDEPA--DLLCGYSGHNPE-VALDPDNLAYVIYTSGSTGQPKGVAI 676
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 702 EHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDR-------AIMQAEQAGATHlILP 774
Cdd:PRK12467 677 SHGALANYVCVIAERLQLAADDSMLMVSTFAFDLGVTELFGALASGATLHLLPPDCArdaeafaALMADQGVTVLK-IVP 755
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 775 TALMSILD---PEQVNGIQAIGMGGEACPNAVVENW---ADKVALYNMYGPTECTVTALSTRLRK----GQPVTIGKPLI 844
Cdd:PRK12467 756 SHLQALLQasrVALPRPQRALVCGGEALQVDLLARVralGPGARLINHYGPTETTVGVSTYELSDeerdFGNVPIGQPLA 835
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 845 HIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDvnnaGQGAATLRIYRTGDKARLLNNGDYE 924
Cdd:PRK12467 836 NLGLYILDHYLNPVPVGVVGELYIGGAGLARGYHRRPALTAERF----VPD----PFGADGGRLYRTGDLARYRADGVIE 907
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 925 YCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQiKVIVAQVGSRPA-LVAYATVKADSSTPEPAAVLIDVAKY----LP 999
Cdd:PRK12467 908 YLGRMDHQVKIRGFRIELGEIEARLLAQ-PGVRE-AVVLAQPGDAGLqLVAYLVPAAVADGAEHQATRDELKAQlrqvLP 985
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1000 EYMVPFRLMLLEDMPLTPNGKLDMKQLP-PVLEANESDGEA-DNPLEADVLAIWRSVLNT-PLGVEDDFFRLGGDSILSI 1076
Cdd:PRK12467 986 DYMVPAHLLLLDSLPLTPNGKLDRKALPkPDASAVQATFVApQTELEKRLAAIWADVLKVeRVGLTDNFFELGGHSLLAT 1065
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1077 QLTTRLRSA-GYACTVKDVFEAKSVRRLCRVLAQNNRDTGTVAEQGTLEGEFALLPIQ--RWFMEQSLARPEHWNQAAMI 1153
Cdd:PRK12467 1066 QVISRVRQRlGIQVPLRTLFEHQTLAGFAQAVAAQQQGAQPALPDVDRDQPLPLSYAQerQWFLWQLEPGSAAYHIPQAL 1145
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1154 QLP-EVDTERLVTMLQALMAQHDALRLGCDAEGQRYLaDVPCPALS-TLDYR--QLGDDGLQQAFTALQSE----FDPAQ 1225
Cdd:PRK12467 1146 RLKgPLDIEALERSFDALVARHESLRTTFVQEDGRTR-QVIHPVGSlTLEEPllLAADKDEAQLKVYVEAEarqpFDLEQ 1224
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1226 GRTMACALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERLYLGE--------PLLP-KTSSY----RQWGAalqhyA 1292
Cdd:PRK12467 1225 GPLLRVGLLRLAAD-EHVLVLTLHHIVSDGWSMQVLVDELVALYAAYsqgqslqlPALPiQYADYavwqRQWMD-----A 1298
|
1290
....*....|...
gi 499404635 1293 TQHAEQLTYWQAQ 1305
Cdd:PRK12467 1299 GERARQLAYWKAQ 1311
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
12-1305 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 668.80 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 12 ERQGVRLALNaqgQLISQSNKEAITAEIGRTIKEN---KDAIVRcLTAQQAFerpitpqnatsgPLSSSQSGLWFIEQYE 88
Cdd:PRK05691 629 DELGIDLNLR---QLFEAPTLAAFSAAVARQLAGGgaaQAAIAR-LPRGQAL------------PQSLAQNRLWLLWQLD 692
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 89 EQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVvNEQGKGEQRIDAYQPFVIQHDDFSLLPEAEREGRLQQ 168
Cdd:PRK05691 693 PQSAAYNIPGGLHLRGELDEAALRASFQRLVERHESLRTRFY-ERDGVALQRIDAQGEFALQRIDLSDLPEAEREARAAQ 771
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 169 QVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQPYPVETTQLNYIDYAH 248
Cdd:PRK05691 772 IREEEARQPFDLEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAACQGQTAELAPLPLGYADYGA 851
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 249 W-------FNSDSFLDYhnefkpfWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKRLCQRYNTSNFI 321
Cdd:PRK05691 852 WqrqwlaqGEAARQLAY-------WKAQLGDEQPVLELATDHPRSARQAHSAARYSLRVDASLSEALRGLAQAHQATLFM 924
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 322 GLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLSAFDHQLYRFEA 401
Cdd:PRK05691 925 VLLAAFQALLHRYSGQGDIRIGVPNANRPRLETQGLVGFFINTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQ 1004
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 402 LSEAIGSDRTTAinpIFQVMLVYQAKvDFNDL--IPGCdAAEEtspvLP-----AKTDISVKVTE-LMGEVRLDWLFATA 473
Cdd:PRK05691 1005 LVEALPQAREQG---LFQVMFNHQQR-DLSALrrLPGL-LAEE----LPwhsreAKFDLQLHSEEdRNGRLTLSFDYAAE 1075
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 474 LFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRfAAVLAETQQLPrsYPQPQLTVTDVIEAVAQRDPQQLAIAF 553
Cdd:PRK05691 1076 LFDAATIERLAEHFLALLEQVCEDPQRALGDVQLLDAAE-RAQLAQWGQAP--CAPAQAWLPELLNEQARQTPERIALVW 1152
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 554 DGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDAN 633
Cdd:PRK05691 1153 DGG----SLDYAELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSG 1228
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 634 LSVILGGDG--QQLAQWSAEQRIDLtDPAVVEQWQdlpgDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLD 711
Cdd:PRK05691 1229 VELLLTQSHllERLPQAEGVSAIAL-DSLHLDSWP----SQAPGLHLHGDNLAYVIYTSGSTGQPKGVGNTHAALAERLQ 1303
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 712 DHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDR-------AIMQAEQAGATHLILPTALMSILDP- 783
Cdd:PRK05691 1304 WMQATYALDDSDVLMQKAPISFDVSVWECFWPLITGCRLVLAGPGEHrdpqriaELVQQYGVTTLHFVPPLLQLFIDEPl 1383
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 784 -EQVNGIQAIGMGGEACPNAV---VENWADKVALYNMYGPTEC--TVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQL 857
Cdd:PRK05691 1384 aAACTSLRRLFSGGEALPAELrnrVLQRLPQVQLHNRYGPTETaiNVTHWQCQAEDGERSPIGRPLGNVLCRVLDAELNL 1463
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 858 CPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNDvnnagQGAatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRG 937
Cdd:PRK05691 1464 LPPGVAGELCIGGAGLARGYLGRPALTAERFVPDPLGE-----DGA---RLYRTGDRARWNADGALEYLGRLDQQVKLRG 1535
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 938 YRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVKAdSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTP 1017
Cdd:PRK05691 1536 FRVEPEEIQARLLAQ-PGVAQAAVLVREGAAGAQLVGYYTGEA-GQEAEAERLKAALAAELPEYMVPAQLIRLDQMPLGP 1613
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1018 NGKLDMKQLP-PVLEANESDgEADNPLEADVLAIWRSVLNTP-LGVEDDFFRLGGDSILSIQLTTRLRSagyACTV---- 1091
Cdd:PRK05691 1614 SGKLDRRALPePVWQQREHV-EPRTELQQQIAAIWREVLGLPrVGLRDDFFALGGHSLLATQIVSRTRQ---ACDVelpl 1689
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1092 KDVFEAKSVRRLCRVLAQnNRDTGTVAEQGTLEGEFALLPI------QR-WFMEQSLARPEHWNQAAMIQLPEV-DTERL 1163
Cdd:PRK05691 1690 RALFEASELGAFAEQVAR-IQAAGERNSQGAIARVDRSQPVplsysqQRmWFLWQMEPDSPAYNVGGMARLSGVlDVDRF 1768
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1164 VTMLQALMAQHDALRL---GCDAEGQRYLADVPCPALSTLDYRQLGDDGLQQAFTALQSE-----FDPAQGRTMACALVR 1235
Cdd:PRK05691 1769 EAALQALILRHETLRTtfpSVDGVPVQQVAEDSGLRMDWQDFSALPADARQQRLQQLADSeahqpFDLERGPLLRACLVK 1848
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1236 HHPQaDTALFLAFHHLVIDAVSWRILVDDLERLY------LGEPLLPKTSSY-------RQWgaaLQhyATQHAEQLTYW 1302
Cdd:PRK05691 1849 AAER-EHYFVLTLHHIVTEGWAMDIFARELGALYeaflddRESPLEPLPVQYldysvwqRQW---LE--SGERQRQLDYW 1922
|
...
gi 499404635 1303 QAQ 1305
Cdd:PRK05691 1923 KAQ 1925
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
54-1421 |
2.33e-162 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 559.19 E-value: 2.33e-162
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 54 LTAQQAFERPI-TPQNATSGPLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGpLDVAALEFAFDALAQRHASLRTRFVvn 132
Cdd:PRK12316 1538 LSQAQLDALPLpAGEIADIYPLSPMQQGMLFHSLYEQEAGDYINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSGFL-- 1614
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 133 EQGkgeqriDAYQPFVIQHDDFSLlPEAEREGR--------LQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQ 204
Cdd:PRK12316 1615 WQD------GLEQPLQVIHKQVEL-PFAELDWRgredlgqaLDALAQAERQKGFDLTRAPLLRLVLVRTGEGRHHLIYTN 1687
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 205 HHIISDGWSVKNLFADFKPAFLAcqncqpYPVETTQLNYIDYAHWFNSDSFLDYHNefkpFWVERLTGIPEVHSLPLDKP 284
Cdd:PRK12316 1688 HHILMDGWSNAQLLGEVLQRYAG------QPVAAPGGRYRDYIAWLQRQDAAASEA----FWKEQLAALEEPTRLAQAAR 1757
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 285 RPAHQNSGGE--VIFSAINNDLWDKFKRlcQRYNTSNFIgLHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGF 360
Cdd:PRK12316 1758 TEDGQVGYGDhqQLLDPAQTRALAEFAR--AQKVTLNTL-VQAAWLLLLQRYTGQETVAFGATVAGRpaELPGIEQQIGL 1834
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 361 FVNTIVLRTQLQDSQNFVDYLQYCREQDLSAFDHQ---LYRFEALSEAIGSdrttainPIFQVMLVYQAKVDFNDLIPGC 437
Cdd:PRK12316 1835 FINTLPVIAAPRPDQSVADWLQEVQALNLALREHEhtpLYDIQRWAGQGGE-------ALFDSLLVFENYPVAEALKQGA 1907
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 438 DAAEETSPVLP-AKTDISVKVTELMGE-VRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAA 515
Cdd:PRK12316 1908 PAGLVFGRVSNhEQTNYPLTLAVTLGEtLSLQYSYDRGHFDAAAIERLDRHLLHLLEQMAEDAQAALGELALLDAGERQR 1987
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 516 VLAETQQLPRSYPQpQLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKR 595
Cdd:PRK12316 1988 ILADWDRTPEAYPR-GPGVHQRIAEQAARAPEAIAVVFGDQ----HLSYAELDSRANRLAHRLRARGVGPEVRVAIAAER 2062
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 596 DRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGDG--QQLAQWSAEQRIDLTDPAvveQWQDLPgDQP 673
Cdd:PRK12316 2063 SFELVVALLAVLKAGGAYVPLDPNYPAERLAYMLEDSGAALLLTQRHllERLPLPAGVARLPLDRDA---EWADYP-DTA 2138
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 674 PAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFG 753
Cdd:PRK12316 2139 PAVQLAGENLAYVIYTSGSTGLPKGVAVSHGALVAHCQAAGERYELSPADCELQFMSFSFDGAHEQWFHPLLNGARVLIR 2218
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 754 EPN----DRAIMQAEQAGATHLILPTA-LMSILDPEQVNG----IQAIGMGGEACPNAVVENWA---DKVALYNMYGPTE 821
Cdd:PRK12316 2219 DDElwdpEQLYDEMERHGVTILDFPPVyLQQLAEHAERDGrppaVRVYCFGGEAVPAASLRLAWealRPVYLFNGYGPTE 2298
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 822 CTVTALSTRLRKGQP-----VTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDV 896
Cdd:PRK12316 2299 AVVTPLLWKCRPQDPcgaayVPIGRALGNRRAYILDADLNLLAPGMAGELYLGGEGLARGYLNRPGLTAERF----VPDP 2374
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 897 NNAGQGaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQiKVIVAQVG-SRPALVAY 975
Cdd:PRK12316 2375 FSASGE----RLYRTGDLARYRADGVVEYLGRIDHQVKIRGFRIELGEIEARLQAH-PAVRE-AVVVAQDGaSGKQLVAY 2448
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 976 aTVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP-PVLEANESDGEA-DNPLEADVLAIWRS 1053
Cdd:PRK12316 2449 -VVPDDAAEDLLAELRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPkPDVSQLRQAYVApQEGLEQRLAAIWQA 2527
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1054 VLNTP-LGVEDDFFRLGGDSILSIQLTTRLR-SAGYACTVKDVFEAKSVRRLCRVLAQNNRDTGTVAEQGTLEGEFALLP 1131
Cdd:PRK12316 2528 VLKVEqVGLDDHFFELGGHSLLATQVVSRVRqDLGLEVPLRILFERPTLAAFAASLESGQTSRAPVLQKVTRVQPLPLSH 2607
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1132 IQR--WFMEQSLARPEHWNQAAMIQLPE-VDTERLVTMLQALMAQHDALRLGCDAEGQRYLADVPcPALSTLDYRQLGDD 1208
Cdd:PRK12316 2608 AQQrqWFLWQLEPESAAYHLPSALHLRGvLDQAALEQAFDALVLRHETLRTRFVEVGEQTRQVIL-PNMSLRIVLEDCAG 2686
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1209 GLQQAFTA-----LQSEFDPAQGRTMACALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERLYLGE------PLLPK 1277
Cdd:PRK12316 2687 VADAAIRQrvaeeIQRPFDLARGPLLRVRLLALDGQ-EHVLVITQHHIVSDGWSMQVMVDELVQAYAGArrgeqpTLPPL 2765
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1278 TSSYRQWGAALQHY--ATQHAEQLTYWQAQEDGVDLTALLAAKDP----QGHASAAILT-LDAKTTGQLVSEANRAFNTd 1350
Cdd:PRK12316 2766 PLQYADYAAWQRAWmdSGEGARQLDYWRERLGGEQPVLELPLDRPrpalQSHRGARLDVaLDVALSRELLALARREGVT- 2844
|
1370 1380 1390 1400 1410 1420 1430
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 499404635 1351 VSDLLLSALTRTLNDLGWGDKARIMLEGHGREaidpTLDVSRTVGWFTSTYPVCLQDKPDWA--SLIQSSKEQ 1421
Cdd:PRK12316 2845 LFMLLLASFQVLLHRYSGQSDIRVGVPIANRN----RAETERLIGFFVNTQVLRAQVDAQLAfrDLLGQVKEQ 2913
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
546-1026 |
7.83e-150 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 471.63 E-value: 7.83e-150
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd05930 1 PDAVAVVDGDQ----SLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILggdgqqlaqwsaeqridlTDPavveqwqdlpgdqppaiprhaQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:cd05930 77 AYILEDSGAKLVL------------------TDP---------------------DDLAYVIYTSGSTGKPKGVMVEHRG 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQA-----EQAGATHLILPTALMSI 780
Cdd:cd05930 118 LVNLLLWMQEAYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEAladllAEEGITVLHLTPSLLRL 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 781 L----DPEQVNGIQAIGMGGEACPNAVVENWAD---KVALYNMYGPTECTVTALSTRLRKG----QPVTIGKPLIHIQAL 849
Cdd:cd05930 198 LlqelELAALPSLRLVLVGGEALPPDLVRRWREllpGARLVNLYGPTEATVDATYYRVPPDdeedGRVPIGRPIPNTRVY 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 850 ILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDVNNAGQgaatlRIYRTGDKARLLNNGDYEYCGRI 929
Cdd:cd05930 278 VLDENLRPVPPGVPGELYIGGAGLARGYLNRPELTAERF----VPNPFGPGE-----RMYRTGDLVRWLPDGNLEFLGRI 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 930 DEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVGS-RPALVAYATVKADsSTPEPAAVLIDVAKYLPEYMVPFRLM 1008
Cdd:cd05930 349 DDQVKIRGYRIELGEIEAALLA-HPGVREAAVVAREDGDgEKRLVAYVVPDEG-GELDEEELRAHLAERLPDYMVPSAFV 426
|
490
....*....|....*...
gi 499404635 1009 LLEDMPLTPNGKLDMKQL 1026
Cdd:cd05930 427 VLDALPLTPNGKVDRKAL 444
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
73-1108 |
3.85e-149 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 518.36 E-value: 3.85e-149
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGpLDVAALEFAFDALAQRHASLRTRFVvnEQGKGEQridayqPFVIQHD 152
Cdd:PRK12316 4104 PLSPMQQGMLFHSLYEQEAGDYINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFV--WQGELGR------PLQVVHK 4174
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLlPEAEREGRLQQQVKA--------EISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPA 224
Cdd:PRK12316 4175 QVSL-PFAELDWRGRADLQAaldalaaaERERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLER 4253
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 225 FLACQNCQPypvettQLNYIDYAHWFNSDSfldyHNEFKPFWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFS-AINND 303
Cdd:PRK12316 4254 YSGRPPAQP------GGRYRDYIAWLQRQD----AAASEAFWREQLAALDEPTRLAQAIARADLRSANGYGEHVrELDAT 4323
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 304 LWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYL 381
Cdd:PRK12316 4324 ATARLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRpaELPGIEGQIGLFINTLPVIATPRAQQSVVEWL 4403
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 382 QYCREQDLSAFDHQLYRFEALSEAIGSdrttAINPIFQVMLVYQAKVDFNDLIPGCDAAEETSPVLP-AKTDISVKVTEL 460
Cdd:PRK12316 4404 QQVQRQNLALREHEHTPLYEIQRWAGQ----GGEALFDSLLVFENYPVSEALQQGAPGGLRFGEVTNhEQTNYPLTLAVG 4479
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 461 MGE-VRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQpQLTVTDVIE 539
Cdd:PRK12316 4480 LGEtLSLQFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVALWNRTDAGYPA-TRCVHQLVA 4558
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 540 AVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPD 619
Cdd:PRK12316 4559 ERARMTPDAVAVVFDEE----KLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPE 4634
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 620 YPPERLRHIITDANLSVILgGDGQQLAQWSAEQRIDLTDPAVVEQWQDLPgDQPPAIPRHAQQLAQVIYTSGSTGLPKGV 699
Cdd:PRK12316 4635 YPRERLAYMMEDSGAALLL-TQSHLLQRLPIPDGLASLALDRDEDWEGFP-AHDPAVRLHPDNLAYVIYTSGSTGRPKGV 4712
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 700 MIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPN----DRAIMQAEQAGATHLILPT 775
Cdd:PRK12316 4713 AVSHGSLVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGASVVIRDDSlwdpERLYAEIHEHRVTVLVFPP 4792
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 776 ALMSIL---DPEQVN--GIQAIGMGGEACPNAVVENW---ADKVALYNMYGPTECTVTALSTRLRKGQP-----VTIGKP 842
Cdd:PRK12316 4793 VYLQQLaehAERDGEppSLRVYCFGGEAVAQASYDLAwraLKPVYLFNGYGPTETTVTVLLWKARDGDAcgaayMPIGTP 4872
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 843 LIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehiTLNDVNNAGQgaatlRIYRTGDKARLLNNGD 922
Cdd:PRK12316 4873 LGNRSGYVLDGQLNPLPVGVAGELYLGGEGVARGYLERPALTAERF---VPDPFGAPGG-----RLYRTGDLARYRADGV 4944
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 923 YEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQiKVIVAQVGSRPA-LVAYaTVKADS---STPEPAAVLIDVAK-- 996
Cdd:PRK12316 4945 IDYLGRVDHQVKIRGFRIELGEIEARLREH-PAVRE-AVVIAQEGAVGKqLVGY-VVPQDPalaDADEAQAELRDELKaa 5021
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 997 ---YLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPP--------VLEANESDgeadnpLEADVLAIWRSVLNTP-LGVEDD 1064
Cdd:PRK12316 5022 lreRLPEYMVPAHLVFLARMPLTPNGKLDRKALPQpdasllqqAYVAPRSE------LEQQVAAIWAEVLQLErVGLDDN 5095
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*
gi 499404635 1065 FFRLGGDSILSIQLTTRLRSA-GYACTVKDVFEAKSVRRLCRVLA 1108
Cdd:PRK12316 5096 FFELGGHSLLAIQVTSRIQLElGLELPLRELFQTPTLAAFVELAA 5140
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
69-1108 |
4.54e-136 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 461.05 E-value: 4.54e-136
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 69 ATSGPLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKgEQRIDAYQPF- 147
Cdd:PRK10252 5 SQHLPLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGEV-WQWVDPALTFp 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 148 VIQHDDFSLLPEAEREGRLQQQvkAEISRPFDLTAGD-LTRVRLVKMSERTHVLMITQHHIISDGWSVkNLFADFKPA-F 225
Cdd:PRK10252 84 LPEIIDLRTQPDPHAAAQALMQ--ADLQQDLRVDSGKpLVFHQLIQLGDNRWYWYQRYHHLLVDGFSF-PAITRRIAAiY 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 226 LACQNCQPYPVET-TQLNYI--DYAHWFNSDSF-LDyhnefKPFWVERLTGIPEVHSLpldKPRPAHQNSGGEVIFSAIN 301
Cdd:PRK10252 161 CAWLRGEPTPASPfTPFADVveEYQRYRASEAWqRD-----AAFWAEQRRQLPPPASL---SPAPLPGRSASADILRLKL 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 302 NDLWDKFKRL------CQRYNTsnfigLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQ 375
Cdd:PRK10252 233 EFTDGAFRQLaaqasgVQRPDL-----ALALVALWLGRLCGRMDYAAGFIFMRRLGSAALTATGPVLNVLPLRVHIAAQE 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 376 NFVDYLQYCREQDLSAFDHQLYRFEAL---SEAIGSDRTTaINPIFQVMlVYQAKVDFndliPGCDAAEE---TSPVlpa 449
Cdd:PRK10252 308 TLPELATRLAAQLKKMRRHQRYDAEQIvrdSGRAAGDEPL-FGPVLNIK-VFDYQLDF----PGVQAQTHtlaTGPV--- 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 450 kTDISVKV-TELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDrfaavlaETQQLPR--- 525
Cdd:PRK10252 379 -NDLELALfPDEHGGLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVDILLPG-------EYAQLAQvna 450
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 526 -SYPQPQLTVTDVIEAVAQRDPQQLAIAFDGeprtDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALL 604
Cdd:PRK10252 451 tAVEIPETTLSALVAQQAAKTPDAPALADAR----YQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALH 526
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 605 AIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGDGQQlAQWSAeqrIDLTDPAVVEQWQdLPGDQPPAIPRHAQQLA 684
Cdd:PRK10252 527 AIVEAGAAWLPLDTGYPDDRLKMMLEDARPSLLITTADQL-PRFAD---VPDLTSLCYNAPL-APQGAAPLQLSQPHHTA 601
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 685 QVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPN---DRAIM 761
Cdd:PRK10252 602 YIIFTSGSTGRPKGVMVGQTAIVNRLLWMQNHYPLTADDVVLQKTPCSFDVSVWEFFWPFIAGAKLVMAEPEahrDPLAM 681
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 762 QA----EQAGATHLIlPT---ALMSILDPEQVNGIQA----IGMGGEACPNAVVENW--ADKVALYNMYGPTECTV---- 824
Cdd:PRK10252 682 QQffaeYGVTTTHFV-PSmlaAFVASLTPEGARQSCAslrqVFCSGEALPADLCREWqqLTGAPLHNLYGPTEAAVdvsw 760
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 825 ---TALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndVNNAGQ 901
Cdd:PRK10252 761 ypaFGEELAAVRGSSVPIGYPVWNTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFI------ADPFAP 834
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 902 GAatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIkVIVAQV--------GSRPALV 973
Cdd:PRK10252 835 GE---RMYRTGDVARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQAL-PDVEQA-VTHACVinqaaatgGDARQLV 909
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 974 AYaTVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP-PVLEANESDGEADNPLEADVLAIWR 1052
Cdd:PRK10252 910 GY-LVSQSGLPLDTSALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKALPlPELKAQVPGRAPKTGTETIIAAAFS 988
|
1050 1060 1070 1080 1090
....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 1053 SVLN-TPLGVEDDFFRLGGDSILSIQLTTRLRSA-GYACTVKDVFEAKSVRRLCRVLA 1108
Cdd:PRK10252 989 SLLGcDVVDADADFFALGGHSLLAMKLAAQLSRQfARQVTPGQVMVASTVAKLATLLD 1046
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
73-1103 |
9.29e-132 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 463.48 E-value: 9.29e-132
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGpLDVAALEFAFDALAQRHASLRTRFV-VNEQGKGEQRIDAYQPFVIQH 151
Cdd:PRK12467 2648 PLSPMQQGMLFHTLYEGGAGDYINQMRVDVEG-LDVERFRTAWQAVIDRHEILRSGFLwDGELEEPLQVVYKQARLPFSR 2726
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 152 DDFSLLPEAEREgrLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADfkpaflACQNC 231
Cdd:PRK12467 2727 LDWRDRADLEQA--LDALAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGE------VLQRY 2798
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 232 QPYPVETTQLNYIDYAHWFNSDSfldyHNEFKPFWVERLTGIPEVHSL-PLDKPRPAHQNSGGEVIFSAINNDLWDKFKR 310
Cdd:PRK12467 2799 FGQPPPAREGRYRDYIAWLQAQD----AEASEAFWKEQLAALEEPTRLaRALYPAPAEAVAGHGAHYLHLDATQTRQLIE 2874
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 311 LCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQD 388
Cdd:PRK12467 2875 FARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRpaQLRGAEQQLGLFINTLPVIASPRAEQTVSDWLQQVQAQN 2954
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 389 LSAFDHQ---LYRFEALSEAIGSdrttainPIFQVMLVYQAkvdfndlIPGCDAAEETSP------------VLPAKTDI 453
Cdd:PRK12467 2955 LALREFEhtpLADIQRWAGQGGE-------ALFDSILVFEN-------YPISEALKQGAPsglrfgavssreQTNYPLTL 3020
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 454 SVKVTELMGevrLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQpQLT 533
Cdd:PRK12467 3021 AVGLGDTLE---LEFSYDRQHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHERRQVLHAWNATAAAYPS-ERL 3096
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 534 VTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAY 613
Cdd:PRK12467 3097 VHQLIEAQVARTPEAPALVFGDQ----QLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAY 3172
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 614 VPLDPDYPPERLRHIITDANLSVILGGDG--QQLAQWSAEQRIDLTDPAvveqWQDLPgDQPPAIPRHAQQLAQVIYTSG 691
Cdd:PRK12467 3173 VPLDPEYPRERLAYMIEDSGVKLLLTQAHllEQLPAPAGDTALTLDRLD----LNGYS-ENNPSTRVMGENLAYVIYTSG 3247
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 692 STGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTL--AFGEPND----RAIMQAEQ 765
Cdd:PRK12467 3248 STGKPKGVGVRHGALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLvvRDNDLWDpeelWQAIHAHR 3327
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 766 AGATHLIlPTALMSIL---DPEQVNGIQAIGMGGEACPNA---VVENWADKVALYNMYGPTECTVTAL-----STRLRKG 834
Cdd:PRK12467 3328 ISIACFP-PAYLQQFAedaGGADCASLDIYVFGGEAVPPAafeQVKRKLKPRGLTNGYGPTEAVVTVTlwkcgGDAVCEA 3406
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 835 QPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQGAATlRIYRTGDK 914
Cdd:PRK12467 3407 PYAPIGRPVAGRSIYVLDGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERF-------VADPFSGSGG-RLYRTGDL 3478
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 915 ARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYaTVKADSSTPEPAAVLIDV 994
Cdd:PRK12467 3479 ARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLLQH-PSVREAVVLARDGAGGKQLVAY-VVPADPQGDWRETLRDHL 3556
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 995 AKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP-PVLEANESDGEADNPLEADVLAIWRSVLNTP-LGVEDDFFRLGGDS 1072
Cdd:PRK12467 3557 AASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPdPDAKGSREYVAPRSEVEQQLAAIWADVLGVEqVGVTDNFFELGGDS 3636
|
1050 1060 1070
....*....|....*....|....*....|..
gi 499404635 1073 ILSIQLTTRLR-SAGYACTVKDVFEAKSVRRL 1103
Cdd:PRK12467 3637 LLALQVLSRIRqSLGLKLSLRDLMSAPTIAEL 3668
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
546-1027 |
3.32e-130 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 416.27 E-value: 3.32e-130
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd17652 1 PDAPAVVFGDE----TLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERI 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILggdgqqlaqwsaeqridltdpavveqwqdlpgdqppaipRHAQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:cd17652 77 AYMLADARPALLL---------------------------------------TTPDNLAYVIYTSGSTGRPKGVVVTHRG 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQ--AEQAGA---THLILPTALMSI 780
Cdd:cd17652 118 LANLAAAQIAAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEplADLLREhriTHVTLPPAALAA 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 781 LDPEQVNGIQAIGMGGEACPNAVVENWADKVALYNMYGPTECTVTALSTR-LRKGQPVTIGKPLIHIQALILDTAGQLCP 859
Cdd:cd17652 198 LPPDDLPDLRTLVVAGEACPAELVDRWAPGRRMINAYGPTETTVCATMAGpLPGGGVPPIGRPVPGTRVYVLDARLRPVP 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 860 VGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNN--AGQGAatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRG 937
Cdd:cd17652 278 PGVPGELYIAGAGLARGYLNRPGLTAERF-------VADpfGAPGS---RMYRTGDLARWRADGQLEFLGRADDQVKIRG 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 938 YRIEPGEIEAQLAAvCPSLKQIKVIVAQVG-SRPALVAYAtVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLT 1016
Cdd:cd17652 348 FRIELGEVEAALTE-HPGVAEAVVVVRDDRpGDKRLVAYV-VPAPGAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLT 425
|
490
....*....|.
gi 499404635 1017 PNGKLDMKQLP 1027
Cdd:cd17652 426 PNGKLDRRALP 436
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
563-961 |
3.23e-129 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 412.04 E-value: 3.23e-129
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 563 TYAELNRQANQLAHWLH-RQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD 641
Cdd:TIGR01733 1 TYRELDERANRLARHLRaAGGVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 GQQLAQWSAEQRIDLTDPAVVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTP 721
Cdd:TIGR01733 81 ALASRLAGLVLPVILLDPLELAALDDAPAPPPPDAPSGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 722 QSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQAEQA------GATHLILPTALMSILDPEQVNGIQAIGM- 794
Cdd:TIGR01733 161 DDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERDDAALLAaliaehPVTVLNLTPSLLALLAAALPPALASLRLv 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 --GGEACPNAVVENWADK---VALYNMYGPTECTVTALSTRL-----RKGQPVTIGKPLIHIQALILDTAGQLCPVGVPG 864
Cdd:TIGR01733 241 ilGGEALTPALVDRWRARgpgARLINLYGPTETTVWSTATLVdpddaPRESPVPIGRPLANTRLYVLDDDLRPVPVGVVG 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 865 ELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQGAATLRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGE 944
Cdd:TIGR01733 321 ELYIGGPGVARGYLNRPELTAERF-------VPDPFAGGDGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGE 393
|
410
....*....|....*..
gi 499404635 945 IEAQLAAvCPSLKQIKV 961
Cdd:TIGR01733 394 IEAALLR-HPGVREAVV 409
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
73-498 |
9.65e-129 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 411.75 E-value: 9.65e-129
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVnEQGKGEQRIDAYQPFVIQHD 152
Cdd:cd19531 3 PLSFAQQRLWFLDQLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVE-VDGEPVQVILPPLPLPLPVV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:cd19531 82 DLSGLPEAEREAEAQRLAREEARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFLAGR 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PYPVETTQLNYIDYAHW----FNSDSF---LDYhnefkpfWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLW 305
Cdd:cd19531 162 PSPLPPLPIQYADYAVWqrewLQGEVLerqLAY-------WREQLAGAPPVLELPTDRPRPAVQSFRGARVRFTLPAELT 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 306 DKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCR 385
Cdd:cd19531 235 AALRALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLARVR 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 386 EQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVDFNDLIPGCDAAEETSPVLPAKTDISVKVTELMGEVR 465
Cdd:cd19531 315 ETALEAYAHQDLPFEKLVEALQPERDLSRSPLFQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTLSLTETDGGLR 394
|
410 420 430
....*....|....*....|....*....|...
gi 499404635 466 LDWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19531 395 GSLEYNTDLFDAATIERMAGHFQTLLEAIVADP 427
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
536-1026 |
4.02e-124 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 400.81 E-value: 4.02e-124
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVP 615
Cdd:cd12117 1 ELFEEQAARTPDAVAVVYGDR----SLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVP 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 616 LDPDYPPERLRHIITDANLSVIlggdgqqLAQWSAEQRIDLTDPAVVEQWQDLPGDQ-PPAIPRHAQQLAQVIYTSGSTG 694
Cdd:cd12117 77 LDPELPAERLAFMLADAGAKVL-------LTDRSLAGRAGGLEVAVVIDEALDAGPAgNPAVPVSPDDLAYVMYTSGSTG 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 695 LPKGVMIEHGSLINLLDDhRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAF---GEPNDRAIMQA--EQAGAT 769
Cdd:cd12117 150 RPKGVAVTHRGVVRLVKN-TNYVTLGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLapkGTLLDPDALGAliAEEGVT 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 770 HLILPTALMSIL---DPEQVNGIQAIGMGGEACP----NAVVENWADkVALYNMYGPTECTVTALSTRLRKGQPVT---- 838
Cdd:cd12117 229 VLWLTAALFNQLadeDPECFAGLRELLTGGEVVSpphvRRVLAACPG-LRLVNGYGPTENTTFTTSHVVTELDEVAgsip 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 839 IGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQGAAtlRIYRTGDKARLL 918
Cdd:cd12117 308 IGRPIANTRVYVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERF-------VADPFGPGE--RLYRTGDLARWL 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 919 NNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIV-AQVGSRPALVAYATVKAdssTPEPAAVLIDVAKY 997
Cdd:cd12117 379 PDGRLEFLGRIDDQVKIRGFRIELGEIEAALRA-HPGVREAVVVVrEDAGGDKRLVAYVVAEG---ALDAAELRAFLRER 454
|
490 500
....*....|....*....|....*....
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd12117 455 LPAYMVPAAFVVLDELPLTANGKVDRRAL 483
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
538-1027 |
3.89e-122 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 395.56 E-value: 3.89e-122
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLD 617
Cdd:cd17651 1 FERQAARTPDAPALVAEGR----RLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 618 PDYPPERLRHIITDANLSVILGgdgQQLAQWSAEQRIDLTDPAVVEQWQDLPGDqPPAIPRHAQQLAQVIYTSGSTGLPK 697
Cdd:cd17651 77 PAYPAERLAFMLADAGPVLVLT---HPALAGELAVELVAVTLLDQPGAAAGADA-EPDPALDADDLAYVIYTSGSTGRPK 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 698 GVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFgePNDRAIMQAE-------QAGATH 770
Cdd:cd17651 153 GVVMPHRSLANLVAWQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVL--PPEEVRTDPPalaawldEQRISR 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 771 LILPTALMSILDPEQVNG------IQAIGMGGEA--CPNAVVENWADK--VALYNMYGPTECTV-TALSTR---LRKGQP 836
Cdd:cd17651 231 VFLPTVALRALAEHGRPLgvrlaaLRYLLTGGEQlvLTEDLREFCAGLpgLRLHNHYGPTETHVvTALSLPgdpAAWPAP 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 837 VTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDVNNAGQgaatlRIYRTGDKAR 916
Cdd:cd17651 311 PPIGRPIDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERF----VPDPFVPGA-----RMYRTGDLAR 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 917 LLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIV-AQVGSRPALVAYATVKADSStPEPAAVLIDVA 995
Cdd:cd17651 382 WLPDGELEFLGRADDQVKIRGFRIELGEIEAALAR-HPGVREAVVLArEDRPGEKRLVAYVVGDPEAP-VDAAELRAALA 459
|
490 500 510
....*....|....*....|....*....|..
gi 499404635 996 KYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17651 460 THLPEYMVPSAFVLLDALPLTPNGKLDRRALP 491
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
535-1026 |
1.25e-121 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 393.95 E-value: 1.25e-121
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 535 TDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYV 614
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGR----TLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 615 PLDPDYPPERLRHIITDANLSVILGGDGQqlaqwsAEQRIDLTDPAVVEQWQDL-PGDQPPAIPRHAQQLAQVIYTSGST 693
Cdd:cd17646 77 PLDPGYPADRLAYMLADAGPAVVLTTADL------AARLPAGGDVALLGDEALAaPPATPPLVPPRPDNLAYVIYTSGST 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 694 GLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDR-------AIMQAEQA 766
Cdd:cd17646 151 GRPKGVMVTHAGIVNRLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHrdpaylaALIREHGV 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 767 GATHLIlPTALMSIL---DPEQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECTVTALSTRLRKGQ---PVT 838
Cdd:cd17646 231 TTCHFV-PSMLRVFLaepAAGSCASLRRVFCSGEALPPELAARFLALpgAELHNLYGPTEAAIDVTHWPVRGPAetpSVP 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 839 IGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNA-GQGAatlRIYRTGDKARL 917
Cdd:cd17646 310 IGRPVPNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERF-------VPDPfGPGS---RMYRTGDLARW 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 918 LNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIV-AQVGSRPALVAYATVKADSSTPEPAAVLIDVAK 996
Cdd:cd17646 380 RPDGALEFLGRSDDQVKIRGFRVEPGEIEAALAA-HPAVTHAVVVArAAPAGAARLVGYVVPAAGAAGPDTAALRAHLAE 458
|
490 500 510
....*....|....*....|....*....|
gi 499404635 997 YLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd17646 459 RLPEYMVPAAFVVLDALPLTANGKLDRAAL 488
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
534-1026 |
1.65e-120 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 390.36 E-value: 1.65e-120
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 534 VTDVIEAVAQRDPQQLAI-AFDGEprtdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:cd05918 1 VHDLIEERARSQPDAPAVcAWDGS-----LTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGA 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDANLSVILggdgqqlaqwsaeqridlTDpavveqwqdlpgdqppaiprHAQQLAQVIYTSGS 692
Cdd:cd05918 76 FVPLDPSHPLQRLQEILQDTGAKVVL------------------TS--------------------SPSDAAYVIFTSGS 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 693 TGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFgePNDRAIMQ-----AEQAG 767
Cdd:cd05918 118 TGKPKGVVIEHRALSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCI--PSEEDRLNdlagfINRLR 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 768 ATHLILPTALMSILDPEQVNGIQAIGMGGEACPNAVVENWADKVALYNMYGPTECTV-TALSTRLRKGQPVTIGKPL--- 843
Cdd:cd05918 196 VTWAFLTPSVARLLDPEDVPSLRTLVLGGEALTQSDVDTWADRVRLINAYGPAECTIaATVSPVVPSTDPRNIGRPLgat 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 844 IHIqaLILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF-EHITLNDVNNAGQGAatlRIYRTGDKARLLNNGD 922
Cdd:cd05918 276 CWV--VDPDNHDRLVPIGAVGELLIEGPILARGYLNDPEKTAAAFiEDPAWLKQEGSGRGR---RLYRTGDLVRYNPDGS 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 923 YEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIV---AQVGSRPALVAYATVKADSSTP--------EPAAVL 991
Cdd:cd05918 351 LEYVGRKDTQVKIRGQRVELGEIEHHLRQSLPGAKEVVVEVvkpKDGSSSPQLVAFVVLDGSSSGSgdgdslflEPSDEF 430
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 499404635 992 IDVAKY--------LPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05918 431 RALVAElrsklrqrLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
546-1026 |
1.67e-119 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 387.03 E-value: 1.67e-119
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd12116 1 PDATAVRDDDR----SLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILGGDGqqlaqwsAEQRIDLTDPAV--VEQWQDLPGDQPPAiPRHAQQLAQVIYTSGSTGLPKGVMIEH 703
Cdd:cd12116 77 RYILEDAEPALVLTDDA-------LPDRLPAGLPVLllALAAAAAAPAAPRT-PVSPDDLAYVIYTSGSTGRPKGVVVSH 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 704 GSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFgepndraimqaeqAGATHLILPTALMSILDP 783
Cdd:cd12116 149 RNLVNFLHSMRERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVI-------------APRETQRDPEALARLIEA 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 784 EQVNGIQAI----------------GM----GGEACPNAVVENWADKVA-LYNMYGPTECTVTALSTRLRKGQ-PVTIGK 841
Cdd:cd12116 216 HSITVMQATpatwrmlldagwqgraGLtalcGGEALPPDLAARLLSRVGsLWNLYGPTETTIWSTAARVTAAAgPIPIGR 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 842 PLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQGAATlRIYRTGDKARLLNNG 921
Cdd:cd12116 296 PLANTQVYVLDAALRPVPPGVPGELYIGGDGVAQGYLGRPALTAERF-------VPDPFAGPGS-RLYRTGDLVRRRADG 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 922 DYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVKaDSSTPEPAAVLIDVAKYLPEY 1001
Cdd:cd12116 368 RLEYLGRADGQVKIRGHRIELGEIEAALAAH-PGVAQAAVVVREDGGDRRLVAYVVLK-AGAAPDAAALRAHLRATLPAY 445
|
490 500
....*....|....*....|....*
gi 499404635 1002 MVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd12116 446 MVPSAFVRLDALPLTANGKLDRKAL 470
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
538-1027 |
1.75e-117 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 382.06 E-value: 1.75e-117
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLD 617
Cdd:cd17655 3 FEEQAEKTPDHTAVVFEDQ----TLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPID 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 618 PDYPPERLRHIITDANLSVILgGDGQQLAQWSAEQRIDLTDPavvEQWQDLPGDQPPaIPRHAQQLAQVIYTSGSTGLPK 697
Cdd:cd17655 79 PDYPEERIQYILEDSGADILL-TQSHLQPPIAFIGLIDLLDE---DTIYHEESENLE-PVSKSDDLAYVIYTSGSTGKPK 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 698 GVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQA-----EQAGATHLI 772
Cdd:cd17655 154 GVMIEHRGVVNLVEWANKVIYQGEHLRVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQAltqyiRQNRITIID 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 773 LPTALMSILDPEQVNG---IQAIGMGGEACPNAVVENW----ADKVALYNMYGPTECTVTA----LSTRLRKGQPVTIGK 841
Cdd:cd17655 234 LTPAHLKLLDAADDSEglsLKHLIVGGEALSTELAKKIielfGTNPTITNAYGPTETTVDAsiyqYEPETDQQVSVPIGK 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 842 PLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDVNNAGQgaatlRIYRTGDKARLLNNG 921
Cdd:cd17655 314 PLGNTRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKF----VDDPFVPGE-----RMYRTGDLARWLPDG 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 922 DYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVA--QVGSrPALVAYATVKADSSTpepAAVLIDVAKYLP 999
Cdd:cd17655 385 NIEFLGRIDHQVKIRGYRIELGEIEARLLQH-PDIKEAVVIARkdEQGQ-NYLCAYIVSEKELPV---AQLREFLARELP 459
|
490 500
....*....|....*....|....*...
gi 499404635 1000 EYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17655 460 DYMIPSYFIKLDEIPLTPNGKVDRKALP 487
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
546-1027 |
6.89e-116 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 375.94 E-value: 6.89e-116
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd17649 1 PDAVALVFGDQ----SLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILGgdgqqlaqwsaeqridltdpavveqwqdlpgdqppaipRHAQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:cd17649 77 RYMLEDSGAGLLLT--------------------------------------HHPRQLAYVIYTSGSTGTPKGVAVSHGP 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPN-----DRAIMQAEQAGATHLILPTA---- 776
Cdd:cd17649 119 LAAHCQATAERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDElwasaDELAEMVRELGVTVLDLPPAylqq 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 777 ---LMSILDPEQVNGIQAIGMGGEACPNAVVENW-ADKVALYNMYGPTECTVTAL----STRLRKGQP-VTIGKPLIHIQ 847
Cdd:cd17649 199 laeEADRTGDGRPPSLRLYIFGGEALSPELLRRWlKAPVRLFNAYGPTEATVTPLvwkcEAGAARAGAsMPIGRPLGGRS 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 848 ALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAgQGAATLRIYRTGDKARLLNNGDYEYCG 927
Cdd:cd17649 279 AYILDADLNPVPVGVTGELYIGGEGLARGYLGRPELTAERF-------VPDP-FGAPGSRLYRTGDLARWRDDGVIEYLG 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 928 RIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVKADSSTPE-PAAVLIDVAKYLPEYMVPFR 1006
Cdd:cd17649 351 RVDHQVKIRGFRIELGEIEAALLEH-PGVREAAVVALDGAGGKQLVAYVVLRAAAAQPElRAQLRTALRASLPDYMVPAH 429
|
490 500
....*....|....*....|.
gi 499404635 1007 LMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17649 430 LVFLARLPLTPNGKLDRKALP 450
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
536-1026 |
2.34e-114 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 370.87 E-value: 2.34e-114
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAVAQRDPQQLAIafdgEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVP 615
Cdd:cd17653 1 DAFERIAAAHPDAVAV----ESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVP 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 616 LDPDYPPERLRHIITDANLSVILGGDGQQlaqwsaeqridltdpavveqwqdlpgdqppaiprhaqQLAQVIYTSGSTGL 695
Cdd:cd17653 77 LDAKLPSARIQAILRTSGATLLLTTDSPD-------------------------------------DLAYIIFTSGSTGI 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 696 PKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQAEQAGATHlILPT 775
Cdd:cd17653 120 PKGVMVPHRGVLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTLVLADPSDPFAHVARTVDALM-STPS 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 776 ALmSILDPEQVNGIQAIGMGGEACPNAVVENWADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAG 855
Cdd:cd17653 199 IL-STLSPQDFPNLKTIFLGGEAVPPSLLDRWSPGRRLYNAYGPTECTISSTMTELLPGQPVTIGKPIPNSTCYILDADL 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 856 QLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNDvnnaGQgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKL 935
Cdd:cd17653 278 QPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFWP----GS-----RMYRTGDYGRWTEDGGLEFLGREDNQVKV 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 936 RGYRIEPGEIEAQLAAVCPSLKQIKVIVaqvgSRPALVAYATvkadsstpePAAVLID-----VAKYLPEYMVPFRLMLL 1010
Cdd:cd17653 349 RGFRINLEEIEEVVLQSQPEVTQAAAIV----VNGRLVAFVT---------PETVDVDglrseLAKHLPSYAVPDRIIAL 415
|
490
....*....|....*.
gi 499404635 1011 EDMPLTPNGKLDMKQL 1026
Cdd:cd17653 416 DSFPLTANGKVDRKAL 431
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
536-1026 |
5.17e-110 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 358.94 E-value: 5.17e-110
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAVAQRDPQQLAIAfDGEPRtdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVP 615
Cdd:cd12115 3 DLVEAQAARTPDAIALV-CGDES---LTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVP 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 616 LDPDYPPERLRHIITDANLSVILggdgqqlaqwsaeqridlTDPavveqwqdlpgdqppaiprhaQQLAQVIYTSGSTGL 695
Cdd:cd12115 79 LDPAYPPERLRFILEDAQARLVL------------------TDP---------------------DDLAYVIYTSGSTGR 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 696 PKGVMIEHGSLINLLDDHRDriDFTPQ--STMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEpNDRAIMQAEQAGATHLI- 772
Cdd:cd12115 120 PKGVAIEHRNAAAFLQWAAA--AFSAEelAGVLASTSICFDLSVFELFGPLATGGKVVLAD-NVLALPDLPAAAEVTLIn 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 773 -LPTALMSILDPEQV-NGIQAIGMGGEACPNAVVENWADK---VALYNMYGPTECTVTALSTRLRKG--QPVTIGKPLIH 845
Cdd:cd12115 197 tVPSAAAELLRHDALpASVRVVNLAGEPLPRDLVQRLYARlqvERVVNLYGPSEDTTYSTVAPVPPGasGEVSIGRPLAN 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 846 IQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndVNNAGQGAatlRIYRTGDKARLLNNGDYEY 925
Cdd:cd12115 277 TQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFL------PDPFGPGA---RLYRTGDLVRWRPDGLLEF 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 926 CGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQiKVIVAQVGS--RPALVAYATVKADSStPEPAAVLIDVAKYLPEYMV 1003
Cdd:cd12115 348 LGRADNQVKVRGFRIELGEIEAALRSI-PGVRE-AVVVAIGDAagERRLVAYIVAEPGAA-GLVEDLRRHLGTRLPAYMV 424
|
490 500
....*....|....*....|...
gi 499404635 1004 PFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd12115 425 PSRFVRLDALPLTPNGKIDRSAL 447
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
546-1026 |
2.47e-108 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 354.31 E-value: 2.47e-108
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd17643 1 PEAVAVVDEDR----RLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERI 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILggdgqqlaqwsaeqridlTDPavveqwqdlpgdqppaiprhaQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:cd17643 77 AFILADSGPSLLL------------------TDP---------------------DDLAYVIYTSGSTGRPKGVVVSHAN 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQS--TMFNcmSLSFDAGNMTTLLPLSSGGTLAFgEPNDRAIMQAE------QAGATHL-ILPTA 776
Cdd:cd17643 118 VLALFAATQRWFGFNEDDvwTLFH--SYAFDFSVWEIWGALLHGGRLVV-VPYEVARSPEDfarllrDEGVTVLnQTPSA 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 777 ---LMSILD--PEQVNGIQAIGMGGEACPNAVVENWADKV-----ALYNMYGPTECTV-------TALSTRLRKGQPvtI 839
Cdd:cd17643 195 fyqLVEAADrdGRDPLALRYVIFGGEALEAAMLRPWAGRFgldrpQLVNMYGITETTVhvtfrplDAADLPAAAASP--I 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 840 GKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAgQGAATLRIYRTGDKARLLN 919
Cdd:cd17643 273 GRPLPGLRVYVLDADGRPVPPGVVGELYVSGAGVARGYLGRPELTAERF-------VANP-FGGPGSRMYRTGDLARRLP 344
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 920 NGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVGS-RPALVAYaTVKADSSTPEPAAVLIDVAKYL 998
Cdd:cd17643 345 DGELEYLGRADEQVKIRGFRIELGEIEAALAT-HPSVRDAAVIVREDEPgDTRLVAY-VVADDGAAADIAELRALLKELL 422
|
490 500
....*....|....*....|....*...
gi 499404635 999 PEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd17643 423 PDYMVPARYVPLDALPLTVNGKLDRAAL 450
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
539-1027 |
4.76e-105 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 345.19 E-value: 4.76e-105
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 539 EAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDP 618
Cdd:cd17644 7 EEQVERTPDAVAVVFEDQ----QLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPLDP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 619 DYPPERLRHIITDANLSVILggdgqqlaqwsaeqridlTDPavveqwqdlpgdqppaiprhaQQLAQVIYTSGSTGLPKG 698
Cdd:cd17644 83 NYPQERLTYILEDAQISVLL------------------TQP---------------------ENLAYVIYTSGSTGKPKG 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 699 VMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAF--GE--PNDRAIMQ-AEQAGATHLIL 773
Cdd:cd17644 124 VMIEHQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLrpEEmrSSLEDFVQyIQQWQLTVLSL 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 774 PTA----LMSILDPEQ---VNGIQAIGMGGEACPNAVVENWA----DKVALYNMYGPTECTVTALSTRLRKGQP-----V 837
Cdd:cd17644 204 PPAywhlLVLELLLSTidlPSSLRLVIVGGEAVQPELVRQWQknvgNFIQLINVYGPTEATIAATVCRLTQLTErnitsV 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 838 TIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQGAATLRIYRTGDKARL 917
Cdd:cd17644 284 PIGRPIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKF-------ISHPFNSSESERLYKTGDLARY 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 918 LNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVA--QVGSRpALVAYaTVKADSSTPEPAAVLIDVA 995
Cdd:cd17644 357 LPDGNIEYLGRIDNQVKIRGFRIELGEIEAVLSQH-NDVKTAVVIVRedQPGNK-RLVAY-IVPHYEESPSTVELRQFLK 433
|
490 500 510
....*....|....*....|....*....|..
gi 499404635 996 KYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17644 434 AKLPDYMIPSAFVVLEELPLTPNGKIDRRALP 465
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
73-1085 |
6.98e-105 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 377.20 E-value: 6.98e-105
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQRIDAYQPFVIQHD 152
Cdd:PRK05691 3259 PLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGETMLQVIHKPGRTPIDYL 3338
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:PRK05691 3339 DWRGLPEDGQEQRLQALHKQEREAGFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMNDFFEIYTALGEGR 3418
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PyPVETTQLNYIDYAHWFNSDSFldyhNEFKPFWVERLTGIPEVHSLPLDKP--RPAHQNSGGEVI---FSAINNDLWDK 307
Cdd:PRK05691 3419 E-AQLPVPPRYRDYIGWLQRQDL----AQARQWWQDNLRGFERPTPIPSDRPflREHAGDSGGMVVgdcYTRLDAADGAR 3493
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 308 FKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGFFVNTIVLRTQL-QDSQ--NFVDYLQ 382
Cdd:PRK05691 3494 LRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRpvSMPQMQRTVGLFINSIALRVQLpAAGQrcSVRQWLQ 3573
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 383 YCREQDLSAFDHQLYRFEALSEaigSDRTTAINPIFQVMLVYQ-AKVDFNDLipgcDAAEE---TSPVLPAKTDISVKVT 458
Cdd:PRK05691 3574 GLLDSNMELREYEYLPLVAIQE---CSELPKGQPLFDSLFVFEnAPVEVSVL----DRAQSlnaSSDSGRTHTNFPLTAV 3646
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 459 ELMGE-VRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVWHLPLMETDRFAAVLAETQQLPRSYPQPQLTVtDV 537
Cdd:PRK05691 3647 CYPGDdLGLHLSYDQRYFDAPTVERLLGEFKRLLLALVQGFHGDLSELPLLGEQERDFLLDGCNRSERDYPLEQSYV-RL 3725
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLD 617
Cdd:PRK05691 3726 FEAQVAAHPQRIAASCLDQ----QWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLGMIVGSFKAGAGYLPLD 3801
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 618 PDYPPERLRHIITDANLSVILggdgqqLAQWSAEQRIDLTDpAVVEQ-------WQDLPGDQP----PAIPRHAQQLAQV 686
Cdd:PRK05691 3802 PGLPAQRLQRIIELSRTPVLV------CSAACREQARALLD-ELGCAnrprllvWEEVQAGEVashnPGIYSGPDNLAYV 3874
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 687 IYTSGSTGLPKGVMIE-HGSLINLLD-------DHRDRIDFTPqstmfncmSLSFDAGNMTTLLPLSSGGTLAFgEPNDR 758
Cdd:PRK05691 3875 IYTSGSTGLPKGVMVEqRGMLNNQLSkvpylalSEADVIAQTA--------SQSFDISVWQFLAAPLFGARVEI-VPNAI 3945
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 759 A------IMQAEQAGATHL-ILPTALMSIL--DPEQVNGIQAIGMGGEACPNAVVENWADK---VALYNMYGPTECT--- 823
Cdd:PRK05691 3946 AhdpqglLAHVQAQGITVLeSVPSLIQGMLaeDRQALDGLRWMLPTGEAMPPELARQWLQRypqIGLVNAYGPAECSddv 4025
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 824 ----VTALSTRlrkGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF-EHITlndvnn 898
Cdd:PRK05691 4026 affrVDLASTR---GSYLPIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLRTALAFvPHPF------ 4096
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 899 agqGAATLRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATv 978
Cdd:PRK05691 4097 ---GAPGERLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQ-AEVREAAVAVQEGVNGKHLVGYLV- 4171
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 979 kADSSTPEPAAVLIDVAKY----LPEYMVPFRLMLLEDMPLTPNGKLDMKQLpPVLEANESDGEA----DNPLEADVLAI 1050
Cdd:PRK05691 4172 -PHQTVLAQGALLERIKQRlraeLPDYMVPLHWLWLDRLPLNANGKLDRKAL-PALDIGQLQSQAylapRNELEQTLATI 4249
|
1050 1060 1070
....*....|....*....|....*....|....*.
gi 499404635 1051 WRSVLNTP-LGVEDDFFRLGGDSILSIQLTTRLRSA 1085
Cdd:PRK05691 4250 WADVLKVErVGVHDNFFELGGHSLLATQIASRVQKA 4285
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
539-1027 |
1.39e-100 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 331.44 E-value: 1.39e-100
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 539 EAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDP 618
Cdd:cd17645 5 EEQVERTPDHVAVVDRGQ----SLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 619 DYPPERLRHIITDANLSVILggdgqqlaqwsaeqridltdpavveqwqdlpgdqppaipRHAQQLAQVIYTSGSTGLPKG 698
Cdd:cd17645 81 DYPGERIAYMLADSSAKILL---------------------------------------TNPDDLAYVIYTSGSTGLPKG 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 699 VMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIMQA-----EQAGATHLIL 773
Cdd:cd17645 122 VMIEHHNLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPSERRLDLDAlndyfNQEGITISFL 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 774 PTALMSILDPEQVNGIQAIGMGGEACPNAVVENWAdkvaLYNMYGPTECTVTALSTRLRKG-QPVTIGKPLIHIQALILD 852
Cdd:cd17645 202 PTGAAEQFMQLDNQSLRVLLTGGDKLKKIERKGYK----LVNNYGPTENTVVATSFEIDKPyANIPIGKPIDNTRVYILD 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 853 TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDVNNAGQgaatlRIYRTGDKARLLNNGDYEYCGRIDEQ 932
Cdd:cd17645 278 EALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKF----IVHPFVPGE-----RMYRTGDLAKFLPDGNIEFLGRLDQQ 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 933 IKLRGYRIEPGEIEAQLAAVcPSLKQIKVI-VAQVGSRPALVAYATVKADSstpEPAAVLIDVAKYLPEYMVPFRLMLLE 1011
Cdd:cd17645 349 VKIRGYRIEPGEIEPFLMNH-PLIELAAVLaKEDADGRKYLVAYVTAPEEI---PHEELREWLKNDLPDYMIPTYFVHLK 424
|
490
....*....|....*.
gi 499404635 1012 DMPLTPNGKLDMKQLP 1027
Cdd:cd17645 425 ALPLTANGKVDRKALP 440
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
534-1026 |
1.57e-98 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 326.00 E-value: 1.57e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 534 VTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAY 613
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGR----RLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVV 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 614 VPLDPDYPPERLRHIITDANLSVILGgdgqqlaqwsaeqridltdpavveqwqdlpgdqppaiprhaqqlAQVIYTSGST 693
Cdd:COG0318 77 VPLNPRLTAEELAYILEDSGARALVT--------------------------------------------ALILYTSGTT 112
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 694 GLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAG-NMTTLLPLSSGGTLAFGEPND-RAIMQA-EQAGATH 770
Cdd:COG0318 113 GRPKGVMLTHRNLLANAAAIAAALGLTPGDVVLVALPLFHVFGlTVGLLAPLLAGATLVLLPRFDpERVLELiERERVTV 192
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 771 LIL-PTALMSILD-----PEQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECTVTALSTRLRKGQ--PVTIG 840
Cdd:COG0318 193 LFGvPTMLARLLRhpefaRYDLSSLRLVVSGGAPLPPELLERFEERfgVRIVEGYGLTETSPVVTVNPEDPGErrPGSVG 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 841 KPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndvnnagqgaatlRIYRTGDKARLLNN 920
Cdd:COG0318 273 RPLPGVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAFRD----------------GWLRTGDLGRLDED 336
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 921 GDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI---VAQVGSRPALVAyatVKADSSTPEPAAVLIDVAKY 997
Cdd:COG0318 337 GYLYIVGRKKDMIISGGENVYPAEVEEVLAA-HPGVAEAAVVgvpDEKWGERVVAFV---VLRPGAELDAEELRAFLRER 412
|
490 500
....*....|....*....|....*....
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:COG0318 413 LARYKVPRRVEFVDELPRTASGKIDRRAL 441
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
546-1026 |
7.41e-98 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 324.99 E-value: 7.41e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd12114 1 PDATAVICGDG----TLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARR 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILggdgqqLAQWSAEQRIDLTDPAVVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:cd12114 77 EAILADAGARLVL------TDGPDAQLDVAVFDVLILDLDALAAPAPPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRA 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDR----AIMQA-EQAGATHLILPTALMSI 780
Cdd:cd12114 151 ALNTILDINRRFAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRrdpaHWAELiERHGVTLWNSVPALLEM 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 781 L-----DPEQVN-GIQAIGMGGE----ACPNAVVENWADkVALYNMYGPTECTVTALSTRLRKGQP--VTI--GKPLIHI 846
Cdd:cd12114 231 LldvleAAQALLpSLRLVLLSGDwiplDLPARLRALAPD-ARLISLGGATEASIWSIYHPIDEVPPdwRSIpyGRPLANQ 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 847 QALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF-EHITLndvnnagqgaatLRIYRTGDKARLLNNGDYEY 925
Cdd:cd12114 310 RYRVLDPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFvTHPDG------------ERLYRTGDLGRYRPDGTLEF 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 926 CGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPF 1005
Cdd:cd12114 378 LGRRDGQVKVRGYRIELGEIEAALQAH-PGVARAVVVVLGDPGGKRLAAFVVPDNDGTPIAPDALRAFLAQTLPAYMIPS 456
|
490 500
....*....|....*....|.
gi 499404635 1006 RLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd12114 457 RVIALEALPLTANGKVDRAAL 477
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
73-498 |
1.49e-96 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 319.37 E-value: 1.49e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGkGEQRI-DAYQpfviqh 151
Cdd:cd19540 3 PLSFAQQRLWFLNRLDGPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGG-PYQVVlPAAE------ 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 152 DDFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLA-CQN 230
Cdd:cd19540 76 ARPDLTVVDVTEDELAARLAEAARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAArRAG 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 231 C----QPYPVEttqlnYIDYAHW--------FNSDSF----LDYhnefkpfWVERLTGIPEVHSLPLDKPRPAHQ-NSGG 293
Cdd:cd19540 156 RapdwAPLPVQ-----YADYALWqrellgdeDDPDSLaarqLAY-------WRETLAGLPEELELPTDRPRPAVAsYRGG 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 294 EVIFSaINNDLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQD 373
Cdd:cd19540 224 TVEFT-IDAELHARLAALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSG 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 374 SQNFVDYLQYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQ----AKVDFndliPGCDAAEETSPVLPA 449
Cdd:cd19540 303 DPTFAELLARVRETDLAAFAHQDVPFERLVEALNPPRSTARHPLFQVMLAFQntaaATLEL----PGLTVEPVPVDTGVA 378
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 450 KTDISVKVTELMGE------VRLDWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19540 379 KFDLSFTLTERRDAdgapagLTGELEYATDLFDRSTAERLADRFVRVLEAVVADP 433
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
542-1026 |
2.71e-96 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 319.19 E-value: 2.71e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQqlAIAFDGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYP 621
Cdd:cd05945 1 AAANPD--RPAVVEGGRT--LTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSP 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 622 PERLRHIItdanlsvilggdgqqlaqwsaeqriDLTDPAVVEQWQDlpgdqppaiprhaqQLAQVIYTSGSTGLPKGVMI 701
Cdd:cd05945 77 AERIREIL-------------------------DAAKPALLIADGD--------------DNAYIIFTSGSTGRPKGVQI 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 702 EHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAfgePNDRAIMQAEQAGATHL---------- 771
Cdd:cd05945 118 SHDNLVSFTNWMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATLV---PVPRDATADPKQLFRFLaehgitvwvs 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 772 ---ILPTALMS-ILDPEQVNGIQAIGMGGEACPNAVVENW---ADKVALYNMYGPTECTVTALSTRLRKGQ-----PVTI 839
Cdd:cd05945 195 tpsFAAMCLLSpTFTPESLPSLRHFLFCGEVLPHKTARALqqrFPDARIYNTYGPTEATVAVTYIEVTPEVldgydRLPI 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 840 GKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITlndvnnaGQGAatlriYRTGDKARLLN 919
Cdd:cd05945 275 GYAKPGAKLVILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFPDE-------GQRA-----YRTGDLVRLEA 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 920 NGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVG-SRPALVAYATVKADSSTPEPAAVLIDVAKYL 998
Cdd:cd05945 343 DGLLFYRGRLDFQVKLNGYRIELEEIEAALRQ-VPGVKEAVVVPKYKGeKVTELIAFVVPKPGAEAGLTKAIKAELAERL 421
|
490 500
....*....|....*....|....*...
gi 499404635 999 PEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05945 422 PPYMIPRRFVYLDELPLNANGKIDRKAL 449
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1126-1528 |
8.10e-96 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 317.27 E-value: 8.10e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1126 EFALLPIQRWFMEQSLARPEHWNQAAMIQLPE-VDTERLVTMLQALMAQHDALRLGCDAEG----QRYLADVPCP-ALST 1199
Cdd:cd19534 1 EVPLTPIQRWFFEQNLAGRHHFNQSVLLRVPQgLDPDALRQALRALVEHHDALRMRFRREDggwqQRIRGDVEELfRLEV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1200 LDYRQL-GDDGLQQAFTALQSEFDPAQGRTMACALVRHHPQADTaLFLAFHHLVIDAVSWRILVDDLERLYL----GEPL 1274
Cdd:cd19534 81 VDLSSLaQAAAIEALAAEAQSSLDLEEGPLLAAALFDGTDGGDR-LLLVIHHLVVDGVSWRILLEDLEAAYEqalaGEPI 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1275 -LPKTSSYRQWGAALQHYATQHA--EQLTYWQAQEDGvDLTALlaAKDP---QGHASAAILTLDAKTTGQLVSEANRAFN 1348
Cdd:cd19534 160 pLPSKTSFQTWAELLAEYAQSPAllEELAYWRELPAA-DYWGL--PKDPeqtYGDARTVSFTLDEEETEALLQEANAAYR 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1349 TDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREAIDPTLDVSRTVGWFTSTYPVCLQDKP--DWASLIQSSKEQLRQVP 1426
Cdd:cd19534 237 TEINDLLLAALALAFQDWTGRAPPAIFLEGHGREEIDPGLDLSRTVGWFTSMYPVVLDLEAseDLGDTLKRVKEQLRRIP 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1427 DKGVGFNPLRYHHPQGNS----LTLSPIVFNYLG-LSVQAAGTWRPVDVAPGCC--VSPGNKPAEVISLHGGITGGQLTL 1499
Cdd:cd19534 317 NKGIGYGILRYLTPEGTKrlafHPQPEISFNYLGqFDQGERDDALFVSAVGGGGsdIGPDTPRFALLDINAVVEGGQLVI 396
|
410 420 430
....*....|....*....|....*....|....
gi 499404635 1500 -----RQVgcLNQRDSERLMTRLTENLRALTEAC 1528
Cdd:cd19534 397 tvsysRNM--YHEETIQQLADSYKEALEALIEHC 428
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
546-1027 |
3.51e-94 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 313.57 E-value: 3.51e-94
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFdGEPRtdtLTYAELNRQANQLAHWLHRQGLGE-QSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPER 624
Cdd:cd17648 1 PDRVAVVY-GDKR---LTYRELNERANRLAHYLLSVAEIRpDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDER 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 625 LRHIITDANLSVILggdgqqlaqwsaeqridlTDPavveqwqdlpgdqppaiprhaQQLAQVIYTSGSTGLPKGVMIEHG 704
Cdd:cd17648 77 IQFILEDTGARVVI------------------TNS---------------------TDLAYAIYTSGTTGKPKGVLVEHG 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 705 SLINLLDDHRDRIDFTPQSTMfNCMSLS---FDAGNMTTLLPLSSGGTLAFGEPNDR-------AIMQAEqaGATHLILP 774
Cdd:cd17648 118 SVVNLRTSLSERYFGRDNGDE-AVLFFSnyvFDFFVEQMTLALLNGQKLVVPPDEMRfdpdrfyAYINRE--KVTYLSGT 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 775 TALMSILDPEQVNGIQAIGMGGEACPNAVVENWADKVA--LYNMYGPTECTVTALSTRLRKGQPV--TIGKPLIHIQALI 850
Cdd:cd17648 195 PSVLQQYDLARLPHLKRVDAAGEEFTAPVFEKLRSRFAglIINAYGPTETTVTNHKRFFPGDQRFdkSLGRPVRNTKCYV 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 851 LDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQGAATL------RIYRTGDKARLLNNGDYE 924
Cdd:cd17648 275 LNDAMKRVPVGAVGELYLGGDGVARGYLNRPELTAERF-------LPNPFQTEQERargrnaRLYKTGDLVRWLPSGELE 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 925 YCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI------VAQVGSRPALVAYATvkADSSTPEPAAVLIDVAKYL 998
Cdd:cd17648 348 YLGRNDFQVKIRGQRIEPGEVEAALAS-YPGVRECAVVakedasQAQSRIQKYLVGYYL--PEPGHVPESDLLSFLRAKL 424
|
490 500
....*....|....*....|....*....
gi 499404635 999 PEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17648 425 PRYMVPARLVRLEGIPVTINGKLDVRALP 453
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
538-936 |
5.15e-92 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 305.78 E-value: 5.15e-92
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFDGeprTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLD 617
Cdd:pfam00501 1 LERQAARTPDKTALEVGE---GRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLN 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 618 PDYPPERLRHIITDANLSVILGGDGQQLAQ----WSAEQRIDLT---DPAVVEQWQDLPGD-------QPPAIPRHAQQL 683
Cdd:pfam00501 78 PRLPAEELAYILEDSGAKVLITDDALKLEElleaLGKLEVVKLVlvlDRDPVLKEEPLPEEakpadvpPPPPPPPDPDDL 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 684 AQVIYTSGSTGLPKGVMIEHGSLINLLDDH----RDRIDFTPQSTMFNCMSLSFDAG-NMTTLLPLSSGGTLAFGEPNDR 758
Cdd:pfam00501 158 AYIIYTSGTTGKPKGVMLTHRNLVANVLSIkrvrPRGFGLGPDDRVLSTLPLFHDFGlSLGLLGPLLAGATVVLPPGFPA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 759 AIMQA-----EQAGATHLIL-PTALMSILD-----PEQVNGIQAIGMGGEACPNAVVENWADKV--ALYNMYGPTECTVT 825
Cdd:pfam00501 238 LDPAAlleliERYKVTVLYGvPTLLNMLLEagapkRALLSSLRLVLSGGAPLPPELARRFRELFggALVNGYGLTETTGV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 826 ALSTRLRKGQPV---TIGKPLIHIQALILDTA-GQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndvnnagq 901
Cdd:pfam00501 318 VTTPLPLDEDLRslgSVGRPLPGTEVKIVDDEtGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFD------------ 385
|
410 420 430
....*....|....*....|....*....|....*
gi 499404635 902 gaaTLRIYRTGDKARLLNNGDYEYCGRIDEQIKLR 936
Cdd:pfam00501 386 ---EDGWYRTGDLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
546-1027 |
8.12e-90 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 301.70 E-value: 8.12e-90
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd17656 2 PDAVAVVFENQ----KLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERR 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVIlggdgqqLAQWSAEQRIDLTDPAVVEQWQDLP--GDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEH 703
Cdd:cd17656 78 IYIMLDSGVRVV-------LTQRHLKSKLSFNKSTILLEDPSISqeDTSNIDYINNSDDLLYIIYTSGTTGKPKGVQLEH 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 704 GSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAF-GEPNDRAIMQAEQAGATH----LILPTALM 778
Cdd:cd17656 151 KNMVNLLHFEREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYIiREETKRDVEQLFDLVKRHnievVFLPVAFL 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 779 SILDPEQ------VNGIQAIGMGGE--ACPNAVVENWADK-VALYNMYGPTECTVTALSTrLRKGQPVT----IGKPLIH 845
Cdd:cd17656 231 KFIFSERefinrfPTCVKHIITAGEqlVITNEFKEMLHEHnVHLHNHYGPSETHVVTTYT-INPEAEIPelppIGKPISN 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 846 IQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndvnNAGQGAATLRIYRTGDKARLLNNGDYEY 925
Cdd:cd17656 310 TWIYILDQEQQLQPQGIVGELYISGASVARGYLNRQELTAEKF---------FPDPFDPNERMYRTGDLARYLPDGNIEF 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 926 CGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVGSRPA-LVAYATVKADSSTPEPAAVLidvAKYLPEYMVP 1004
Cdd:cd17656 381 LGRADHQVKIRGYRIELGEIEAQLLN-HPGVSEAVVLDKADDKGEKyLCAYFVMEQELNISQLREYL---AKQLPEYMIP 456
|
490 500
....*....|....*....|...
gi 499404635 1005 FRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17656 457 SFFVPLDQLPLTPNGKVDRKALP 479
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
73-499 |
2.29e-89 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 299.63 E-value: 2.29e-89
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQRIDAYQPFVIQHD 152
Cdd:pfam00668 6 PLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEERPFELEII 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:pfam00668 86 DISDLSESEEEEAIEAFIQRDLQSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQLLKGE 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PYPVETTQlNYIDYAHWFNSDSFLDYHNEFKPFWVERLTGIPEVHSLPLDKPRPAHQN-SGGEVIFSaINNDLWDKFKRL 311
Cdd:pfam00668 166 PLPLPPKT-PYKDYAEWLQQYLQSEDYQKDAAYWLEQLEGELPVLQLPKDYARPADRSfKGDRLSFT-LDEDTEELLRKL 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 312 CQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLSA 391
Cdd:pfam00668 244 AKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKRVQEDLLSA 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 392 FDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQ------AKVDFNDLiPGCDAAEETSPVLPAKTDISVKVTELMGEVR 465
Cdd:pfam00668 324 EPHQGYPFGDLVNDLRLPRDLSRHPLFDPMFSFQnylgqdSQEEEFQL-SELDLSVSSVIEEEAKYDLSLTASERGGGLT 402
|
410 420 430
....*....|....*....|....*....|....
gi 499404635 466 LDWLFATALFERQTIQYYADRFIRLIEAVVENPE 499
Cdd:pfam00668 403 IKIDYNTSLFDEETIERFAEHFKELLEQAIAHPS 436
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
546-1026 |
2.46e-88 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 296.30 E-value: 2.46e-88
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDgeprTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL 625
Cdd:cd17650 1 PDAIAVSDA----TRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 RHIITDANLSVILggdgqqlaqwsaeqridlTDPavveqwqdlpgdqppaiprhaQQLAQVIYTSGSTGLPKGVMIEHGS 705
Cdd:cd17650 77 QYMLEDSGAKLLL------------------TQP---------------------EDLAYVIYTSGTTGKPKGVMVEHRN 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 706 LINLLDDHRDRIDFTPQST-MFNCMSLSFDAGNMTTLLPLSSGGTLAFGePNDraiMQAEQAGATHLIL----------P 774
Cdd:cd17650 118 VAHAAHAWRREYELDSFPVrLLQMASFSFDVFAGDFARSLLNGGTLVIC-PDE---VKLDPAALYDLILksritlmestP 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 775 T---ALMSILDPEQVN--GIQAIGMGGEACPNA----VVENWADKVALYNMYGPTECTVTalST-------RLRKGQPVT 838
Cdd:cd17650 194 AlirPVMAYVYRNGLDlsAMRLLIVGSDGCKAQdfktLAARFGQGMRIINSYGVTEATID--STyyeegrdPLGDSANVP 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 839 IGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLndvnnagqgAATLRIYRTGDKARLL 918
Cdd:cd17650 272 IGRPLPNTAMYVLDERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPF---------APGERMYRTGDLARWR 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 919 NNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPA-LVAYATVKADSSTPEPAAVLidvAKY 997
Cdd:cd17650 343 ADGNVELLGRVDHQVKIRGFRIELGEIESQLARH-PAIDEAVVAVREDKGGEArLCAYVVAAATLNTAELRAFL---AKE 418
|
490 500
....*....|....*....|....*....
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd17650 419 LPSYMIPSYYVQLDALPLTPNGKVDRRAL 447
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
1566-1982 |
1.37e-83 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 281.78 E-value: 1.37e-83
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALESECAS--IQVIVKQADLPFYY 1643
Cdd:cd19543 2 YPLSPMQEGMLFHSLLDPGSGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGepLQVVLKDRKLPWRE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1644 QDL--MQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQG 1721
Cdd:cd19543 82 LDLshLSEAEQEAELEALAEEDRERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALGEG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 QvlmhgdAPAIQVDRAYVDYARHAVAQ-QSAVDAFWQQRqslLAQTNDVSMLFAAAGKRADLSQhltqiEPQVTSVSLNE 1800
Cdd:cd19543 162 Q------PPSLPPVRPYRDYIAWLQRQdKEAAEAYWREY---LAGFEEPTPLPKELPADADGSY-----EPGEVSFELSA 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1801 KDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSVGLYINSLPLALSWQQPVSLQQH 1880
Cdd:cd19543 228 ELTARLQELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRPAELPGIETMVGLFINTLPVRVRLDPDQTVLEL 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1881 LVQLQNELMAMNQHATQSLI---ALTAGRSRLFNSLFIYENYPDAKAEQGQRADDPHRLYPEfsAAYEKVEMPLNLVVRE 1957
Cdd:cd19543 308 LKDLQAQQLELREHEYVPLYeiqAWSEGKQALFDHLLVFENYPVDESLEEEQDEDGLRITDV--SAEEQTNYPLTVVAIP 385
|
410 420
....*....|....*....|....*
gi 499404635 1958 QSGcMLLRFEFDADALDSAQARRVL 1982
Cdd:cd19543 386 GEE-LTIKLSYDAEVFDEATIERLL 409
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
73-498 |
5.18e-83 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 280.30 E-value: 5.18e-83
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEqgkGEqridAYQpfVIQHD 152
Cdd:cd19538 3 PLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPEED---GV----PYQ--LILEE 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLP----EAEREgRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLAC 228
Cdd:cd19538 74 DEATPKleikEVDEE-ELESEINEAVRYPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRAR 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 229 QNCQPYPVETTQLNYIDYAHW----FNSDSFLDYHNEFK-PFWVERLTGIPEVHSLPLDKPRPA-HQNSGGEVIFSaINN 302
Cdd:cd19538 153 CKGEAPELAPLPVQYADYALWqqelLGDESDPDSLIARQlAYWKKQLAGLPDEIELPTDYPRPAeSSYEGGTLTFE-IDS 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 303 DLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQ 382
Cdd:cd19538 232 ELHQQLLQLAKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLE 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 383 YCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVDFNDLIPGCDAAEETSPVLPAKTDISVKVTELMG 462
Cdd:cd19538 312 RVKETNLEAYEHQDIPFERLVEALNPTRSRSRHPLFQIMLALQNTPQPSLDLPGLEAKLELRTVGSAKFDLTFELREQYN 391
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 499404635 463 -------EVRLDwlFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19538 392 dgtpngiEGFIE--YRTDLFDHETIEALAQRYLLLLESAVENP 432
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
73-498 |
1.13e-75 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 258.85 E-value: 1.13e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQRIDAYQPFVIQHD 152
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGVPRQEILPPGPAPLEVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLlPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:cd19539 83 DLSD-PDSDRERRLEELLRERESRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRKGP 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PYPVETTQLNYIDYAHWFNSDSFLDYHNEFKPFWVERLTGIpEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKRLC 312
Cdd:cd19539 162 AAPLPELRQQYKEYAAWQREALAAPRAAELLDFWRRRLRGA-EPTALPTDRPRPAGFPYPGADLRFELDAELVAALRELA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 313 QRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLSAF 392
Cdd:cd19539 241 KRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKALVDAQ 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 393 DHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVDFNDLIPGCDAAEETSPVLP-AKTDISVKVTELMGEVRLDWLFA 471
Cdd:cd19539 321 RHQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNAPAGELELAGGLSYTEGSDIPDgAKFDLNLTVTEEGTGLRGSLGYA 400
|
410 420
....*....|....*....|....*..
gi 499404635 472 TALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19539 401 TSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
538-1026 |
7.03e-67 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 235.95 E-value: 7.03e-67
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLD 617
Cdd:PRK04813 8 IEEFAQTQPDFPAYDYLGE----KLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPVD 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 618 PDYPPERLRHIITDANLSVILGgdgqqlaqwSAEQRIDLTDPAVV--EQWQDLPGDQPPAIPRHAQQLAQV---IYTSGS 692
Cdd:PRK04813 84 VSSPAERIEMIIEVAKPSLIIA---------TEELPLEILGIPVItlDELKDIFATGNPYDFDHAVKGDDNyyiIFTSGT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 693 TGLPKGVMIEHGSLIN----LLDDHRdridfTPQ-STMFNCMSLSFDAGNMTTLLPLSSGGTLaFGEPNDrAIMQAEQAG 767
Cdd:PRK04813 155 TGKPKGVQISHDNLVSftnwMLEDFA-----LPEgPQFLNQAPYSFDLSVMDLYPTLASGGTL-VALPKD-MTANFKQLF 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 768 AThliLPT------------ALMSILDP----EQVNGIQAIGMGGEACPNAVVENWAD---KVALYNMYGPTECTVtALS 828
Cdd:PRK04813 228 ET---LPQlpinvwvstpsfADMCLLDPsfneEHLPNLTHFLFCGEELPHKTAKKLLErfpSATIYNTYGPTEATV-AVT 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 829 ----TR--LRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHItlndvnnAGQg 902
Cdd:PRK04813 304 sieiTDemLDQYKRLPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAFFTF-------DGQ- 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 903 aatlRIYRTGDKARLlNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL--------AAVCPSLKQIKVIvaqvgsrpALVA 974
Cdd:PRK04813 376 ----PAYHTGDAGYL-EDGLLFYQGRIDFQIKLNGYRIELEEIEQNLrqssyvesAVVVPYNKDHKVQ--------YLIA 442
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 975 YATVKADSSTPEPA---AVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK04813 443 YVVPKEEDFEREFEltkAIKKELKERLMEYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
73-498 |
1.62e-63 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 223.83 E-value: 1.62e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVvNEQGKGEQRI-DAYQPFVIQH 151
Cdd:cd19066 3 PLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFC-EEAGRYEQVVlDKTVRFRIEI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 152 DDFSLLpeAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNC 231
Cdd:cd19066 82 IDLRNL--ADPEARLLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAAERQ 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 232 QPYPVETTqLNYIDYAHWFNSDSFLDYHNEFKPFWVERLTGIPEVHSLPLDKPRPA-HQNSGGEVIFSaINNDLWDKFKR 310
Cdd:cd19066 160 KPTLPPPV-GSYADYAAWLEKQLESEAAQADLAYWTSYLHGLPPPLPLPKAKRPSQvASYEVLTLEFF-LRSEETKRLRE 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 311 LCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLS 390
Cdd:cd19066 238 VARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPELLKRTKEQSRE 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 391 AFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVDFNDLIPGCDAAEET-SPVLPAKTDISVKVTELM-GEVRLDW 468
Cdd:cd19066 318 AIEHQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFTTPVyTSSEGTVFDLDLEASEDPdGDLLLRL 397
|
410 420 430
....*....|....*....|....*....|
gi 499404635 469 LFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19066 398 EYSRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
682-1022 |
3.21e-63 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 219.46 E-value: 3.21e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 682 QLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPND--RA 759
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLPKFDpeAA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 760 IMQAEQAGATHLIL-PTALMSILDPEQVNG-----IQAIGMGGEACPNAVVENWAD--KVALYNMYGPTECTVTALSTRL 831
Cdd:cd04433 81 LELIEREKVTILLGvPTLLARLLKAPESAGydlssLRALVSGGAPLPPELLERFEEapGIKLVNGYGLTETGGTVATGPP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 832 RKG--QPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndvnnagQGAatlriY 909
Cdd:cd04433 161 DDDarKPGSVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEATAAVDE-----------DGW-----Y 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 910 RTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIV---AQVGSRPALVayaTVKADSSTPE 986
Cdd:cd04433 225 RTGDLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLG-HPGVAEAAVVGvpdPEWGERVVAV---VVLRPGADLD 300
|
330 340 350
....*....|....*....|....*....|....*..
gi 499404635 987 PAAvLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:cd04433 301 AEE-LRAhVRERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
73-498 |
1.32e-62 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 220.92 E-value: 1.32e-62
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQRIDAYQPFVIQHD 152
Cdd:cd19543 3 PLSPMQEGMLFHSLLDPGSGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVVLKDRKLPWREL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:cd19543 83 DLSHLSEAEQEAELEALAEEDRERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALGEGQ 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PYPVETTQlNYIDYAHWfnsdsfLDYHN--EFKPFWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKR 310
Cdd:cd19543 163 PPSLPPVR-PYRDYIAW------LQRQDkeAAEAYWREYLAGFEEPTPLPKELPADADGSYEPGEVSFELSAELTARLQE 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 311 LCQRYN-TSNFIgLHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQ 387
Cdd:cd19543 236 LARQHGvTLNTV-VQGAWALLLSRYSGRDDVVFGTTVSGRpaELPGIETMVGLFINTLPVRVRLDPDQTVLELLKDLQAQ 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 388 DLSAFDHQ---LYRFEALSEAIGsdrttainPIFQVMLVYQ--------------AKVDFNDLipgcDAAEETSpvlpak 450
Cdd:cd19543 315 QLELREHEyvpLYEIQAWSEGKQ--------ALFDHLLVFEnypvdesleeeqdeDGLRITDV----SAEEQTN------ 376
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 499404635 451 TDISVKVTELmGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19543 377 YPLTVVAIPG-EELTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| D-ala-DACP-lig |
TIGR01734 |
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also ... |
538-1026 |
1.72e-62 |
|
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also called D-alanine-D-alanyl carrier protein ligase) which activates D-alanine as an adenylate via the reaction D-ala + ATP -> D-ala-AMP + PPi, and further catalyzes the condensation of the amino acid adenylate with the D-alanyl carrier protein (D-ala-ACP). The D-alanine is then further transferred to teichoic acid in the biosynthesis of lipoteichoic acid (LTA) and wall teichoic acid (WTA) in gram positive bacteria, both polysacchatides. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan]
Pssm-ID: 273780 [Multi-domain] Cd Length: 502 Bit Score: 223.10 E-value: 1.72e-62
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFdgepRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLD 617
Cdd:TIGR01734 6 IQAFAETYPQTIAYRY----QGQELTYQQLKEQSDRLAAFIQKRILPKKSPIIVYGHMEPHMLVAFLGSIKSGHAYIPVD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 618 PDYPPERLRHIITDANLSVILGgdgqqlaqwSAEQRIDLTDPAV--VEQWQDLPGDQPPAIPRHA---QQLAQVIYTSGS 692
Cdd:TIGR01734 82 TSIPSERIEMIIEAAGPELVIH---------TAELSIDAVGTQIitLSALEQAETSGGPVSFDHAvkgDDNYYIIYTSGS 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 693 TGLPKGVMIEHGSLINLLDDHRDriDF-TPQSTMF-NCMSLSFDAGNMTTLLPLSSGGTLafgEPNDRAIMQA-----EQ 765
Cdd:TIGR01734 153 TGNPKGVQISHDNLVSFTNWMLA--DFpLSEGKQFlNQAPFSFDLSVMDLYPCLASGGTL---HCLDKDITNNfkllfEE 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 766 AGATHLILPT-----ALMSILDP----EQVNGIQAIGMGGEACPNAVVENWAD---KVALYNMYGPTECTVTALSTRLRK 833
Cdd:TIGR01734 228 LPKTGLNVWVstpsfVDMCLLDPnfnqENYPHLTHFLFCGEELPVKTAKALLErfpKATIYNTYGPTEATVAVTSVKITQ 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 834 GQ-------PVTIGKPLIHIQalILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlNDVNNagqgaatL 906
Cdd:TIGR01734 308 EIldqyprlPIGFAKPDMNLF--IMDEEGEPLPEGEKGEIVIVGPSVSKGYLNNPEKTAEAF-----FSHEG-------Q 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 907 RIYRTGDKARLlNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL--------AAVCPSL-KQIKVIvaqvgsrpALVAYAT 977
Cdd:TIGR01734 374 PAYRTGDAGTI-TDGQLFYQGRLDFQIKLHGYRIELEDIEFNLrqssyiesAVVVPKYnKDHKVE--------YLIAAIV 444
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 499404635 978 VKADSSTPE---PAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:TIGR01734 445 PETEDFEKEfqlTKAIKKELKKSLPAYMIPRKFIYRDQLPLTANGKIDRKAL 496
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
73-496 |
1.57e-60 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 215.20 E-value: 1.57e-60
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQgKGEQRIDAYQPFVIQHD 152
Cdd:cd20483 3 PMSTFQRRLWFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDD-FGEQQVLDDPSFHLIVI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSllPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQ 232
Cdd:cd20483 82 DLS--EAADPEAALDQLVRNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDALRAGR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 233 PY-PVETTQLNYIDYAHWFN---SDSFLDYHNEFkpfWVERLTGIPEVHS-LPLDK-PRPAHQNSGGEVIFSAINNDLWD 306
Cdd:cd20483 160 DLaTVPPPPVQYIDFTLWHNallQSPLVQPLLDF---WKEKLEGIPDASKlLPFAKaERPPVKDYERSTVEATLDKELLA 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 307 KFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCRE 386
Cdd:cd20483 237 RMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLESTKT 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 387 QDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQ-----AKVDFNDLipgcDAAEETSPVLPAKTDISVKVTELM 461
Cdd:cd20483 317 TCLEAYEHSAVPFDYIVDALDVPRSTSHFPIGQIAVNYQvhgkfPEYDTGDF----KFTDYDHYDIPTACDIALEAEEDP 392
|
410 420 430
....*....|....*....|....*....|....*.
gi 499404635 462 -GEVRLDWLFATALFERQTIQYYADRFIRLIEAVVE 496
Cdd:cd20483 393 dGGLDLRLEFSTTLYDSADMERFLDNFVTFLTSVIR 428
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
71-498 |
1.87e-60 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 214.63 E-value: 1.87e-60
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 71 SGPLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVN-EQGKGEQRIDAYQPFVI 149
Cdd:cd19532 1 TEPMSFGQSRFWFLQQYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFFTDpEDGEPMQGVLASSPLRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 150 QHDDFSLLPEAERE-GRLQQQVkaeisrpFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFlac 228
Cdd:cd19532 81 EHVQISDEAEVEEEfERLKNHV-------YDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAY--- 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 229 qNCQPYPVETTQlnYIDYAhwfnSDSFLDYHN-EFKP---FWVERLTGIPEVhsLPL-----DKPRPAHQNSGGEVIFSA 299
Cdd:cd19532 151 -NGQPLLPPPLQ--YLDFA----ARQRQDYESgALDEdlaYWKSEFSTLPEP--LPLlpfakVKSRPPLTRYDTHTAERR 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 300 INNDLWDKFKRLCQRYNTSNFiglH---AVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQN 376
Cdd:cd19532 222 LDAALAARIKEASRKLRVTPF---HfylAALQVLLARLLDVDDICIGIADANRTDEDFMETIGFFLNLLPLRFRRDPSQT 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 377 FVDYLQYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVdfNDLIPGCDAAEETSPVLPAKT--DIS 454
Cdd:cd19532 299 FADVLKETRDKAYAALAHSRVPFDVLLDELGVPRSATHSPLFQVFINYRQGV--AESRPFGDCELEGEEFEDARTpyDLS 376
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 499404635 455 VKVTEL-MGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19532 377 LDIIDNpDGDCLLTLKVQSSLYSEEDAELLLDSYVNLLEAFARDP 421
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
74-318 |
1.72e-58 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 202.58 E-value: 1.72e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 74 LSSSQSGLWFIEQyeeQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVnEQGKGEQRIDAYQPFVIQHDD 153
Cdd:COG4908 1 LSPAQKRFLFLEP---GSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVE-EDGEPVQRIDPDADLPLEVVD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 154 FSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQNCQP 233
Cdd:COG4908 77 LSALPEPEREAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEGEP 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 234 YPVETTQLNYIDYAHWFNSDSFLDYHNEFKPFWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKRLCQ 313
Cdd:COG4908 157 PPLPELPIQYADYAAWQRAWLQSEALEKQLEYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLSFTLPAELTEALKALAK 236
|
....*
gi 499404635 314 RYNTS 318
Cdd:COG4908 237 AHGAT 241
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
265-1085 |
8.02e-58 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 221.48 E-value: 8.02e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 265 FWVERLTGiPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLwdkfkrLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGS 344
Cdd:TIGR03443 1 RWSERLDN-PTLSVLPHDYLRPANNRLVEATYSLQLPSAE------VTAGGGSTPFIILLAAFAALVYRLTGDEDIVLGT 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 345 PLAYRERPdiedvvgffvntIVLRTQLQDSQNFVD-YLQYCREQDLSAFDHQLyRFEALSEAIGSDRTTAINPIFqVMLV 423
Cdd:TIGR03443 74 SSNKSGRP------------FVLRLNITPELSFLQlYAKVSEEEKEGASDIGV-PFDELSEHIQAAKKLERTPPL-FRLA 139
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 424 YQAKVDFNDlipgcDAAEETSPvlpakTDISVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENPETDVW 503
Cdd:TIGR03443 140 FQDAPDNQQ-----TTYSTGST-----TDLTVFLTPSSPELELSIYYNSLLFSSDRITIVADQLAQLLSAASSNPDEPIG 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 504 HLPLMETDrfaavlaETQQLPRsyPQPQL-------TVTDVIEAVAQRDPQQLAI-----AFDGEPRTDTLTYAELNRQA 571
Cdd:TIGR03443 210 KVSLITPS-------QKSLLPD--PTKDLdwsgfrgAIHDIFADNAEKHPDRTCVvetpsFLDPSSKTRSFTYKQINEAS 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 572 NQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPErlRHIITdanLSV------ILGGDGQQL 645
Cdd:TIGR03443 281 NILAHYLLKTGIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPA--RQTIY---LSVakpralIVIEKAGTL 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 646 AQwSAEQRID------LTDPAVveQWQD---LPGDQPPA----IPRHAQQLAQ----VI----------YTSGSTGLPKG 698
Cdd:TIGR03443 356 DQ-LVRDYIDkelelrTEIPAL--ALQDdgsLVGGSLEGgetdVLAPYQALKDtptgVVvgpdsnptlsFTSGSEGIPKG 432
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 699 VMIEHGSLINLLDDHRDRIDFTPQS--TMfncmsLSFDAG-----NMTTllPLSSGGTLA------FGEPNDRA-IMQAE 764
Cdd:TIGR03443 433 VLGRHFSLAYYFPWMAKRFGLSENDkfTM-----LSGIAHdpiqrDMFT--PLFLGAQLLvptaddIGTPGRLAeWMAKY 505
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 765 QAGATHLilpTALMSildpeQVNGIQAIgmggEACP---NAV-------------VENWADKVALYNMYGPTEC------ 822
Cdd:TIGR03443 506 GATVTHL---TPAMG-----QLLSAQAT----TPIPslhHAFfvgdiltkrdclrLQTLAENVCIVNMYGTTETqravsy 573
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 823 ----TVTALSTRLRKGQPVT-IGKPLIHIQALIL---DTAgQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF------ 888
Cdd:TIGR03443 574 feipSRSSDSTFLKNLKDVMpAGKGMKNVQLLVVnrnDRT-QTCGVGEVGEIYVRAGGLAEGYLGLPELNAEKFvnnwfv 652
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 889 ---EHITLNDVNNAGQGAATL----RIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKV 961
Cdd:TIGR03443 653 dpsHWIDLDKENNKPEREFWLgprdRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTL 732
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 962 IVAQVGSRPALVAYATVKADSSTPEPAAVLIDVA-------------------------KYLPEYMVPFRLMLLEDMPLT 1016
Cdd:TIGR03443 733 VRRDKDEEPTLVSYIVPQDKSDELEEFKSEVDDEessdpvvkglikyrklikdireylkKKLPSYAIPTVIVPLKKLPLN 812
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1017 PNGKLDMKQLP-P-----VLEANESDGEAD----NPLEADVLAIWRSVL---NTPLGVEDDFFRLGGDSILSIQLTTRLR 1083
Cdd:TIGR03443 813 PNGKVDKPALPfPdtaqlAAVAKNRSASAAdeefTETEREIRDLWLELLpnrPATISPDDSFFDLGGHSILATRMIFELR 892
|
..
gi 499404635 1084 SA 1085
Cdd:TIGR03443 893 KK 894
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
542-1022 |
3.92e-57 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 205.54 E-value: 3.92e-57
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYP 621
Cdd:cd17631 5 ARRHPDRTALVFGGR----SLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 622 PERLRHIITDANLSVILGgdgqqlaqwsaeqridltdpavveqwqdlpgdqppaiprhaqQLAQVIYTSGSTGLPKGVMI 701
Cdd:cd17631 81 PPEVAYILADSGAKVLFD------------------------------------------DLALLMYTSGTTGRPKGAML 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 702 EHGSLINLLDDHRDRIDFTPQSTMFNCMSLS-FDAGNMTTLLPLSSGGTL----AFgEPnDRAIMQAEQAGATHLIL-PT 775
Cdd:cd17631 119 THRNLLWNAVNALAALDLGPDDVLLVVAPLFhIGGLGVFTLPTLLRGGTVvilrKF-DP-ETVLDLIERHRVTSFFLvPT 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 776 ALMSILDPEQVN-----GIQAIGMGGEACPNAVVENWADK-VALYNMYGPTECT--VTALSTRLRKGQPVTIGKPLIHIQ 847
Cdd:cd17631 197 MIQALLQHPRFAttdlsSLRAVIYGGAPMPERLLRALQARgVKFVQGYGMTETSpgVTFLSPEDHRRKLGSAGRPVFFVE 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 848 ALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndvnnaGQgaatlriYRTGDKARLLNNGDYEYCG 927
Cdd:cd17631 277 VRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAFRD---------GW-------FHTGDLGRLDEDGYLYIVD 340
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 928 RIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIV---AQVGSRPALVAyatVKADSSTPEPAAVLIDVAKYLPEYMVP 1004
Cdd:cd17631 341 RKKDMIISGGENVYPAEVEDVLYEH-PAVAEVAVIGvpdEKWGEAVVAVV---VPRPGAELDEDELIAHCRERLARYKIP 416
|
490
....*....|....*...
gi 499404635 1005 FRLMLLEDMPLTPNGKLD 1022
Cdd:cd17631 417 KSVEFVDALPRNATGKIL 434
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
536-1026 |
8.08e-56 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 202.79 E-value: 8.08e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAVAQRDPQQLAIAFDGEPrtdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVP 615
Cdd:cd05936 3 DLLEEAARRFPDKTALIFMGRK----LTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVP 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 616 LDPDYPPERLRHIITDANLSVILggdgqqlaqwsaeqrIDLTDPAVVEQWQDLPGDQPpaipRHAQQLAQVIYTSGSTGL 695
Cdd:cd05936 79 LNPLYTPRELEHILNDSGAKALI---------------VAVSFTDLLAAGAPLGERVA----LTPEDVAVLQYTSGTTGV 139
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 696 PKGVMIEHGSLI-NLLD-DHRDRIDFTPQSTMFNCMSLsFDAGNMTT--LLPLSSGGTLAFgEPN--DRAIMQA-EQAGA 768
Cdd:cd05936 140 PKGAMLTHRNLVaNALQiKAWLEDLLEGDDVVLAALPL-FHVFGLTValLLPLALGATIVL-IPRfrPIGVLKEiRKHRV 217
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 769 THLI-LPTALMSIL-----DPEQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECT-VTALSTRLRKGQPVTI 839
Cdd:cd05936 218 TIFPgVPTMYIALLnapefKKRDFSSLRLCISGGAPLPVEVAERFEELtgVPIVEGYGLTETSpVVAVNPLDGPRKPGSI 297
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 840 GKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAgqgaatlriYRTGDKARLLN 919
Cdd:cd05936 298 GIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAF-------VDGW---------LRTGDIGYMDE 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 920 NGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQikviVAQVG-----SRPALVAYAtVKADSSTPEPAAVLIDV 994
Cdd:cd05936 362 DGYFFIVDRKKDMIIVGGFNVYPREVEEVLYEH-PAVAE----AAVVGvpdpySGEAVKAFV-VLKEGASLTEEEIIAFC 435
|
490 500 510
....*....|....*....|....*....|..
gi 499404635 995 AKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05936 436 REQLAGYKVPRQVEFRDELPKSAVGKILRREL 467
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
542-1021 |
1.24e-55 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 204.96 E-value: 1.24e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAFDGEPRTD-TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDY 620
Cdd:COG0365 19 AEGRGDKVALIWEGEDGEErTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSPVFPGF 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 621 PPERLRHIITDANLSVILGGDGQqlaqWSAEQRIDLT---DPAV-----VEQ------------------WQDLPGDQP- 673
Cdd:COG0365 99 GAEALADRIEDAEAKVLITADGG----LRGGKVIDLKekvDEALeelpsLEHvivvgrtgadvpmegdldWDELLAAASa 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 674 --PAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGS-LINLLDDHRDRIDFTPQSTMFnCMSlsfDAGNMTTLL-----PLS 745
Cdd:COG0365 175 efEPEPTDADDPLFILYTSGTTGKPKGVVHTHGGyLVHAATTAKYVLDLKPGDVFW-CTA---DIGWATGHSyivygPLL 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 746 SG-------GTLAFGEPnDRAIMQAEQAGATHLIL-PTALMSIL--DPEQVNG-----IQAIGMGGEACPNAVVENWAD- 809
Cdd:COG0365 251 NGatvvlyeGRPDFPDP-GRLWELIEKYGVTVFFTaPTAIRALMkaGDEPLKKydlssLRLLGSAGEPLNPEVWEWWYEa 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 810 -KVALYNMYGPTECTVTALSTRLrkGQPV---TIGKPLIHIQALILDTAGQLCPVGVPGELCLAG--LGLARGYLNQPQm 883
Cdd:COG0365 330 vGVPIVDGWGQTETGGIFISNLP--GLPVkpgSMGKPVPGYDVAVVDEDGNPVPPGEEGELVIKGpwPGMFRGYWNDPE- 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 884 tasRFEHITLNDVNNagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL--------AAVCPS 955
Cdd:COG0365 407 ---RYRETYFGRFPG---------WYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALvshpavaeAAVVGV 474
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 499404635 956 LKQIKvivaqvGSRPalVAYATVKADSstpEPAAVLID-----VAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:COG0365 475 PDEIR------GQVV--KAFVVLKPGV---EPSDELAKelqahVREELGPYAYPREIEFVDELPKTRSGKI 534
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
1124-1543 |
7.05e-53 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 193.70 E-value: 7.05e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1124 EGEFALLPIQ--RWFMEQSLARPEHWNQAAMIQL-PEVDTERLVTMLQALMAQHDALRLGCDAEG-----QRYLADVPCP 1195
Cdd:pfam00668 2 QDEYPLSPAQkrMWFLEKLEPHSSAYNMPAVLKLtGELDPERLEKALQELINRHDALRTVFIRQEngepvQVILEERPFE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1196 aLSTLDYRQLGDDGLQQAFTA-----LQSEFDPAQGRTMACALVRHHPQADTaLFLAFHHLVIDAVSWRILVDDLERLYL 1270
Cdd:pfam00668 82 -LEIIDISDLSESEEEEAIEAfiqrdLQSPFDLEKGPLFRAGLFRIAENRHH-LLLSMHHIIVDGVSLGILLRDLADLYQ 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1271 ----GEPL-LPKTSSYRQWGAALQHYATQHA--EQLTYWQAQEDGVDLTALLA---AKDPQGHASAAILTLD-AKTTGQL 1339
Cdd:pfam00668 160 qllkGEPLpLPPKTPYKDYAEWLQQYLQSEDyqKDAAYWLEQLEGELPVLQLPkdyARPADRSFKGDRLSFTlDEDTEEL 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1340 VSEANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREaiDPtlDVSRTVGWFTSTYPVCLQDKP--DWASLIQS 1417
Cdd:pfam00668 240 LRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRP--SP--DIERMVGMFVNTLPLRIDPKGgkTFSELIKR 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1418 SKEQLRQV-PDKGVGFNPLRYHHPQGNSLTLSP-----IVF-NYLGLSVQaAGTWRPVDVAPGCCVSPGNKPAEVISLHG 1490
Cdd:pfam00668 316 VQEDLLSAePHQGYPFGDLVNDLRLPRDLSRHPlfdpmFSFqNYLGQDSQ-EEEFQLSELDLSVSSVIEEEAKYDLSLTA 394
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 1491 GITGGQLTLR---QVGCLNQRDSERLMTRLTENLRALTEACLTQLSHgvVFTPSDF 1543
Cdd:pfam00668 395 SERGGGLTIKidyNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSE--LDLLSDA 448
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
533-1026 |
5.17e-52 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 192.69 E-value: 5.17e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:TIGR03098 1 LLHHLLEDAAARLPDATALVHHDR----TLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGV 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDANLSVILggdgqqlaqwSAEQRIDLTDPAVVE--------------------------QWQ 666
Cdd:TIGR03098 77 FVPINPLLKAEQVAHILADCNVRLLV----------TSSERLDLLHPALPGchdlrtliivgdpahaseghpgeepaSWP 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 667 DLP--GDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPL 744
Cdd:TIGR03098 147 KLLalGDADPPHPVIDSDMAAILYTSGSTGRPKGVVLSHRNLVAGAQSVATYLENRPDDRLLAVLPLSFDYGFNQLTTAF 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 745 SSGGTLAFGE---PND--RAIMQAEQAGATHLILPTALMSILD--PEQVNGIQAIGMGGEACPNAVV---ENWADKVALY 814
Cdd:TIGR03098 227 YVGATVVLHDyllPRDvlKALEKHGITGLAAVPPLWAQLAQLDwpESAAPSLRYLTNSGGAMPRATLsrlRSFLPNARLF 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 815 NMYGPTEC-TVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITL 893
Cdd:TIGR03098 307 LMYGLTEAfRSTYLPPEEVDRRPDSIGKAIPNAEVLVLREDGSECAPGEEGELVHRGALVAMGYWNDPEKTAERFRPLPP 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 894 NDVNNAGQGAATLriyrTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVAQV--GSRPA 971
Cdd:TIGR03098 387 FPGELHLPELAVW----SGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVAFGVPDPtlGQAIV 462
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 972 LVAYATVKAdssTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:TIGR03098 463 LVVTPPGGE---ELDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKAL 514
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
71-498 |
3.86e-51 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 187.91 E-value: 3.86e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 71 SGPLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTrfVVNEQ-GKGEQRIDAYQPFVI 149
Cdd:cd20484 1 RSPLSEGQKGLWMLQKMSPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKS--VIEEEdGVPFQKIEPSKPLSF 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 150 QHDDFSLLPEAEREGRLQQQVKaeisRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQ 229
Cdd:cd20484 79 QEEDISSLKESEIIAYLREKAK----EPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQALL 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 230 NCQPYPVETTQLNYIDYAHWfnSDSFLDYHN--EFKPFWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDK 307
Cdd:cd20484 155 QGKQPTLASSPASYYDFVAW--EQDMLAGAEgeEHRAYWKQQLSGTLPILELPADRPRSSAPSFEGQTYTRRLPSELSNQ 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 308 FKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQ 387
Cdd:cd20484 233 IKSFARSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSDFIRKLQLT 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 388 DLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVMLVYQAKVDFNDLIpgcDAAEETSPVLP----------AKTDISVKV 457
Cdd:cd20484 313 VLDGLDHAAYPFPAMVRDLNIPRSQANSPVFQVAFFYQNFLQSTSLQ---QFLAEYQDVLSiefvegihqeGEYELVLEV 389
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 499404635 458 TELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd20484 390 YEQEDRFTLNIKYNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
1567-2005 |
9.03e-50 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 184.46 E-value: 9.03e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALESECAS--IQVIVKQADLPFYYQ 1644
Cdd:pfam00668 6 PLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGepVQVILEERPFELEII 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DL--MQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQ 1722
Cdd:pfam00668 86 DIsdLSESEEEEAIEAFIQRDLQSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQLLKGE 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1723 VLmhgDAPAIQvdrAYVDYA-RHAVAQQSAV----DAFWQQRqslLAQTNDVSMLFAAAGKRADLSqhltqIEPQVTSVS 1797
Cdd:pfam00668 166 PL---PLPPKT---PYKDYAeWLQQYLQSEDyqkdAAYWLEQ---LEGELPVLQLPKDYARPADRS-----FKGDRLSFT 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1798 LNEKDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPveDVASSVGLYINSLPLALSWQQPVSL 1877
Cdd:pfam00668 232 LDEDTEELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSP--DIERMVGMFVNTLPLRIDPKGGKTF 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1878 QQHLVQLQNELMAMNQHA--------TQSLIALTAGRSRLFNSLFIYENYP--DAKAEQGQRADDPhrlYPEFSAAYEKV 1947
Cdd:pfam00668 310 SELIKRVQEDLLSAEPHQgypfgdlvNDLRLPRDLSRHPLFDPMFSFQNYLgqDSQEEEFQLSELD---LSVSSVIEEEA 386
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 1948 EMPLNLVVREQSGCMLLRFEFDADALDSAqarrVLMRWHDEVVALVNSVPQQPAEIIG 2005
Cdd:pfam00668 387 KYDLSLTASERGGGLTIKIDYNTSLFDEE----TIERFAEHFKELLEQAIAHPSQPLS 440
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
73-498 |
2.19e-48 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 179.49 E-value: 2.19e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEqGKGEQRIDAYQPFVIQHD 152
Cdd:cd19533 3 PLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEE-GEPYQWIDPYTPVPIRHI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DFSllPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVkNLF----ADFKPAFLAC 228
Cdd:cd19533 82 DLS--GDPDPEGAAQQWMQEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSF-ALFgqrvAEIYTALLKG 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 229 QNCQPYPVETTQLNYIDYAHWFNSDSFLdyhnEFKPFWVERLTGIPEVHSLpldKPRPAHQNSGGEVIFSAINNDLWDKF 308
Cdd:cd19533 159 RPAPPAPFGSFLDLVEEEQAYRQSERFE----RDRAFWTEQFEDLPEPVSL---ARRAPGRSLAFLRRTAELPPELTRTL 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 309 KRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQD 388
Cdd:cd19533 232 LEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVSREL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 389 LSAFDHQLYRFEALSEAIG--SDRTTAINPIFQVMlVYQAKVDFndliPGCDAAEETSPVLPAkTDISVKVTELM--GEV 464
Cdd:cd19533 312 RSLLRHQRYRYEDLRRDLGltGELHPLFGPTVNYM-PFDYGLDF----GGVVGLTHNLSSGPT-NDLSIFVYDRDdeSGL 385
|
410 420 430
....*....|....*....|....*....|....
gi 499404635 465 RLDWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19533 386 RIDFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
563-1027 |
2.65e-48 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 179.41 E-value: 2.65e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 563 TYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDAnlsvilggdG 642
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINTALRGDELAYIIDHS---------G 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 643 QQLAqwsaeqridLTDPAvveqwqdlpgdqppaiprhaqqlaQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQ 722
Cdd:cd05934 76 AQLV---------VVDPA------------------------SILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLGED 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 723 STMFNCMSLSF-DAGNMTTLLPLSSGGTLAFGE--PNDRAIMQAEQAGAT--HLI--LPTALMSilDPEQVNGIQA---I 792
Cdd:cd05934 123 DVYLTVLPLFHiNAQAVSVLAALSVGATLVLLPrfSASRFWSDVRRYGATvtNYLgaMLSYLLA--QPPSPDDRAHrlrA 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 793 GMGGEAcPNAVVENWADK--VALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCL-- 868
Cdd:cd05934 201 AYGAPN-PPELHEEFEERfgVRLLEGYGMTETIVGVIGPRDEPRRPGSIGRPAPGYEVRIVDDDGQELPAGEPGELVIrg 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 869 -AGLGLARGYLNQPQMTASRFEHItlndvnnagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:cd05934 280 lRGWGFFKGYYNMPEATAEAMRNG----------------WFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVER 343
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLAAVcPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd05934 344 AILRH-PAVREAAVVAVPDEVGEDEVKAVVVLRPGETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVAKAQLR 422
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
571-1026 |
3.28e-48 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 179.94 E-value: 3.28e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 571 ANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA----YVPLDPDYPPERLRHIITDANLSVILGGDGqqLA 646
Cdd:cd05922 3 VSAAASALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGRlglvFVPLNPTLKESVLRYLVADAGGRIVLADAG--AA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 647 QWSAEQRIDLTDPAVV---EQWQDlPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQS 723
Cdd:cd05922 81 DRLRDALPASPDPGTVldaDGIRA-ARASAPAHEVSHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLGITADD 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 724 TMFNCMSLSFDAGNMTTLLPLSSGGTLAF---GEPNDRAIMQAEQAGATHL-ILPTaLMSIL-----DPEQVNGIQAIGM 794
Cdd:cd05922 160 RALTVLPLSYDYGLSVLNTHLLRGATLVLtndGVLDDAFWEDLREHGATGLaGVPS-TYAMLtrlgfDPAKLPSLRYLTQ 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 GGEACPNAVVENWADKVA---LYNMYGPTECT--VTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLA 869
Cdd:cd05922 239 AGGRLPQETIARLRELLPgaqVYVMYGQTEATrrMTYLPPERILEKPGSIGLAIPGGEFEILDDDGTPTPPGEPGEIVHR 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 870 GLGLARGYLNQPQmtasrfehitlndvnNAGQGAATLRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL 949
Cdd:cd05922 319 GPNVMKGYWNDPP---------------YRRKEGRGGGVLHTGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAA 383
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 499404635 950 AAVcpslKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05922 384 RSI----GLIIEAAAVGLPDPLGEKLALFVTAPDKIDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
1565-1981 |
6.59e-44 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 166.47 E-value: 6.59e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1565 LLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRA--ALESECASIQVIVKQADLPFY 1642
Cdd:cd19536 1 MYPLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTsfIEDGLGQPVQVVHRQAQVPVT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1643 YQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVL-LSCHHSVIDGWSGPQLLGavhrDYQTLMQG 1721
Cdd:cd19536 81 ELDLTPLEEQLDPLRAYKEETKIRRFDLGRAPLVRAALVRKDERERFLLvISDHHSILDGWSLYLLVK----EILAVYNQ 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 QVLMHGDAPAIQVDraYVDYARH--AVAQQSAVDAFWQQRqslLAqtnDVSMLFAAAGKRAdLSQHLTQIEPQVTSVSLn 1799
Cdd:cd19536 157 LLEYKPLSLPPAQP--YRDFVAHerASIQQAASERYWREY---LA---GATLATLPALSEA-VGGGPEQDSELLVSVPL- 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1800 ekdQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSVGLYINSLPLALSWQQpVSLQQ 1879
Cdd:cd19536 227 ---PVRSRSLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEETTGAERLLGLFLNTLPLRVTLSE-ETVED 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1880 HLVQLQNELMAM--NQHATQSLIALTAGRSRLFNSLFIYENYPDAKAEQGQRADDPHRLYPEFSAayEKVEMPLNLVVRE 1957
Cdd:cd19536 303 LLKRAQEQELESlsHEQVPLADIQRCSEGEPLFDSIVNFRHFDLDFGLPEWGSDEGMRRGLLFSE--FKSNYDVNLSVLP 380
|
410 420
....*....|....*....|....
gi 499404635 1958 QSGCMLLRFEFDADALDSAQARRV 1981
Cdd:cd19536 381 KQDRLELKLAYNSQVLDEEQAQRL 404
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
550-1026 |
1.60e-43 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 166.11 E-value: 1.60e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 550 AIAFDGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHII 629
Cdd:cd17654 5 ALIIDQTTSDTTVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVM 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 630 TDANLSVILGGDGQ---QLAQWSAEQRIDLtdpavveqwqdlpgdqppaipRHAQQLAQVIYTSGSTGLPKGVMIEHGSL 706
Cdd:cd17654 85 KKCHVSYLLQNKELdnaPLSFTPEHRHFNI---------------------RTDECLAYVIHTSGTTGTPKIVAVPHKCI 143
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 707 INLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGE-----------PNDRAIMQAEQAGATHLILPT 775
Cdd:cd17654 144 LPNIQHFRSLFNITSEDILFLTSPLTFDPSVVEIFLSLSSGATLLIVPtsvkvlpsklaDILFKRHRITVLQATPTLFRR 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 776 ALMSILDPEQVNGIQAI---GMGGEACP-NAVVENWA---DKVALYNMYGPTECTVTALSTRLRKGQ-PVTIGKPLIHIQ 847
Cdd:cd17654 224 FGSQSIKSTVLSATSSLrvlALGGEPFPsLVILSSWRgkgNRTRIFNIYGITEVSCWALAYKVPEEDsPVQLGSPLLGTV 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 848 ALILDtagqLCPVGVPGELCLAGL---GLARGYLNQPQMTasrfehitlndvnnagqgaatlrIYRTGDKARlLNNGDYE 924
Cdd:cd17654 304 IEVRD----QNGSEGTGQVFLGGLnrvCILDDEVTVPKGT-----------------------MRATGDFVT-VKDGELF 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 925 YCGRIDEQIKLRGYRIEPGEIEaqlaAVCPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIDvakyLPEYMVP 1004
Cdd:cd17654 356 FLGRKDSQIKRRGKRINLDLIQ----QVIESCLGVESCAVTLSDQQRLIAFIVGESSSSRIHKELQLTL----LSSHAIP 427
|
490 500
....*....|....*....|..
gi 499404635 1005 FRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd17654 428 DTFVQIDKLPLTSHGKVDKSEL 449
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
549-1026 |
2.11e-42 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 162.46 E-value: 2.11e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 549 LAIAFDGeprtDTLTYAELNRQANQLAHWLHRQG-LGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRH 627
Cdd:cd05941 3 IAIVDDG----DSITYADLVARAARLANRLLALGkDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEY 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 628 IITDANLSVILggdgqqlaqwsaeqridltDPAVVeqwqdlpgdqppaiprhaqqlaqvIYTSGSTGLPKGVMIEHGSLI 707
Cdd:cd05941 79 VITDSEPSLVL-------------------DPALI------------------------LYTSGTTGRPKGVVLTHANLA 115
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 708 NLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGT---LAFGEPNDRAIMQAEQAGATHLILPTALMSILD- 782
Cdd:cd05941 116 ANVRALVDAWRWTEDDVLLHVLPLHHVHGLVNALLcPLFAGASvefLPKFDPKEVAISRLMPSITVFMGVPTIYTRLLQy 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 783 ----PEQVNGIQAIGM--------GGEACPNAVVENWADKV--ALYNMYGPTEcTVTALSTRLrKGQPV--TIGKPLIHI 846
Cdd:cd05941 196 yeahFTDPQFARAAAAerlrlmvsGSAALPVPTLEEWEAITghTLLERYGMTE-IGMALSNPL-DGERRpgTVGMPLPGV 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 847 QALILDT-AGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndvnnagqgaATLRIYRTGDKARLLNNGDYEY 925
Cdd:cd05941 274 QARIVDEeTGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEF---------------TDDGWFKTGDLGVVDEDGYYWI 338
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 926 CGRI-DEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI-VAQVGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMV 1003
Cdd:cd05941 339 LGRSsVDIIKSGGYKVSALEIERVLLAH-PGVSECAVIgVPDPDWGERVVAVVVLRAGAAALSLEELKEWAKQRLAPYKR 417
|
490 500
....*....|....*....|...
gi 499404635 1004 PFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05941 418 PRRLILVDELPRNAMGKVNKKEL 440
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
559-1021 |
3.01e-42 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 163.15 E-value: 3.01e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 559 TDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVIL 638
Cdd:cd05911 8 GKELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPKVIF 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 639 gGDGQQL-------AQWSAEQRIDLTDPAV-----VEQ-WQDLPG----DQPPAIPRHAQQLAQVIYTSGSTGLPKGVMI 701
Cdd:cd05911 88 -TDPDGLekvkeaaKELGPKDKIIVLDDKPdgvlsIEDlLSPTLGeedeDLPPPLKDGKDDTAAILYSSGTTGLPKGVCL 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 702 EHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFD--AGNMTTLLPLSSGGTL-AFGEPNDRAIMQA-EQAGATHLILPTAL 777
Cdd:cd05911 167 SHRNLIANLSQVQTFLYGNDGSNDVILGFLPLYhiYGLFTTLASLLNGATViIMPKFDSELFLDLiEKYKITFLYLVPPI 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 778 MSIL------DPEQVNGIQAIGMGGEACPNAVVE---NWADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQA 848
Cdd:cd05911 247 AAALakspllDKYDLSSLRVILSGGAPLSKELQEllaKRFPNATIKQGYGMTETGGILTVNPDGDDKPGSVGRLLPNVEA 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 849 LILDTAG-QLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndvnnagQGaatlrIYRTGDKARLLNNGDYEYCG 927
Cdd:cd05911 327 KIVDDDGkDSLGPNEPGEICVRGPQVMKGYYNNPEATKETFDE----------DG-----WLHTGDIGYFDEDGYLYIVD 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 928 RIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI---VAQVGSRPAlvAYaTVKADSSTPEPAAVLIDVAKYLPEYmvp 1004
Cdd:cd05911 392 RKKELIKYKGFQVAPAELEAVLLEH-PGVADAAVIgipDEVSGELPR--AY-VVRKPGEKLTEKEVKDYVAKKVASY--- 464
|
490 500
....*....|....*....|.
gi 499404635 1005 FRL----MLLEDMPLTPNGKL 1021
Cdd:cd05911 465 KQLrggvVFVDEIPKSASGKI 485
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
73-498 |
3.98e-40 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 155.72 E-value: 3.98e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFvVNEQGKGEQRI---DAYQPfvi 149
Cdd:cd19546 6 PATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTF-PGDGGDVHQRIldaDAARP--- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 150 qhdDFSLLPEAEREgrLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFLACQ 229
Cdd:cd19546 82 ---ELPVVPATEEE--LPALLADRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYGARR 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 230 NCQPYPVETTQLNYIDYAHWF--------NSDSFLdyhNEFKPFWVERLTGIPEVHSLPLDKPRPAHQNSGGEVIFSAIN 301
Cdd:cd19546 157 EGRAPERAPLPLQFADYALWErellagedDRDSLI---GDQIAYWRDALAGAPDELELPTDRPRPVLPSRRAGAVPLRLD 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 302 NDLWDKFKRLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYR-ERPDIEDVVGFFVNTIVLRTQLQDSQNFVDY 380
Cdd:cd19546 234 AEVHARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDdEEGDLEGMVGPFARPLALRTDLSGDPTFREL 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 381 LQYCREQDLSAFDHQLYRFEALSEAIGSDRTTAINPIFQVML-VYQAKVDFNDL--IPGCDAAEETSPVLPAKTDISVKV 457
Cdd:cd19546 314 LGRVREAVREARRHQDVPFERLAELLALPPSADRHPVFQVALdVRDDDNDPWDApeLPGLRTSPVPLGTEAMELDLSLAL 393
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|.
gi 499404635 458 TE----------LMGEVRldwlFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19546 394 TErrnddgdpdgLDGSLR----YAADLFDRATAAALARRLVRVLEQVAADP 440
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
558-1027 |
6.11e-40 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 157.29 E-value: 6.11e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 558 RTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERlrhiiTDANLSVi 637
Cdd:cd17647 17 KTRSFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPAR-----QNIYLGV- 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 638 lggdgqqlaqwsAEQR--IDLTDPAVVEQwqdlpgdqPPAIPrhaqqlaQVIYTSGSTGLPKGVMIEHGSLINLLDDHRD 715
Cdd:cd17647 91 ------------AKPRglIVIRAAGVVVG--------PDSNP-------TLSFTSGSEGIPKGVLGRHFSLAYYFPWMAK 143
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 716 RIDFTPqSTMFNCMS-LSFDAGNMTTLLPLSSGGTLAFGEPND-----RAIMQAEQAGATHLILPTALMSILDPEQVNGI 789
Cdd:cd17647 144 RFNLSE-NDKFTMLSgIAHDPIQRDMFTPLFLGAQLLVPTQDDigtpgRLAEWMAKYGATVTHLTPAMGQLLTAQATTPF 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 790 ----QAIGMGG----EACpnAVVENWADKVALYNMYGPTEC--TVTALSTRLRKGQP---------VTIGKPLIHIQALI 850
Cdd:cd17647 223 pklhHAFFVGDiltkRDC--LRLQTLAENVRIVNMYGTTETqrAVSYFEVPSRSSDPtflknlkdvMPAGRGMLNVQLLV 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 851 LD--TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF--------EH-ITLNDVNNAGQGAATL----RIYRTGDKA 915
Cdd:cd17647 301 VNrnDRTQICGIGEVGEIYVRAGGLAEGYRGLPELNKEKFvnnwfvepDHwNYLDKDNNEPWRQFWLgprdRLYRTGDLG 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 916 RLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVAQVGSRPALVAY--------------ATVKAD 981
Cdd:cd17647 381 RYLPNGDCECCGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLVSYivprfdkpddesfaQEDVPK 460
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 982 SSTPEPAA-------VLID-----VAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:cd17647 461 EVSTDPIVkgligyrKLIKdirefLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQ 518
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
532-1400 |
6.84e-40 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 163.80 E-value: 6.84e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAVAQRDPQQLAIAF--DGEPRTDTLTYAELNRQANQLAHWLHRQ-GLGEQSLVGVLAKRDryFVIALLAIWK 608
Cdd:PRK05691 9 LTLVQALQRRAAQTPDRLALRFlaDDPGEGVVLSYRDLDLRARTIAAALQARaSFGDRAVLLFPSGPD--YVAAFFGCLY 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 609 AGAAYVPLdpdYPPE--------RLRHIITDANLSVILGGDG-----QQLAQWSAEQR-----IDLTDPAVVEQWQDlpg 670
Cdd:PRK05691 87 AGVIAVPA---YPPEsarrhhqeRLLSIIADAEPRLLLTVADlrdslLQMEELAAANApellcVDTLDPALAEAWQE--- 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 671 dqpPAIPrhAQQLAQVIYTSGSTGLPKGVMIEHGSLI--NLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSG 747
Cdd:PRK05691 161 ---PALQ--PDDIAFLQYTSGSTALPKGVQVSHGNLVanEQLIRHGFGIDLNPDDVIVSWLPLYHDMGLIGGLLqPIFSG 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 748 GTLAFGEPND------RAIMQAEQAGAT---------HLILPTALMSILDPEQVNGIQAIGMGGEACPNAVVENWADKVA 812
Cdd:PRK05691 236 VPCVLMSPAYflerplRWLEAISEYGGTisggpdfayRLCSERVSESALERLDLSRWRVAYSGSEPIRQDSLERFAEKFA 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 813 --------LYNMYGPTECTVTALSTRLRKGQP----------------------VTIGKPLIHIQALILDTA-GQLCPVG 861
Cdd:PRK05691 316 acgfdpdsFFASYGLAEATLFVSGGRRGQGIPaleldaealarnraepgtgsvlMSCGRSQPGHAVLIVDPQsLEVLGDN 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 862 VPGELCLAGLGLARGYLNQPQMTASRFehitlndVNNAGQgaatlRIYRTGDKArLLNNGDYEYCGRIDEQIKLRGYRIE 941
Cdd:PRK05691 396 RVGEIWASGPSIAHGYWRNPEASAKTF-------VEHDGR-----TWLRTGDLG-FLRDGELFVTGRLKDMLIVRGHNLY 462
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 942 PGEIEAQLAAVCPSLKQIKVI---VAQVGSRPALVAyATVKADSSTPEPAAVLID-----VAKYLPEymVPFRLMLLED- 1012
Cdd:PRK05691 463 PQDIEKTVEREVEVVRKGRVAafaVNHQGEEGIGIA-AEISRSVQKILPPQALIKsirqaVAEACQE--APSVVLLLNPg 539
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1013 -MPLTPNGK--------------LDMKQLPPVLEANESDGEADNP--LEADVLAIWRSVLNTP-LGVEDDFFRLGGDSIL 1074
Cdd:PRK05691 540 aLPKTSSGKlqrsacrlrladgsLDSYALFPALQAVEAAQTAASGdeLQARIAAIWCEQLKVEqVAADDHFFLLGGNSIA 619
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1075 SIQLTTRLR-SAGYACTVKDVFEAKSVRRLCRVLAQnnrdtgTVAEQGTLEGEFALLPIQRWFmEQSLARPEHW------ 1147
Cdd:PRK05691 620 ATQVVARLRdELGIDLNLRQLFEAPTLAAFSAAVAR------QLAGGGAAQAAIARLPRGQAL-PQSLAQNRLWllwqld 692
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1148 NQAAMIQLP-------EVDTERLVTMLQALMAQHDALRLGCDAEG----QRYLADVPCPaLSTLDYRQLGDDGLQQAFTA 1216
Cdd:PRK05691 693 PQSAAYNIPgglhlrgELDEAALRASFQRLVERHESLRTRFYERDgvalQRIDAQGEFA-LQRIDLSDLPEAEREARAAQ 771
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1217 LQSE-----FDPAQGRTMACALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERLYL----GEP--LLPKTSSYRQWG 1285
Cdd:PRK05691 772 IREEearqpFDLEKGPLLRVTLVRLDDE-EHQLLVTLHHIVADGWSLNILLDEFSRLYAaacqGQTaeLAPLPLGYADYG 850
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1286 AALQHYATQH--AEQLTYWQAQEDGVDLTALLAAKDPQGH---ASAAILTLD-AKTTGQLVSEANRAFNTDVSDLLLSAL 1359
Cdd:PRK05691 851 AWQRQWLAQGeaARQLAYWKAQLGDEQPVLELATDHPRSArqaHSAARYSLRvDASLSEALRGLAQAHQATLFMVLLAAF 930
|
970 980 990 1000
....*....|....*....|....*....|....*....|.
gi 499404635 1360 TRTLNDLGWGDKARIMLEGHGReaidPTLDVSRTVGWFTST 1400
Cdd:PRK05691 931 QALLHRYSGQGDIRIGVPNANR----PRLETQGLVGFFINT 967
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
562-1021 |
4.04e-39 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 152.49 E-value: 4.04e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILggd 641
Cdd:cd05972 1 WSFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIV--- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 gqqlaqwsaeqrIDLTDPAVVeqwqdlpgdqppaiprhaqqlaqvIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTP 721
Cdd:cd05972 78 ------------TDAEDPALI------------------------YFTSGTTGLPKGVLHTHSYPLGHIPTAAYWLGLRP 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 722 QSTMFNCMSLSFDAGNMTTLL-PLSSGGT--LAFGEPND--RAIMQAEQAGATHLIL-PTA--LMSILDPEQVN--GIQA 791
Cdd:cd05972 122 DDIHWNIADPGWAKGAWSSFFgPWLLGATvfVYEGPRFDaeRILELLERYGVTSFCGpPTAyrMLIKQDLSSYKfsHLRL 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 792 IGMGGEACPNAVVENWADKVAL--YNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELC-- 867
Cdd:cd05972 202 VVSAGEPLNPEVIEWWRAATGLpiRDGYGQTETGLTVGNFPDMPVKPGSMGRPTPGYDVAIIDDDGRELPPGEEGDIAik 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 868 LAGLGLARGYLNQPQMTASRFEhitlNDVnnagqgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:cd05972 282 LPPPGLFLGYVGDPEKTEASIR----GDY------------YLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVES 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLaavcpsLKQIKVIVAQVGSRPALVAYATVKAD---SSTPEPAAVLID-----VAKYLPEYMVPFRLMLLEDMPLTPNG 1019
Cdd:cd05972 346 AL------LEHPAVAEAAVVGSPDPVRGEVVKAFvvlTSGYEPSEELAEelqghVKKVLAPYKYPREIEFVEELPKTISG 419
|
..
gi 499404635 1020 KL 1021
Cdd:cd05972 420 KI 421
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
1566-2000 |
1.24e-38 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 150.15 E-value: 1.24e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSMLYHRLRCPqdDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAA-LESECAS--IQVIVKQADLPFY 1642
Cdd:cd19542 2 YPCTPMQEGMLLSQLRSP--GLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVfVESSAEGtfLQVVLKSLDPPIE 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1643 -YQDLMQdadplaVIERYRQQDLRTGFDLSQPPLlRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQtlmqG 1721
Cdd:cd19542 80 eVETDED------SLDALTRDLLDDPTLFGQPPH-RLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYN----G 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 QVLmhGDAPAiqvdraYVDYARHAVAQ-QSAVDAFWQQrqsLLAqtndvsmlfaaaGKRADLSQHLTQIEPQVTSVSLNE 1800
Cdd:cd19542 149 QLL--PPAPP------FSDYISYLQSQsQEESLQYWRK---YLQ------------GASPCAFPSLSPKRPAERSLSSTR 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1801 KDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSVGLYINSLPLALSWQQPVSLQQH 1880
Cdd:cd19542 206 RSLAKLEAFCASLGVTLASLFQAAWALVLARYTGSRDVVFGYVVSGRDLPVPGIDDIVGPCINTLPVRVKLDPDWTVLDL 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1881 LVQLQNELMAMNQHATQSLIAL-----TAGRSRLFNSLFIYENYPDAKAEQGQRAddphrLYPEFSAAYEKVEMPLNLVV 1955
Cdd:cd19542 286 LRQLQQQYLRSLPHQHLSLREIqralgLWPSGTLFNTLVSYQNFEASPESELSGS-----SVFELSAAEDPTEYPVAVEV 360
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 499404635 1956 REQSGCMLLRFEFDADALDSAQARRVLmrwhDEVVALVNSVPQQP 2000
Cdd:cd19542 361 EPSGDSLKVSLAYSTSVLSEEQAEELL----EQFDDILEALLANP 401
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
542-981 |
1.71e-38 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 153.16 E-value: 1.71e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAF--DGEPRTDTLTYAELNRQANQLAHWLHRQGL-GEqsLVGVLAKRDRYFVIALLAIWKAGAAYVPLDP 618
Cdd:cd05931 3 AAARPDRPAYTFldDEGGREETLTYAELDRRARAIAARLQAVGKpGD--RVLLLAPPGLDFVAAFLGCLYAGAIAVPLPP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 619 DYPP---ERLRHIITDANLSVIL--GGDGQQLAQWSAEQRIDLTDP-AVVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGS 692
Cdd:cd05931 81 PTPGrhaERLAAILADAGPRVVLttAAALAAVRAFAASRPAAGTPRlLVVDLLPDTSAADWPPPSPDPDDIAYLQYTSGS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 693 TGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTLAFGEPND---------RAImq 762
Cdd:cd05931 161 TGTPKGVVVTHRNLLANVRQIRRAYGLDPGDVVVSWLPLYHDMGLIGGLLtPLYSGGPSVLMSPAAflrrplrwlRLI-- 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 763 aEQAGATHLILPT-AL------MSILDPEQVN--GIQAIGMGGEACPNAVVENWADKVALYNM--------YGPTECTVt 825
Cdd:cd05931 239 -SRYRATISAAPNfAYdlcvrrVRDEDLEGLDlsSWRVALNGAEPVRPATLRRFAEAFAPFGFrpeafrpsYGLAEATL- 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 826 ALSTRLRKGQPVTI---------------------------GKPLIHIQALILDTAG-QLCPVGVPGELCLAGLGLARGY 877
Cdd:cd05931 317 FVSGGPPGTGPVVLrvdrdalagravavaaddpaarelvscGRPLPDQEVRIVDPETgRELPDGEVGEIWVRGPSVASGY 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 878 LNQPQMTASRFEHItlndvnnAGQGAATLriYRTGDKARLLnNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLK 957
Cdd:cd05931 397 WGRPEATAETFGAL-------AATDEGGW--LRTGDLGFLH-DGELYITGRLKDLIIVRGRNHYPQDIEATAEEAHPALR 466
|
490 500 510
....*....|....*....|....*....|....*...
gi 499404635 958 --------------QIKVIVAQVGSRPALVAYATVKAD 981
Cdd:cd05931 467 pgcvaafsvpddgeERLVVVAEVERGADPADLAAIAAA 504
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
529-1026 |
1.81e-38 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 152.65 E-value: 1.81e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 529 QPQLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWK 608
Cdd:PRK06187 3 DYPLTIGRILRHGARKHPDKEAVYFDGR----RTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPK 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 609 AGAAYVPLDPDYPPERLRHIITDANLSVILGGDG------QQLAQ-------WSAEQRIDLTDPAVVEQWQDLPGDQPPA 675
Cdd:PRK06187 79 IGAVLHPINIRLKPEEIAYILNDAEDRVVLVDSEfvpllaAILPQlptvrtvIVEGDGPAAPLAPEVGEYEELLAAASDT 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 676 IPRHA---QQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQST------MFNCMSLsfdagnMTTLLPLSS 746
Cdd:PRK06187 159 FDFPDideNDAAAMLYTSGTTGHPKGVVLSHRNLFLHSLAVCAWLKLSRDDVylvivpMFHVHAW------GLPYLALMA 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 747 GGTL----AFgEPnDRAIMQAEQAGATHLIL-PTALMSILD-----PEQVNGIQAIGMGGEACPNAVVENWADK--VALY 814
Cdd:PRK06187 233 GAKQviprRF-DP-ENLLDLIETERVTFFFAvPTIWQMLLKaprayFVDFSSLRLVIYGGAALPPALLREFKEKfgIDLV 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 815 NMYGPTECTVTALSTRLRKGQP------VTIGKPLIHIQALILDTAGQLCPV--GVPGELCLAGLGLARGYLNQPQMTAS 886
Cdd:PRK06187 311 QGYGMTETSPVVSVLPPEDQLPgqwtkrRSAGRPLPGVEARIVDDDGDELPPdgGEVGEIIVRGPWLMQGYWNRPEATAE 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 887 RFEHitlndvnnaGQgaatlriYRTGDKARLLNNGdYEY-CGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI-VA 964
Cdd:PRK06187 391 TIDG---------GW-------LHTGDVGYIDEDG-YLYiTDRIKDVIISGGENIYPRELEDALYG-HPAVAEVAVIgVP 452
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 499404635 965 --QVGSRPalVAYATVKADsSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK06187 453 deKWGERP--VAVVVLKPG-ATLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVL 513
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
561-982 |
9.98e-38 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 148.90 E-value: 9.98e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAkRDRY-FVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG 639
Cdd:cd05907 5 PITWAEFAEEVRALAKGLIALGVEPGDRVAILS-RNRPeWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKALFV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 GDgqqlaqwsaeqridltdpavveqwqdlPGDqppaiprhaqqLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDF 719
Cdd:cd05907 84 ED---------------------------PDD-----------LATIIYTSGTTGRPKGVMLSHRNILSNALALAERLPA 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 720 TPQSTMFNCMSLSFDAGNMTTL-LPLSSGGTLAFGEPnDRAIMQAEQAgathlILPTALMS---ILDPEQvNGIQAIGM- 794
Cdd:cd05907 126 TEGDRHLSFLPLAHVFERRAGLyVPLLAGARIYFASS-AETLLDDLSE-----VRPTVFLAvprVWEKVY-AAIKVKAVp 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 --------------------GGEACPNAVVENW-ADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPL--IHIQalil 851
Cdd:cd05907 199 glkrklfdlavggrlrfaasGGAPLPAELLHFFrALGIPVYEGYGLTETSAVVTLNPPGDNRIGTVGKPLpgVEVR---- 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 852 dtagqlcpVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndvnnagQGAatlriYRTGDKARLLNNGDYEYCGRIDE 931
Cdd:cd05907 275 --------IADDGEILVRGPNVMLGYYKNPEATAEALDA----------DGW-----LHTGDLGEIDEDGFLHITGRKKD 331
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 499404635 932 QIKLR-GYRIEPGEIEAQLAAvCPSLKQIkVIVAQvgSRPALVAYATVKADS 982
Cdd:cd05907 332 LIITSgGKNISPEPIENALKA-SPLISQA-VVIGD--GRPFLVALIVPDPEA 379
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
532-1026 |
1.26e-37 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 150.05 E-value: 1.26e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGA 611
Cdd:PRK07656 5 MTLPELLARAARRFGDKEAYVFGDQ----RLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 612 AYVPLDPDYPPERLRHIITDANLSVILGGDGQQLAQWSA-------EQRIDLTDPAVVEQ------WQDL--PGDQP-PA 675
Cdd:PRK07656 81 VVVPLNTRYTADEAAYILARGDAKALFVLGLFLGVDYSAttrlpalEHVVICETEEDDPHtekmktFTDFlaAGDPAeRA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 676 IPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQST------MFN--CMSLSFDAgnmttllPLSSG 747
Cdd:PRK07656 161 PEVDPDDVADILFTSGTTGRPKGAMLTHRQLLSNAADWAEYLGLTEGDRylaanpFFHvfGYKAGVNA-------PLMRG 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 748 GTLaFGEPN---DRAIMQAEQAGAThlIL---PTALMSILD-----PEQVNGIQAIGMGGEACPNAVVENWADKVALYNM 816
Cdd:PRK07656 234 ATI-LPLPVfdpDEVFRLIETERIT--VLpgpPTMYNSLLQhpdrsAEDLSSLRLAVTGAASMPVALLERFESELGVDIV 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 817 ---YGPTECTVTALSTRL---RKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTasrfeh 890
Cdd:PRK07656 311 ltgYGLSEASGVTTFNRLdddRKTVAGTIGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYDDPEAT------ 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 891 itlndvnnagqgAATLRI---YRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI----- 962
Cdd:PRK07656 385 ------------AAAIDAdgwLHTGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEH-PAVAEAAVIgvpde 451
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 963 -VAQVGsrpalVAYATVKADSSTPEpaAVLIDVAK-YLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK07656 452 rLGEVG-----KAYVVLKPGAELTE--EELIAYCReHLAKYKVPRSIEFLDELPKNATGKVLKRAL 510
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
533-1021 |
2.51e-36 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 146.23 E-value: 2.51e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK08316 12 TIGDILRRSARRYPDKTALVFGDR----SWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAV 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDANLSVILGGDG-----QQLAQWSAEQRIDLTDPAV----------VEQWQDLPGDQPPAIP 677
Cdd:PRK08316 88 HVPVNFMLTGEELAYILDHSGARAFLVDPAlaptaEAALALLPVDTLILSLVLGgreapggwldFADWAEAGSVAEPDVE 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 678 RHAQQLAQVIYTSGSTGLPKGVMIEHGSLIN-----LLDdhrdrIDFTPQSTMFNCMSLSFDAGNMTTLLP-LSSGGT-L 750
Cdd:PRK08316 168 LADDDLAQILYTSGTESLPKGAMLTHRALIAeyvscIVA-----GDMSADDIPLHALPLYHCAQLDVFLGPyLYVGATnV 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 751 AFGEPNDRAIMQA-EQAGATHLIL-PTALMSIL-----DPEQVNGIQAIGMGGEACPNAVVENWADK---VALYNMYGPT 820
Cdd:PRK08316 243 ILDAPDPELILRTiEAERITSFFApPTVWISLLrhpdfDTRDLSSLRKGYYGASIMPVEVLKELRERlpgLRFYNCYGQT 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 821 EctVTALSTRLR----KGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndv 896
Cdd:PRK08316 323 E--IAPLATVLGpeehLRRPGSAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAFRG------ 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 897 nnaGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL--------AAV--CPSLKQIKVIVAQV 966
Cdd:PRK08316 395 ---GW-------FHSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALythpavaeVAVigLPDPKWIEAVTAVV 464
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 967 gsrpalvayatVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK08316 465 -----------VPKAGATVTEDELIAHCRARLAGFKVPKRVIFVDELPRNPSGKI 508
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
508-1032 |
2.03e-34 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 141.33 E-value: 2.03e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 508 METDRFAAVLAETQQ------LPRS--YPQPQLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLH 579
Cdd:PRK06178 1 MAEEAYLAELRALQQaawpagIPREpeYPHGERPLTEYLRAWARERPQRPAIIFYGH----VITYAELDELSDRFAALLR 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 580 RQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD------GQQLAQWSAEQR 653
Cdd:PRK06178 77 QRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHELSYELNDAGAEVLLALDqlapvvEQVRAETSLRHV 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 654 I--DLTD-----------------PAVVEQWQDL------PGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLI- 707
Cdd:PRK06178 157 IvtSLADvlpaeptlplpdslrapRLAAAGAIDLlpalraCTAPVPLPPPALDALAALNYTGGTTGMPKGCEHTQRDMVy 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 708 ----NLLDDHRDRIDftpqSTMFNCMSLSFDAG-NMTTLLPLSSGGTLAFGEPND-RAIMQA-EQAGATHLILPT-ALMS 779
Cdd:PRK06178 237 taaaAYAVAVVGGED----SVFLSFLPEFWIAGeNFGLLFPLFSGATLVLLARWDaVAFMAAvERYRVTRTVMLVdNAVE 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 780 ILD-PE----------QVNGIQAIgmggEACPNAVVENWAD---KVALYNMYGPTEcTVTALSTRL--------RKGQPV 837
Cdd:PRK06178 313 LMDhPRfaeydlsslrQVRVVSFV----KKLNPDYRQRWRAltgSVLAEAAWGMTE-THTCDTFTAgfqdddfdLLSQPV 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 838 TIGKPLIHIQALILD-TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTasrfehitlndvnnagqgAATLR--IYRTGDK 914
Cdd:PRK06178 388 FVGLPVPGTEFKICDfETGELLPLGAEGEIVVRTPSLLKGYWNKPEAT------------------AEALRdgWLHTGDI 449
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 915 ARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAavcpslKQIKVIVAQVGSRP------ALVAYATVKADSSTpEPA 988
Cdd:PRK06178 450 GKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEALLG------QHPAVLGSAVVGRPdpdkgqVPVAFVQLKPGADL-TAA 522
|
570 580 590 600
....*....|....*....|....*....|....*....|....
gi 499404635 989 AVLIDVAKYLPEYMVPfRLMLLEDMPLTPNGKLDMKQLPPVLEA 1032
Cdd:PRK06178 523 ALQAWCRENMAVYKVP-EIRIVDALPMTATGKVRKQDLQALAEE 565
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
562-1026 |
3.04e-34 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 138.00 E-value: 3.04e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVilggd 641
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKV----- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 gqqlaqwsaeqridltdpAVVEQWQDlpgdqppaiprhaqQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTP 721
Cdd:cd05935 77 ------------------AVVGSELD--------------DLALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTGLTP 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 722 QSTMFNCMSLSFDAGNMTTL-LPLSSGGTLAFGEPNDR--AIMQAEQAGATHLI-LPTALMSIL-DPE----QVNGIQAI 792
Cdd:cd05935 125 SDVILACLPLFHVTGFVGSLnTAVYVGGTYVLMARWDRetALELIEKYKVTFWTnIPTMLVDLLaTPEfktrDLSSLKVL 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 793 GMGGEACPNAVVENWADKVALYNM--YGPTE-CTVTALSTRLR-KGQpvTIGKPLIHIQALILD-TAGQLCPVGVPGELC 867
Cdd:cd05935 205 TGGGAPMPPAVAEKLLKLTGLRFVegYGLTEtMSQTHTNPPLRpKLQ--CLGIP*FGVDARVIDiETGRELPPNEVGEIV 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 868 LAGLGLARGYLNQPQMTASRFehITLNdvnnaGQgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:cd05935 283 VRGPQIFKGYWNRPEETEESF--IEIK-----GR-----RFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEA 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLAAvCPSLKQIKVIVA---QVGSRP-ALVAYATVKADSSTPEpaavliDVAKYLPEYM----VPFRLMLLEDMPLTPNG 1019
Cdd:cd05935 351 KLYK-HPAI*EVCVISVpdeRVGEEVkAFIVLRPEYRGKVTEE------DIIEWAREQMaaykYPREVEFVDELPRSASG 423
|
....*..
gi 499404635 1020 KLDMKQL 1026
Cdd:cd05935 424 KILWRLL 430
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
1565-1984 |
4.23e-34 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 137.54 E-value: 4.23e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1565 LLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAA-LESECASIQVIVKQADLP-FY 1642
Cdd:cd19066 1 KIPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRfCEEAGRYEQVVLDKTVRFrIE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1643 YQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQ 1722
Cdd:cd19066 81 IIDLRNLADPEARLLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAAERQK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1723 vlmhgDAPAIQVDrAYVDYA------RHAVAQQSAVdAFWqqrQSLLAQTNDVSMLFaAAGKRADLSqhltQIEPQVTSV 1796
Cdd:cd19066 161 -----PTLPPPVG-SYADYAawlekqLESEAAQADL-AYW---TSYLHGLPPPLPLP-KAKRPSQVA----SYEVLTLEF 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1797 SLNEKDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPveDVASSVGLYINSLPLALSWQQPVS 1876
Cdd:cd19066 226 FLRSEETKRLREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDE--AVEDTIGLFLNLLPLRIDTSPDAT 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1877 LQQHLVQLQNELMAMNQHATQSLI--------ALTAGRSRLFNSLFIYENYPDAKAEQGQRADDPHRLYPEFSAAYEkve 1948
Cdd:cd19066 304 FPELLKRTKEQSREAIEHQRVPFIelvrhlgvVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFTTPVYTSSEGTVFD--- 380
|
410 420 430
....*....|....*....|....*....|....*..
gi 499404635 1949 mpLNLVVREQS-GCMLLRFEFDADALDSAQARRVLMR 1984
Cdd:cd19066 381 --LDLEASEDPdGDLLLRLEYSRGVYDERTIDRFAER 415
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1563-2000 |
6.22e-34 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 143.46 E-value: 6.22e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1563 DTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALESECASIQVIVKQ---ADL 1639
Cdd:COG1020 15 AAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVIQPvvaAPL 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1640 PFYYQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLM 1719
Cdd:COG1020 95 PVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAELLRLYLAAY 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1720 QGQVLMHGDAPAIQVDRAYVDYARHAVAQQSAVDAFWQQRQSLLAqtnDVSMLFAAAGKRADLSQHLTQIepqvtSVSLN 1799
Cdd:COG1020 175 AGAPLPLPPLPIQYADYALWQREWLQGEELARQLAYWRQQLAGLP---PLLELPTDRPRPAVQSYRGARV-----SFRLP 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1800 EKDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPveDVASSVGLYINSLPLALSWQQPVSLQQ 1879
Cdd:COG1020 247 AELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRP--ELEGLVGFFVNTLPLRVDLSGDPSFAE 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1880 HLVQLQNELMAMNQHATQSLIAL--------TAGRSRLFNSLFIYENYPDAKAEQGQRADDPHRLypefsaAYEKVEMPL 1951
Cdd:COG1020 325 LLARVRETLLAAYAHQDLPFERLveelqperDLSRNPLFQVMFVLQNAPADELELPGLTLEPLEL------DSGTAKFDL 398
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 499404635 1952 NLVVREQSGCMLLRFEFDADALDSAQARRVLMRWHDEVVALVNSvPQQP 2000
Cdd:COG1020 399 TLTVVETGDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAAD-PDQP 446
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
533-974 |
6.57e-34 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 140.24 E-value: 6.57e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAF--DGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAkRDRY-FVIALLAIWKA 609
Cdd:COG1022 12 TLPDLLRRRAARFPDRVALREkeDGIWQS--LTWAEFAERVRALAAGLLALGVKPGDRVAILS-DNRPeWVIADLAILAA 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 610 GAAYVPLDPDYPPERLRHIITDANLSVILGGDGQQLAQ--------------WSAEQRIDLTDPAVV--EQWQDLpGDQP 673
Cdd:COG1022 89 GAVTVPIYPTSSAEEVAYILNDSGAKVLFVEDQEQLDKllevrdelpslrhiVVLDPRGLRDDPRLLslDELLAL-GREV 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 674 PAIPRHAQQLAQV--------IYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLS 745
Cdd:COG1022 168 ADPAELEARRAAVkpddlatiIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTLSFLPLAHVFERTVSYYALA 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 746 SGGTLAFGE-------------PN-------------DRAIMQAEQAGAT-----HLILPTALMSILDPEQVNGI----- 789
Cdd:COG1022 248 AGATVAFAEspdtlaedlrevkPTfmlavprvwekvyAGIQAKAEEAGGLkrklfRWALAVGRRYARARLAGKSPslllr 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 790 ---------------QAIG-------MGGEACPNAVVE-NWADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHI 846
Cdd:COG1022 328 lkhaladklvfsklrEALGgrlrfavSGGAALGPELARfFRALGIPVLEGYGLTETSPVITVNRPGDNRIGTVGPPLPGV 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 847 QALILDTagqlcpvgvpGELCLAGLGLARGYLNQPQMTasrfehitlndvnnagqgAATLRI---YRTGDKARLLNNGDY 923
Cdd:COG1022 408 EVKIAED----------GEILVRGPNVMKGYYKNPEAT------------------AEAFDAdgwLHTGDIGELDEDGFL 459
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 499404635 924 EYCGRIDEQIKLR-GYRIEPGEIEAQLAAvCPSLKQIkVIVAQvgSRPALVA 974
Cdd:COG1022 460 RITGRKKDLIVTSgGKNVAPQPIENALKA-SPLIEQA-VVVGD--GRPFLAA 507
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
561-1021 |
6.82e-34 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 137.13 E-value: 6.82e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILgg 640
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFV-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 dgqqlaqwsAEQRIDLTDPAvveqwqDLPGDqppaiprhaqqLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFT 720
Cdd:cd05903 79 ---------VPERFRQFDPA------AMPDA-----------VALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLGLG 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 721 PQSTMFNCMSLSFDAGNM-TTLLPLSSGGT---LAFGEPnDRAIMQAEQAGATHLILPTA-LMSILD-----PEQVNGIQ 790
Cdd:cd05903 133 PGDVFLVASPMAHQTGFVyGFTLPLLLGAPvvlQDIWDP-DKALALMREHGVTFMMGATPfLTDLLNaveeaGEPLSRLR 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 791 AIGMGGEACPNAVVENWADKVALY--NMYGPTEC--TVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGEL 866
Cdd:cd05903 212 TFVCGGATVPRSLARRAAELLGAKvcSAYGSTECpgAVTSITPAPEDRRLYTDGRPLPGVEIKVVDDTGATLAPGVEGEL 291
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 867 CLAGLGLARGYLNQPQMTASRFEhitlndvnnagQGaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIE 946
Cdd:cd05903 292 LSRGPSVFLGYLDRPDLTADAAP-----------EG-----WFRTGDLARLDEDGYLRITGRSKDIIIRGGENIPVLEVE 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 947 AQLAAVcPSLKQIKVIV---AQVGSRPALVAYATVKADSSTPEPAAVL--IDVAK-YLPEymvpfRLMLLEDMPLTPNGK 1020
Cdd:cd05903 356 DLLLGH-PGVIEAAVVAlpdERLGERACAVVVTKSGALLTFDELVAYLdrQGVAKqYWPE-----RLVHVDDLPRTPSGK 429
|
.
gi 499404635 1021 L 1021
Cdd:cd05903 430 V 430
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
1567-1982 |
8.50e-34 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 136.67 E-value: 8.50e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL--ESECASIQVIVKQADLPFYYQ 1644
Cdd:cd19547 3 PLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFtwRDRAEPLQYVRDDLAPPWALL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DLMQDaDP---LAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQG 1721
Cdd:cd19547 83 DWSGE-DPdrrAELLERLLADDRAAGLSLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEELAHG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 QvlmhgdAPAIQVDRAYVDYA---RHAVAQQSAVDAFWQQrqsLLAQTNDVSMLFAAAGKRADLSQHLTQIEPQVTSVsL 1798
Cdd:cd19547 162 R------EPQLSPCRPYRDYVrwiRARTAQSEESERFWRE---YLRDLTPSPFSTAPADREGEFDTVVHEFPEQLTRL-V 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1799 NEKdqatltafAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPVEDVASSVGLYINSLPLALSWQQPVSLQ 1878
Cdd:cd19547 232 NEA--------ARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPELEGSEHMVGIFINTIPLRIRLDPDQTVT 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1879 QHLVQLQNEL--MAMNQHATQSLIALTAGRSRL-----FNSLFIYENYPDAKA---EQGQRADDPHrlypefsaAYEKVE 1948
Cdd:cd19547 304 GLLETIHRDLatTAAHGHVPLAQIKSWASGERLsggrvFDNLVAFENYPEDNLpgdDLSIQIIDLH--------AQEKTE 375
|
410 420 430
....*....|....*....|....*....|....
gi 499404635 1949 MPLNLVVREQSGcMLLRFEFDADALDSAQARRVL 1982
Cdd:cd19547 376 YPIGLIVLPLQK-LAFHFNYDTTHFTRAQVDRFI 408
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
559-1022 |
1.70e-33 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 137.50 E-value: 1.70e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 559 TDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITD--ANLSV 636
Cdd:cd05959 27 AGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLTPDDYAYYLEDsrARVVV 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 637 ILGGDGQQLAQ-----WSAEQRIDLTDPA--------VVEQWQDLPGDQPPAiPRHAQQLAQVIYTSGSTGLPKGVMIEH 703
Cdd:cd05959 107 VSGELAPVLAAaltksEHTLVVLIVSGGAgpeagallLAELVAAEAEQLKPA-ATHADDPAFWLYSSGSTGRPKGVVHLH 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 704 GSLINLLDDH-RDRIDFTPQSTMFNCMSLSF--DAGNMTTLlPLSSGGT--LAFGEPNDRAIMQAEQAGATHLI--LPTA 776
Cdd:cd05959 186 ADIYWTAELYaRNVLGIREDDVCFSAAKLFFayGLGNSLTF-PLSVGATtvLMPERPTPAAVFKRIRRYRPTVFfgVPTL 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 777 LMSIL-DPE-QVNGIQAIGM---GGEACPNAVVENWADK--VALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQAL 849
Cdd:cd05959 265 YAAMLaAPNlPSRDLSSLRLcvsAGEALPAEVGERWKARfgLDILDGIGSTEMLHIFLSNRPGRVRYGTTGKPVPGYEVE 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 850 ILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndvnnagQGAATlriyRTGDKARLLNNGDYEYCGRI 929
Cdd:cd05959 345 LRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRDTF------------QGEWT----RTGDKYVRDDDGFYTYAGRA 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 930 DEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVGSR-PALVAYATVKADSSTPEPAAV-LIDVAK-YLPEYMVPFR 1006
Cdd:cd05959 409 DDMLKVSGIWVSPFEVESALVQ-HPAVLEAAVVGVEDEDGlTKPKAFVVLRPGYEDSEALEEeLKEFVKdRLAPYKYPRW 487
|
490
....*....|....*.
gi 499404635 1007 LMLLEDMPLTPNGKLD 1022
Cdd:cd05959 488 IVFVDELPKTATGKIQ 503
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
563-1026 |
3.26e-33 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 135.27 E-value: 3.26e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 563 TYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD- 641
Cdd:TIGR01923 1 TWQDLDCEAAHLAKALKAQGIRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQLLLTDSl 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 -GQQLAQWSAEQRIDLTDPAVVEQWQDLPGDQPpaiprhaqqlAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFT 720
Cdd:TIGR01923 81 lEEKDFQADSLDRIEAAGRYETSLSASFNMDQI----------ATLMFTSGTTGKPKAVPHTFRNHYASAVGSKENLGFT 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 721 PQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEP-NDRAIMQAEQAgATHLIL-PTALMSILDPEQVN-GIQAIGMGGE 797
Cdd:TIGR01923 151 EDDNWLLSLPLYHISGLSILFRWLIEGATLRIVDKfNQLLEMIANER-VTHISLvPTQLNRLLDEGGHNeNLRKILLGGS 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 798 ACPNAVVENWADK-VALYNMYGPTE--CTVTALSTRLRKGQPvTIGKPLIHIQALIldtaGQLCPVGVpGELCLAGLGLA 874
Cdd:TIGR01923 230 AIPAPLIEEAQQYgLPIYLSYGMTEtcSQVTTATPEMLHARP-DVGRPLAGREIKI----KVDNKEGH-GEIMVKGANLM 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 875 RGYLNQPQMTASRFEHITLNdvnnagqgaatlriyrTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEaQLAAVCP 954
Cdd:TIGR01923 304 KGYLYQGELTPAFEQQGWFN----------------TGDIGELDGEGFLYVLGRRDDLIISGGENIYPEEIE-TVLYQHP 366
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 955 SLKQIKVIVAQ---VGSRPalVAYATVKADSStpepAAVLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:TIGR01923 367 GIQEAVVVPKPdaeWGQVP--VAYIVSESDIS----QAKLIAyLTEKLAKYKVPIAFEKLDELPYNASGKILRNQL 436
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
557-1022 |
4.13e-33 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 135.90 E-value: 4.13e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 557 PRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSV 636
Cdd:cd05926 10 GSTPALTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEFYLADLGSKL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 637 ILGGDGQQLAQWSAEQR---------IDLTDPAVVEQWQDLPG---DQPPAIPR---HAQQLAQVIYTSGSTGLPKGVMI 701
Cdd:cd05926 90 VLTPKGELGPASRAASKlglailelaLDVGVLIRAPSAESLSNllaDKKNAKSEgvpLPDDLALILHTSGTTGRPKGVPL 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 702 EHGSLI----NLLDDHRdridFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGtlafgepndRAIMQA-----------EQ 765
Cdd:cd05926 170 THRNLAasatNITNTYK----LTPDDRTLVVMPLFHVHGLVASLLsTLAAGG---------SVVLPPrfsastfwpdvRD 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 766 AGATHL-ILPTALMSILDPEQVNGIQA------IGMGGEACPNAVVENWADKVA--LYNMYGPTECTVTALSTRLRKGQ- 835
Cdd:cd05926 237 YNATWYtAVPTIHQILLNRPEPNPESPppklrfIRSCSASLPPAVLEALEATFGapVLEAYGMTEAAHQMTSNPLPPGPr 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 836 -PVTIGKPlIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHItlndvnnagqgaatlRIYRTGDK 914
Cdd:cd05926 317 kPGSVGKP-VGVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKD---------------GWFRTGDL 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 915 ARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQikviVAQVGSRPAL----VAYATVKADSSTPEPAAV 990
Cdd:cd05926 381 GYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLS-HPAVLE----AVAFGVPDEKygeeVAAAVVLREGASVTEEEL 455
|
490 500 510
....*....|....*....|....*....|..
gi 499404635 991 LIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:cd05926 456 RAFCRKHLAAFKVPKKVYFVDELPKTATGKIQ 487
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
1568-1817 |
8.66e-33 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 128.62 E-value: 8.66e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1568 LSSLQQSMLYHRlrcPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIVKQADLPFYYQDL 1646
Cdd:COG4908 1 LSPAQKRFLFLE---PGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFvEEDGEPVQRIDPDADLPLEVVDL 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1647 MQ--DADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQVL 1724
Cdd:COG4908 78 SAlpEPEREAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEGEPP 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1725 MHGDAPaiqvdRAYVDYAR--HAVAQQSAVDA---FWQQRQSLLAQTNDVSMLFAAAGKRADLSQHLTqiepqvtsVSLN 1799
Cdd:COG4908 158 PLPELP-----IQYADYAAwqRAWLQSEALEKqleYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLS--------FTLP 224
|
250
....*....|....*...
gi 499404635 1800 EKDQATLTAFAREVGITP 1817
Cdd:COG4908 225 AELTEALKALAKAHGATV 242
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
559-1021 |
1.23e-32 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 133.36 E-value: 1.23e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 559 TDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDAnlsvil 638
Cdd:cd05919 8 DRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDC------ 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 639 ggdgqqlaqwsaeqridltdpavveqwqdlpgdQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDH-RDRI 717
Cdd:cd05919 82 ---------------------------------EARLVVTSADDIAYLLYSSGTTGPPKGVMHAHRDPLLFADAMaREAL 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 718 DFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGT--LAFGEPN-DRAIMQAEQAGATHLI-LPTALMSILD-----PEQVN 787
Cdd:cd05919 129 GLTPGDRVFSSAKMFFGYGLGNSLWfPLAVGASavLNPGWPTaERVLATLARFRPTVLYgVPTFYANLLDscagsPDALR 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 788 GIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGE 865
Cdd:cd05919 209 SLRLCVSAGEALPRGLGERWMEHfgGPILDGIGATEVGHIFLSNRPGAWRLGSTGRPVPGYEIRLVDEEGHTIPPGEEGD 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 866 LCLAGLGLARGYLNQPQMTASRFehitlndvnNAGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEI 945
Cdd:cd05919 289 LLVRGPSAAVGYWNNPEKSRATF---------NGGW-------YRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSPVEV 352
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 946 EAQLAAVCPSLKQIKVIVAQV--GSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:cd05919 353 ESLIIQHPAVAEAAVVAVPEStgLSRLTAFVVLKSPAAPQESLARDIHRHLLERLSAHKVPRRIAFVDELPRTATGKL 430
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
73-498 |
5.18e-32 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 130.89 E-value: 5.18e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGlwFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFV-VNEQGKGEQRI-DAYQPFVIQ 150
Cdd:cd19542 3 PCTPMQEG--MLLSQLRSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFVeSSAEGTFLQVVlKSLDPPIEE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 151 HDDfsllpeaeREGRLQQQVKAEISRPFdLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKpaflACQN 230
Cdd:cd19542 81 VET--------DEDSLDALTRDLLDDPT-LFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLA----AAYN 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 231 CQPyPVETTQL-NYIDYAHWFNSDSFLDYhnefkpfWVERLTGIPEVHsLPLDKPRPAHQNSGGEVIFSainndlWDKFK 309
Cdd:cd19542 148 GQL-LPPAPPFsDYISYLQSQSQEESLQY-------WRKYLQGASPCA-FPSLSPKRPAERSLSSTRRS------LAKLE 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 310 RLCQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRE--RPDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQ 387
Cdd:cd19542 213 AFCASLGVTLASLFQAAWALVLARYTGSRDVVFGYVVSGRDlpVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQ 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 388 DLSAFDHQLYRFEALSEAIGSDRTTainPIFQVMLVYQAKVDFNDLIP-GCDAAEETSPVLPAKTDISVKVTELMGEVRL 466
Cdd:cd19542 293 YLRSLPHQHLSLREIQRALGLWPSG---TLFNTLVSYQNFEASPESELsGSSVFELSAAEDPTEYPVAVEVEPSGDSLKV 369
|
410 420 430
....*....|....*....|....*....|..
gi 499404635 467 DWLFATALFERQTIQYYADRFIRLIEAVVENP 498
Cdd:cd19542 370 SLAYSTSVLSEEQAEELLEQFDDILEALLANP 401
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
531-1022 |
1.81e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 131.93 E-value: 1.81e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 531 QLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAG 610
Cdd:PRK07798 2 AWNIADLFEAVADAVPDRVALVCGDR----RLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKAR 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 611 AAYVPLDPDYPPERLRHIITDANLSVILGGDgqQLAQWSAEQRIDLTDPAVVEQWQD------LPG------------DQ 672
Cdd:PRK07798 78 AVPVNVNYRYVEDELRYLLDDSDAVALVYER--EFAPRVAEVLPRLPKLRTLVVVEDgsgndlLPGavdyedalaagsPE 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 673 PPAIPRHAQQLaQVIYTSGSTGLPKGVMIEH---------------GSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGN 737
Cdd:PRK07798 156 RDFGERSPDDL-YLLYTGGTTGMPKGVMWRQedifrvllggrdfatGEPIEDEEELAKRAAAGPGMRRFPAPPLMHGAGQ 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 738 MTTLLPLSSGGTLAFGEPN----DRAIMQAEQAGATHLILPTALM------SILDPEQVN--GIQAIGMGGEACPNAVVE 805
Cdd:PRK07798 235 WAAFAALFSGQTVVLLPDVrfdaDEVWRTIEREKVNVITIVGDAMarplldALEARGPYDlsSLFAIASGGALFSPSVKE 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 806 NWAD---KVALYNMYGPTECTVTALSTrLRKGQPVTiGKPLIHIQA--LILDTAGQLCPVGVPGELCLAGLG-LARGYLN 879
Cdd:PRK07798 315 ALLEllpNVVLTDSIGSSETGFGGSGT-VAKGAVHT-GGPRFTIGPrtVVLDEDGNPVEPGSGEIGWIARRGhIPLGYYK 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 880 QPQMTASRFehITLNDVnnagqgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQi 959
Cdd:PRK07798 393 DPEKTAETF--PTIDGV----------RYAIPGDRARVEADGTITLLGRGSVCINTGGEKVFPEEVEEALKAH-PDVAD- 458
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 960 kVIVAQV-----GSR-PALVAyatvKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:PRK07798 459 -ALVVGVpderwGQEvVAVVQ----LREGARPDLAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGKAD 522
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
558-1028 |
2.01e-31 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 129.86 E-value: 2.01e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 558 RTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVI 637
Cdd:cd05971 3 TPEKVTFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASAL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 638 LggdgqqlaqwsaeqridlTDPAvveqwqdlpgDQPpaiprhaqqlAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRI 717
Cdd:cd05971 83 V------------------TDGS----------DDP----------ALIIYTSGTTGPPKGALHAHRVLLGHLPGVQFPF 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 718 DFTPQSTmfNCMSLSFD----AGNMTTLLPlssggTLAFGEP----------NDRAIMQAEQAGATHLILP-TALMSI-- 780
Cdd:cd05971 125 NLFPRDG--DLYWTPADwawiGGLLDVLLP-----SLYFGVPvlahrmtkfdPKAALDLMSRYGVTTAFLPpTALKMMrq 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 781 ----LDPEQVNgIQAIGMGGEAcPNAVVENWAD---KVALYNMYGPTECT-VTALSTRLRKGQPVTIGKPLI-HIQAlIL 851
Cdd:cd05971 198 qgeqLKHAQVK-LRAIATGGES-LGEELLGWAReqfGVEVNEFYGQTECNlVIGNCSALFPIKPGSMGKPIPgHRVA-IV 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 852 DTAGQLCPVGVPGELCL------AGLGlargYLNQPQMTASRFehitlndvnnAGQgaatlrIYRTGDKARLLNNGDYEY 925
Cdd:cd05971 275 DDNGTPLPPGEVGEIAVelpdpvAFLG----YWNNPSATEKKM----------AGD------WLLTGDLGRKDSDGYFWY 334
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 926 CGRIDEQIKLRGYRIEPGEIEAQLaavcpsLKQIKVIVAQVGSRPALV------AYATVKADSSTPEPAAVLID--VAKY 997
Cdd:cd05971 335 VGRDDDVITSSGYRIGPAEIEECL------LKHPAVLMAAVVGIPDPIrgeivkAFVVLNPGETPSDALAREIQelVKTR 408
|
490 500 510
....*....|....*....|....*....|.
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGKLDMKQLPP 1028
Cdd:cd05971 409 LAAHEYPREIEFVNELPRTATGKIRRRELRA 439
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
542-1021 |
3.57e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 130.31 E-value: 3.57e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAFDGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYP 621
Cdd:PRK09088 5 ARLQPQRLAAVDLALGRR--WTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLS 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 622 PERLRHIITDANLSVILGGDGQQLAqwsaeqRIDLTDPAVVEQWQD-LPGDQPPAIPRHAQQLaqVIYTSGSTGLPKGVM 700
Cdd:PRK09088 83 ASELDALLQDAEPRLLLGDDAVAAG------RTDVEDLAAFIASADaLEPADTPSIPPERVSL--ILFTSGTSGQPKGVM 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 701 IEHGSL----INL----LDDHRDRidFTPQSTMFNCMSLsfdagnMTTLLP-LSSGGTLAFG---EPNDRAIMQAEQA-G 767
Cdd:PRK09088 155 LSERNLqqtaHNFgvlgRVDAHSS--FLCDAPMFHIIGL------ITSVRPvLAVGGSILVSngfEPKRTLGRLGDPAlG 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 768 ATHLILPTALMSIL------DPEQVNGIQAIGMGGEACPNAVVENW-ADKVALYNMYGPTEC-TVTALSTR--LRKGQPV 837
Cdd:PRK09088 227 ITHYFCVPQMAQAFraqpgfDAAALRHLTALFTGGAPHAAEDILGWlDDGIPMVDGFGMSEAgTVFGMSVDcdVIRAKAG 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 838 TIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndvnnaGQGAatlriYRTGDKARL 917
Cdd:PRK09088 307 AAGIPTPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAFT----------GDGW-----FRTGDIARR 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 918 LNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKViVAQVGSRPALVAY-ATVKADSSTPEPAAVLIDVAK 996
Cdd:PRK09088 372 DADGFFWVVDRKKDMFISGGENVYPAEIEAVLADH-PGIRECAV-VGMADAQWGEVGYlAIVPADGAPLDLERIRSHLST 449
|
490 500
....*....|....*....|....*
gi 499404635 997 YLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK09088 450 RLAKYKVPKHLRLVDALPRTASGKL 474
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
533-1026 |
3.94e-31 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 129.94 E-value: 3.94e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAfdgEPRTDT-LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGA 611
Cdd:cd05923 2 TVFEMLRRAASRAPDACAIA---DPARGLrLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGA 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 612 AYVPLDPDYPPERLRHIITDANLSVILGGDGQQLAQWSAE---------QRIDLTDPAVVeqwqdlpGDQPPAIPRHAQQ 682
Cdd:cd05923 79 VPALINPRLKAAELAELIERGEMTAAVIAVDAQVMDAIFQsgvrvlalsDLVGLGEPESA-------GPLIEDPPREPEQ 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 683 LAQVIYTSGSTGLPKGVMIEHGSLIN--LLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTLAFGEPNDRA 759
Cdd:cd05923 152 PAFVFYTSGTTGLPKGAVIPQRAAESrvLFMSTQAGLRHGRHNVVLGLMPLYHVIGFFAVLVaALALDGTYVVVEEFDPA 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 760 ----IMQAEQ-----AGATHL--ILPTALMSildPEQVNGIQAIGMGGEACPNAVVE--NWADKVALYNMYGPTEctvTA 826
Cdd:cd05923 232 dalkLIEQERvtslfATPTHLdaLAAAAEFA---GLKLSSLRHVTFAGATMPDAVLErvNQHLPGEKVNIYGTTE---AM 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 LSTRLRKGQPVTIGKPLIHIQ---ALILDTAGQLCPVGVPGELCLAGLGLA--RGYLNQPQMTASRfehitLNDvnnagq 901
Cdd:cd05923 306 NSLYMRDARTGTEMRPGFFSEvriVRIGGSPDEALANGEEGELIVAAAADAafTGYLNQPEATAKK-----LQD------ 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 902 gaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIkVIVAQVGSRPALVAYATVKAD 981
Cdd:cd05923 375 -----GWYRTGDVGYVDPSGDVRILGRVDDMIISGGENIHPSEIERVLSRH-PGVTEV-VVIGVADERWGQSVTACVVPR 447
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 499404635 982 SSTpePAAVLID---VAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05923 448 EGT--LSADELDqfcRASELADFKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
537-1028 |
5.02e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 130.82 E-value: 5.02e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 537 VIEAVAQRDPQQLAIAFDgeprTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPL 616
Cdd:PRK07788 54 LVAHAARRAPDRAALIDE----RGTLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARIILL 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 617 DPDYPPERL-----RH----IITDANLSVILGGDGQQLAQWSAEQRIDLTDPAVVEQWQDLpgDQ---------PPAIPR 678
Cdd:PRK07788 130 NTGFSGPQLaevaaREgvkaLVYDDEFTDLLSALPPDLGRLRAWGGNPDDDEPSGSTDETL--DDliagsstapLPKPPK 207
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 679 HAqqlAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFgepndR 758
Cdd:PRK07788 208 PG---GIVILTSGTTGTPKGAPRPEPSPLAPLAGLLSRVPFRAGETTLLPAPMFHATGWAHLTLAMALGSTVVL-----R 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 759 AIMQAEQA-------GATHLIL-PTALMSILD-PEQVNG------IQAIGMGGEACPNAVVENWADKVA--LYNMYGPTE 821
Cdd:PRK07788 280 RRFDPEATlediakhKATALVVvPVMLSRILDlGPEVLAkydtssLKIIFVSGSALSPELATRALEAFGpvLYNLYGSTE 359
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 822 CTVTALSTR--LRKGqPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYlnqpqmTASRFEHItlndVNNa 899
Cdd:PRK07788 360 VAFATIATPedLAEA-PGTVGRPPKGVTVKILDENGNEVPRGVVGRIFVGNGFPFEGY------TDGRDKQI----IDG- 427
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 900 gqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI-V--AQVGSRpaLVAYA 976
Cdd:PRK07788 428 --------LLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGH-PDVVEAAVIgVddEEFGQR--LRAFV 496
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 499404635 977 tVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPP 1028
Cdd:PRK07788 497 -VKAPGAALDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKVLKRELRE 547
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
562-1021 |
5.91e-31 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 128.40 E-value: 5.91e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHiitdanlsvILGGD 641
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEH---------RLRTS 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 GQQLAQWSAEQRIDLTDPAVVEqwqdlpgdqppaiprhaqqlaqvIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTP 721
Cdd:cd05973 72 GARLVVTDAANRHKLDSDPFVM-----------------------MFTSGTTGLPKGVPVPLRALAAFGAYLRDAVDLRP 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 722 QSTMFNCMSLSFDAGNMTTLL-PLSSG--GTL---AFGEPNDRAIMqaEQAGATHLI-LPTALMSILD-----PEQVNG- 788
Cdd:cd05973 129 EDSFWNAADPGWAYGLYYAITgPLALGhpTILlegGFSVESTWRVI--ERLGVTNLAgSPTAYRLLMAagaevPARPKGr 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 789 IQAIGMGGEACpNAVVENWADK---VALYNMYGPTE-----CTVTALSTRLRKGqpvTIGKPLIHIQALILDTAGQLCPV 860
Cdd:cd05973 207 LRRVSSAGEPL-TPEVIRWFDAalgVPIHDHYGQTElgmvlANHHALEHPVHAG---SAGRAMPGWRVAVLDDDGDELGP 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 861 GVPGElclaglgLARGYLNQPQMtasrfehiTLNDVNNAGQGAATLRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRI 940
Cdd:cd05973 283 GEPGR-------LAIDIANSPLM--------WFRGYQLPDTPAIDGGYYLTGDTVEFDPDGSFSFIGRADDVITMSGYRI 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 941 EPGEIEAQLAAvCPSLKQIKVIVAQVGSRPALV-AYATVKAD-SSTPEPAAVL-IDVAKYLPEYMVPFRLMLLEDMPLTP 1017
Cdd:cd05973 348 GPFDVESALIE-HPAVAEAAVIGVPDPERTEVVkAFVVLRGGhEGTPALADELqLHVKKRLSAHAYPRTIHFVDELPKTP 426
|
....
gi 499404635 1018 NGKL 1021
Cdd:cd05973 427 SGKI 430
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
1126-1456 |
9.89e-31 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 127.53 E-value: 9.89e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1126 EFALLPIQR--WFMEQSLARPEHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLGCDAEGQRY----LADVPCPALS 1198
Cdd:cd19066 1 KIPLSPMQRgmWFLKKLATDPSAFNVAIEMFLTgSLDLARLKQALDAVMERHDVLRTRFCEEAGRYeqvvLDKTVRFRIE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1199 TLDYRQLGD------DGLQQAftaLQSEFDPAQGRTMACALVRHHPQADTaLFLAFHHLVIDAVSWRILVDDLERLYLG- 1271
Cdd:cd19066 81 IIDLRNLADpearllELIDQI---QQTIYDLERGPLVRVALFRLADERDV-LVVAIHHIIVDGGSFQILFEDISSVYDAa 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1272 ----EPLLPKTSSYRQWGAALQHYAT--QHAEQLTYWQAQEDGVDLTA-LLAAKDPQGHASAAILTLDAKTTGQLVS--- 1341
Cdd:cd19066 157 erqkPTLPPPVGSYADYAAWLEKQLEseAAQADLAYWTSYLHGLPPPLpLPKAKRPSQVASYEVLTLEFFLRSEETKrlr 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1342 EANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREAIdptlDVSRTVGWFTSTYPVCLQD--KPDWASLIQSSK 1419
Cdd:cd19066 237 EVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDE----AVEDTIGLFLNLLPLRIDTspDATFPELLKRTK 312
|
330 340 350 360
....*....|....*....|....*....|....*....|.
gi 499404635 1420 EQLRQVPDKGVGFNPLRYHH----PQGNSLTLSPIVFNYLG 1456
Cdd:cd19066 313 EQSREAIEHQRVPFIELVRHlgvvPEAPKHPLFEPVFTFKN 353
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
562-984 |
5.60e-30 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 126.81 E-value: 5.60e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGd 641
Cdd:cd05932 7 FTWGEVADKARRLAAALRALGLEPGSKIALISKNCAEWFITDLAIWMAGHISVPLYPTLNPDTIRYVLEHSESKALFVG- 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 gqQLAQWSAEQ--------RIDLTDPAVV---EQWQDLPGDQPP---AIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLI 707
Cdd:cd05932 86 --KLDDWKAMApgvpegliSISLPPPSAAncqYQWDDLIAQHPPleeRPTRFPEQLATLIYTSGTTGQPKGVMLTFGSFA 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 708 NLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTLAFGEPNDRAIMQAEQAGATHLI-------------- 772
Cdd:cd05932 164 WAAQAGIEHIGTEENDRMLSYLPLAHVTERVFVEGgSLYGGVLVAFAESLDTFVEDVQRARPTLFFsvprlwtkfqqgvq 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 773 --LPTA----LMSI-----------LDPEQVNGIQAIGMGGEACPNAVVEnWADKVAL--YNMYGPTECTVTALSTRLRK 833
Cdd:cd05932 244 dkIPQQklnlLLKIpvvnslvkrkvLKGLGLDQCRLAGCGSAPVPPALLE-WYRSLGLniLEAYGMTENFAYSHLNYPGR 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 834 GQPVTIGKPLIHIQALILDTagqlcpvgvpGELCLAGLGLARGYLNQPQMTASRFehitlndvNNAGqgaatlrIYRTGD 913
Cdd:cd05932 323 DKIGTVGNAGPGVEVRISED----------GEILVRSPALMMGYYKDPEATAEAF--------TADG-------FLRTGD 377
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 914 KARLLNNGDYEYCGRIDEQIKL-RGYRIEPGEIEAQLaAVCPSLKQIKVIVAQVGSRPALV---AYATVKADSST 984
Cdd:cd05932 378 KGELDADGNLTITGRVKDIFKTsKGKYVAPAPIENKL-AEHDRVEMVCVIGSGLPAPLALVvlsEEARLRADAFA 451
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
1567-1982 |
1.40e-29 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 123.56 E-value: 1.40e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQSMLYHRLRcpQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECA-SIQVIVKQADLPFYYQ 1644
Cdd:cd19545 3 PCTPLQEGLMALTAR--QPGAYVGQRVFELPPDIDLARLQAAWEQVVQANPILRTRIvQSDSGgLLQVVVKESPISWTES 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DLMQDadplavierYRQQDLRTGFDLSQPpLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQtlmqgqvl 1724
Cdd:cd19545 81 TSLDE---------YLEEDRAAPMGLGGP-LVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQ-------- 142
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1725 mhGDAPAIQVD-RAYVDYARHAvaQQSAVDAFWQQRqslLAqtNDVSMLFAAagkradLSQHLTQIEPQVT-SVSLNEKD 1802
Cdd:cd19545 143 --GEPVPQPPPfSRFVKYLRQL--DDEAAAEFWRSY---LA--GLDPAVFPP------LPSSRYQPRPDATlEHSISLPS 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1803 QATLtafarevGITPSIIAQYAWHRLLARSTG-DAVSIvGNVLSGRESPVEDVASSVGLYINSLPLA--LSWQQPVslQQ 1879
Cdd:cd19545 208 SASS-------GVTLATVLRAAWALVLSRYTGsDDVVF-GVTLSGRNAPVPGIEQIVGPTIATVPLRvrIDPEQSV--ED 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1880 HLVQLQNELMAMNQHATQSL-----IALTAGRSRLFNSLFIYENYPDAKAEQGQRADDPHRL--YPEFSAAyekvemPLN 1952
Cdd:cd19545 278 FLQTVQKDLLDMIPFEHTGLqnirrLGPDARAACNFQTLLVVQPALPSSTSESLELGIEEESedLEDFSSY------GLT 351
|
410 420 430
....*....|....*....|....*....|
gi 499404635 1953 LVVREQSGCMLLRFEFDADALDSAQARRVL 1982
Cdd:cd19545 352 LECQLSGSGLRVRARYDSSVISEEQVERLL 381
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
523-949 |
2.08e-29 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 125.84 E-value: 2.08e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 523 LPRSYPQPQLTVTDVIEAVAQRDPQQLAIAFDGEPrtdtLTYAELNRQANQLAHWLHRQ-GLGEQSLVGVLAKRDRYFVI 601
Cdd:PRK08314 1 LPKSLTLPETSLFHNLEVSARRYPDKTAIVFYGRA----ISYRELLEEAERLAGYLQQEcGVRKGDRVLLYMQNSPQFVI 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 602 ALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSV-ILGGD-GQQLAQWSAEQRI------------------------- 654
Cdd:PRK08314 77 AYYAILRANAVVVPVNPMNREEELAHYVTDSGARVaIVGSElAPKVAPAVGNLRLrhvivaqysdylpaepeiavpawlr 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 655 ------DLTDPAVVeQWQDL--PGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMF 726
Cdd:PRK08314 157 aepplqALAPGGVV-AWKEAlaAGLAPPPHTAGPDDLAVLPYTSGTTGVPKGCMHTHRTVMANAVGSVLWSNSTPESVVL 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 727 NCMSLsFDAGNMTTLL--PLSSGGTLAFGEPNDRAImqAEQAGATHLI-----LPTALMSILDPEQVNG-----IQAIGM 794
Cdd:PRK08314 236 AVLPL-FHVTGMVHSMnaPIYAGATVVLMPRWDREA--AARLIERYRVthwtnIPTMVVDFLASPGLAErdlssLRYIGG 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 GGEACPNAVVENWADKVALYNM--YGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTA-GQLCPVGVPGELCLAGL 871
Cdd:PRK08314 313 GGAAMPEAVAERLKELTGLDYVegYGLTETMAQTHSNPPDRPKLQCLGIPTFGVDARVIDPEtLEELPPGEVGEIVVHGP 392
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 872 GLARGYLNQPQMTASRFehITLNdvnnaGQgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL 949
Cdd:PRK08314 393 QVFKGYWNRPEATAEAF--IEID-----GK-----RFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVENLL 458
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
682-1026 |
3.39e-29 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 120.51 E-value: 3.39e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 682 QLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAIM 761
Cdd:cd17630 1 RLATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGFGGGDSWLLSLPLYHVGGLAILVRSLLAGAELVLLERNQALAE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 762 QAEQAGATHLIL-PTALMSILD----PEQVNGIQAIGMGGEACPNAVVENWADK-VALYNMYGPTE--CTVTALSTRLRK 833
Cdd:cd17630 81 DLAPPGVTHVSLvPTQLQRLLDsgqgPAALKSLRAVLLGGAPIPPELLERAADRgIPLYTTYGMTEtaSQVATKRPDGFG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 834 GQPVtiGKPLIHIQALILDtagqlcpvgvPGELCLAGLGLARGYLNQPqmtasrfehiTLNDVNNAGqgaatlrIYRTGD 913
Cdd:cd17630 161 RGGV--GVLLPGRELRIVE----------DGEIWVGGASLAMGYLRGQ----------LVPEFNEDG-------WFTTKD 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 914 KARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQ---VGSRPALVayatVKADSStPEPAAV 990
Cdd:cd17630 212 LGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAH-PAVRDAFVVGVPdeeLGQRPVAV----IVGRGP-ADPAEL 285
|
330 340 350
....*....|....*....|....*....|....*.
gi 499404635 991 LIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd17630 286 RAWLKDKLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
560-954 |
5.85e-29 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 123.50 E-value: 5.85e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 560 DTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG 639
Cdd:cd05904 31 RALTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLGAVVTTANPLSTPAEIAKQVKDSGAKLAFT 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 gDGQQLAQW-SAEQRIDLTDPAVVEQW------QDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDD 712
Cdd:cd05904 111 -TAELAEKLaSLALPVVLLDSAEFDSLsfsdllFEADEAEPPVVVIKQDDVAALLYSSGTTGRSKGVMLTHRNLIAMVAQ 189
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 713 HRDRIDFTPQST--------MFNCMSLSFdagnmTTLLPLSSGGTL-AFGEPNDRAIMQAEQA-GATHL-ILPTALM--- 778
Cdd:cd05904 190 FVAGEGSNSDSEdvflcvlpMFHIYGLSS-----FALGLLRLGATVvVMPRFDLEELLAAIERyKVTHLpVVPPIVLalv 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 779 --SILDPEQVNGIQAIGMGGEACPNAVVENWADK---VALYNMYGPTECTVTALSTRLRKGQPV---TIGKPLIHIQALI 850
Cdd:cd05904 265 ksPIVDKYDLSSLRQIMSGAAPLGKELIEAFRAKfpnVDLGQGYGMTESTGVVAMCFAPEKDRAkygSVGRLVPNVEAKI 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 851 LDTA-GQLCPVGVPGELCLAGLGLARGYLNQPQMTASrfehiTLNDvnnagQGaatlrIYRTGDKARLLNNGDYEYCGRI 929
Cdd:cd05904 345 VDPEtGESLPPNQTGELWIRGPSIMKGYLNNPEATAA-----TIDK-----EG-----WLHTGDLCYIDEDGYLFIVDRL 409
|
410 420 430
....*....|....*....|....*....|...
gi 499404635 930 DEQIKLRGYRIEPGEIEAQL--------AAVCP 954
Cdd:cd05904 410 KELIKYKGFQVAPAELEALLlshpeildAAVIP 442
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
536-1021 |
1.17e-28 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 123.37 E-value: 1.17e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAVAQRDPQQLAIAF---DGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:cd05970 21 DVVDAMAKEYPDKLALVWcddAGEERI--FTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAI 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDANLSVILGGDGQQLAQ---------WSAEQRIDLTDPaVVEQWQD---LPGDQPPAIPR-H 679
Cdd:cd05970 99 AIPATHQLTAKDIVYRIESADIKMIVAIAEDNIPEeiekaapecPSKPKLVWVGDP-VPEGWIDfrkLIKNASPDFERpT 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 680 A------QQLAQVIYTSGSTGLPKgvMIEH------GSLI------NLLDD--HRDRIDFTPQSTMFNCMSLSFDAGnmt 739
Cdd:cd05970 178 AnsypcgEDILLVYFSSGTTGMPK--MVEHdftyplGHIVtakywqNVREGglHLTVADTGWGKAVWGKIYGQWIAG--- 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 740 tllplSSGGTLAFGEPNDRAIMQ-AEQAGATHLILPTALMSILDPEQV-----NGIQAIGMGGEACPNAVVENWADK--V 811
Cdd:cd05970 253 -----AAVFVYDYDKFDPKALLEkLSKYGVTTFCAPPTIYRFLIREDLsrydlSSLRYCTTAGEALNPEVFNTFKEKtgI 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 812 ALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCL-----AGLGLARGYLNQPQMTAS 886
Cdd:cd05970 328 KLMEGFGQTETTLTIATFPWMEPKPGSMGKPAPGYEIDLIDREGRSCEAGEEGEIVIrtskgKPVGLFGGYYKDAEKTAE 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 887 RFEHitlndvnnagqgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLaavcpsLKQIKVIVAQV 966
Cdd:cd05970 408 VWHD----------------GYYHTGDAAWMDEDGYLWFVGRTDDLIKSSGYRIGPFEVESAL------IQHPAVLECAV 465
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 499404635 967 GSRPALVAYATVKAD---SSTPEPAAVLID-----VAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:cd05970 466 TGVPDPIRGQVVKATivlAKGYEPSEELKKelqdhVKKVTAPYKYPRIVEFVDELPKTISGKI 528
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
688-1020 |
1.69e-28 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 119.30 E-value: 1.69e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 688 YTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTM------FNCMSLSfdagnMTTLLPLSSGGTLAFGEP--NDRA 759
Cdd:cd05917 9 FTSGTTGSPKGATLTHHNIVNNGYFIGERLGLTEQDRLcipvplFHCFGSV-----LGVLACLTHGATMVFPSPsfDPLA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 760 IMQA---EQAGATHLIlPTALMSILD-PEQVN--------GIqaigMGGEACPNAVVEnwaDKVALYNM------YGPTE 821
Cdd:cd05917 84 VLEAiekEKCTALHGV-PTMFIAELEhPDFDKfdlsslrtGI----MAGAPCPPELMK---RVIEVMNMkdvtiaYGMTE 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 822 CTVTALSTRLRKGQP---VTIGKPLIHIQALILD-TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfEHITlNDvn 897
Cdd:cd05917 156 TSPVSTQTRTDDSIEkrvNTVGRIMPHTEAKIVDpEGGIVPPVGVPGELCIRGYSVMKGYWNDPEKTA---EAID-GD-- 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 898 nagqgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLaavcpsLKQIKVIVAQVGSRP------A 971
Cdd:cd05917 230 ---------GWLHTGDLAVMDEDGYCRIVGRIKDMIIRGGENIYPREIEEFL------HTHPKVSDVQVVGVPderygeE 294
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|...
gi 499404635 972 LVAYATVKADSSTPEPaavliDVAKYLPE----YMVPFRLMLLEDMPLTPNGK 1020
Cdd:cd05917 295 VCAWIRLKEGAELTEE-----DIKAYCKGkiahYKVPRYVFFVDEFPLTVSGK 342
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
543-1021 |
2.00e-28 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 123.07 E-value: 2.00e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 543 QRDPQQLAIAFDGE--PRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDY 620
Cdd:cd17634 64 RENGDRTAIIYEGDdtSQSRTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGF 143
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 621 PPERLRHIITDANLSVILGGDG-----------------QQLAQWSAEQRIDLTDPAVVEQWQ--------DLPGDQPPA 675
Cdd:cd17634 144 APEAVAGRIIDSSSRLLITADGgvragrsvplkknvddaLNPNVTSVEHVIVLKRTGSDIDWQegrdlwwrDLIAKASPE 223
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 676 ---IPRHAQQLAQVIYTSGSTGLPKGVMIEHGS-LINLLDDHRDRIDFTPqSTMFNCMSlsfDAGNMTT---LL--PLSS 746
Cdd:cd17634 224 hqpEAMNAEDPLFILYTSGTTGKPKGVLHTTGGyLVYAATTMKYVFDYGP-GDIYWCTA---DVGWVTGhsyLLygPLAC 299
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 747 GGT--LAFGEPN----DRAIMQAEQAGATHLIL-PTALMSIL--DPEQVNG-----IQAIGMGGEACpNAVVENWADKV- 811
Cdd:cd17634 300 GATtlLYEGVPNwptpARMWQVVDKHGVNILYTaPTAIRALMaaGDDAIEGtdrssLRILGSVGEPI-NPEAYEWYWKKi 378
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 812 -----ALYNMYGPTEcTVTALSTRLRKGQPVTIG---KPLIHIQALILDTAGQLCPVGVPGELCLAGL--GLARGYLNQP 881
Cdd:cd17634 379 gkekcPVVDTWWQTE-TGGFMITPLPGAIELKAGsatRPVFGVQPAVVDNEGHPQPGGTEGNLVITDPwpGQTRTLFGDH 457
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 882 QmtasRFEHITLNDVNNagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQikv 961
Cdd:cd17634 458 E----RFEQTYFSTFKG---------MYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAH-PKVAE--- 520
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 499404635 962 iVAQVGSRPAL-----VAYATVKA-DSSTPEPAAVLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:cd17634 521 -AAVVGIPHAIkgqapYAYVVLNHgVEPSPELYAELRNwVRKEIGPLATPDVVHWVDSLPKTRSGKI 586
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
527-1020 |
3.60e-28 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 122.76 E-value: 3.60e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 527 YPQPQLTVT--DVIEAVAQRDPQQLAIAF--DGEP--RTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFV 600
Cdd:PRK07529 18 LAARDLPAStyELLSRAAARHPDAPALSFllDADPldRPETWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPETH 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 601 IALLAIWKAGAAyVPLDPDYPPERLRHIITDANLSVI--LGGD-GQQLAQWSAEQR-----------IDLTDPAVVEQWQ 666
Cdd:PRK07529 98 FALWGGEAAGIA-NPINPLLEPEQIAELLRAAGAKVLvtLGPFpGTDIWQKVAEVLaalpelrtvveVDLARYLPGPKRL 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 667 DLPGDQPPAI----------------------PRHAQQLAQVIYTSGSTGLPKGVMIEHGS------LINLLddhrdrID 718
Cdd:PRK07529 177 AVPLIRRKAHarildfdaelarqpgdrlfsgrPIGPDDVAAYFHTGGTTGMPKLAQHTHGNevanawLGALL------LG 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 719 FTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTLAFGEP---NDRAIMQ-----AEQAGATHLI-LPTALMSILD-PeqVN 787
Cdd:PRK07529 251 LGPGDTVFCGLPLFHVNALLVTGLaPLARGAHVVLATPqgyRGPGVIAnfwkiVERYRINFLSgVPTVYAALLQvP--VD 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 788 GIQ------AIGmGGEACPNAVVENWADK--VALYNMYGPTECT-VTALSTRLRKGQPVTIGKPLIH--IQALILDTAGQ 856
Cdd:PRK07529 329 GHDisslryALC-GAAPLPVEVFRRFEAAtgVRIVEGYGLTEATcVSSVNPPDGERRIGSVGLRLPYqrVRVVILDDAGR 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 857 L---CPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNdvnnagqgaatlriyrTGDKARLLNNGDYEYCGRIDEQI 933
Cdd:PRK07529 408 YlrdCAVDEVGVLCIAGPNVFSGYLEAAHNKGLWLEDGWLN----------------TGDLGRIDADGYFWLTGRAKDLI 471
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 934 KLRGYRIEPGEIEAQLA---AVcpslkqikVIVAQVGsRPAL------VAYATVKADSSTPEPAavLIDVAK-YLPE-YM 1002
Cdd:PRK07529 472 IRGGHNIDPAAIEEALLrhpAV--------ALAAAVG-RPDAhagelpVAYVQLKPGASATEAE--LLAFARdHIAErAA 540
|
570
....*....|....*...
gi 499404635 1003 VPFRLMLLEDMPLTPNGK 1020
Cdd:PRK07529 541 VPKHVRILDALPKTAVGK 558
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
533-1016 |
1.17e-27 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 120.23 E-value: 1.17e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQqlAIAFDGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK06164 11 TLASLLDAHARARPD--AVALIDEDRP--LSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGAT 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDA--------------NLSVILGGDGQQLAQwsAEQRIDLTD----------PAVVEQWQDL 668
Cdd:PRK06164 87 VIAVNTRYRSHEVAHILGRGrarwlvvwpgfkgiDFAAILAAVPPDALP--PLRAIAVVDdaadatpapaPGARVQLFAL 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 669 PGDQPP--AIPRHAQQLAQVIY--TSGSTGLPKGVMIEHGSLInlldDHRDRI----DFTPQSTMFnCMSLSFDAGNMTT 740
Cdd:PRK06164 165 PDPAPPaaAGERAADPDAGALLftTSGTTSGPKLVLHRQATLL----RHARAIarayGYDPGAVLL-AALPFCGVFGFST 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 741 LL-PLSSGGTL----AFGEPndRAIMQAEQAGATHLILPTALMS-ILDPEQVNG----IQAIGMGGEACPNAVVENWADK 810
Cdd:PRK06164 240 LLgALAGGAPLvcepVFDAA--RTARALRRHRVTHTFGNDEMLRrILDTAGERAdfpsARLFGFASFAPALGELAALARA 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 811 --VALYNMYGPTEctVTALSTRLRKGQPVTI----GKPLIHIQAL--ILDTA-GQLCPVGVPGELCLAGLGLARGYLNQP 881
Cdd:PRK06164 318 rgVPLTGLYGSSE--VQALVALQPATDPVSVriegGGRPASPEARvrARDPQdGALLPDGESGEIEIRAPSLMRGYLDNP 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 882 QMTAsrfEHITLNDvnnagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKV 961
Cdd:PRK06164 396 DATA---RALTDDG------------YFRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEA-LPGVAAAQV 459
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 962 IVAQVGSRPalVAYATVKADSST-PEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLT 1016
Cdd:PRK06164 460 VGATRDGKT--VPVAFVIPTDGAsPDEAGLMAACREALAGFKVPARVQVVEAFPVT 513
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
677-1026 |
2.72e-27 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 118.20 E-value: 2.72e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 677 PRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAG-NMTTLLPLSSGGTLAFgEP 755
Cdd:cd05909 143 PVQPDDPAVILFTSGSEGLPKGVVLSHKNLLANVEQITAIFDPNPEDVVFGALPFFHSFGlTGCLWLPLLSGIKVVF-HP 221
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 756 ND---RAIMQ-AEQAGATHLI-LPTALMSIL---DPEQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECT-V 824
Cdd:cd05909 222 NPldyKKIPElIYDKKATILLgTPTFLRGYAraaHPEDFSSLRLVVAGAEKLKDTLRQEFQEKfgIRILEGYGTTECSpV 301
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 825 TALSTRLRKGQPVTIGKPLIHIQALILDTAGQL-CPVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndvnnagqga 903
Cdd:cd05909 302 ISVNTPQSPNKEGTVGRPLPGMEVKIVSVETHEeVPIGEGGLLLVRGPNVMLGYLNEPELTSFAFGD------------- 368
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 904 atlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVAQVGSR-PALVAYATvkadS 982
Cdd:cd05909 369 ---GWYDTGDIGKIDGEGFLTITGRLSRFAKIAGEMVSLEAIEDILSEILPEDNEVAVVSVPDGRKgEKIVLLTT----T 441
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 499404635 983 STPEPAAvLIDVAKY--LPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05909 442 TDTDPSS-LNDILKNagISNLAKPSYIHQVEEIPLLGTGKPDYVTL 486
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
1129-1351 |
7.83e-27 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 111.28 E-value: 7.83e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1129 LLPIQR--WFMEQSLArpeHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLGCDAEG----QRYLADVPCPaLSTLD 1201
Cdd:COG4908 1 LSPAQKrfLFLEPGSN---AYNIPAVLRLEgPLDVEALERALRELVRRHPALRTRFVEEDgepvQRIDPDADLP-LEVVD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1202 YRQLGDDGLQQAFTALQSE-----FDPAQGRTMACALVRHHPQADtALFLAFHHLVIDAVSWRILVDDLERLY----LGE 1272
Cdd:COG4908 77 LSALPEPEREAELEELVAEeasrpFDLARGPLLRAALIRLGEDEH-VLLLTIHHIISDGWSLGILLRELAALYaallEGE 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1273 PLL--PKTSSYRQWGAALQHYATQHA--EQLTYWQAQEDGVDLTALLAAKDPQG-----HASAAILTLDAKTTGQLVSEA 1343
Cdd:COG4908 156 PPPlpELPIQYADYAAWQRAWLQSEAleKQLEYWRQQLAGAPPVLELPTDRPRPavqtfRGATLSFTLPAELTEALKALA 235
|
....*...
gi 499404635 1344 nRAFNTDV 1351
Cdd:COG4908 236 -KAHGATV 242
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
530-1028 |
1.72e-26 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 115.47 E-value: 1.72e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 530 PQLTVTDVIEAVAQRDpqqlAIAFDGeprtDTLTYAELNRQANQLAHWLHRQGLgeqslVGVLAKRDRYFVIALLAIWKA 609
Cdd:PRK07787 2 ASLNPAAVAAAADIAD----AVRIGG----RVLSRSDLAGAATAVAERVAGARR-----VAVLATPTLATVLAVVGALIA 68
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 610 GAAYVPLDPDYPPERLRHIITDANLSVILGGDGQQLAqwsAEQRIDLTDPAVVEQWQDLPGDQPPAIprhaqqlaqVIYT 689
Cdd:PRK07787 69 GVPVVPVPPDSGVAERRHILADSGAQAWLGPAPDDPA---GLPHVPVRLHARSWHRYPEPDPDAPAL---------IVYT 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 690 SGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTLA-FGEPNDRAIMQAEQAG 767
Cdd:PRK07787 137 SGTTGPPKGVVLSRRAIAADLDALAEAWQWTADDVLVHGLPLFHVHGLVLGVLgPLRIGNRFVhTGRPTPEAYAQALSEG 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 768 ATHLI-LPTALMSIL-DPEQ---VNGIQAIGMGGEACPNAVVENWADKV--ALYNMYGPTEcTVTALSTRL---RKgqPV 837
Cdd:PRK07787 217 GTLYFgVPTVWSRIAaDPEAaraLRGARLLVSGSAALPVPVFDRLAALTghRPVERYGMTE-TLITLSTRAdgeRR--PG 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 838 TIGKPLIHIQALILDTAGQLCPVGVP--GELCLAGLGLARGYLNQPQMTASRFehitlndvnnAGQGaatlrIYRTGDKA 915
Cdd:PRK07787 294 WVGLPLAGVETRLVDEDGGPVPHDGEtvGELQVRGPTLFDGYLNRPDATAAAF----------TADG-----WFRTGDVA 358
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 916 RLLNNGDYEYCGR--IDeQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVA---QVGSRpaLVAYATvkadSSTPEPAAV 990
Cdd:PRK07787 359 VVDPDGMHRIVGResTD-LIKSGGYRIGAGEIETALLG-HPGVREAAVVGVpddDLGQR--IVAYVV----GADDVAADE 430
|
490 500 510
....*....|....*....|....*....|....*....
gi 499404635 991 LID-VAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPP 1028
Cdd:PRK07787 431 LIDfVAQQLSVHKRPREVRFVDALPRNAMGKVLKKQLLS 469
|
|
| benz_CoA_lig |
TIGR02262 |
benzoate-CoA ligase family; Characterized members of this protein family include benzoate-CoA ... |
551-954 |
1.73e-26 |
|
benzoate-CoA ligase family; Characterized members of this protein family include benzoate-CoA ligase, 4-hydroxybenzoate-CoA ligase, 2-aminobenzoate-CoA ligase, etc. Members are related to fatty acid and acetate CoA ligases.
Pssm-ID: 274059 [Multi-domain] Cd Length: 505 Bit Score: 116.09 E-value: 1.73e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 551 IAFDGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIIT 630
Cdd:TIGR02262 22 TAFIDDISS--LSYGELEAQVRRLAAALRRLGVKREERVLLLMLDGVDFPIAFLGAIRAGIVPVALNTLLTADDYAYMLE 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 631 DANLSVILG------------GDGQQLaqwsaEQRIDLTDPAVVE-QWQDLPGDQPP---AIPRHAQQLAQVIYTSGSTG 694
Cdd:TIGR02262 100 DSRARVVFVsgallpvikaalGKSPHL-----EHRVVVGRPEAGEvQLAELLATESEqfkPAATQADDPAFWLYSSGSTG 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 695 LPKGVMIEHGSLINLLDDH-RDRIDFTPQSTMFNCMSLSF--DAGNMTTLlPLSSGGT-LAFGE-PNDRAIMQAEQAGAT 769
Cdd:TIGR02262 175 MPKGVVHTHSNPYWTAELYaRNTLGIREDDVCFSAAKLFFayGLGNALTF-PMSVGATtVLMGErPTPDAVFDRLRRHQP 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 770 HLI--LPTALMSIL-DP----EQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECTVTALSTRLRKGQPVTIG 840
Cdd:TIGR02262 254 TIFygVPTLYAAMLaDPnlpsEDQVRLRLCTSAGEALPAEVGQRWQARfgVDIVDGIGSTEMLHIFLSNLPGDVRYGTSG 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 841 KPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndvnnagQGAATlriyRTGDKARLLNN 920
Cdd:TIGR02262 334 KPVPGYRLRLVGDGGQDVADGEPGELLISGPSSATMYWNNRAKSRDTF------------QGEWT----RSGDKYVRNDD 397
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 499404635 921 GDYEYCGRIDEQIKLRGYRIEPGEIEAQL--------AAVCP 954
Cdd:TIGR02262 398 GSYTYAGRTDDMLKVSGIYVSPFEIESALiqhpavleAAVVG 439
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
533-1026 |
1.82e-26 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 116.24 E-value: 1.82e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAFDGeprtDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK06188 13 TYGHLLVSALKRYPDRPALVLGD----TRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGAAQLAGLR 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRHIITDANLSVILGGDGQ-------------QLAQW----SAEQRIDLTDPAVVEQWQDL-PGDQPP 674
Cdd:PRK06188 89 RTALHPLGSLDDHAYVLEDAGISTLIVDPAPfveralallarvpSLKHVltlgPVPDGVDLLAAAAKFGPAPLvAAALPP 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 675 AIprhaqqlAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGnmTTLLP-LSSGGTL--- 750
Cdd:PRK06188 169 DI-------AGLAYTGGTTGKPKGVMGTHRSIATMAQIQLAEWEWPADPRFLMCTPLSHAGG--AFFLPtLLRGGTVivl 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 751 -AFgEPND--RAImQAEQAGAThLILPTALMSILDPEQV-----NGIQAIGMGGEA-CPNAVVEnwADKV---ALYNMYG 818
Cdd:PRK06188 240 aKF-DPAEvlRAI-EEQRITAT-FLVPTMIYALLDHPDLrtrdlSSLETVYYGASPmSPVRLAE--AIERfgpIFAQYYG 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 819 PTECTVTAlsTRLRKG-----QPVTI---GKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEH 890
Cdd:PRK06188 315 QTEAPMVI--TYLRKRdhdpdDPKRLtscGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAFRD 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 891 ITLndvnnagqgaatlriyRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI-VAQVGSR 969
Cdd:PRK06188 393 GWL----------------HTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEH-PAVAQVAVIgVPDEKWG 455
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 499404635 970 PALVAYATVKADSStPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK06188 456 EAVTAVVVLRPGAA-VDAAELQAHVKERKGSVHAPKQVDFVDSLPLTALGKPDKKAL 511
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
95-497 |
2.68e-26 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 113.82 E-value: 2.68e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 95 NMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEqGKGEQRIDAYQPFVIQHDDFSllpeaeregrlqqqVKAEI 174
Cdd:cd19537 25 NVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPRD-GGLRRSYSSSPPRVQRVDTLD--------------VWKEI 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 175 SRPFDLTAGDLTRVRlvkMSERThvLMITQHHIISDGWSVKNLFADFKpafLACQNCQPYPVettQLNYIDYAHWFN--S 252
Cdd:cd19537 90 NRPFDLEREDPIRVF---ISPDT--LLVVMSHIICDLTTLQLLLREVS---AAYNGKLLPPV---RREYLDSTAWSRpaS 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 253 DSFLDyhnefkpFWVERLTGIPevhslPLDKPRPAHQNS-GGEVIFSAINNDLWDKFKRLCqrynTSNFIGLH----AVF 327
Cdd:cd19537 159 PEDLD-------FWSEYLSGLP-----LLNLPRRTSSKSyRGTSRVFQLPGSLYRSLLQFS----TSSGITLHqlalAAV 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 328 SLMLARISGEKDIVIGSPLAYRERPDIEDVVGFFVNTIVLRTQLQDSQN--FVDYLQYCREQDLSAFDHQLyRFEALSEA 405
Cdd:cd19537 223 ALALQDLSDRTDIVLGAPYLNRTSEEDMETVGLFLEPLPIRIRFPSSSDasAADFLRAVRRSSQAALAHAI-PWHQLLEH 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 406 IGSDRTTAINPIFQVMlvyqakVDFNDL--------IPGCDaaeetspVLP-----AKTDISVKVTELMGE---VRLDWl 469
Cdd:cd19537 302 LGLPPDSPNHPLFDVM------VTFHDDrgvslalpIPGVE-------PLYtwaegAKFPLMFEFTALSDDsllLRLEY- 367
|
410 420
....*....|....*....|....*...
gi 499404635 470 fATALFERQTIQYYADRFIRLIEAVVEN 497
Cdd:cd19537 368 -DTDCFSEEEIDRIESLILAALELLVEG 394
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
1567-1982 |
5.41e-26 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 112.92 E-value: 5.41e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALESECAS--IQVIVKQADLPFYYQ 1644
Cdd:cd19544 3 PLAPLQEGILFHHLLAEEGDPYLLRSLLAFDSRARLDAFLAALQQVIDRHDILRTAILWEGLSepVQVVWRQAELPVEEL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DLMQDADPLA-VIERYRQQDLRtgFDLSQPPLLRIACFRLGEQD-YRVLLSCHHSVIDGWSgpqlLGAVHRDYQTLMQGQ 1722
Cdd:cd19544 83 TLDPGDDALAqLRARFDPRRYR--LDLRQAPLLRAHVAEDPANGrWLLLLLFHHLISDHTS----LELLLEEIQAILAGR 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1723 VlmHGDAPAIQVdRAYVDYARHAVAQQSAVDAFwqqrQSLLAqtnDVSM------LFAAAGKRADLSQHLTQIEPQVTsv 1796
Cdd:cd19544 157 A--AALPPPVPY-RNFVAQARLGASQAEHEAFF----REMLG---DVDEptapfgLLDVQGDGSDITEARLALDAELA-- 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1797 slnekdqATLTAFAREVGITPSIIAQYAWHRLLARSTG--DAVsiVGNVLSGRESPVEDVASSVGLYINSLPLALSWQQp 1874
Cdd:cd19544 225 -------QRLRAQARRLGVSPASLFHLAWALVLARCSGrdDVV--FGTVLSGRMQGGAGADRALGMFINTLPLRVRLGG- 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1875 VSLQQHLVQLQNELMAMNQHATQSLiALT------AGRSRLFNSLFiyeNYP-DAKAEQGQRADDPHRLypEFSAAYEKV 1947
Cdd:cd19544 295 RSVREAVRQTHARLAELLRHEHASL-ALAqrcsgvPAPTPLFSALL---NYRhSAAAAAAAALAAWEGI--ELLGGEERT 368
|
410 420 430
....*....|....*....|....*....|....*
gi 499404635 1948 EMPLNLVVREQSGcmllRFEFDADALDSAQARRVL 1982
Cdd:cd19544 369 NYPLTLSVDDLGD----GFSLTAQVVAPIDAERVC 399
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
514-1027 |
7.00e-26 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 114.32 E-value: 7.00e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 514 AAVLAETQQLPR--SYPQPQLTVTdvieavAQRDPQQLAIAFDgeprTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGV 591
Cdd:PRK13383 21 RAVLRLLREASRggTNPYTLLAVT------AARWPGRTAIIDD----DGALSYRELQRATESLARRLTRDGVAPGRAVGV 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 592 LAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD--GQQLAqwSAEQRIDLTDPAVVEqwqdlp 669
Cdd:PRK13383 91 MCRNGRGFVTAVFAVGLLGADVVPISTEFRSDALAAALRAHHISTVVADNefAERIA--GADDAVAVIDPATAG------ 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 670 GDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEH------GSLINLLDDHRDRID--FTPQSTMFNCMSLSFdagnmtTL 741
Cdd:PRK13383 163 AEESGGRPAVAAPGRIVLLTSGTTGKPKGVPRAPqlrsavGVWVTILDRTRLRTGsrISVAMPMFHGLGLGM------LM 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 742 LPLSSGGTLAFGEPND--RAIMQAEQAGATHL-ILPTALMSILD-PEQVNG------IQAIGMGGEACPNAVVENWADKV 811
Cdd:PRK13383 237 LTIALGGTVLTHRHFDaeAALAQASLHRADAFtAVPVVLARILElPPRVRArnplpqLRVVMSSGDRLDPTLGQRFMDTY 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 812 A--LYNMYGPTECTVTALST--RLRKGqPVTIGKPLIHIQALILDTAGQlcPVGvpgelclaglglargylnqPQMTASR 887
Cdd:PRK13383 317 GdiLYNGYGSTEVGIGALATpaDLRDA-PETVGKPVAGCPVRILDRNNR--PVG-------------------PRVTGRI 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 888 FEHITLN-DVNNAGQGAATLR-IYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI-VA 964
Cdd:PRK13383 375 FVGGELAgTRYTDGGGKAVVDgMTSTGDMGYLDNAGRLFIVGREDDMIISGGENVYPRAVENALAA-HPAVADNAVIgVP 453
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 965 --QVGSRpaLVAYATVKADSSTpePAAVLIDVAK-YLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:PRK13383 454 deRFGHR--LAAFVVLHPGSGV--DAAQLRDYLKdRVSRFEQPRDINIVSSIPRNPTGKVLRKELP 515
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1539-2003 |
1.73e-25 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 116.60 E-value: 1.73e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1539 TPSDFPAVNLSQTQLDSLS-QRYDIDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFP 1617
Cdd:PRK12316 2575 TLAAFAASLESGQTSRAPVlQKVTRVQPLPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHE 2654
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1618 ALRAALESECA-SIQVIVKQADLPFYYQDLMQDADplAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHH 1696
Cdd:PRK12316 2655 TLRTRFVEVGEqTRQVILPNMSLRIVLEDCAGVAD--AAIRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHH 2732
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1697 SVIDGWSGPQLLGAVHRDYQTLMQGQVLMHGDAPAIQVDRAYVDYARHAVAQQSAVDAFWQQRqsllAQTNDVSMLFAAA 1776
Cdd:PRK12316 2733 IVSDGWSMQVMVDELVQAYAGARRGEQPTLPPLPLQYADYAAWQRAWMDSGEGARQLDYWRER----LGGEQPVLELPLD 2808
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1777 GKRADLSQHLTQIEPQVTSVSLNEKdqatLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPveDVAS 1856
Cdd:PRK12316 2809 RPRPALQSHRGARLDVALDVALSRE----LLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRA--ETER 2882
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1857 SVGLYINSLPLALSWQQPVSLQQHLVQLQNELMAMNQHA----TQSLIALTAGRSR----LFNSLFIYENYPDAKAEQGq 1928
Cdd:PRK12316 2883 LIGFFVNTQVLRAQVDAQLAFRDLLGQVKEQALGAQAHQdlpfEQLVEALQPERSLshspLFQVMYNHQSGERAAAQLP- 2961
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 1929 rADDPHRLYPEFSAAyekvEMPLNLVVREQSGCMLLRFEFDADALDSAQARRVLMRWHDEVVALVNSVPQQPAEI 2003
Cdd:PRK12316 2962 -GLHIESFAWDGAAT----QFDLALDTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDEL 3031
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
532-1021 |
1.77e-25 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 113.06 E-value: 1.77e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGA 611
Cdd:PRK06145 2 FNLSASIAFHARRTPDRAALVYRDQ----EISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGA 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 612 AYVPLDPDYPPERLRHIITDANLSVILgGDGQQLAQWSAEQRIDLTDPAVVEQWQDL--PGDQ-PPAIPRHAQQLAQVIY 688
Cdd:PRK06145 78 VFLPINYRLAADEVAYILGDAGAKLLL-VDEEFDAIVALETPKIVIDAAAQADSRRLaqGGLEiPPQAAVAPTDLVRLMY 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 689 TSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSL-SFDAGNMTTLLPLSSGGTLAFGEPND-RAIMQAEQ- 765
Cdd:PRK06145 157 TSGTTDRPKGVMHSYGNLHWKSIDHVIALGLTASERLLVVGPLyHVGAFDLPGIAVLWVGGTLRIHREFDpEAVLAAIEr 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 766 ----AGATHLILPTALMSILDPEQ--VNGIQAIGMGGEACPNAVVENWAD---KVALYNMYGPTE-CTVTALSTRLRKGQ 835
Cdd:PRK06145 237 hrltCAWMAPVMLSRVLTVPDRDRfdLDSLAWCIGGGEKTPESRIRDFTRvftRARYIDAYGLTEtCSGDTLMEAGREIE 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 836 PV-TIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDvnnagqgaatlrIYRTGDK 914
Cdd:PRK06145 317 KIgSTGRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAF----YGD------------WFRSGDV 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 915 ARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVA---QVGSRPALVayaTVKADSSTPEPAAVL 991
Cdd:PRK06145 381 GYLDEEGFLYLTDRKKDMIISGGENIASSEVERVIYEL-PEVAEAAVIGVhddRWGERITAV---VVLNPGATLTLEALD 456
|
490 500 510
....*....|....*....|....*....|
gi 499404635 992 IDVAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK06145 457 RHCRQRLASFKVPRQLKVRDELPRNPSGKV 486
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
532-1026 |
4.18e-25 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 112.16 E-value: 4.18e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAVAQRDPQQLAIAfDGEPRtdtLTYAELNRQANQLAHWLHRQGLGeqslvgvlaKRDR---------YFVIA 602
Cdd:COG1021 25 ETLGDLLRRRAERHPDRIAVV-DGERR---LSYAELDRRADRLAAGLLALGLR---------PGDRvvvqlpnvaEFVIV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 603 LLAIWKAGAAYVPLdpdYPPER---LRHII--TDANLSVILGGDG---------QQLAQWSA-EQRIDLTDPAVVEQWQD 667
Cdd:COG1021 92 FFALFRAGAIPVFA---LPAHRraeISHFAeqSEAVAYIIPDRHRgfdyralarELQAEVPSlRHVLVVGDAGEFTSLDA 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 668 L---PGDQPPAIPrHAQQLAQVIYTSGSTGLPKgvMIEHgslinlldDHRDRI----------DFTPQSTMFNCMSLsfd 734
Cdd:COG1021 169 LlaaPADLSEPRP-DPDDVAFFQLSGGTTGLPK--LIPR--------THDDYLysvrasaeicGLDADTVYLAALPA--- 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 735 AGNMTTLLP-----LSSGGTLAF---GEPnDRAIMQAEQAGATHLIL-PTALMSILD-----PEQVNGIQAIGMGGEACP 800
Cdd:COG1021 235 AHNFPLSSPgvlgvLYAGGTVVLapdPSP-DTAFPLIERERVTVTALvPPLALLWLDaaersRYDLSSLRVLQVGGAKLS 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 801 NAVvenwADKV------ALYNMYGPTECTVTalSTRLrkGQPV-----TIGKPL-IHIQALILDTAGQLCPVGVPGELCL 868
Cdd:COG1021 314 PEL----ARRVrpalgcTLQQVFGMAEGLVN--YTRL--DDPEeviltTQGRPIsPDDEVRIVDEDGNPVPPGEVGELLT 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 869 AGLGLARGYLNQPQMTASRFEHitlndvnnagQGaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQ 948
Cdd:COG1021 386 RGPYTIRGYYRAPEHNARAFTP----------DG-----FYRTGDLVRRTPDGYLVVEGRAKDQINRGGEKIAAEEVENL 450
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 949 LAAvCPSlkqikviVAQVgsrpALVAY----------ATVKADSSTPEPAAVLidvaKYL-----PEYMVPFRLMLLEDM 1013
Cdd:COG1021 451 LLA-HPA-------VHDA----AVVAMpdeylgerscAFVVPRGEPLTLAELR----RFLrerglAAFKLPDRLEFVDAL 514
|
570
....*....|...
gi 499404635 1014 PLTPNGKLDMKQL 1026
Cdd:COG1021 515 PLTAVGKIDKKAL 527
|
|
| NRPS-para261 |
TIGR01720 |
non-ribosomal peptide synthase domain TIGR01720; This domain appears to be located immediately ... |
1414-1556 |
5.29e-25 |
|
non-ribosomal peptide synthase domain TIGR01720; This domain appears to be located immediately downstream from a condensation domain (pfam00668), and is followed primarily by the end of the molecule or another condensation domain (in a few cases it is followed by pfam00501, an AMP-binding module). The converse is not true, pfam00668 domains are not always followed by this domain. This implicates this domain in possible post-condensation modification events. This model is 171 amino acids long and contains three very highly conserved regions. At the N-terminus is a nearly invariant lysine (position 11) followed by xxxRxxPxxGxGYG in which the proline and the first glycine are invariant. This is followed approximately 22 residues later by the motif FNYLG. Near the C-terminus of the domain is the sequence TxSD where the serine and aspartate are nearly invariant.
Pssm-ID: 273774 [Multi-domain] Cd Length: 153 Bit Score: 103.12 E-value: 5.29e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1414 LIQSSKEQLRQVPDKGVGFNPLRYHHPQGNSLTLSP---IVFNYLG---LSVQaAGTWRPVDVAPGCCVSPGNKPAEVIS 1487
Cdd:TIGR01720 5 LIKAVKEQLRRIPNKGVGYGVLRYLTEPEEKLAASPqpeISFNYLGqfdADSN-DELFQPSSYSPGEAISPESPRPYALE 83
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 1488 LHGGITGGQLTLRQV--GCLNQRDS-ERLMTRLTENLRALTEACLTQLSHGvvFTPSDFPAVNLSQTQLDSL 1556
Cdd:TIGR01720 84 INAMIEDGELTLTWSypTQLFSEDTiEQLADRFKEALEALIAHCAGKEGGG--LTPSDFSLKDLTQDELDEL 153
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
554-1026 |
9.00e-25 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 111.18 E-value: 9.00e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 554 DGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLA-KRDRYFViALLAIWKAGAAYVPLDPDYPPERL------- 625
Cdd:cd12119 18 THEGEVHRYTYAEVAERARRLANALRRLGVKPGDRVATLAwNTHRHLE-LYYAVPGMGAVLHTINPRLFPEQIayiinha 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 626 --RHIITDANLS---------------VILGGDGQQLA------QWSAEQRIDLTDPavVEQWQDLPGDQPPAIprhaqq 682
Cdd:cd12119 97 edRVVFVDRDFLplleaiaprlptvehVVVMTDDAAMPepagvgVLAYEELLAAESP--EYDWPDFDENTAAAI------ 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 683 laqvIYTSGSTGLPKGVMIEHGSLInLlddHrdridftpqsTMFNCMSLSFDAGNMTTLLPLS----------------S 746
Cdd:cd12119 169 ----CYTSGTTGNPKGVVYSHRSLV-L---H----------AMAALLTDGLGLSESDVVLPVVpmfhvnawglpyaaamV 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 747 GGTLAFGEPNDRA-----IMQAEQAGATHLIlPTALMSILDPEQVNG-----IQAIGMGGEACPNAVVENWADK-VALYN 815
Cdd:cd12119 231 GAKLVLPGPYLDPaslaeLIEREGVTFAAGV-PTVWQGLLDHLEANGrdlssLRRVVIGGSAVPRSLIEAFEERgVRVIH 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 816 MYGPTE----CTVTALSTRLRKGQP-------VTIGKPLIHIQALILDTAGQLCPV-GVP-GELCLAGLGLARGYLNQPQ 882
Cdd:cd12119 310 AWGMTEtsplGTVARPPSEHSNLSEdeqlalrAKQGRPVPGVELRIVDDDGRELPWdGKAvGELQVRGPWVTKSYYKNDE 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 883 MTASRFEHITLndvnnagqgaatlriyRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI 962
Cdd:cd12119 390 ESEALTEDGWL----------------RTGDVATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMA-HPAVAEAAVI 452
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 499404635 963 VA---QVGSRPALVayaTVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd12119 453 GVphpKWGERPLAV---VVLKEGATVTAEELLEFLADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
506-1021 |
9.01e-25 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 111.30 E-value: 9.01e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 506 PLMETDRFAAVLAETQQLPRsypqpqlTVTDVIEAVAQRDPQQLAI--AFDGEPRTDTLTYAELNRQANQLAHWLHRQGL 583
Cdd:PRK13295 5 AVLLPPRRAASIAAGHWHDR-------TINDDLDACVASCPDKTAVtaVRLGTGAPRRFTYRELAALVDRVAVGLARLGV 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 584 GEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVIL------GGDGQQLAQ-----WSAEQ 652
Cdd:PRK13295 78 GRGDVVSCQLPNWWEFTVLYLACSRIGAVLNPLMPIFRERELSFMLKHAESKVLVvpktfrGFDHAAMARrlrpeLPALR 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 653 RI-------------DLTDPAvveqWQDLPGDQPP-AIPR-HAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRI 717
Cdd:PRK13295 158 HVvvvggdgadsfeaLLITPA----WEQEPDAPAIlARLRpGPDDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 718 DFTPQSTMFNCMSLSFDAGNMTTL-LPLSSGGTLAFGE--PNDRAIMQAEQAGATHLILPTALMSIL------DPEQVNG 788
Cdd:PRK13295 234 GLGADDVILMASPMAHQTGFMYGLmMPVMLGATAVLQDiwDPARAAELIRTEGVTFTMASTPFLTDLtravkeSGRPVSS 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 789 IQAIGMGGEACPNAVVENwADKV---ALYNMYGPTEC---TVTALSTRLRKGQpVTIGKPLIHIQALILDTAGQLCPVGV 862
Cdd:PRK13295 314 LRTFLCAGAPIPGALVER-ARAAlgaKIVSAWGMTENgavTLTKLDDPDERAS-TTDGCPLPGVEVRVVDADGAPLPAGQ 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 863 PGELCLAGLGLARGYLNQPQMTASRFEhitlndvnnaGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEP 942
Cdd:PRK13295 392 IGRLQVRGCSNFGGYLKRPQLNGTDAD----------GW-------FDTGDLARIDADGYIRISGRSKDVIIRGGENIPV 454
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 943 GEIEAQLAAvCPSLKQIKVIV---AQVGSRpaLVAYATVKADSSTPEPAAV-LID---VAK-YLPEymvpfRLMLLEDMP 1014
Cdd:PRK13295 455 VEIEALLYR-HPAIAQVAIVAypdERLGER--ACAFVVPRPGQSLDFEEMVeFLKaqkVAKqYIPE-----RLVVRDALP 526
|
....*..
gi 499404635 1015 LTPNGKL 1021
Cdd:PRK13295 527 RTPSGKI 533
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
508-1027 |
1.34e-24 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 110.62 E-value: 1.34e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 508 METDRFAAVLAETQQLprsypqpQLTVTDVIEAVAQRDPQQLAIAFDgeprTDTLTYAELNRQANQLAHWLHRQGLGEQS 587
Cdd:PRK13382 26 MRPDRYLRIVAAMRRE-------GMGPTSGFAIAAQRCPDRPGLIDE----LGTLTWRELDERSDALAAALQALPIGEPR 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 588 LVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD------GQQLAQWSAEQRI----DLT 657
Cdd:PRK13382 95 VVGIMCRNHRGFVEALLAANRIGADILLLNTSFAGPALAEVVTREGVDTVIYDEefsatvDRALADCPQATRIvawtDED 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 658 DPAVVEQWQDLP-GDQPPAIPRHAQqlaQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQST------MFNC-- 728
Cdd:PRK13382 175 HDLTVEVLIAAHaGQRPEPTGRKGR---VILLTSGTTGTPKGARRSGPGGIGTLKAILDRTPWRAEEPtvivapMFHAwg 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 729 -----MSLSFdAGNMTTLLPLSSGGTLAFGEPNDraimqaeqagATHL-ILPTALMSILD-PEQV------NGIQAIGMG 795
Cdd:PRK13382 252 fsqlvLAASL-ACTIVTRRRFDPEATLDLIDRHR----------ATGLaVVPVMFDRIMDlPAEVrnrysgRSLRFAAAS 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 796 GEACPNAVVENWADKV--ALYNMYGPTECTVTALST--RLRKgQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAgl 871
Cdd:PRK13382 321 GSRMRPDVVIAFMDQFgdVIYNNYNATEAGMIATATpaDLRA-APDTAGRPAEGTEIRILDQDFREVPTGEVGTIFVR-- 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 872 glargylnqpqmTASRFEHITLNDVNNAGQGAATlriyrTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAA 951
Cdd:PRK13382 398 ------------NDTQFDGYTSGSTKDFHDGFMA-----SGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLAT 460
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 952 VcPSLKQIKVIVA---QVGSRpaLVAYATVKADSS-TPEPAAVliDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:PRK13382 461 H-PDVAEAAVIGVddeQYGQR--LAAFVVLKPGASaTPETLKQ--HVRDNLANYKVPRDIVVLDELPRGATGKILRRELQ 535
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
525-1021 |
2.04e-23 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 107.15 E-value: 2.04e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 525 RSYPQPQLTVTDVIEAVAQRDPQQLAIAFDGEPRTdtltYAELNRQANQLAHWLHRQGLGEQSLVGVL-AKRDRYFVIAL 603
Cdd:PRK06155 14 DPLPPSERTLPAMLARQAERYPDRPLLVFGGTRWT----YAEAARAAAAAAHALAAAGVKRGDRVALMcGNRIEFLDVFL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 604 LAIWkAGAAYVPLDPDYPPERLRHIITD-------------ANLSVILGGDGQQLAQWSAEQRIDLTDPAVVEQWQDLPG 670
Cdd:PRK06155 90 GCAW-LGAIAVPINTALRGPQLEHILRNsgarllvveaallAALEAADPGDLPLPAVWLLDAPASVSVPAGWSTAPLPPL 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 671 DQ--PPAIPRHAQQLAqVIYTSGSTGLPKGVMIEHGSL----INLLDDhrdrIDFTPQSTMFNCMSLsFDAGNMTTLLP- 743
Cdd:PRK06155 169 DApaPAAAVQPGDTAA-ILYTSGTTGPSKGVCCPHAQFywwgRNSAED----LEIGADDVLYTTLPL-FHTNALNAFFQa 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 744 LSSGGTLAFGEpndR-------AIMQAEQAGATHLIlpTALMSILD-----PEQVNGIQAIGMGGeACPNAVVENWADK- 810
Cdd:PRK06155 243 LLAGATYVLEP---RfsasgfwPAVRRHGATVTYLL--GAMVSILLsqparESDRAHRVRVALGP-GVPAALHAAFRERf 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 811 -VALYNMYGPTEcTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAG---LGLARGYLNQPqmtas 886
Cdd:PRK06155 317 gVDLLDGYGSTE-TNFVIAVTHGSQRPGSMGRLAPGFEARVVDEHDQELPDGEPGELLLRAdepFAFATGYFGMP----- 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 887 rfehitlndvnnagqgAATLRIYR-----TGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKV 961
Cdd:PRK06155 391 ----------------EKTVEAWRnlwfhTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLS-HPAVAAAAV 453
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 962 IVAQVGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK06155 454 FPVPSELGEDEVMAAVVLRDGTALEPVALVRHCEPRLAYFAVPRYVEFVAALPKTENGKV 513
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
542-1026 |
4.33e-23 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 105.93 E-value: 4.33e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAI--AFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPD 619
Cdd:PRK13391 7 AQTTPDKPAVimASTGE----VVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNSH 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 620 YPPERLRHIITDANlSVILGGDGQQL--AQWSAEQ------RIDLTDPAVVEQWQDLPG--DQPPAIPRHAQQLAQ-VIY 688
Cdd:PRK13391 83 LTPAEAAYIVDDSG-ARALITSAAKLdvARALLKQcpgvrhRLVLDGDGELEGFVGYAEavAGLPATPIADESLGTdMLY 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 689 TSGSTGLPKGVMIEHGSLinllddhrdRIDFTPQSTMFNCMSLSFDAGnMTTLLP---------------LSSGGTLAFG 753
Cdd:PRK13391 162 SSGTTGRPKGIKRPLPEQ---------PPDTPLPLTAFLQRLWGFRSD-MVYLSPaplyhsapqravmlvIRLGGTVIVM 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 754 EPND--RAIMQAEQAGATH-LILPTALMSILD-PEQVNG------IQAIGMGGEACPNAVVE---NWADKVaLYNMYGPT 820
Cdd:PRK13391 232 EHFDaeQYLALIEEYGVTHtQLVPTMFSRMLKlPEEVRDkydlssLEVAIHAAAPCPPQVKEqmiDWWGPI-IHEYYAAT 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 821 ECT-VTALSTRLRKGQPVTIGKPLIHIqALILDTAGQLCPVGVPGELCLAGlGLARGYLNQPQMTA-SRFEHITLNDVNN 898
Cdd:PRK13391 311 EGLgFTACDSEEWLAHPGTVGRAMFGD-LHILDDDGAELPPGEPGTIWFEG-GRPFEYLNDPAKTAeARHPDGTWSTVGD 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 899 AGQGAATLRIYRTGDKARLLNNGdyeycgrideqiklrGYRIEPGEIEaQLAAVCPslkqiKVIVAQVGSRP-------- 970
Cdd:PRK13391 389 IGYVDEDGYLYLTDRAAFMIISG---------------GVNIYPQEAE-NLLITHP-----KVADAAVFGVPnedlgeev 447
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 971 -ALVayATVKADSSTPEPAAVLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKLdMKQL 1026
Cdd:PRK13391 448 kAVV--QPVDGVDPGPALAAELIAfCRQRLSRQKCPRSIDFEDELPRLPTGKL-YKRL 502
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1548-2031 |
4.60e-23 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 108.32 E-value: 4.60e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1548 LSQTQLDSLSQrYDIDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESE 1626
Cdd:PRK12467 1100 QQQGAQPALPD-VDRDQPLPLSYAQERQWFLWQLEPGSAAYHIPQALRLKGPLDIEALERSFDALVARHESLRTTFvQED 1178
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1627 CASIQVIVKQADLPFYYQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQ 1706
Cdd:PRK12467 1179 GRTRQVIHPVGSLTLEEPLLLAADKDEAQLKVYVEAEARQPFDLEQGPLLRVGLLRLAADEHVLVLTLHHIVSDGWSMQV 1258
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1707 LLGAVHRDYQTLMQGQVLmhgDAPAIQVDraYVDYarhAVAQQSAVDAFWQQRQ-----SLLAQTNDVSMLFAAAGKRAD 1781
Cdd:PRK12467 1259 LVDELVALYAAYSQGQSL---QLPALPIQ--YADY---AVWQRQWMDAGERARQlaywkAQLGGEQPVLELPTDRPRPAV 1330
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1782 LS----QHLTQIEPQVTSvslnekdqaTLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESpvEDVASS 1857
Cdd:PRK12467 1331 QShrgaRLAFELPPALAE---------GLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNR--AETEGL 1399
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1858 VGLYINSLPLALSWQQPVSLQQHLVQLQNELMAMNQHA----TQSLIALTAGRSRLFNSLF--IYENYPDAKAEQGQrad 1931
Cdd:PRK12467 1400 IGFFVNTQVLRAEVDGQASFQQLLQQVKQAALEAQAHQdlpfEQLVEALQPERSLSHSPLFqvMFNHQRDDHQAQAQ--- 1476
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1932 dPHRLYPE-FSAAYEKVEMPLNLVVREQSGCMLLRFEFDADALDSAQARRVLMRWHDevvaLVNSVPQQPAEIIGhdKAT 2010
Cdd:PRK12467 1477 -LPGLSVEsLSWESQTAQFDLTLDTYESSEGLQASLTYATDLFEASTIERLAGHWLN----LLQGLVADPERRLG--ELD 1549
|
490 500
....*....|....*....|.
gi 499404635 2011 GLVAAQKTVADSGINQPDTSF 2031
Cdd:PRK12467 1550 LLDEAERRQILEGWNATHTGY 1570
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
73-425 |
4.60e-23 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 104.45 E-value: 4.60e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQRIDAYQPFVIQHD 152
Cdd:cd19536 3 PLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVHRQAQVPVTEL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 153 DfsLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLM-ITQHHIISDGWSVKNLFADFKPAFLACQNC 231
Cdd:cd19536 83 D--LTPLEEQLDPLRAYKEETKIRRFDLGRAPLVRAALVRKDERERFLLvISDHHSILDGWSLYLLVKEILAVYNQLLEY 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 232 QPYPVETTQlNYIDYAHWfNSDSFLDyhNEFKPFWVERLTGipeVHSLPLDKPRPAHQNSGGEVIFSAINNDLWDKFKRL 311
Cdd:cd19536 161 KPLSLPPAQ-PYRDFVAH-ERASIQQ--AASERYWREYLAG---ATLATLPALSEAVGGGPEQDSELLVSVPLPVRSRSL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 312 CQRYNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGFFVNTIVLRTQLQDsQNFVDYLQYCREQDL 389
Cdd:cd19536 234 AKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRseETTGAERLLGLFLNTLPLRVTLSE-ETVEDLLKRAQEQEL 312
|
330 340 350
....*....|....*....|....*....|....*.
gi 499404635 390 SAFDHQLYRFEALSeaigsdRTTAINPIFQVMLVYQ 425
Cdd:cd19536 313 ESLSHEQVPLADIQ------RCSEGEPLFDSIVNFR 342
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
524-1020 |
4.73e-23 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 106.24 E-value: 4.73e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 524 PRSYPQPQLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIAL 603
Cdd:PRK05605 24 PHDLDYGDTTLVDLYDNAVARFGDRPALDFFGA----TTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAF 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 604 LAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGDG-----QQLA---------------------QWS-------- 649
Cdd:PRK05605 100 YAVLRLGAVVVEHNPLYTAHELEHPFEDHGARVAIVWDKvaptvERLRrttpletivsvnmiaampllqRLAlrlpipal 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 650 AEQRIDLTDPAV-VEQWQDLPGDQPPA---IPRH----AQQLAQVIYTSGSTGLPKGVMIEHGSLI-NLL------DDHR 714
Cdd:PRK05605 180 RKARAALTGPAPgTVPWETLVDAAIGGdgsDVSHprptPDDVALILYTSGTTGKPKGAQLTHRNLFaNAAqgkawvPGLG 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 715 DRidftpQSTMFNCMSLsFDAGNMTTLLPLSS--GGTLA-FGEPNDRAIMQA-EQAGATHL-ILPTALMSILDPEQVNGI 789
Cdd:PRK05605 260 DG-----PERVLAALPM-FHAYGLTLCLTLAVsiGGELVlLPAPDIDLILDAmKKHPPTWLpGVPPLYEKIAEAAEERGV 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 790 QAIGM-----GGEACPNAVVENWADKVA--LYNMYGPTECTVTALSTRLRKG-QPVTIGKPLIHIQALILD--TAGQLCP 859
Cdd:PRK05605 334 DLSGVrnafsGAMALPVSTVELWEKLTGglLVEGYGLTETSPIIVGNPMSDDrRPGYVGVPFPDTEVRIVDpeDPDETMP 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 860 VGVPGELCLAGLGLARGYLNQPQMTASRFehitLNDvnnagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYR 939
Cdd:PRK05605 414 DGEEGELLVRGPQVFKGYWNRPEETAKSF----LDG------------WFRTGDVVVMEEDGFIRIVDRIKELIITGGFN 477
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 940 IEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNG 1019
Cdd:PRK05605 478 VYPAEVEEVLREH-PGVEDAAVVGLPREDGSEEVVAAVVLEPGAALDPEGLRAYCREHLTRYKVPRRFYHVDELPRDQLG 556
|
.
gi 499404635 1020 K 1020
Cdd:PRK05605 557 K 557
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
1566-1980 |
4.83e-23 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 104.36 E-value: 4.83e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSM-LYHRLRcPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIVKQADLPFYY 1643
Cdd:cd19531 2 LPLSFAQQRLwFLDQLE-PGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFvEVDGEPVQVILPPLPLPLPV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1644 QDL--MQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQG 1721
Cdd:cd19531 81 VDLsgLPEAEREAEAQRLAREEARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFLAG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 Q--VLmhgDAPAIQvdraYVDYAR--HAVAQQSAVD---AFWQQRqslLAQTNDVSML-----------FAAAGKRADLS 1783
Cdd:cd19531 161 RpsPL---PPLPIQ----YADYAVwqREWLQGEVLErqlAYWREQ---LAGAPPVLELptdrprpavqsFRGARVRFTLP 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1784 QHLTQiepqvtsvslnekdqaTLTAFAREVGITPSIIAQYAWHRLLARSTG--DAVsiVGNVLSGRESP-VEDVassVGL 1860
Cdd:cd19531 231 AELTA----------------ALRALARREGATLFMTLLAAFQVLLHRYSGqdDIV--VGTPVAGRNRAeLEGL---IGF 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1861 YINSLPL--ALSWQQPVS--LQQ-----------------HLVQ-LQNElmamnqhatQSLialtaGRSRLFNSLFIYEN 1918
Cdd:cd19531 290 FVNTLVLrtDLSGDPTFRelLARvretaleayahqdlpfeKLVEaLQPE---------RDL-----SRSPLFQVMFVLQN 355
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 1919 YPDAKAEQGQRADDPHRLYPEfSAAYEkvempLNLVVREQSGCMLLRFEFDADALDSAQARR 1980
Cdd:cd19531 356 APAAALELPGLTVEPLEVDSG-TAKFD-----LTLSLTETDGGLRGSLEYNTDLFDAATIER 411
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
524-946 |
6.92e-23 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 105.66 E-value: 6.92e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 524 PRSYPQPQLTVTDVIEAVAQRDPQQLAIAF-DGEPRtdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIA 602
Cdd:PRK08315 8 PTDVPLLEQTIGQLLDRTAARYPDREALVYrDQGLR---WTYREFNEEVDALAKGLLALGIEKGDRVGIWAPNVPEWVLT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 603 LLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGDG----------QQLAQWSAEQ-----------------RID 655
Cdd:PRK08315 85 QFATAKIGAILVTINPAYRLSELEYALNQSGCKALIAADGfkdsdyvamlYELAPELATCepgqlqsarlpelrrviFLG 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 656 LTDPAVVEQWQDLPGD----QPPAIPRHAQQLA--QVI---YTSGSTGLPKGVMIEHGsliNLLDDHR---DRIDFTPQS 723
Cdd:PRK08315 165 DEKHPGMLNFDELLALgravDDAELAARQATLDpdDPIniqYTSGTTGFPKGATLTHR---NILNNGYfigEAMKLTEED 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 724 TM------FNC--MSLsfdaGNMTTLlplSSGGTLAFgePNDR----AIMQA-EQAGATHLI-LPTALMSILD-PEQVN- 787
Cdd:PRK08315 242 RLcipvplYHCfgMVL----GNLACV---THGATMVY--PGEGfdplATLAAvEEERCTALYgVPTMFIAELDhPDFARf 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 788 -------GIqaigMGGEACPNAVVENWADKValyNM------YGPTEC----TVTALSTRLRKgQPVTIGKPLIHIQALI 850
Cdd:PRK08315 313 dlsslrtGI----MAGSPCPIEVMKRVIDKM---HMsevtiaYGMTETspvsTQTRTDDPLEK-RVTTVGRALPHLEVKI 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 851 LDTA-GQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfEHItlnDVNnagqgaatlRIYRTGDKARLLNNGdyeYC--- 926
Cdd:PRK08315 385 VDPEtGETVPRGEQGELCTRGYSVMKGYWNDPEKTA---EAI---DAD---------GWMHTGDLAVMDEEG---YVniv 446
|
490 500
....*....|....*....|.
gi 499404635 927 GRIDEQIkLR-GYRIEPGEIE 946
Cdd:PRK08315 447 GRIKDMI-IRgGENIYPREIE 466
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
538-1026 |
8.84e-23 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 104.56 E-value: 8.84e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWL-HRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPL 616
Cdd:PRK06839 8 IEKRAYLHPDRIAIITEEE----EMTYKQLHEYVSKVAAYLiYELNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 617 DPDYPPERLRHIITDANLSVILGGDGQQLAQWSAEQR------IDLTDPAVVEQWQ----DLPGDQPPAIprhaqqlaqV 686
Cdd:PRK06839 84 NIRLTENELIFQLKDSGTTVLFVEKTFQNMALSMQKVsyvqrvISITSLKEIEDRKidnfVEKNESASFI---------I 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 687 IYTSGSTGLPKGVMIEH-----GSLINLLddhrdRIDFTPQSTMFNCMSLSFDAG-NMTTLLPLSSGGTLAFG---EPnD 757
Cdd:PRK06839 155 CYTSGTTGKPKGAVLTQenmfwNALNNTF-----AIDLTMHDRSIVLLPLFHIGGiGLFAFPTLFAGGVIIVPrkfEP-T 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 758 RAIMQAEQAGATHLI-LPT---ALMSILDPEQVNgIQAIGM---GGEACPNAVVENWADKVALYNM-YGPTEC--TVTAL 827
Cdd:PRK06839 229 KALSMIEKHKVTVVMgVPTihqALINCSKFETTN-LQSVRWfynGGAPCPEELMREFIDRGFLFGQgFGMTETspTVFML 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 828 STRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfehitlNDVNNAGqgaatlr 907
Cdd:PRK06839 308 SEEDARRKVGSIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATE--------ETIQDGW------- 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 908 iYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEaQLAAVCPSLKQIKVIvaqvgSRPAlVAYATVKADSSTPEP 987
Cdd:PRK06839 373 -LCTGDLARVDEDGFVYIVGRKKEMIISGGENIYPLEVE-QVINKLSDVYEVAVV-----GRQH-VKWGEIPIAFIVKKS 444
|
490 500 510 520
....*....|....*....|....*....|....*....|....*
gi 499404635 988 AAVLID------VAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK06839 445 SSVLIEkdviehCRLFLAKYKIPKEIVFLKELPKNATGKIQKAQL 489
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
520-1022 |
9.19e-23 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 104.97 E-value: 9.19e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 520 TQQLPRSYPQPQLTvtDVIEAVAQRDPQQLAIAFDGEpRTdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYF 599
Cdd:PRK05852 6 GAAPMASDFGPRIA--DLVEVAATRLPEAPALVVTAD-RI-AISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEF 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 600 VIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG---GDGQQLAQ----WSAEQRI---DLTDPAVVEQWQDLP 669
Cdd:PRK05852 82 VVALLAASRADLVVVPLDPALPIAEQRVRSQAAGARVVLIdadGPHDRAEPttrwWPLTVNVggdSGPSGGTLSVHLDAA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 670 GdQPPAIPRHAQQL----AQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLP-L 744
Cdd:PRK05852 162 T-EPTPATSTPEGLrpddAMIMFTGGTTGLPKMVPWTHANIASSVRAIITGYRLSPRDATVAVMPLYHGHGLIAALLAtL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 745 SSGGTL---AFGEPNDRAIM-QAEQAGAT--------HLIL------------PTALMSI------LDPEQVNGIQAIGM 794
Cdd:PRK05852 241 ASGGAVllpARGRFSAHTFWdDIKAVGATwytavptiHQILleraatepsgrkPAALRFIrscsapLTAETAQALQTEFA 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 GGEACPnavvenwadkvalynmYGPTECTVTALSTRL----RKGQPVTIGKPLIH---IQALILDTAGQLCPVGVPGELC 867
Cdd:PRK05852 321 APVVCA----------------FGMTEATHQVTTTQIegigQTENPVVSTGLVGRstgAQIRIVGSDGLPLPAGAVGEVW 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 868 LAGLGLARGYLNQPQMTASRFEHITLndvnnagqgaatlriyRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:PRK05852 385 LRGTTVVRGYLGDPTITAANFTDGWL----------------RTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEG 448
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLAAvCPSlkqikVIVAQVGSRP-----ALVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:PRK05852 449 VLAS-HPN-----VMEAAVFGVPdqlygEAVAAVIVPRESAPPTAEELVQFCRERLAAFEIPASFQEASGLPHTAKGSLD 522
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
561-1021 |
9.41e-23 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 104.06 E-value: 9.41e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGG 640
Cdd:cd05914 7 PLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEAKAIFVS 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 DgqqlaqwsaeqridltdpavveqwqdlpgdqppaiprhAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHR------ 714
Cdd:cd05914 87 D--------------------------------------EDDVALINYTSGTTGNSKGVMLTYRNIVSNVDGVKevvllg 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 715 --DRI-DFTPQSTMFNCMslsfdagnMTTLLPLSSGGTLAFGE--PNDRAIMQAEQAGATHLILPTAL-------MSILD 782
Cdd:cd05914 129 kgDKIlSILPLHHIYPLT--------FTLLLPLLNGAHVVFLDkiPSAKIIALAFAQVTPTLGVPVPLviekifkMDIIP 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 783 P----------------------------EQVNG-IQAIGMGGEACPNAVVENwadkvaLYNM-------YGPTECTVTA 826
Cdd:cd05914 201 KltlkkfkfklakkinnrkirklafkkvhEAFGGnIKEFVIGGAKINPDVEEF------LRTIgfpytigYGMTETAPII 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 LSTRLRKGQPVTIGKPLIHIQALILDTAgqlcPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlnDVNNAgqgaatl 906
Cdd:cd05914 275 SYSPPNRIRLGSAGKVIDGVEVRIDSPD----PATGEGEIIVRGPNVMKGYYKNPEATAEAF------DKDGW------- 337
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 907 riYRTGDKARLLNNGDYEYCGRIDEQIKL-RGYRIEPGEIEAQLAAVCPSLkqIKVIVAQVGSRPALV----AYATVKAD 981
Cdd:cd05914 338 --FHTGDLGKIDAEGYLYIRGRKKEMIVLsSGKNIYPEEIEAKINNMPFVL--ESLVVVQEKKLVALAyidpDFLDVKAL 413
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 499404635 982 SSTPEPAAVLIDVA-KY---LPEY--MVPFRLMlLEDMPLTPNGKL 1021
Cdd:cd05914 414 KQRNIIDAIKWEVRdKVnqkVPNYkkISKVKIV-KEEFEKTPKGKI 458
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
561-1026 |
2.35e-22 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 102.56 E-value: 2.35e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWL-HRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG 639
Cdd:cd05958 10 EWTYRDLLALANRIANVLvGELGIVPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILDKARITVALC 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 GDGqqlaqwsaeqridLTdpavveqwqdlpgdqppaiprHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDH-RDRID 718
Cdd:cd05958 90 AHA-------------LT---------------------ASDDICILAFTSGTTGAPKATMHFHRDPLASADRYaVNVLR 135
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 719 FTPQSTMFNCMSLSFDAGNMTTLL-PLSSGG-TLAFGE--PNDRAIMQAEQAGATHLILPTALMSILD--PEQVNGIQAI 792
Cdd:cd05958 136 LREDDRFVGSPPLAFTFGLGGVLLfPFGVGAsGVLLEEatPDLLLSAIARYKPTVLFTAPTAYRAMLAhpDAAGPDLSSL 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 793 GM---GGEACPNAVVENW--ADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELC 867
Cdd:cd05958 216 RKcvsAGEALPAALHRAWkeATGIPIIDGIGSTEMFHIFISARPGDARPGATGKPVPGYEAKVVDDEGNPVPDGTIGRLA 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 868 LAGLGLARGYLNQPQMTASRFEHITlndvnnagqgaatlriyrTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:cd05958 296 VRGPTGCRYLADKRQRTYVQGGWNI------------------TGDTYSRDPDGYFRHQGRSDDMIVSGGYNIAPPEVED 357
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLAAvCPSLKQIKVIVAQVGSRPALV-AYATVKAD-SSTPEPAAVLIDVAK-YLPEYMVPFRLMLLEDMPLTPNGKLDMK 1024
Cdd:cd05958 358 VLLQ-HPAVAECAVVGHPDESRGVVVkAFVVLRPGvIPGPVLARELQDHAKaHIAPYKYPRAIEFVTELPRTATGKLQRF 436
|
..
gi 499404635 1025 QL 1026
Cdd:cd05958 437 AL 438
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
683-1026 |
2.44e-22 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 101.02 E-value: 2.44e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 683 LAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTLAFGEP---NDR 758
Cdd:cd05944 4 VAAYFHTGGTTGTPKLAQHTHSNEVYNAWMLALNSLFDPDDVLLCGLPLFHVNGSVVTLLtPLASGAHVVLAGPagyRNP 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 759 AIMQ-----AEQAGATHLI-LPT---ALMSILDPEQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECT-VTA 826
Cdd:cd05944 84 GLFDnfwklVERYRITSLStVPTvyaALLQVPVNADISSLRFAMSGAAPLPVELRARFEDAtgLPVVEGYGLTEATcLVA 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 LSTRLRKGQPVTIGKPLIHIQA--LILDTAGQL---CPVGVPGELCLAGLGLARGYLNqpqmtasrfehiTLNDVNNAGQ 901
Cdd:cd05944 164 VNPPDGPKRPGSVGLRLPYARVriKVLDGVGRLlrdCAPDEVGEICVAGPGVFGGYLY------------TEGNKNAFVA 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 902 GaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI---VAQVGSRPalVAYATV 978
Cdd:cd05944 232 D----GWLNTGDLGRLDADGYLFITGRAKDLIIRGGHNIDPALIEEALLR-HPAVAFAGAVgqpDAHAGELP--VAYVQL 304
|
330 340 350 360
....*....|....*....|....*....|....*....|....*....
gi 499404635 979 KADSSTpEPAAVLIDVAKYLPEY-MVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05944 305 KPGAVV-EEEELLAWARDHVPERaAVPKHIEVLEELPVTAVGKVFKPAL 352
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
562-1035 |
3.14e-22 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 102.20 E-value: 3.14e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGgd 641
Cdd:cd05969 1 YTFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLIT-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 GQQLAqwsaeQRIDLTDPAVveqwqdlpgdqppaiprhaqqlaqVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTP 721
Cdd:cd05969 79 TEELY-----ERTDPEDPTL------------------------LHYTSGTTGTPKGVLHVHDAMIFYYFTGKYVLDLHP 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 722 QStMFNCMSlsfDAGNMTTLL-----PLSSGGTLAFGEPNDRA-----IMQAEQAGATHlILPTA--LMSILDPEQV--- 786
Cdd:cd05969 130 DD-IYWCTA---DPGWVTGTVygiwaPWLNGVTNVVYEGRFDAeswygIIERVKVTVWY-TAPTAirMLMKEGDELArky 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 787 --NGIQAIGMGGEAC-PNAVVenWADKV---ALYNMYGPTECTVTALSTRL-RKGQPVTIGKPLIHIQALILDTAGQLCP 859
Cdd:cd05969 205 dlSSLRFIHSVGEPLnPEAIR--WGMEVfgvPIHDTWWQTETGSIMIANYPcMPIKPGSMGKPLPGVKAAVVDENGNELP 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 860 VGVPGELCL-AGL-GLARGYLNQPQmtasRFEHITLNDvnnagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRG 937
Cdd:cd05969 283 PGTKGILALkPGWpSMFRGIWNDEE----RYKNSFIDG------------WYLTGDLAYRDEDGYFWFVGRADDIIKTSG 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 938 YRIEPGEIEAQLAAvCPSLKQIKVIVAQ---VGSRPalVAYATVKADSSTPEPAAVLID--VAKYLPEYMVPFRLMLLED 1012
Cdd:cd05969 347 HRVGPFEVESALME-HPAVAEAGVIGKPdplRGEII--KAFISLKEGFEPSDELKEEIInfVRQKLGAHVAPREIEFVDN 423
|
490 500
....*....|....*....|...
gi 499404635 1013 MPLTPNGKLdMKQlppVLEANES 1035
Cdd:cd05969 424 LPKTRSGKI-MRR---VLKAKEL 442
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
538-928 |
3.58e-22 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 103.44 E-value: 3.58e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIAF------DGEPRTDTLTYAELNRQANQLAHWLHRQGL--GEQSLVGVLAKRDryFVIALLAIWKA 609
Cdd:PRK09274 12 LPRAAQERPDQLAVAVpggrgaDGKLAYDELSFAELDARSDAIAHGLNAAGIgrGMRAVLMVTPSLE--FFALTFALFKA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 610 GAAYVPLDPDYPPERLRHIITDANLSVILGgdgQQLAQW----------SAEQRIdltdpaVVEQ---W---------QD 667
Cdd:PRK09274 90 GAVPVLVDPGMGIKNLKQCLAEAQPDAFIG---IPKAHLarrlfgwgkpSVRRLV------TVGGrllWggttlatllRD 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 668 LPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSL---INLLDDH----RDRIDftpqSTMFNCMSLsFD-AGNMT 739
Cdd:PRK09274 161 GAAAPFPMADLAPDDMAAILFTSGSTGTPKGVVYTHGMFeaqIEALREDygiePGEID----LPTFPLFAL-FGpALGMT 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 740 TLLPlssggTLAFGEP---NDRAIMQA-EQAGATHLILPTALMSIL------DPEQVNGIQAIGMGGEACPNAVVENW-- 807
Cdd:PRK09274 236 SVIP-----DMDPTRPatvDPAKLFAAiERYGVTNLFGSPALLERLgrygeaNGIKLPSLRRVISAGAPVPIAVIERFra 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 808 --ADKVALYNMYGPTEC---TVTALSTRLRKGQPVT-------IGKPL----IHIQAL----ILDTAGQL-CPVGVPGEL 866
Cdd:PRK09274 311 mlPPDAEILTPYGATEAlpiSSIESREILFATRAATdngagicVGRPVdgveVRIIAIsdapIPEWDDALrLATGEIGEI 390
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 867 CLAGLGLARGYLNQPQMTAsrfehitLNDVNNagqGAATLRiYRTGDKARLLNNGDYEYCGR 928
Cdd:PRK09274 391 VVAGPMVTRSYYNRPEATR-------LAKIPD---GQGDVW-HRMGDLGYLDAQGRLWFCGR 441
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
528-753 |
5.02e-22 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 103.03 E-value: 5.02e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 528 PQPQLTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIW 607
Cdd:PRK08279 33 PDSKRSLGDVFEEAAARHPDRPALLFEDQ----SISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLA 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 608 KAGAAYVPLDPDYPPERLRHII--TDANLsVILGGD--------GQQLA----QWSAEQrIDLTDPAVVEQWQDLPGDQP 673
Cdd:PRK08279 109 KLGAVVALLNTQQRGAVLAHSLnlVDAKH-LIVGEElveafeeaRADLArpprLWVAGG-DTLDDPEGYEDLAAAAAGAP 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 674 PAIPRHAQQL-----AQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCmslsfdagnmttlLPL--SS 746
Cdd:PRK08279 187 TTNPASRSGVtakdtAFYIYTSGTTGLPKAAVMSHMRWLKAMGGFGGLLRLTPDDVLYCC-------------LPLyhNT 253
|
....*..
gi 499404635 747 GGTLAFG 753
Cdd:PRK08279 254 GGTVAWS 260
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
100-498 |
6.54e-22 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 100.45 E-value: 6.54e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 100 FRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQRIDAYQPFVIQHddFSLLPEAeregrLQQQVkaeiSRPFD 179
Cdd:cd19545 28 FELPPDIDLARLQAAWEQVVQANPILRTRIVQSDSGGLLQVVVKESPISWTE--STSLDEY-----LEEDR----AAPMG 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 180 LtAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADFKPAFlacQNCQPYPVettqlnyidyaHWFNS-DSFLDY 258
Cdd:cd19545 97 L-GGPLVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAY---QGEPVPQP-----------PPFSRfVKYLRQ 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 259 HN--EFKPFWVERLTGIPEVHSLPLdkPRPAHQNSGGEVIFSAINNDlwdkfKRLCQRYNTSNFIglHAVFSLMLARISG 336
Cdd:cd19545 162 LDdeAAAEFWRSYLAGLDPAVFPPL--PSSRYQPRPDATLEHSISLP-----SSASSGVTLATVL--RAAWALVLSRYTG 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 337 EKDIVIGSPLAYRERP--DIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLSAFDHQLYRFEALSeAIGSDRTTAI 414
Cdd:cd19545 233 SDDVVFGVTLSGRNAPvpGIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMIPFEHTGLQNIR-RLGPDARAAC 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 415 NpiFQVMLVYQAKVDFNDLIPGCDAAEETSPVLPAKTD--ISVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIE 492
Cdd:cd19545 312 N--FQTLLVVQPALPSSTSESLELGIEEESEDLEDFSSygLTLECQLSGSGLRVRARYDSSVISEEQVERLLDQFEHVLQ 389
|
....*.
gi 499404635 493 AVVENP 498
Cdd:cd19545 390 QLASAP 395
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
563-1021 |
8.75e-22 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 102.13 E-value: 8.75e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 563 TYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG--- 639
Cdd:PRK06087 51 TYSALDHAASRLANWLLAKGIEPGDRVAFQLPGWCEFTIIYLACLKVGAVSVPLLPSWREAELVWVLNKCQAKMFFAptl 130
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 ---GDGQQLAQWSAEQ-----RIDLTD---PAVVE-QWQDLPGDQPP---AIPRHAQQLAQVIYTSGSTGLPKGVMIEHG 704
Cdd:PRK06087 131 fkqTRPVDLILPLQNQlpqlqQIVGVDklaPATSSlSLSQIIADYEPlttAITTHGDELAAVLFTSGTEGLPKGVMLTHN 210
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 705 sliNLLDDHR---DRIDFTPQSTMFNCMSLSFDAGNMTTL-LPLSSGGTLAFGE--PNDRAIMQAEQA------GATHLI 772
Cdd:PRK06087 211 ---NILASERaycARLNLTWQDVFMMPAPLGHATGFLHGVtAPFLIGARSVLLDifTPDACLALLEQQrctcmlGATPFI 287
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 773 lptalMSIL-----DPEQVNGIQAIGMGGEACPNAVVEN-WADKVALYNMYGPTECTVTALstrLRKGQPV-----TIGK 841
Cdd:PRK06087 288 -----YDLLnllekQPADLSALRFFLCGGTTIPKKVAREcQQRGIKLLSVYGSTESSPHAV---VNLDDPLsrfmhTDGY 359
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 842 PLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASrfehiTLNDvnnagQGAatlriYRTGDKARLLNNG 921
Cdd:PRK06087 360 AAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGYLDEPELTAR-----ALDE-----EGW-----YYSGDLCRMDEAG 424
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 922 DYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVA---QVGSRpaLVAYATVKADSSTPEPAAVLIDVA-KY 997
Cdd:PRK06087 425 YIKITGRKKDIIVRGGENISSREVEDILLQ-HPKIHDACVVAMpdeRLGER--SCAYVVLKAPHHSLTLEEVVAFFSrKR 501
|
490 500
....*....|....*....|....
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK06087 502 VAKYKYPEHIVVIDKLPRTASGKI 525
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
541-1024 |
9.76e-22 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 102.43 E-value: 9.76e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 541 VAQRDPqqlaiafdGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDY 620
Cdd:PRK12582 68 LAQREP--------GHGQWRKVTYGEAKRAVDALAQALLDLGLDPGRPVMILSGNSIEHALMTLAAMQAGVPAAPVSPAY 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 621 PP-----ERLRHIITDANLSVILGGDGQQLAQWSAEqrIDLTDPAVVEqwQDLPGDQPPAIP---------------RHA 680
Cdd:PRK12582 140 SLmshdhAKLKHLFDLVKPRVVFAQSGAPFARALAA--LDLLDVTVVH--VTGPGEGIASIAfadlaatpptaavaaAIA 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 681 Q----QLAQVIYTSGSTGLPKGVMIEHGSL---INLLDDHRDRIDFTPQSTMFNCMSLSFD-AGNMTTLLPLSSGGTLAF 752
Cdd:PRK12582 216 AitpdTVAKYLFTSGSTGMPKAVINTQRMMcanIAMQEQLRPREPDPPPPVSLDWMPWNHTmGGNANFNGLLWGGGTLYI 295
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 753 GEPNDRAIMQAEQAGATHLILPT----------ALMSILDPEQV------NGIQAIGMGGEACPNAVVENWAD------- 809
Cdd:PRK12582 296 DDGKPLPGMFEETIRNLREISPTvygnvpagyaMLAEAMEKDDAlrrsffKNLRLMAYGGATLSDDLYERMQAlavrttg 375
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 810 -KVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQAlildtagQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF 888
Cdd:PRK12582 376 hRIPFYTGYGATETAPTTTGTHWDTERVGLIGLPLPGVEL-------KLAPVGDKYEVRVKGPNVTPGYHKDPELTAAAF 448
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 889 EHitlndvnnagQGaatlrIYRTGDKARLLNNGDYE----YCGRIDEQIKL-RGYRIEPGEIEAQLAAVCPSLKQIKVIV 963
Cdd:PRK12582 449 DE----------EG-----FYRLGDAARFVDPDDPEkgliFDGRVAEDFKLsTGTWVSVGTLRPDAVAACSPVIHDAVVA 513
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 964 AQvgSRP---ALV------AYATVKADSSTPEPAAVLIDVAKYLPEYMVPF------------RLMLLEDMPLTPNGKLD 1022
Cdd:PRK12582 514 GQ--DRAfigLLAwpnpaaCRQLAGDPDAAPEDVVKHPAVLAILREGLSAHnaeaggsssriaRALLMTEPPSIDAGEIT 591
|
..
gi 499404635 1023 MK 1024
Cdd:PRK12582 592 DK 593
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
525-1026 |
1.09e-21 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 101.25 E-value: 1.09e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 525 RSYPQPQlTVTDVIEAVAQRDPQQLAIAfDGEPRtdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALL 604
Cdd:cd05920 9 AGYWQDE-PLGDLLARSAARHPDRIAVV-DGDRR---LTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFF 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 605 AIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGDgqqlaqwsaeqRIDLTDPavVEQWQDLPGDQPpaiprhaqQLA 684
Cdd:cd05920 84 ALLRLGAVPVLALPSHRRSELSAFCAHAEAVAYIVPD-----------RHAGFDH--RALARELAESIP--------EVA 142
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 685 QVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAgnmttllPLSSGG---TLAFG-------- 753
Cdd:cd05920 143 LFLLSGGTTGTPKLIPRTHNDYAYNVRASAEVCGLDQDTVYLAVLPAAHNF-------PLACPGvlgTLLAGgrvvlapd 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 754 -EPNDR-AIMQAEQAGATHLILPTALM-------SILDPEQVNGIQAIGMGGEACPNAVVENwADKVALYNMYGPTECTV 824
Cdd:cd05920 216 pSPDAAfPLIEREGVTVTALVPALVSLwldaaasRRADLSSLRLLQVGGARLSPALARRVPP-VLGCTLQQVFGMAEGLL 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 825 TAlsTRLRKGQPV---TIGKPLI-HIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndvnnaG 900
Cdd:cd05920 295 NY--TRLDDPDEViihTQGRPMSpDDEIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFT----------P 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 901 QGaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQ---VGSRpaLVAYAT 977
Cdd:cd05920 363 DG-----FYRTGDLVRRTPDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRH-PAVHDAAVVAMPdelLGER--SCAFVV 434
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 499404635 978 VKadsstpEPAAVLIDVAKYLPE-----YMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05920 435 LR------DPPPSAAQLRRFLRErglaaYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
677-1026 |
1.82e-21 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 102.69 E-value: 1.82e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 677 PRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCM----SLSFDAgnmTTLLPLSSG-GTLA 751
Cdd:PRK08633 778 TFKPDDTATIIFSSGSEGEPKGVMLSHHNILSNIEQISDVFNLRNDDVILSSLpffhSFGLTV---TLWLPLLEGiKVVY 854
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 752 FGEPND-RAIMQ-AEQAGATHLI-LPTALMSIL-----DPEQVNGIQAIGMGGEACPNAVVENWADK--VALYNMYGPTE 821
Cdd:PRK08633 855 HPDPTDaLGIAKlVAKHRATILLgTPTFLRLYLrnkklHPLMFASLRLVVAGAEKLKPEVADAFEEKfgIRILEGYGATE 934
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 822 CT-VTALST---------RLRKGQPVTIGKPLIHIQALILD-TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfEH 890
Cdd:PRK08633 935 TSpVASVNLpdvlaadfkRQTGSKEGSVGMPLPGVAVRIVDpETFEELPPGEDGLILIGGPQVMKGYLGDPEKTA---EV 1011
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 891 ITLNDvnnagqgaaTLRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVA----QV 966
Cdd:PRK08633 1012 IKDID---------GIGWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEELAKALGGEEVVFAVTAvpdeKK 1082
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 967 GSRPALVAyatvkadSSTPEPAAVLIDVAK--YLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK08633 1083 GEKLVVLH-------TCGAEDVEELKRAIKesGLPNLWKPSRYFKVEALPLLGSGKLDLKGL 1137
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
533-1021 |
1.89e-21 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 101.00 E-value: 1.89e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAFdgEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK12583 19 TIGDAFDATVARFPDREALVV--RHQALRYTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAI 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPPERLRH----------IITDA----NLSVILGGDGQQLAQWSAEQ-------------RIDLTDPAVVEQW 665
Cdd:PRK12583 97 LVNINPAYRASELEYalgqsgvrwvICADAfktsDYHAMLQELLPGLAEGQPGAlacerlpelrgvvSLAPAPPPGFLAW 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 666 QDLPGdQPPAIPRHAQQLAQ----------VIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTM------FNCM 729
Cdd:PRK12583 177 HELQA-RGETVSREALAERQasldrddpinIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRLcvpvplYHCF 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 730 SLSfdagnMTTLLPLSSGGTLAFgePNDR----AIMQA-EQAGATHLI-LPTALMSILD-PEQVN--------GIqaigM 794
Cdd:PRK12583 256 GMV-----LANLGCMTVGACLVY--PNEAfdplATLQAvEEERCTALYgVPTMFIAELDhPQRGNfdlsslrtGI----M 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 GGEACPNAVVENWADKVALYNM---YGPTECT-VTALSTR---LRKgQPVTIGKPLIHIQALILDTAGQLCPVGVPGELC 867
Cdd:PRK12583 325 AGAPCPIEVMRRVMDEMHMAEVqiaYGMTETSpVSLQTTAaddLER-RVETVGRTQPHLEVKVVDPDGATVPRGEIGELC 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 868 LAGLGLARGYLNQPQMTAsrfEHITLNDvnnagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:PRK12583 404 TRGYSVMKGYWNNPEATA---ESIDEDG------------WMHTGDLATMDEQGYVRIVGRSKDMIIRGGENIYPREIEE 468
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLaavcpsLKQIKVIVAQVGSRP------ALVAYATVKadsstPEPAAVLIDVAKY----LPEYMVPFRLMLLEDMPLTP 1017
Cdd:PRK12583 469 FL------FTHPAVADVQVFGVPdekygeEIVAWVRLH-----PGHAASEEELREFckarIAHFKVPRYFRFVDEFPMTV 537
|
....
gi 499404635 1018 NGKL 1021
Cdd:PRK12583 538 TGKV 541
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1566-2075 |
2.82e-21 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 102.55 E-value: 2.82e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIVKQADLPFYYQ 1644
Cdd:PRK12467 50 IPLSYAQERQWFLWQLDPDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFvQDEEGFRQVIDASLSLTIPLD 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DL--MQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQ 1722
Cdd:PRK12467 130 DLanEQGRARESQIEAYINEEVARPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAYSQGR 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1723 VLMHGDAPaiqvdrayVDYARHAVAQQSAVDA--------FWQQR----QSLLAQTND----VSMLFAAAGKRADLSQHL 1786
Cdd:PRK12467 210 EPSLPALP--------IQYADYAIWQRSWLEAgererqlaYWQEQlggeHTVLELPTDrprpAVPSYRGARLRVDLPQAL 281
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1787 TqiepqvtsvslnekdqATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESpvEDVASSVGLYINSLP 1866
Cdd:PRK12467 282 S----------------AGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNR--VETERLIGFFVNTQV 343
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1867 LALSWQQPVSLQQHLVQLQNELMAMNQHA----TQSLIALTAGRSRLFNSLF--IYENYPDAKA-EQGQRADDPHRLYPE 1939
Cdd:PRK12467 344 LKAEVDPQASFLELLQQVKRTALGAQAHQdlpfEQLVEALQPERSLSHSPLFqvMFNHQNTATGgRDREGAQLPGLTVEE 423
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1940 FSAAYEKVEMPLNLVVREQSGCMLLRFEFDADALDSAQARRVLMRWHDEVVALVNSVPQQPAEIIGHDKATglvaAQKTV 2019
Cdd:PRK12467 424 LSWARHTAQFDLALDTYESAQGLWAAFTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEE----RAREL 499
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 2020 ADSgiNQPDTSFA-QTLLRAW---------AQTLHLGEPGLGESDLWSRT------LCESGVDSLQRIALAQ 2075
Cdd:PRK12467 500 VRW--NAPATEYApDCVHQLIeaqarqhpeRPALVFGEQVLSYAELNRQAnrlahvLIAAGVGPDVLVGIAV 569
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
551-1021 |
3.12e-21 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 99.98 E-value: 3.12e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 551 IAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRD-RYFVIALLAIwKAGAAYVPLDPDYPPERLRHII 629
Cdd:PRK08276 5 MAPSGE----VVTYGELEARSNRLAHGLRALGLREGDVVAILLENNpEFFEVYWAAR-RSGLYYTPINWHLTAAEIAYIV 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 630 TDANLSVILGGDG--QQLAQWSAEQRIDLT----DPAVVEQWQDLP---GDQPP-AIPRHAQQlAQVIYTSGSTGLPKGV 699
Cdd:PRK08276 80 DDSGAKVLIVSAAlaDTAAELAAELPAGVPlllvVAGPVPGFRSYEealAAQPDtPIADETAG-ADMLYSSGTTGRPKGI 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 700 MIEHgslinlldDHRDRIDFTPQSTMFNCMSLSFDAGNmTTLLP---------------LSSGGTLAFGEPND-----RA 759
Cdd:PRK08276 159 KRPL--------PGLDPDEAPGMMLALLGFGMYGGPDS-VYLSPaplyhtaplrfgmsaLALGGTVVVMEKFDaeealAL 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 760 ImqaEQAGATHLIL-PTALMSILD-PEQVNG------IQAIGMGGEACPNAV----VENWADkvALYNMYGPTE-CTVTA 826
Cdd:PRK08276 230 I---ERYRVTHSQLvPTMFVRMLKlPEEVRArydvssLRVAIHAAAPCPVEVkramIDWWGP--IIHEYYASSEgGGVTV 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 LSTR--LRKgqPVTIGKPLIHiQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASrfehitlndvNNAGQGAA 904
Cdd:PRK08276 305 ITSEdwLAH--PGSVGKAVLG-EVRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTAA----------ARNPHGWV 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 905 TLriyrtGDKARLLNNGdYEY-CGRIDEQIKLRGYRIEPGEIEAQL--------AAVcpslkqIKVIVAQVGSRpalvay 975
Cdd:PRK08276 372 TV-----GDVGYLDEDG-YLYlTDRKSDMIISGGVNIYPQEIENLLvthpkvadVAV------FGVPDEEMGER------ 433
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 499404635 976 atVKA-----DSSTPEP--AAVLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK08276 434 --VKAvvqpaDGADAGDalAAELIAwLRGRLAHYKCPRSIDFEDELPRTPTGKL 485
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
73-496 |
6.23e-21 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 98.09 E-value: 6.23e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSglWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFvVNEQGKGEQRI--DAYQPFVIQ 150
Cdd:cd19534 3 PLTPIQR--WFFEQNLAGRHHFNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRF-RREDGGWQQRIrgDVEELFRLE 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 151 -HDDFSLLPEAEREGRLqqqvkAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDG--WSVknLFADFKPAFLA 227
Cdd:cd19534 80 vVDLSSLAQAAAIEALA-----AEAQSSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGvsWRI--LLEDLEAAYEQ 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 228 CQNCQPYPVETTQlnyiDYAHWfnSDSFLDYHNEFK-----PFWVERLTgiPEVHSLPLDkpRPAHQNSGGEVIFSainn 302
Cdd:cd19534 153 ALAGEPIPLPSKT----SFQTW--AELLAEYAQSPAlleelAYWRELPA--ADYWGLPKD--PEQTYGDARTVSFT---- 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 303 dlWDK------FKRLCQRYNTS-NFIgLHAVFSLMLARISGEKDIVI-----GsplayRE----RPDIEDVVGFFVNTIV 366
Cdd:cd19534 219 --LDEeetealLQEANAAYRTEiNDL-LLAALALAFQDWTGRAPPAIfleghG-----REeidpGLDLSRTVGWFTSMYP 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 367 LRTQLQDSQNFVDYLQYCREQdLSA-----FDHQLYRF--EALSEAIGSDRTTAINpiFQVMLVYQAKVDFNDLipGCDA 439
Cdd:cd19534 291 VVLDLEASEDLGDTLKRVKEQ-LRRipnkgIGYGILRYltPEGTKRLAFHPQPEIS--FNYLGQFDQGERDDAL--FVSA 365
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 499404635 440 AEETSPVLPAKT------DISVKVTElmGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVE 496
Cdd:cd19534 366 VGGGGSDIGPDTprfallDINAVVEG--GQLVITVSYSRNMYHEETIQQLADSYKEALEALIE 426
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
519-1026 |
1.11e-20 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 99.10 E-value: 1.11e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 519 ETQQLPRSYPQPQLTV---TDVIEAVAQRDPQ----QLAIAFDGEP-RTDTLTYAELNRQANQLAHWLHRQGLGEQSLVG 590
Cdd:cd05968 41 QTLDLSGGKPWAAWFVggrMNIVEQLLDKWLAdtrtRPALRWEGEDgTSRTLTYGELLYEVKRLANGLRALGVGKGDRVG 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 591 VLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGDGQqlaqWSAEQRIDLTDPA---------- 660
Cdd:cd05968 121 IYLPMIPEIVPAFLAVARIGGIVVPIFSGFGKEAAATRLQDAEAKALITADGF----TRRGREVNLKEEAdkacaqcptv 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 661 ---VVEQ---------------WQDLPGDQPPAIPR-HAQQLAQVIYTSGSTGLPKGVMIEHGSL-INLLDDHRDRIDFT 720
Cdd:cd05968 197 ekvVVVRhlgndftpakgrdlsYDEEKETAGDGAERtESEDPLMIIYTSGTTGKPKGTVHVHAGFpLKAAQDMYFQFDLK 276
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 721 PQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAF--GEPN----DRAIMQAEQAGATHLILPTALMSILDP--------EQV 786
Cdd:cd05968 277 PGDLLTWFTDLGWMMGPWLIFGGLILGATMVLydGAPDhpkaDRLWRMVEDHEITHLGLSPTLIRALKPrgdapvnaHDL 356
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 787 NGIQAIGMGGEacP-NAVVENW------ADKVALYNMYGPTECTVTALSTRL-RKGQPVTIGKPLIHIQALILDTAGQLC 858
Cdd:cd05968 357 SSLRVLGSTGE--PwNPEPWNWlfetvgKGRNPIINYSGGTEISGGILGNVLiKPIKPSSFNGPVPGMKADVLDESGKPA 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 859 PVGVpGELCLAG--LGLARGYLNQP----QMTASRFEHITLNdvnnagqgaatlriyrtGDKARLLNNGDYEYCGRIDEQ 932
Cdd:cd05968 435 RPEV-GELVLLApwPGMTRGFWRDEdrylETYWSRFDNVWVH-----------------GDFAYYDEEGYFYILGRSDDT 496
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 933 IKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVAQVGSRPALVAYATVKAD-SSTPEPAAVLID-VAKYLPEYMVPFRLMLL 1010
Cdd:cd05968 497 INVAGKRVGPAEIESVLNAHPAVLESAAIGVPHPVKGEAIVCFVVLKPGvTPTEALAEELMErVADELGKPLSPERILFV 576
|
570
....*....|....*.
gi 499404635 1011 EDMPLTPNGKLdMKQL 1026
Cdd:cd05968 577 KDLPKTRNAKV-MRRV 591
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1135-1305 |
1.19e-20 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 97.14 E-value: 1.19e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1135 WFMEQSLARPEHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLgC---DAEG----QRYLADVPCpalsTLDYRQLG 1206
Cdd:cd19532 12 WFLQQYLEDPTTFNVTFSYRLTgPLDVARLERAVRAVGQRHEALRT-CfftDPEDgepmQGVLASSPL----RLEHVQIS 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1207 DDG-LQQAFTALQS-EFDPAQGRTMACALVRHHPQADTaLFLAFHHLVIDAVSWRILVDDLERLYLGEPLLPKTSSYRQW 1284
Cdd:cd19532 87 DEAeVEEEFERLKNhVYDLESGETMRIVLLSLSPTEHY-LIFGYHHIAMDGVSFQIFLRDLERAYNGQPLLPPPLQYLDF 165
|
170 180
....*....|....*....|....
gi 499404635 1285 gAALQH--YAT-QHAEQLTYWQAQ 1305
Cdd:cd19532 166 -AARQRqdYESgALDEDLAYWKSE 188
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
550-1026 |
1.31e-20 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 98.37 E-value: 1.31e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 550 AIAFDGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHII 629
Cdd:cd17642 33 TIAFTDAHTGVNYSYAEYLEMSVRLAEALKKYGLKQNDRIAVCSENSLQFFLPVIAGLFIGVGVAPTNDIYNERELDHSL 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 630 TDANLSVILGGDG--QQLAQWSAEQRI-----------DL----TDPAVVEQwQDLPGDQ-----PPAIPRHaQQLAQVI 687
Cdd:cd17642 113 NISKPTIVFCSKKglQKVLNVQKKLKIiktiiildskeDYkgyqCLYTFITQ-NLPPGFNeydfkPPSFDRD-EQVALIM 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 688 YTSGSTGLPKGVMIEHGSLINLLDDHRDRI---DFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLA----FGEP----- 755
Cdd:cd17642 191 NSSGSTGLPKGVQLTHKNIVARFSHARDPIfgnQIIPDTAILTVIPFHHGFGMFTTLGYLICGFRVVlmykFEEElflrs 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 756 -NDRAIMQAeqagathLILPTaLMS------ILDPEQVNGIQAIGMGGEACPNAVVENWADKVALYNM---YGPTECTVT 825
Cdd:cd17642 271 lQDYKVQSA-------LLVPT-LFAffakstLVDKYDLSNLHEIASGGAPLSKEVGEAVAKRFKLPGIrqgYGLTETTSA 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 826 ALSTRLRKGQPVTIGK--PLIHIQALILDTaGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRfehitlndVNNAGQga 903
Cdd:cd17642 343 ILITPEGDDKPGAVGKvvPFFYAKVVDLDT-GKTLGPNERGELCVKGPMIMKGYVNNPEATKAL--------IDKDGW-- 411
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 904 atlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLaavcpsLKQIKVIVAQVGSRPalvayatvkaDSS 983
Cdd:cd17642 412 -----LHSGDIAYYDEDGHFFIVDRLKSLIKYKGYQVPPAELESIL------LQHPKIFDAGVAGIP----------DED 470
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 984 TPE-PAA-VLIDVAKYLPEYMV----------PFRL----MLLEDMPLTPNGKLDMKQL 1026
Cdd:cd17642 471 AGElPAAvVVLEAGKTMTEKEVmdyvasqvstAKRLrggvKFVDEVPKGLTGKIDRRKI 529
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
1567-1982 |
1.35e-20 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 97.06 E-value: 1.35e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALESECASI--QVIVKQADLPFYYQ 1644
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGVprQEILPPGPAPLEVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DLM-QDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSgpqlLGAVHRD----YQTLM 1719
Cdd:cd19539 83 DLSdPDSDRERRLEELLRERESRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWS----LDVFARDlaalYAARR 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1720 QGQVlmhGDAPAIQVdrAYVDYA----RHAVAQQSAVD-AFWQQRQSLLAQTNDVSMLFAAAGKRADLSQHLTQIEPQVT 1794
Cdd:cd19539 159 KGPA---APLPELRQ--QYKEYAawqrEALAAPRAAELlDFWRRRLRGAEPTALPTDRPRPAGFPYPGADLRFELDAELV 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1795 svslnekdqATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPveDVASSVGLYINSLPLALSWQQP 1874
Cdd:cd19539 234 ---------AALRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHP--RFESTVGFFVNLLPLRVDVSDC 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1875 VSLQQHLVQLQNELMAMNQHAT---QSLIAL-----TAGRSRLFNSLFIYENYPDA-KAEQGQRAddphrlYPEFSAAYE 1945
Cdd:cd19539 303 ATFRDLIARVRKALVDAQRHQElpfQQLVAElpvdrDAGRHPLVQIVFQVTNAPAGeLELAGGLS------YTEGSDIPD 376
|
410 420 430
....*....|....*....|....*....|....*..
gi 499404635 1946 KVEMPLNLVVREQSGCMLLRFEFDADALDSAQARRVL 1982
Cdd:cd19539 377 GAKFDLNLTVTEEGTGLRGSLGYATSLFDEETIQGFL 413
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
1566-1970 |
1.63e-20 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 96.67 E-value: 1.63e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIVKQADLPFYYQ 1644
Cdd:cd19533 2 LPLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFtEEEGEPYQWIDPYTPVPIRHI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1645 DLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQVL 1724
Cdd:cd19533 82 DLSGDPDPEGAAQQWMQEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTALLKGRPA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1725 mhGDAPAIQVDRAYVDYARHAVAQQSAVD-AFWQQRqslLAQTND-VSMLFAAAGKRADLSQHltqiepqvtSVSLNEKD 1802
Cdd:cd19533 162 --PPAPFGSFLDLVEEEQAYRQSERFERDrAFWTEQ---FEDLPEpVSLARRAPGRSLAFLRR---------TAELPPEL 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1803 QATLTAFAREVGITPSIIAQYAWHRLLARSTG--DAV--SIVGNVLSGRESPVedvassVGLYINSLPLALSWQQPVSLQ 1878
Cdd:cd19533 228 TRTLLEAAEAHGASWPSFFIALVAAYLHRLTGanDVVlgVPVMGRLGAAARQT------PGMVANTLPLRLTVDPQQTFA 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1879 QHLVQLQNELMAMNQHatQSL--------IALTAGRSRLFNSLFIYENYPdakaeQGQRADDPHRLYPEFSAAYEKvemP 1950
Cdd:cd19533 302 ELVAQVSRELRSLLRH--QRYryedlrrdLGLTGELHPLFGPTVNYMPFD-----YGLDFGGVVGLTHNLSSGPTN---D 371
|
410 420
....*....|....*....|
gi 499404635 1951 LNLVVREQSGCMLLRFEFDA 1970
Cdd:cd19533 372 LSIFVYDRDDESGLRIDFDA 391
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
542-986 |
5.63e-20 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 95.32 E-value: 5.63e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYP 621
Cdd:PRK09029 13 AQVRPQAIALRLNDE----VLTWQQLCARIDQLAAGFAQQGVVEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLP 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 622 PERLRHIITDANLSVILGGDGQQLAQWSAEQRIDLTDPAVVEQWQdlpgdqppaiprhAQQLAQVIYTSGSTGLPKGVMi 701
Cdd:PRK09029 89 QPLLEELLPSLTLDFALVLEGENTFSALTSLHLQLVEGAHAVAWQ-------------PQRLATMTLTSGSTGLPKAAV- 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 702 eHgSLINLLDDHR---DRIDFTPQSTMFncmsLSfdagnmttlLP-------------LSSGGTLAFGEPNDraiMQAEQ 765
Cdd:PRK09029 155 -H-TAQAHLASAEgvlSLMPFTAQDSWL----LS---------LPlfhvsgqgivwrwLYAGATLVVRDKQP---LEQAL 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 766 AGATHLIL-PTALMSILD-PEQVNGIQAIGMGGEACPNAVVENWADK-VALYNMYGPTE--CTVTALSTRLRKGqpvtIG 840
Cdd:PRK09029 217 AGCTHASLvPTQLWRLLDnRSEPLSLKAVLLGGAAIPVELTEQAEQQgIRCWCGYGLTEmaSTVCAKRADGLAG----VG 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 841 KPLIHIQALILDtagqlcpvgvpGELCLAGLGLARGYLNQPQMtasrfehITLndVNNAGQgaatlriYRTGDKARlLNN 920
Cdd:PRK09029 293 SPLPGREVKLVD-----------GEIWLRGASLALGYWRQGQL-------VPL--VNDEGW-------FATRDRGE-WQN 344
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 921 GDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQikVIV-----AQVGSRP-ALVAYATVKADSSTPE 986
Cdd:PRK09029 345 GELTILGRLDNLFFSGGEGIQPEEIERVINQH-PLVQQ--VFVvpvadAEFGQRPvAVVESDSEAAVVNLAE 413
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
98-397 |
6.09e-20 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 94.86 E-value: 6.09e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 98 VYFRLTGP-LDVAALEFAFDALAQRHASLRTRFvvNEQgkGEQRIDAYQP-FVIQHDDFSLLPEAEREGRLqQQVKAEIS 175
Cdd:cd19535 28 AYLEFDGEdLDPDRLERAWNKLIARHPMLRAVF--LDD--GTQQILPEVPwYGITVHDLRGLSEEEAEAAL-EELRERLS 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 176 -RPFDLTAGDLTRVRLVKMSERTHVLmitqhHI-----ISDGWSVKNLFADfkpaFLACQNCQPYPVETTQLNYIDYAHW 249
Cdd:cd19535 103 hRVLDVERGPLFDIRLSLLPEGRTRL-----HLsidllVADALSLQILLRE----LAALYEDPGEPLPPLELSFRDYLLA 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 250 FNSDSFLDYHNEfKPFWVERLTGIPEVHSLPLDKpRPAhqnSGGEVIFS----AINNDLWDKFKRLCQRYNTSNFIGLHA 325
Cdd:cd19535 174 EQALRETAYERA-RAYWQERLPTLPPAPQLPLAK-DPE---EIKEPRFTrrehRLSAEQWQRLKERARQHGVTPSMVLLT 248
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 499404635 326 VFSLMLARISGEKDIVIGSPLAYRER--PDIEDVVGFFVNTIVLRTQLQDSQNFVDYLQYCREQDLSAFDHQLY 397
Cdd:cd19535 249 AYAEVLARWSGQPRFLLNLTLFNRLPlhPDVNDVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWEDLDHSSY 322
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1520-1914 |
8.34e-20 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 97.55 E-value: 8.34e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1520 NLRALTEACltqlshgvvfTPSDFPAvNLSQTQLDSLSQRYDIDTLLPLSSLQQSMLYHRLRC-----PQDDAYHLQTPI 1594
Cdd:PRK05691 636 NLRQLFEAP----------TLAAFSA-AVARQLAGGGAAQAAIARLPRGQALPQSLAQNRLWLlwqldPQSAAYNIPGGL 704
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1595 RYAHVLDVEGYRQAWQRQIQRFPALRAA-LESECASIQVIVKQADLPFYYQDL--MQDADPLAVIERYRQQDLRTGFDLS 1671
Cdd:PRK05691 705 HLRGELDEAALRASFQRLVERHESLRTRfYERDGVALQRIDAQGEFALQRIDLsdLPEAEREARAAQIREEEARQPFDLE 784
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1672 QPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQVLMHGDAPAiqvdrAYVDYA---RHAVAQ 1748
Cdd:PRK05691 785 KGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAACQGQTAELAPLPL-----GYADYGawqRQWLAQ 859
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1749 QSAVdafwQQRQSLLAQTNDVSMLFAAAGKRADLSQHltQIEPQVTSVSLNEKDQATLTAFAREVGITPSIIAQYAWHRL 1828
Cdd:PRK05691 860 GEAA----RQLAYWKAQLGDEQPVLELATDHPRSARQ--AHSAARYSLRVDASLSEALRGLAQAHQATLFMVLLAAFQAL 933
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1829 LARSTGDAVSIVGnvLSGRESPVEDVASSVGLYINSLPLALSWQQPVSLQQHLVQLQNELMAMNQHA----TQSLIALTA 1904
Cdd:PRK05691 934 LHRYSGQGDIRIG--VPNANRPRLETQGLVGFFINTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQdlpfEQLVEALPQ 1011
|
410
....*....|.
gi 499404635 1905 GRSR-LFNSLF 1914
Cdd:PRK05691 1012 AREQgLFQVMF 1022
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1567-2000 |
5.29e-19 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 91.99 E-value: 5.29e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQS--MLyHRLrCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALESECAS-IQVIVKQADLPFYY 1643
Cdd:cd20484 3 PLSEGQKGlwML-QKM-SPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEEDGVpFQKIEPSKPLSFQE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1644 QDLMqDADPLAVIErYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQV 1723
Cdd:cd20484 81 EDIS-SLKESEIIA-YLREKAKEPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQALLQGKQ 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1724 LMHGDAPAIQVDraYVDYARHAVAQQSAVD--AFWQQRqslLAQTNDVSMLFaaagkrADLSQHLTQ-IEPQVTSVSLNE 1800
Cdd:cd20484 159 PTLASSPASYYD--FVAWEQDMLAGAEGEEhrAYWKQQ---LSGTLPILELP------ADRPRSSAPsFEGQTYTRRLPS 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1801 KDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGResPVEDVASSVGLYINSLPLALSWQQPVSLQQH 1880
Cdd:cd20484 228 ELSNQIKSFARSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGR--PEERFDSLIGYFINMLPIRSRILGEETFSDF 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1881 LVQLQNELMAMNQHA-------TQSL-IALTAGRSRLFNSLFIYENYPDAKAEQGQRADDPHRLYPEF-SAAYEKVEMPL 1951
Cdd:cd20484 306 IRKLQLTVLDGLDHAaypfpamVRDLnIPRSQANSPVFQVAFFYQNFLQSTSLQQFLAEYQDVLSIEFvEGIHQEGEYEL 385
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 499404635 1952 NLVVREQSGCMLLRFEFDADALDSAQARRVLmrwhDEVVALVNSVPQQP 2000
Cdd:cd20484 386 VLEVYEQEDRFTLNIKYNPDLFDASTIERMM----EHYVKLAEELIANP 430
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
561-1026 |
7.73e-19 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 91.25 E-value: 7.73e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDpdyppERLRHiitdanlsvilgg 640
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLN-----TRLTP------------- 62
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 dgQQLAQWSAEQRIDLTDpavveqwqdlpgdqppaiprhaqqLAQVIYTSGSTGLPKGVMI---EH-----GSLINL-LD 711
Cdd:cd05912 63 --NELAFQLKDSDVKLDD------------------------IATIMYTSGTTGKPKGVQQtfgNHwwsaiGSALNLgLT 116
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 712 DHRDRIDFTPqstMFNCMSLS-----------------FDAGNMTTLLplssggtlafgepNDRAImqaeqagaTHLILP 774
Cdd:cd05912 117 EDDNWLCALP---LFHISGLSilmrsviygmtvylvdkFDAEQVLHLI-------------NSGKV--------TIISVV 172
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 775 TA----LMSILDPEQVNGIQAIGMGGEACPNAVVENWADK-VALYNMYGPTE-----CTVTALSTRLRKGqpvTIGKPLI 844
Cdd:cd05912 173 PTmlqrLLEILGEGYPNNLRCILLGGGPAPKPLLEQCKEKgIPVYQSYGMTEtcsqiVTLSPEDALNKIG---SAGKPLF 249
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 845 HIQALILDTAGqlcPVGVPGELCLAGLGLARGYLNQPQMTASRFEhitlndvNNAgqgaatlriYRTGDKARLLNNGdYE 924
Cdd:cd05912 250 PVELKIEDDGQ---PPYEVGEILLKGPNVTKGYLNRPDATEESFE-------NGW---------FKTGDIGYLDEEG-FL 309
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 925 YC-GRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIV---AQVGSRPalVAYatVKADSSTPEpaAVLID-VAKYLP 999
Cdd:cd05912 310 YVlDRRSDLIISGGENIYPAEIEEVLLSH-PAIKEAGVVGipdDKWGQVP--VAF--VVSERPISE--EELIAyCSEKLA 382
|
490 500
....*....|....*....|....*..
gi 499404635 1000 EYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05912 383 KYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
523-1032 |
1.94e-18 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 91.57 E-value: 1.94e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 523 LPRSYPQPQlTVTDVIEAVAQRDPQQ--LAIAFDGEPrtDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFV 600
Cdd:cd05906 2 LHRPEGAPR-TLLELLLRAAERGPTKgiTYIDADGSE--EFQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFI 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 601 IALLAIWKAGAAYVPLD--PDYPP-----ERLRHIITDANLSVILGGDG--QQLAQWSAEQRIDLTDPAVVEQWQDLPGD 671
Cdd:cd05906 79 PAFWACVLAGFVPAPLTvpPTYDEpnarlRKLRHIWQLLGSPVVLTDAElvAEFAGLETLSGLPGIRVLSIEELLDTAAD 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 672 qPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAG-NMTTLLPLSSGgtl 750
Cdd:cd05906 159 -HDLPQSRPDDLALLMLTSGSTGFPKAVPLTHRNILARSAGKIQHNGLTPQDVFLNWVPLDHVGGlVELHLRAVYLG--- 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 751 afgepndraiMQAEQAgATHLIL--PTALMSILDPEQVN---------------------------GIQAIGMGGEACPN 801
Cdd:cd05906 235 ----------CQQVHV-PTEEILadPLRWLDLIDRYRVTitwapnfafallndlleeiedgtwdlsSLRYLVNAGEAVVA 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 802 AVVENWADKVALYNM--------YGPTE----CTVTALSTRLRKGQP---VTIGKPLIHIQALILDTAGQLCPVGVPGEL 866
Cdd:cd05906 304 KTIRRLLRLLEPYGLppdairpaFGMTEtcsgVIYSRSFPTYDHSQAlefVSLGRPIPGVSMRIVDDEGQLLPEGEVGRL 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 867 CLAGLGLARGYLNQPQMTASRFehitLNDvnnaGQgaatlriYRTGDKArLLNNGDYEYCGRIDEQIKLRGYRIEPGEIE 946
Cdd:cd05906 384 QVRGPVVTKGYYNNPEANAEAF----TED----GW-------FRTGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIE 447
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 947 A---QLAAVCPSLkqikviVAQVGSRPA-------LVAYATVKADSstPEPAAVLIDVAKYL-------PEYMVPFRlml 1009
Cdd:cd05906 448 AaveEVPGVEPSF------TAAFAVRDPgaeteelAIFFVPEYDLQ--DALSETLRAIRSVVsrevgvsPAYLIPLP--- 516
|
570 580
....*....|....*....|...
gi 499404635 1010 LEDMPLTPNGKLDMKQLPPVLEA 1032
Cdd:cd05906 517 KEEIPKTSLGKIQRSKLKAAFEA 539
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
542-1026 |
3.14e-18 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 90.41 E-value: 3.14e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYP 621
Cdd:PRK03640 12 AFLTPDRTAIEFEEK----KVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLS 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 622 PERLRHIITDANLSVILGGD-------GQQLAQWSAEQRIDLTDPAVVEQWQDlpgdqppaiprhaQQLAQVIYTSGSTG 694
Cdd:PRK03640 88 REELLWQLDDAEVKCLITDDdfeakliPGISVKFAELMNGPKEEAEIQEEFDL-------------DEVATIMYTSGTTG 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 695 LPKGVMI---EH-----GSLINL-LDDHRDRIDFTPqstMFNCMSLS-----------------FDAGNMTTLLpLSSGG 748
Cdd:PRK03640 155 KPKGVIQtygNHwwsavGSALNLgLTEDDCWLAAVP---IFHISGLSilmrsviygmrvvlvekFDAEKINKLL-QTGGV 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 749 TlafgepndraIMQAEQAgathliLPTALMSILDPEQVNG-IQAIGMGGEACPNAVVENWADK-VALYNMYGPTE----- 821
Cdd:PRK03640 231 T----------IISVVST------MLQRLLERLGEGTYPSsFRCMLLGGGPAPKPLLEQCKEKgIPVYQSYGMTEtasqi 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 822 CTVTALSTRLRKGqpvTIGKPLIHIQALILDTaGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNdvnnagq 901
Cdd:PRK03640 295 VTLSPEDALTKLG---SAGKPLFPCELKIEKD-GVVVPPFEEGEIVVKGPNVTKGYLNREDATRETFQDGWFK------- 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 902 gaatlriyrTGDKARLLNNGdYEYC-GRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI---VAQVGSRPalVAYat 977
Cdd:PRK03640 364 ---------TGDIGYLDEEG-FLYVlDRRSDLIISGGENIYPAEIEEVLLSH-PGVAEAGVVgvpDDKWGQVP--VAF-- 428
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 499404635 978 VKADSSTPEpaAVLIDVAK-YLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK03640 429 VVKSGEVTE--EELRHFCEeKLAKYKVPKRFYFVEELPRNASGKLLRHEL 476
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
561-1026 |
3.71e-18 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 90.65 E-value: 3.71e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQ-GLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLS--VI 637
Cdd:PRK12492 49 TLSYAELERHSAAFAAYLQQHtDLVPGDRIAVQMPNVLQYPIAVFGALRAGLIVVNTNPLYTAREMRHQFKDSGARalVY 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 638 LGGDGQQLAQWSAEQRI---------DLTDPA-------VVEQWQD------LP-------------GDQPPAIPRHAQQ 682
Cdd:PRK12492 129 LNMFGKLVQEVLPDTGIeylieakmgDLLPAAkgwlvntVVDKVKKmvpayhLPqavpfkqalrqgrGLSLKPVPVGLDD 208
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 683 LAQVIYTSGSTGLPKGVMIEHGSLI-NLLDDH----RDRIDFTP-----QSTMF-------------NCMSLSFdAGNMT 739
Cdd:PRK12492 209 IAVLQYTGGTTGLAKGAMLTHGNLVaNMLQVRaclsQLGPDGQPlmkegQEVMIaplplyhiyaftaNCMCMMV-SGNHN 287
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 740 TLL--PLSSGGTlafgepndraIMQAEQAGATHLI----LPTALMSILDPEQVN--GIQAIGMGGEACPNAVVENWADKV 811
Cdd:PRK12492 288 VLItnPRDIPGF----------IKELGKWRFSALLglntLFVALMDHPGFKDLDfsALKLTNSGGTALVKATAERWEQLT 357
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 812 --ALYNMYGPTECTVTALS----TRLRKGqpvTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTA 885
Cdd:PRK12492 358 gcTIVEGYGLTETSPVASTnpygELARLG---TVGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVMKGYWQQPEATA 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 886 SRFEhitlndvnnaGQGAatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvcpslkQIKVIVAQ 965
Cdd:PRK12492 435 EALD----------AEGW-----FKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIEDVVMA------HPKVANCA 493
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 966 VGSRPALVAYATVKADSSTPEPAAVLIDVAKYLPE----YMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK12492 494 AIGVPDERSGEAVKLFVVARDPGLSVEELKAYCKEnftgYKVPKHIVLRDSLPMTPVGKILRREL 558
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
73-382 |
4.70e-18 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 89.29 E-value: 4.70e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 73 PLSSSQSGLWFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFVVNEQGKGEQ--RIDAYQPFVIQ 150
Cdd:cd19547 3 PLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQyvRDDLAPPWALL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 151 hdDFSLLPEAEREGRLQQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFAD-FKPAFLACQ 229
Cdd:cd19547 83 --DWSGEDPDRRAELLERLLADDRAAGLSLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDvFRVYEELAH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 230 NCQPY--PVETtqlnYIDYAHWFNSDSflDYHNEFKPFWVERLTGIpevhslpldKPRP-AHQNSGGEVIFSAINNDLWD 306
Cdd:cd19547 161 GREPQlsPCRP----YRDYVRWIRART--AQSEESERFWREYLRDL---------TPSPfSTAPADREGEFDTVVHEFPE 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 307 KFKRL----CQRYN-TSNFIGlHAVFSLMLARISGEKDIVIGSPLAYR--ERPDIEDVVGFFVNTIVLRTQLQDSQNFVD 379
Cdd:cd19547 226 QLTRLvneaARGYGvTTNAIS-QAAWSMLLALQTGARDVVHGLTIAGRppELEGSEHMVGIFINTIPLRIRLDPDQTVTG 304
|
...
gi 499404635 380 YLQ 382
Cdd:cd19547 305 LLE 307
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
542-1020 |
1.54e-17 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 88.77 E-value: 1.54e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAIAFDGEPRTD--TLTYAELNRQANQLAHWLHRQGLGeqslvgvlaKRDR---YF------VIALLAIWKAG 610
Cdd:cd05966 63 LKERGDKVAIIWEGDEPDQsrTITYRELLREVCRFANVLKSLGVK---------KGDRvaiYMpmipelVIAMLACARIG 133
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 611 AAYVPLDPDYPPERLRHIITDANLSVILGGDGQqlaqWSAEQRIDL---TDPAV-----VEQ------------------ 664
Cdd:cd05966 134 AVHSVVFAGFSAESLADRINDAQCKLVITADGG----YRGGKVIPLkeiVDEALekcpsVEKvlvvkrtggevpmtegrd 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 665 --WQDLPGDQPPAIP---RHAQQLAQVIYTSGSTGLPKGVMieH---GSLINLLDDHRDRIDFTPQSTMFnCMSlsfDAG 736
Cdd:cd05966 210 lwWHDLMAKQSPECEpewMDSEDPLFILYTSGSTGKPKGVV--HttgGYLLYAATTFKYVFDYHPDDIYW-CTA---DIG 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 737 NMT-----TLLPLSSGGT-LAF-GEPN----DRAIMQAEQAGATHL-ILPTA---LMSiLDPEQVNG-----IQAIGMGG 796
Cdd:cd05966 284 WITghsyiVYGPLANGATtVMFeGTPTypdpGRYWDIVEKHKVTIFyTAPTAiraLMK-FGDEWVKKhdlssLRVLGSVG 362
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 797 EacP-NAVVENWadkvaLYNMYGPTECTV--------------TAL--STRLRkgqPVTIGKPLIHIQALILDTAGQLCP 859
Cdd:cd05966 363 E--PiNPEAWMW-----YYEVIGKERCPIvdtwwqtetggimiTPLpgATPLK---PGSATRPFFGIEPAILDEEGNEVE 432
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 860 VGVPGELCLAGL--GLARGYLNQPQmtasRFEHITLNDVNNagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRG 937
Cdd:cd05966 433 GEVEGYLVIKRPwpGMARTIYGDHE----RYEDTYFSKFPG---------YYFTGDGARRDEDGYYWITGRVDDVINVSG 499
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 938 YRIEPGEIEAQLAAvCPslkqiKVIVAQVGSRP------ALVAYATVKADSS-TPEPAAVLID-VAKYLPEYMVPFRLML 1009
Cdd:cd05966 500 HRLGTAEVESALVA-HP-----AVAEAAVVGRPhdikgeAIYAFVTLKDGEEpSDELRKELRKhVRKEIGPIATPDKIQF 573
|
570
....*....|.
gi 499404635 1010 LEDMPLTPNGK 1020
Cdd:cd05966 574 VPGLPKTRSGK 584
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
561-1020 |
3.53e-17 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 86.64 E-value: 3.53e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVIlgg 640
Cdd:cd05940 3 ALTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGAVAALINYNLRGESLAHCLNVSSAKHL--- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 dgqqlaqwsaeqridLTDPAVveqwqdlpgdqppaiprhaqqlaqVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFT 720
Cdd:cd05940 80 ---------------VVDAAL------------------------YIYTSGTTGLPKAAIISHRRAWRGGAFFAGSGGAL 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 721 PQSTMFNCMSLSFDAGNMTTLLP-LSSGGTLAFGepndraimqaEQAGATHlilptaLMSILDPEQVNGIQAIG------ 793
Cdd:cd05940 121 PSDVLYTCLPLYHSTALIVGWSAcLASGATLVIR----------KKFSASN------FWDDIRKYQATIFQYIGelcryl 184
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 794 MGGEACPN-------AVVEN------WADKVALYNM------YGPTECTVTAL------------STRLRKGQPVTIGKP 842
Cdd:cd05940 185 LNQPPKPTerkhkvrMIFGNglrpdiWEEFKERFGVpriaefYAATEGNSGFInffgkpgaigrnPSLLRKVAPLALVKY 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 843 LIHIQALILDTAGQL--CPVGVPGELCLAGLGLAR--GYLNQPQMTASRfehitLNDVNNAGQgaatlRIYRTGDKARLL 918
Cdd:cd05940 265 DLESGEPIRDAEGRCikVPRGEPGLLISRINPLEPfdGYTDPAATEKKI-----LRDVFKKGD-----AWFNTGDLMRLD 334
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 919 NNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLI-DVAKY 997
Cdd:cd05940 335 GEGFWYFVDRLGDTFRWKGENVSTTEVAAVLGAF-PGVEEANVYGVQVPGTDGRAGMAAIVLQPNEEFDLSALAaHLEKN 413
|
490 500
....*....|....*....|...
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGK 1020
Cdd:cd05940 414 LPGYARPLFLRLQPEMEITGTFK 436
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
548-949 |
6.55e-17 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 86.87 E-value: 6.55e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 548 QLAIAFDGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPE---- 623
Cdd:PRK04319 60 KVALRYLDASRKEKYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFMEEavrd 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 624 RL-----RHIITDANL-------------SVILGGDGQQLAqwsaEQRIDLtdPAVVEQwqdlPGDQPPAIPRHAQQLAQ 685
Cdd:PRK04319 140 RLedseaKVLITTPALlerkpaddlpslkHVLLVGEDVEEG----PGTLDF--NALMEQ----ASDEFDIEWTDREDGAI 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 VIYTSGSTGLPKGVMIEHGSLIN-------LLDDHRDRIdftpqstmFNCMSlsfDAGNMT-----TLLPLSSGGTLAFg 753
Cdd:PRK04319 210 LHYTSGSTGKPKGVLHVHNAMLQhyqtgkyVLDLHEDDV--------YWCTA---DPGWVTgtsygIFAPWLNGATNVI- 277
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 754 epnDRAIMQAEqagATHLIL-----------PTA---LMSiLDPEQVNG-----IQAIGMGGEAC-PNAVVenWADKVal 813
Cdd:PRK04319 278 ---DGGRFSPE---RWYRILedykvtvwytaPTAirmLMG-AGDDLVKKydlssLRHILSVGEPLnPEVVR--WGMKV-- 346
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 814 YNM-----YGPTE------CTVTALSTRlrkgqPVTIGKPLIHIQALILDTAGQLCPVGVPGELCL-AGL-GLARGYLNQ 880
Cdd:PRK04319 347 FGLpihdnWWMTEtggimiANYPAMDIK-----PGSMGKPLPGIEAAIVDDQGNELPPNRMGNLAIkKGWpSMMRGIWNN 421
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 881 PQmtasRFEHITLNDvnnagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQL 949
Cdd:PRK04319 422 PE----KYESYFAGD------------WYVSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKL 474
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
562-1026 |
8.06e-17 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 85.91 E-value: 8.06e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD 641
Cdd:PRK12406 12 RSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILEDSGARVLIAHA 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 G--QQLA----------------QWSAEQRID---LTDPAVVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVm 700
Cdd:PRK12406 92 DllHGLAsalpagvtvlsvptppEIAAAYRISpalLTPPAGAIDWEGWLAQQEPYDGPPVPQPQSMIYTSGTTGHPKGV- 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 701 iehgslinllddhrDRIDFTPQSTMFNCMSLSFDAG---NMTTLLPlssgGTLAFGEPNDRAIMQAEQAGA--------- 768
Cdd:PRK12406 171 --------------RRAAPTPEQAAAAEQMRALIYGlkpGIRALLT----GPLYHSAPNAYGLRAGRLGGVlvlqprfdp 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 769 ------------THL-ILPTALMSILD-PEQV------NGIQAIGMGGEACP----NAVVENWADkvALYNMYGPTECTV 824
Cdd:PRK12406 233 eellqlierhriTHMhMVPTMFIRLLKlPEEVrakydvSSLRHVIHAAAPCPadvkRAMIEWWGP--VIYEYYGSTESGA 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 825 TALSTR---LRKgqPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLAR-GYLNQPQMTAS--RFEHITLNDVNn 898
Cdd:PRK12406 311 VTFATSedaLSH--PGTVGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPDfTYHNKPEKRAEidRGGFITSGDVG- 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 899 agqgaatlriyrtgdkarLLNNGDYEY-CGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI---VAQVGSrpALVA 974
Cdd:PRK12406 388 ------------------YLDADGYLFlCDRKRDMVISGGVNIYPAEIEAVLHA-VPGVHDCAVFgipDAEFGE--ALMA 446
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 499404635 975 YATVKAdSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK12406 447 VVEPQP-GATLDEADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRL 497
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
561-1035 |
1.05e-16 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 86.05 E-value: 1.05e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQ-GLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVI-- 637
Cdd:PLN02574 66 SISYSELQPLVKSMAAGLYHVmGVRQGDVVLLLLPNSVYFPVIFLAVLSLGGIVTTMNPSSSLGEIKKRVVDCSVGLAft 145
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 638 -------LGGDGQQLAQWSAEQRIDLTDPAVVEQWQDLPGDQP--PAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLIN 708
Cdd:PLN02574 146 spenvekLSPLGVPVIGVPENYDFDSKRIEFPKFYELIKEDFDfvPKPVIKQDDVAAIMYSSGTTGASKGVVLTHRNLIA 225
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 709 LLDDHrdrIDF------TPQST--------MFNCMSLSFDAGNMttllpLSSGGTLAFGEPND--RAIMQAEQAGATHL- 771
Cdd:PLN02574 226 MVELF---VRFeasqyeYPGSDnvylaalpMFHIYGLSLFVVGL-----LSLGSTIVVMRRFDasDMVKVIDRFKVTHFp 297
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 772 ILPTALMSILDPEQVNGIQAIGMGGEACPNAV------VENWAD---KVALYNMYGPTECTvtALSTR------LRKGQP 836
Cdd:PLN02574 298 VVPPILMALTKKAKGVCGEVLKSLKQVSCGAAplsgkfIQDFVQtlpHVDFIQGYGMTEST--AVGTRgfntekLSKYSS 375
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 837 VTIGKPliHIQALILD-TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRfehitlndVNNAGQgaatlriYRTGDKA 915
Cdd:PLN02574 376 VGLLAP--NMQAKVVDwSTGCLLPPGNCGELWIQGPGVMKGYLNNPKATQST--------IDKDGW-------LRTGDIA 438
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 916 RLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCpslKQIKVIVAQVGSRPA---LVAYaTVKADSSTPEPAAVLI 992
Cdd:PLN02574 439 YFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHP---EIIDAAVTAVPDKECgeiPVAF-VVRRQGSTLSQEAVIN 514
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 499404635 993 DVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEANES 1035
Cdd:PLN02574 515 YVAKQVAPYKKVRKVVFVQSIPKSPAGKILRRELKRSLTNSVS 557
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
520-1021 |
2.37e-16 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 84.83 E-value: 2.37e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 520 TQQLPRSYPQPQLTV----TDVIEAVAQRDPQQLAIAFDGeprtDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKR 595
Cdd:PRK07786 1 TRALTLAQEQPYLARrqnwVNQLARHALMQPDAPALRFLG----NTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLN 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 596 DRYFVIALLAIWKAGAAYVPLDPDY-PPE--------RLRHIITDANLS---------------VILGGDGQQLAQWSAE 651
Cdd:PRK07786 77 RTEFVESVLAANMLGAIAVPVNFRLtPPEiaflvsdcGAHVVVTEAALApvatavrdivpllstVVVAGGSSDDSVLGYE 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 652 QRIDLTDPAVveQWQDLPGDQPPAIprhaqqlaqvIYTSGSTGLPKGVMIEHGSL----INLLD----DHRDRIDFTpQS 723
Cdd:PRK07786 157 DLLAEAGPAH--APVDIPNDSPALI----------MYTSGTTGRPKGAVLTHANLtgqaMTCLRtngaDINSDVGFV-GV 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 724 TMFNCMSLsfdaGNMTTLLPLssGGTL------AFgEPNDRA-IMQAEQAGATHLIlPTALMSILDPEQVNG----IQAI 792
Cdd:PRK07786 224 PLFHIAGI----GSMLPGLLL--GAPTviyplgAF-DPGQLLdVLEAEKVTGIFLV-PAQWQAVCAEQQARPrdlaLRVL 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 793 GMGGEACPNAVVENWAD---KVALYNMYGPTECT-VTAL---STRLRKGQPVtiGKPLIHIQALILDTAGQLCPVGVPGE 865
Cdd:PRK07786 296 SWGAAPASDTLLRQMAAtfpEAQILAAFGQTEMSpVTCMllgEDAIRKLGSV--GKVIPTVAARVVDENMNDVPVGEVGE 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 866 LCLAGLGLARGYLNQPQMTASRFEhitlndvnnAGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEI 945
Cdd:PRK07786 374 IVYRAPTLMSGYWNNPEATAEAFA---------GGW-------FHSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEV 437
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 946 EAQLAAvCPSLKQIKVI---VAQVGSRPalVAYATVKADSSTPEpaavLIDVAKYLPE----YMVPFRLMLLEDMPLTPN 1018
Cdd:PRK07786 438 ENVLAS-HPDIVEVAVIgraDEKWGEVP--VAVAAVRNDDAALT----LEDLAEFLTDrlarYKHPKALEIVDALPRNPA 510
|
...
gi 499404635 1019 GKL 1021
Cdd:PRK07786 511 GKV 513
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
560-1033 |
4.19e-16 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 83.88 E-value: 4.19e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 560 DTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDY-PPE--------RLRHIIT 630
Cdd:PLN02246 49 RVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAVTTTANPFYtPAEiakqakasGAKLIIT 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 631 DANLSVILggdgQQLAQWSAEQRIDLTDPA--VVEQWQDLPGDQ--PPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSL 706
Cdd:PLN02246 129 QSCYVDKL----KGLAEDDGVTVVTIDDPPegCLHFSELTQADEneLPEVEISPDDVVALPYSSGTTGLPKGVMLTHKGL 204
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 707 IN----LLDDHRDRIDFTPQST------MFNCMSLsfdagNMTTLLPLSSGGTLAfgepndraIMQAEQAGA------TH 770
Cdd:PLN02246 205 VTsvaqQVDGENPNLYFHSDDVilcvlpMFHIYSL-----NSVLLCGLRVGAAIL--------IMPKFEIGAlleliqRH 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 771 ----------LILPTALMSILDPEQVNGIQAIgMGGEA-------------CPNAVvenwadkvaLYNMYGPTEC-TVTA 826
Cdd:PLN02246 272 kvtiapfvppIVLAIAKSPVVEKYDLSSIRMV-LSGAAplgkeledafrakLPNAV---------LGQGYGMTEAgPVLA 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 LSTRLRKgQPVTI-----GKPLIHIQALILDT-AGQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfehitlndvnnag 900
Cdd:PLN02246 342 MCLAFAK-EPFPVksgscGTVVRNAELKIVDPeTGASLPRNQPGEICIRGPQIMKGYLNDPEATA--------------- 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 901 qgaatlriyRTGDKARLLNNGDYEY---------CGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKViVAQ----VG 967
Cdd:PLN02246 406 ---------NTIDKDGWLHTGDIGYiddddelfiVDRLKELIKYKGFQVAPAELEALLIS-HPSIADAAV-VPMkdevAG 474
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 968 SRPalVAYaTVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEAN 1033
Cdd:PLN02246 475 EVP--VAF-VVRSNGSEITEDEIKQFVAKQVVFYKRIHKVFFVDSIPKAPSGKILRKDLRAKLAAG 537
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
532-1035 |
5.10e-16 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 83.29 E-value: 5.10e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGlGEQSLVGVLAKRDRYFVIALLAIWKAGA 611
Cdd:PRK07638 1 MGITKEYKKHASLQPNKIAIKENDR----VLTYKDWFESVCKVANWLNEKE-SKNKTIAILLENRIEFLQLFAGAAMAGW 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 612 AYVPLDPDYPPERLRH---------IITDA-NLSVILGGDGQ--QLAQWSAEQRIDLTDPAVVEQWQDLP---Gdqppai 676
Cdd:PRK07638 76 TCVPLDIKWKQDELKErlaisnadmIVTERyKLNDLPDEEGRviEIDEWKRMIEKYLPTYAPIENVQNAPfymG------ 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 677 prhaqqlaqviYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMF---NCMSLSFDAGNMTTLLplsSGGTLAFG 753
Cdd:PRK07638 150 -----------FTSGSTGKPKAFLRAQQSWLHSFDCNVHDFHMKREDSVLiagTLVHSLFLYGAISTLY---VGQTVHLM 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 754 E---PND-RAIMQAEQAGATHLIlPTALMSILD----PEQVNGIQAIGMGGEACPNAVVENWADKVALYNMYGPTECT-V 824
Cdd:PRK07638 216 RkfiPNQvLDKLETENISVMYTV-PTMLESLYKenrvIENKMKIISSGAKWEAEAKEKIKNIFPYAKLYEFYGASELSfV 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 825 TALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLN----QPQMTASrfEHITLNDVNnag 900
Cdd:PRK07638 295 TALVDEESERRPNSVGRPFHNVQVRICNEAGEEVQKGEIGTVYVKSPQFFMGYIIggvlARELNAD--GWMTVRDVG--- 369
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 901 qgaatlRIYRTGdkarllnngdYEYC-GRIDEQIKLRGYRIEPGEIEaQLAAVCPSLKQIKVI-VAQV--GSRPalVAYA 976
Cdd:PRK07638 370 ------YEDEEG----------FIYIvGREKNMILFGGINIFPEEIE-SVLHEHPAVDEIVVIgVPDSywGEKP--VAII 430
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 977 TVKADSSTPEPAavlidVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEANES 1035
Cdd:PRK07638 431 KGSATKQQLKSF-----CLQRLSSFKIPKEWHFVDEIPYTNSGKIARMEAKSWIENQEK 484
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1567-1867 |
5.38e-16 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 82.69 E-value: 5.38e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1567 PLSSLQQSMLY-HRLrcpQDDAYHLQTPI--RYAHVLDVEGYRQAWQRQIQRFPALRAALESECA-SIQVIVKQADLPFY 1642
Cdd:cd20483 3 PMSTFQRRLWFlHNF---LEDKTFLNLLLvcHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDDfGEQQVLDDPSFHLI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1643 YQDLMQDADPLAVIERYRQQDLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQGQ 1722
Cdd:cd20483 80 VIDLSEAADPEAALDQLVRNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDALRAGR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1723 VLMHGDAPAIQvdraYVDYA--RHAVAQQSAVD---AFWQQRqslLAQTNDVSML--FAAAGKRAdlsqhLTQIEPQVTS 1795
Cdd:cd20483 160 DLATVPPPPVQ----YIDFTlwHNALLQSPLVQpllDFWKEK---LEGIPDASKLlpFAKAERPP-----VKDYERSTVE 227
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 1796 VSLNEKDQATLTAFAREVGITPSIIAQYAWHRLLARSTGDAVSIVGNVLSGRESPveDVASSVGLYINSLPL 1867
Cdd:cd20483 228 ATLDKELLARMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHP--DFDDLVGFFVNMLPI 297
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
562-1026 |
6.14e-16 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 83.53 E-value: 6.14e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITD--ANLSVILg 639
Cdd:PRK07059 49 ITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRAGYVVVNVNPLYTPRELEHQLKDsgAEAIVVL- 127
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 gdgQQLAQwSAEQRIDLTD--PAVVEQWQDLPGDQ---------------PP-AIPRH-----------AQQLAQVI--- 687
Cdd:PRK07059 128 ---ENFAT-TVQQVLAKTAvkHVVVASMGDLLGFKghivnfvvrrvkkmvPAwSLPGHvrfndalaegaRQTFKPVKlgp 203
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 688 -------YTSGSTGLPKGVMIEHGSLI-NLLDDH---------RDRID--FT----PQSTMF----NCMsLSFDAGNMTT 740
Cdd:PRK07059 204 ddvaflqYTGGTTGVSKGATLLHRNIVaNVLQMEawlqpafekKPRPDqlNFvcalPLYHIFaltvCGL-LGMRTGGRNI 282
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 741 LLPlssggtlafgEPNDRAIMQAEQAGATHLILP------TALMSILDPEQV---NGIQAIGmGGEACPNAVVENWADKV 811
Cdd:PRK07059 283 LIP----------NPRDIPGFIKELKKYQVHIFPavntlyNALLNNPDFDKLdfsKLIVANG-GGMAVQRPVAERWLEMT 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 812 --ALYNMYGPTECTVTALSTRLRKGQ-PVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQ-----M 883
Cdd:PRK07059 352 gcPITEGYGLSETSPVATCNPVDATEfSGTIGLPLPSTEVSIRDDDGNDLPLGEPGEICIRGPQVMAGYWNRPDetakvM 431
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 884 TASRFehitlndvnnagqgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEaQLAAVCPSLKQIKVI- 962
Cdd:PRK07059 432 TADGF--------------------FRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEIE-EVVASHPGVLEVAAVg 490
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 499404635 963 VAQVGSRPALVAYaTVKADSSTPEpAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK07059 491 VPDEHSGEAVKLF-VVKKDPALTE-EDVKAFCKERLTNYKRPKFVEFRTELPKTNVGKILRREL 552
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
684-1021 |
8.14e-16 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 81.15 E-value: 8.14e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 684 AQVIYTSGSTGLPKGVMIEHGSLINLLDD-HRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPN--DRAI 760
Cdd:cd17635 4 LAVIFTSGTTGEPKAVLLANKTFFAVPDIlQKEGLNWVVGDVTYLPLPATHIGGLWWILTCLIHGGLCVTGGENttYKSL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 761 MQAEQ--AGATHLILPTAlMSILDPEQVNGIQA------IGMGGEACPNAVVEN--WADKVALYNMYGPTECT-VTALST 829
Cdd:cd17635 84 FKILTtnAVTTTCLVPTL-LSKLVSELKSANATvpslrlIGYGGSRAIAADVRFieATGLTNTAQVYGLSETGtALCLPT 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 830 RLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNdvnnagqgaatlriy 909
Cdd:cd17635 163 DDDSIEINAVGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLIDGWVN--------------- 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 910 rTGDKARlLNNGDYEYC-GRIDEQIKLRGYRIEPGEIEaQLAAVCPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPA 988
Cdd:cd17635 228 -TGDLGE-RREDGFLFItGRSSESINCGGVKIAPDEVE-RIAEGVSGVQECACYEISDEEFGELVGLAVVASAELDENAI 304
|
330 340 350
....*....|....*....|....*....|....
gi 499404635 989 AVLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:cd17635 305 RALKHtIRRELEPYARPSTIVIVTDIPRTQSGKV 338
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
562-1026 |
1.15e-15 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 81.85 E-value: 1.15e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRhiitdanlsvilggd 641
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIPATTLLTPDDLR--------------- 65
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 642 gqqlaqwsaeQRIDLTDPAVVEQWQDLPGDQPpaiprhaqqlAQVIYTSGSTGLPKGVMIEH-----GSLINLLddhrdR 716
Cdd:cd05974 66 ----------DRVDRGGAVYAAVDENTHADDP----------MLLYFTSGTTSKPKLVEHTHrsypvGHLSTMY-----W 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 717 IDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGTL-AFGEP--NDRAIMQA-EQAGATHLILPTALMSILDPEQVNG--- 788
Cdd:cd05974 121 IGLKPGDVHWNISSPGWAKHAWSCFFaPWNAGATVfLFNYArfDAKRVLAAlVRYGVTTLCAPPTVWRMLIQQDLASfdv 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 789 -IQAIGMGGEACPNAVVEN----WAdkVALYNMYGPTECTVTALSTrlrKGQPV---TIGKPLIHIQALILDtagqlcPV 860
Cdd:cd05974 201 kLREVVGAGEPLNPEVIEQvrraWG--LTIRDGYGQTETTALVGNS---PGQPVkagSMGRPLPGYRVALLD------PD 269
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 861 GVP---GELCLA-----GLGLARGYLNQPQMTASrfehitlndvnnAGQGAatlrIYRTGDKARLLNNGDYEYCGRIDEQ 932
Cdd:cd05974 270 GAPateGEVALDlgdtrPVGLMKGYAGDPDKTAH------------AMRGG----YYRTGDIAMRDEDGYLTYVGRADDV 333
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 933 IKLRGYRIEPGEIEAQL--------AAVCPSLKQIKVIVAQvgsrpalvAYATVKAdSSTPEPAAVLiDVAKYLPEYMVP 1004
Cdd:cd05974 334 FKSSDYRISPFELESVLiehpavaeAAVVPSPDPVRLSVPK--------AFIVLRA-GYEPSPETAL-EIFRFSRERLAP 403
|
490 500
....*....|....*....|....*
gi 499404635 1005 F---RLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05974 404 YkriRRLEFAELPKTISGKIRRVEL 428
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
555-952 |
1.48e-15 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 82.35 E-value: 1.48e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 555 GEPRT-DTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITD-- 631
Cdd:PRK07768 22 GEPDApVRHTWGEVHERARRIAGGLAAAGVGPGDAVAVLAGAPVEIAPTAQGLWMRGASLTMLHQPTPRTDLAVWAEDtl 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 632 -------ANLsVILGGDGQQLAQWSAEQRIdlTDPAVVEQWQDLPGDqPPAIPRHAQQLAQViyTSGSTGLPKGVMIEHG 704
Cdd:PRK07768 102 rvigmigAKA-VVVGEPFLAAAPVLEEKGI--RVLTVADLLAADPID-PVETGEDDLALMQL--TSGSTGSPKAVQITHG 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 705 SLINLLDDHRDRIDFTPQS-TMFNCMSLSFDAGNMTTL-LPLSSGGTLAFGEPND---------------RAIMQAEQAG 767
Cdd:PRK07768 176 NLYANAEAMFVAAEFDVETdVMVSWLPLFHDMGMVGFLtVPMYFGAELVKVTPMDflrdpllwaeliskyRGTMTAAPNF 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 768 AtHLILPTALMSILDPEQVN--GIQAIGMGGEACPNAVVENWADKVALYNM--------YGPTECTVTA----------- 826
Cdd:PRK07768 256 A-YALLARRLRRQAKPGAFDlsSLRFALNGAEPIDPADVEDLLDAGARFGLrpeailpaYGMAEATLAVsfspcgaglvv 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 ------LSTRLRKGQP---------VTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLnqpqmTASRFEhi 891
Cdd:PRK07768 335 devdadLLAALRRAVPatkgntrrlATLGPPLPGLEVRVVDEDGQVLPPRGVGVIELRGESVTPGYL-----TMDGFI-- 407
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 499404635 892 tlndvnnAGQGAATLriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAV 952
Cdd:PRK07768 408 -------PAQDADGW--LDTGDLGYLTEEGEVVVCGRVKDVIIMAGRNIYPTDIERAAARV 459
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1156-1424 |
2.02e-15 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 81.00 E-value: 2.02e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1156 PEVDTERLVTMLQALMAQHDALRLGCDAEG-QRYLADVPCPALSTLDYRQLGDDGLQQAFTALQSE-----FDPAQGRTM 1229
Cdd:cd19535 35 EDLDPDRLERAWNKLIARHPMLRAVFLDDGtQQILPEVPWYGITVHDLRGLSEEEAEAALEELRERlshrvLDVERGPLF 114
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1230 ACALVRHhPQADTALFLAFHHLVIDAVSWRILVDDLERLYL--GEPLLPKTSSYRQWGAALQ-HYATQHAEQLTYWQAQE 1306
Cdd:cd19535 115 DIRLSLL-PEGRTRLHLSIDLLVADALSLQILLRELAALYEdpGEPLPPLELSFRDYLLAEQaLRETAYERARAYWQERL 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1307 DgvDL---TALLAAKDPQGHASAAI----LTLDAKTTGQLVSEAnRAFNTDVSDLLLSALTRTLNdlGWGDKAR--IMLE 1377
Cdd:cd19535 194 P--TLppaPQLPLAKDPEEIKEPRFtrreHRLSAEQWQRLKERA-RQHGVTPSMVLLTAYAEVLA--RWSGQPRflLNLT 268
|
250 260 270 280
....*....|....*....|....*....|....*....|....*....
gi 499404635 1378 GHGREAIDPtlDVSRTVGWFTST--YPVCLQDKPDWASLIQSSKEQLRQ 1424
Cdd:cd19535 269 LFNRLPLHP--DVNDVVGDFTSLllLEVDGSEGQSFLERARRLQQQLWE 315
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
561-1026 |
2.66e-15 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 80.97 E-value: 2.66e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLgEQSLVGVLAKRDRYFVIAL-LAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG 639
Cdd:cd05910 2 RLSFRELDERSDRIAQGLTAYGI-RRGMRAVLMVPPGPDFFALtFALFKAGAVPVLIDPGMGRKNLKQCLQEAEPDAFIG 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 gdgqqlaqwsaeqridltdpavveqwqdlpgdqppaIPRhAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDF 719
Cdd:cd05910 81 ------------------------------------IPK-ADEPAAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLYGI 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 720 TPQSTMFNCMSLS--FD-AGNMTTLLPlsSGGTLAFGEPNDRAIMQA-EQAGATHLILPTALMSIL------DPEQVNGI 789
Cdd:cd05910 124 RPGEVDLATFPLFalFGpALGLTSVIP--DMDPTRPARADPQKLVGAiRQYGVSIVFGSPALLERVarycaqHGITLPSL 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 790 QAIGMGGEACPNAVVENW----ADKVALYNMYGPTEC-TVTALSTR-LR--------KGQPVTIGKPLIHIQALILDT-- 853
Cdd:cd05910 202 RRVLSAGAPVPIALAARLrkmlSDEAEILTPYGATEAlPVSSIGSReLLatttaatsGGAGTCVGRPIPGVRVRIIEIdd 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 854 ------AGQLC-PVGVPGELCLAGLGLARGYLNQPQMTAsrfehitLNDVNNAGQGAatlrIYRTGDKARLLNNGDYEYC 926
Cdd:cd05910 282 epiaewDDTLElPRGEIGEITVTGPTVTPTYVNRPVATA-------LAKIDDNSEGF----WHRMGDLGYLDDEGRLWFC 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 927 GRIDEQIKLRGYRIEPGEIEAqLAAVCPSLKQIKV--IVAQVGSRPALVayatVKADSSTPEPAA----VLIDVAKYLPE 1000
Cdd:cd05910 351 GRKAHRVITTGGTLYTEPVER-VFNTHPGVRRSALvgVGKPGCQLPVLC----VEPLPGTITPRArleqELRALAKDYPH 425
|
490 500
....*....|....*....|....*...
gi 499404635 1001 YMVPFRLMLLEDMPLTP--NGKLDMKQL 1026
Cdd:cd05910 426 TQRIGRFLIHPSFPVDIrhNAKIFREKL 453
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
541-1032 |
4.33e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 80.86 E-value: 4.33e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 541 VAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDY 620
Cdd:PRK07470 16 AARRFPDRIALVWGDR----SWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVPTNFRQ 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 621 PPERLRHIITDANLSVILG-GDGQQLAQWSAEQRIDLT------DPAVVEQWQDLPGDQPPAIPRHAQ----QLAQVIYT 689
Cdd:PRK07470 92 TPDEVAYLAEASGARAMIChADFPEHAAAVRAASPDLThvvaigGARAGLDYEALVARHLGARVANAAvdhdDPCWFFFT 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 690 SGSTGLPKGVMIEHGSLINLLDDHRdrIDFTPQSTMFNC----MSLSFDAGnMTTLLPLSSGGT--LAFGEPNDRAIMQA 763
Cdd:PRK07470 172 SGTTGRPKAAVLTHGQMAFVITNHL--ADLMPGTTEQDAslvvAPLSHGAG-IHQLCQVARGAAtvLLPSERFDPAEVWA 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 764 --EQAGATHLI-LPTAL-MSILDPE-----------------------QVNGIQAIGmggeacpnavvenwadKVaLYNM 816
Cdd:PRK07470 249 lvERHRVTNLFtVPTILkMLVEHPAvdrydhsslryviyagapmyradQKRALAKLG----------------KV-LVQY 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 817 YGPTECT--VTALSTRLRKGQPV------TIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF 888
Cdd:PRK07470 312 FGLGEVTgnITVLPPALHDAEDGpdarigTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNPEANAKAF 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 889 EHitlndvnnaGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI-VA--- 964
Cdd:PRK07470 392 RD---------GW-------FRTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLT-HPAVSEVAVLgVPdpv 454
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 965 --QVGsrpalVAyATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEA 1032
Cdd:PRK07470 455 wgEVG-----VA-VCVARDGAPVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKITKKMVREELEE 518
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
525-1021 |
4.91e-15 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 80.85 E-value: 4.91e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 525 RSYPQ--PQLTVTDV------IEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRD 596
Cdd:PRK06710 9 KSYPEeiPSTISYDIqplhkyVEQMASRYPEKKALHFLGK----DITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNC 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 597 RYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGGD--GQQLAQWSAEQRID------------------- 655
Cdd:PRK06710 85 PQAVIGYYGTLLAGGIVVQTNPLYTERELEYQLHDSGAKVILCLDlvFPRVTNVQSATKIEhvivtriadflpfpknlly 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 656 -------------LTDPAVVEQWQDLPGDQPPAI-----PRHaqQLAQVIYTSGSTGLPKGVMIEHGSLIN--LLDDHrd 715
Cdd:PRK06710 165 pfvqkkqsnlvvkVSESETIHLWNSVEKEVNTGVevpcdPEN--DLALLQYTGGTTGFPKGVMLTHKNLVSntLMGVQ-- 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 716 ridftpqsTMFNCMSLS---------FDAGNMTTLLPLS--SGGTLAFGEPND-RAIMQAEQAGATHLI--LPTALMSIL 781
Cdd:PRK06710 241 --------WLYNCKEGEevvlgvlpfFHVYGMTAVMNLSimQGYKMVLIPKFDmKMVFEAIKKHKVTLFpgAPTIYIALL 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 782 DPE-----QVNGIQAIGMGGEACPNAVVENWADKVA--LYNMYGPTECTVTALSTRL-RKGQPVTIGKPLIHIQALILD- 852
Cdd:PRK06710 313 NSPllkeyDISSIRACISGSAPLPVEVQEKFETVTGgkLVEGYGLTESSPVTHSNFLwEKRVPGSIGVPWPDTEAMIMSl 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 853 TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNdvnnagqgaatlriyrTGDKARLLNNGDYEYCGRIDEQ 932
Cdd:PRK06710 393 ETGEALPPGEIGEIVVKGPQIMKGYWNKPEETAAVLQDGWLH----------------TGDVGYMDEDGFFYVKDRKKDM 456
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 933 IKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVAQVGSRPALVAYATVKADSSTPEPAAVLIdVAKYLPEYMVPFRLMLLED 1012
Cdd:PRK06710 457 IVASGFNVYPREVEEVLYEHEKVQEVVTIGVPDPYRGETVKAFVVLKEGTECSEEELNQF-ARKYLAAYKVPKVYEFRDE 535
|
....*....
gi 499404635 1013 MPLTPNGKL 1021
Cdd:PRK06710 536 LPKTTVGKI 544
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
561-1026 |
8.96e-15 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 79.92 E-value: 8.96e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLhrqgLGEQSLvgvlAKRDRY---------FVIALLAIWKAGAAYVPLDPDYPPERLRHIITD 631
Cdd:PRK08751 50 TITYREADQLVEQFAAYL----LGELQL----KKGDRValmmpnclqYPIATFGVLRAGLTVVNVNPLYTPRELKHQLID 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 632 ANLSVILGGDG------QQLAQWSAEQRI-----DLTDPA-------VVEQWQDL-PGDQPPAIPRHAQQLAQ------- 685
Cdd:PRK08751 122 SGASVLVVIDNfgttvqQVIADTPVKQVIttglgDMLGFPkaalvnfVVKYVKKLvPEYRINGAIRFREALALgrkhsmp 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 -----------VIYTSGSTGLPKGVMIEHGSLI-NLLddhrdridftpQSTMFNCMSLSFDAGNMT--TLLPLSSGGTLA 751
Cdd:PRK08751 202 tlqiepddiafLQYTGGTTGVAKGAMLTHRNLVaNMQ-----------QAHQWLAGTGKLEEGCEVviTALPLYHIFALT 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 752 fgePNDRAIMQAeqAGATHLI-----LP-----------TALMSI------------LDPEQVNGIQAIGMGGEACPNAV 803
Cdd:PRK08751 271 ---ANGLVFMKI--GGCNHLIsnprdMPgfvkelkktrfTAFTGVntlfngllntpgFDQIDFSSLKMTLGGGMAVQRSV 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 804 VENW--ADKVALYNMYGPTECTVTALSTRLR-KGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQ 880
Cdd:PRK08751 346 AERWkqVTGLTLVEAYGLTETSPAACINPLTlKEYNGSIGLPIPSTDACIKDDAGTVLAIGEIGELCIKGPQVMKGYWKR 425
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 881 PQMTASRFEhitlndvnnaGQGAatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIE---------AQLAA 951
Cdd:PRK08751 426 PEETAKVMD----------ADGW-----LHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEdviammpgvLEVAA 490
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 952 V-CPSLKQ---IKVIVaqVGSRPALVAyATVKADSSTpepaavliDVAKYLPEYMVPFRlmllEDMPLTPNGKLDMKQL 1026
Cdd:PRK08751 491 VgVPDEKSgeiVKVVI--VKKDPALTA-EDVKAHARA--------NLTGYKQPRIIEFR----KELPKTNVGKILRREL 554
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
1157-1425 |
3.16e-14 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 77.24 E-value: 3.16e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1157 EVDTERLVTMLQALMAQHDALRLGCDAEG-----QRYLADVPCPaLSTLDYRQLGDDGLQQAFTALQSE-----FDPAQG 1226
Cdd:cd19543 35 PLDPDRFRAAWQAVVDRHPILRTSFVWEGlgeplQVVLKDRKLP-WRELDLSHLSEAEQEAELEALAEEdrergFDLARA 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1227 RTMACALVRHHPQADTaLFLAFHHLVIDAVSWRILVDDLERLYLG-----EPLLPKTSSYRQWGAALQHYATQHAEQltY 1301
Cdd:cd19543 114 PLMRLTLIRLGDDRYR-LVWSFHHILLDGWSLPILLKELFAIYAAlgegqPPSLPPVRPYRDYIAWLQRQDKEAAEA--Y 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1302 WQAQEDGVD-----LTALLAAKDPQGHASAAILTLDAKTTGQLVSEANRA---FNTDVS---DLLLSALTRTlNDLGWGd 1370
Cdd:cd19543 191 WREYLAGFEeptplPKELPADADGSYEPGEVSFELSAELTARLQELARQHgvtLNTVVQgawALLLSRYSGR-DDVVFG- 268
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 1371 karimLEGHGREAIDPtlDVSRTVGWFTSTYPVCLQDKPDwasliQSSKEQLRQV 1425
Cdd:cd19543 269 -----TTVSGRPAELP--GIETMVGLFINTLPVRVRLDPD-----QTVLELLKDL 311
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
688-1022 |
5.20e-14 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 75.52 E-value: 5.20e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 688 YTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTL----AFGEPNDRAIMQA 763
Cdd:cd17633 7 FTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFigqrKFNPKSWIRKINQ 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 764 EQAGATHLIlPT---ALMSILDPEqvNGIQAIGMGGEACPN---AVVENWADKVALYNMYGPTECTVTALSTRLRKGQPV 837
Cdd:cd17633 87 YNATVIYLV-PTmlqALARTLEPE--SKIKSIFSSGQKLFEstkKKLKNIFPKANLIEFYGTSELSFITYNFNQESRPPN 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 838 TIGKPLIHIQALILDTAGqlcpvGVPGELClaglglargyLNQPQMtasrFEHITLNDVNNAGQGaatlriYRTGDKARL 917
Cdd:cd17633 164 SVGRPFPNVEIEIRNADG-----GEIGKIF----------VKSEMV----FSGYVRGGFSNPDGW------MSVGDIGYV 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 918 LNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIkVIVAQVGSRPALVAYATVKADSSTPEpaAVLIDVAKY 997
Cdd:cd17633 219 DEEGYLYLVGRESDMIIIGGINIFPTEIESVLKA-IPGIEEA-IVVGIPDARFGEIAVALYSGDKLTYK--QLKRFLKQK 294
|
330 340
....*....|....*....|....*
gi 499404635 998 LPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:cd17633 295 LSRYEIPKKIIFVDSLPYTSSGKIA 319
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
561-962 |
5.41e-14 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 77.01 E-value: 5.41e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDAnLSVILgg 640
Cdd:cd17640 5 RITYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSDSSVEELLYILNHS-ESVAL-- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 dgqqlaqwsaeqridltdpaVVEQwqdlpgdqppaiprHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFT 720
Cdd:cd17640 82 --------------------VVEN--------------DSDDLATIIYTSGTTGNPKGVMLTHANLLHQIRSLSDIVPPQ 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 721 PQSTMfncMSL-----SFDAGNMTTLlpLSSGGTLAFGEPndRAIMQAEQAGATHLILPT-----ALMSILDPEQVN--- 787
Cdd:cd17640 128 PGDRF---LSIlpiwhSYERSAEYFI--FACGCSQAYTSI--RTLKDDLKRVKPHYIVSVprlweSLYSGIQKQVSKssp 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 788 ------------GIQAIGM-GGEACPNAVVENW-ADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILD- 852
Cdd:cd17640 201 ikqflflfflsgGIFKFGIsGGGALPPHVDTFFeAIGIEVLNGYGLTETSPVVSARRLKCNVRGSVGRPLPGTEIKIVDp 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 853 TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfEHITLNDVNNagqgaatlriyrTGDKARLLNNGDYEYCGRIDEQ 932
Cdd:cd17640 281 EGNVVLPPGEKGIVWVRGPQVMKGYYKNPEATS---KVLDSDGWFN------------TGDLGWLTCGGELVLTGRAKDT 345
|
410 420 430
....*....|....*....|....*....|.
gi 499404635 933 IKLR-GYRIEPGEIEAQLAAvCPSLKQIKVI 962
Cdd:cd17640 346 IVLSnGENVEPQPIEEALMR-SPFIEQIMVV 375
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
538-965 |
5.91e-14 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 77.09 E-value: 5.91e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 538 IEAVAQRDPQQLAIA-FDGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPL 616
Cdd:cd05921 1 LAHWARQAPDRTWLAeREGNGGWRRVTYAEALRQVRAIAQGLLDLGLSAERPLLILSGNSIEHALMALAAMYAGVPAAPV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 617 DPDYPP-----ERLRHIITDANLSVILGGDGQQLAQwsAEQRIDLTDPAVVEQWQDLPGD----------QPP--AIPRH 679
Cdd:cd05921 81 SPAYSLmsqdlAKLKHLFELLKPGLVFAQDAAPFAR--ALAAIFPLGTPLVVSRNAVAGRgaisfaelaaTPPtaAVDAA 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 680 AQQ-----LAQVIYTSGSTGLPKGVMIEHGSL---INLLDDHRDRIDFTPqSTMFNCM--SLSFdAGNMTTLLPLSSGGT 749
Cdd:cd05921 159 FAAvgpdtVAKFLFTSGSTGLPKAVINTQRMLcanQAMLEQTYPFFGEEP-PVLVDWLpwNHTF-GGNHNFNLVLYNGGT 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 750 LAF--GEPNDRAIMQA-----EQAGATHLILPTA---LMSILDPEQV------NGIQAIGMGGEACPNAV--------VE 805
Cdd:cd05921 237 LYIddGKPMPGGFEETlrnlrEISPTVYFNVPAGwemLVAALEKDEAlrrrffKRLKLMFYAGAGLSQDVwdrlqalaVA 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 806 NWADKVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQAlildtagQLCPVGVPGELCLAGLGLARGYLNQPQMTA 885
Cdd:cd05921 317 TVGERIPMMAGLGATETAPTATFTHWPTERSGLIGLPAPGTEL-------KLVPSGGKYEVRVKGPNVTPGYWRQPELTA 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 886 SRFEHitlndvnnagQGaatlrIYRTGDKARLLNNGDYE----YCGRIDEQIKLR-GYRIEPGEIEAQLAAVCPSLKQIK 960
Cdd:cd05921 390 QAFDE----------EG-----FYCLGDAAKLADPDDPAkglvFDGRVAEDFKLAsGTWVSVGPLRARAVAACAPLVHDA 454
|
....*
gi 499404635 961 VIVAQ 965
Cdd:cd05921 455 VVAGE 459
|
|
| AFD_CAR-like |
cd17632 |
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation ... |
529-757 |
6.36e-14 |
|
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation domain of carboxylic acid reductase enzymes (CARs), and performs an equivalent function to that of the ANL superfamily of adenylating enzymes. It takes a carboxylic acid substrate and ATP, and produces an AMP-acyl phosphoester intermediate, releasing pyrophosphate. Kinetic analysis using various substrates shows that this enzyme has a broad but similar substrate specificity, preferring electron-rich acids. This suggests that attack by the carboxylate on the alpha-phosphate of adenosine triphosphate (ATP) is the step that determines the substrate specificity and reaction kinetics. CAR is an important enzyme for use as a biocatalyst providing regiospecific route to aldehydes from their respective carboxylic acids.
Pssm-ID: 341287 [Multi-domain] Cd Length: 588 Bit Score: 77.11 E-value: 6.36e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 529 QPQLTVTDVIE----------AVAQRDPQQLAIAFDGE------PRTDTLTYAELNRQANQLAHWLH-RQGLGEQSLVGV 591
Cdd:cd17632 19 RPGLRLAQIIAtvmtgyadrpALGQRATELVTDPATGRttlrllPRFETITYAELWERVGAVAAAHDpEQPVRPGDFVAV 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 592 LAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIIT--------------DANLSVILGG---------------DG 642
Cdd:cd17632 99 LGFTSPDYATVDLALTRLGAVSVPLQAGASAAQLAPILAeteprllavsaehlDLAVEAVLEGgtpprlvvfdhrpevDA 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 643 QQLAQWSAEQRI------DLTDPAVVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDR 716
Cdd:cd17632 179 HRAALESARERLaavgipVTTLTLIAVRGRDLPPAPLFRPEPDDDPLALLIYTSGSTGTPKGAMYTERLVATFWLKVSSI 258
|
250 260 270 280
....*....|....*....|....*....|....*....|..
gi 499404635 717 IDFTPQ-STMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPND 757
Cdd:cd17632 259 QDIRPPaSITLNFMPMSHIAGRISLYGTLARGGTAYFAAASD 300
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
560-1026 |
7.49e-14 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 76.65 E-value: 7.49e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 560 DTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDyPPERLRHIITDAN---LSV 636
Cdd:cd05929 16 RLLLLDVYSIALNRNARAAAAEGVWIADGVYIYLINSILTVFAAAAAWKCGACPAYKSSR-APRAEACAIIEIKaaaLVC 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 637 ILGGDGQQLAQWSaeqridlTDPAVveqwqdlPGDQP-PAIPRHAQQLAqVIYTSGSTGLPKGVMIEH-GSLINllDDHR 714
Cdd:cd05929 95 GLFTGGGALDGLE-------DYEAA-------EGGSPeTPIEDEAAGWK-MLYSGGTTGRPKGIKRGLpGGPPD--NDTL 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 715 ----DRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPND-----RAImqaEQAGATHL-ILPTALMSILD-P 783
Cdd:cd05929 158 maaaLGFGPGADSVYLSPAPLYHAAPFRWSMTALFMGGTLVLMEKFDpeeflRLI---ERYRVTFAqFVPTMFVRLLKlP 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 784 EQVNG------IQAIGMGGEACPNAVVENWAD--KVALYNMYGPTECT-VTALSTRLRKGQPVTIGKPL---IHiqalIL 851
Cdd:cd05929 235 EAVRNaydlssLKRVIHAAAPCPPWVKEQWIDwgGPIIWEYYGGTEGQgLTIINGEEWLTHPGSVGRAVlgkVH----IL 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 852 DTAGQLCPVGVPGELCLAGlGLARGYLNQPQMTA-SRFEHitlndvnnagqGAATLriyrtGDKARLLNNGDYEYCGRID 930
Cdd:cd05929 311 DEDGNEVPPGEIGEVYFAN-GPGFEYTNDPEKTAaARNEG-----------GWSTL-----GDVGYLDEDGYLYLTDRRS 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 931 EQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVI---VAQVGSRP-ALVayATVKADSSTPEPAAVLIDVAK-YLPEYMVPF 1005
Cdd:cd05929 374 DMIISGGVNIYPQEIENALIA-HPKVLDAAVVgvpDEELGQRVhAVV--QPAPGADAGTALAEELIAFLRdRLSRYKCPR 450
|
490 500
....*....|....*....|.
gi 499404635 1006 RLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05929 451 SIEFVAELPRDDTGKLYRRLL 471
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
533-1021 |
8.86e-14 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 76.59 E-value: 8.86e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQqlAIAFDGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK05857 15 TVLDRVFEQARQQPE--AIALRRCDGTSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAI 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPLDPDYPP---ERLRHIITDANLSVILGG--DGQQLAQWSAE---QRIDLTDPAvVEQWQDLPGDQPPAIPRH-AQQL 683
Cdd:PRK05857 93 AVMADGNLPIaaiERFCQITDPAAALVAPGSkmASSAVPEALHSipvIAVDIAAVT-RESEHSLDAASLAGNADQgSEDP 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 684 AQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDR----IDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRA 759
Cdd:PRK05857 172 LAMIFTSGTTGEPKAVLLANRTFFAVPDILQKEglnwVTWVVGETTYSPLPATHIGGLWWILTCLMHGGLCVTGGENTTS 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 760 IMQA--EQAGATHLILPTaLMSILDPE------QVNGIQAIGMGGEACPNAVVENW-ADKVALYNMYGPTECTVTAL--- 827
Cdd:PRK05857 252 LLEIltTNAVATTCLVPT-LLSKLVSElksanaTVPSLRLVGYGGSRAIAADVRFIeATGVRTAQVYGLSETGCTALclp 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 828 --STRLRKGQPVTIGKPLIHIQALILDT--AGQLCPVGVP----GELCLAGLGLARGYLNQPQMTAsrfEHITLNDVNna 899
Cdd:PRK05857 331 tdDGSIVKIEAGAVGRPYPGVDVYLAATdgIGPTAPGAGPsasfGTLWIKSPANMLGYWNNPERTA---EVLIDGWVN-- 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 900 gqgaatlriyrTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEaQLAAVCPSLKQ---IKVIVAQVGSRPALVAYA 976
Cdd:PRK05857 406 -----------TGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVD-RIAEGVSGVREaacYEIPDEEFGALVGLAVVA 473
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 499404635 977 TVKADSSTPEPAAVLIdVAKYL--PEYMV-PFRLMLLEDMPLTPNGKL 1021
Cdd:PRK05857 474 SAELDESAARALKHTI-AARFRreSEPMArPSTIVIVTDIPRTQSGKV 520
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
533-1026 |
8.86e-14 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 76.64 E-value: 8.86e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAF-DGEPRTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGA 611
Cdd:PRK08008 8 HLRQMWDDLADVYGHKTALIFeSSGGVVRRYSYLELNEEINRTANLFYSLGIRKGDKVALHLDNCPEFIFCWFGLAKIGA 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 612 AYVPLDPDYPPERLRHII--TDANLSVI---LGGDGQQLAQWSAEQR-----IDLTDPAV--VEQWQDLPGDQPP----A 675
Cdd:PRK08008 88 IMVPINARLLREESAWILqnSQASLLVTsaqFYPMYRQIQQEDATPLrhiclTRVALPADdgVSSFTQLKAQQPAtlcyA 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 676 IPRHAQQLAQVIYTSGSTGLPKGVMIEHGSL----------INLLDDhrDRIdftpQSTM------FNCmslsfdagnmT 739
Cdd:PRK08008 168 PPLSTDDTAEILFTSGTTSRPKGVVITHYNLrfagyysawqCALRDD--DVY----LTVMpafhidCQC----------T 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 740 TLLP-LSSGGTLAFGEP-NDRAI---MQAEQAGATH---LILPTaLMsiLDPEQVNGIQAigmggeaCPNAVV--ENWAD 809
Cdd:PRK08008 232 AAMAaFSAGATFVLLEKySARAFwgqVCKYRATITEcipMMIRT-LM--VQPPSANDRQH-------CLREVMfyLNLSD 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 810 ----------KVALYNMYGPTECTVTALSTRlrKGQP---VTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGL---GL 873
Cdd:PRK08008 302 qekdafeerfGVRLLTSYGMTETIVGIIGDR--PGDKrrwPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICIKGVpgkTI 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 874 ARGYLNQPQMTASRFEhitlndvnnaGQGAatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvC 953
Cdd:PRK08008 380 FKEYYLDPKATAKVLE----------ADGW-----LHTGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIAT-H 443
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 499404635 954 PSLKQIKVI-VAQVGSRPALVAYaTVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK08008 444 PKIQDIVVVgIKDSIRDEAIKAF-VVLNEGETLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
551-1026 |
1.68e-13 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 75.79 E-value: 1.68e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 551 IAFDGEPRTDTLTYAELNRQANQLAHWLHRQGLGE-QSLVGVLAKRDRYFVIALlAIWKAGAAYVPLDPDYPPERLRHII 629
Cdd:PLN02330 45 VAFVEAVTGKAVTYGEVVRDTRRFAKALRSLGLRKgQVVVVVLPNVAEYGIVAL-GIMAAGGVFSGANPTALESEIKKQA 123
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 630 TDANLSVILGGDgqqlAQWSAEQRIDLtdPAVV---------EQWQDL------PGDQPPAIPRHAQQLAQVIYTSGSTG 694
Cdd:PLN02330 124 EAAGAKLIVTND----TNYGKVKGLGL--PVIVlgeekiegaVNWKELleaadrAGDTSDNEEILQTDLCALPFSSGTTG 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 695 LPKGVMIEHGSLI-NLLddhrdridftpqSTMFNCMSLSFdaGNMTTL--LPL---------------SSGGTLAFGEPN 756
Cdd:PLN02330 198 ISKGVMLTHRNLVaNLC------------SSLFSVGPEMI--GQVVTLglIPFfhiygitgiccatlrNKGKVVVMSRFE 263
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 757 DRAIMQA---EQAGATHLILPTALMSILDP--EQVN----GIQAIGMGgeACPNA-----VVENWADKVALYNMYGPTEC 822
Cdd:PLN02330 264 LRTFLNAlitQEVSFAPIVPPIILNLVKNPivEEFDlsklKLQAIMTA--AAPLApelltAFEAKFPGVQVQEAYGLTEH 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 823 TVTALS-TRLRKGQPV----TIGKPLIHIQALILD-TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHitlndv 896
Cdd:PLN02330 342 SCITLThGDPEKGHGIakknSVGFILPNLEVKFIDpDTGRSLPKNTPGELCVRSQCVMQGYYNNKEETDRTIDE------ 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 897 nnagQGAatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIV---AQVGSRPALV 973
Cdd:PLN02330 416 ----DGW-----LHTGDIGYIDDDGDIFIVDRIKELIKYKGFQVAPAELEAILLT-HPSVEDAAVVPlpdEEAGEIPAAC 485
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 499404635 974 AYATVKADSSTPEPAA-VLIDVAKYLPEYMVPFrlmlLEDMPLTPNGKLdMKQL 1026
Cdd:PLN02330 486 VVINPKAKESEEDILNfVAANVAHYKKVRVVQF----VDSIPKSLSGKI-MRRL 534
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
821-1114 |
2.03e-13 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 73.25 E-value: 2.03e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 821 ECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGElclaGLGLARGYLNQPQMTASRFEHITLNDVNNAG 900
Cdd:COG3433 1 IAIATPPPAPPTPDEPPPVIPPAIVQARALLLIVDLQGYFGGFGG----EGGLLGAGLLLRIRLLAAAARAPFIPVPYPA 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 901 QGAATLRiyrtgDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIVAQVGSRPALVAYATVKA 980
Cdd:COG3433 77 QPGRQAD-----DLRLLLRRGLGPGGGLERLVQQVVIRAERGEEEELLLVLRAAAVVRVAVLAALRGAGVGLLLIVGAVA 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 981 DSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEANESDGEAD------NPLEADVLAIWRSV 1054
Cdd:COG3433 152 ALDGLAAAAALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAEALLAAASPapaletALTEEELRADVAEL 231
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 499404635 1055 LNTP---LGVEDDFFRLGGDSILSIQLTTRLRSAGYACTVKDVFEAKSVRRLCRVLAQNNRDT 1114
Cdd:COG3433 232 LGVDpeeIDPDDNLFDLGLDSIRLMQLVERWRKAGLDVSFADLAEHPTLAAWWALLAAAQAAA 294
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
536-1026 |
2.18e-13 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 75.48 E-value: 2.18e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWLhRQGLGeqslvgvLAKRDRY---------FVIALLAI 606
Cdd:PRK08974 27 DMFEQAVARYADQPAFINMGE----VMTFRKLEERSRAFAAYL-QNGLG-------LKKGDRValmmpnllqYPIALFGI 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 607 WKAGAAYVPLDPDYPPERLRHIITDA---------NL--------------SVILGGDGQQLaqwSAEQRIdLTDPAV-- 661
Cdd:PRK08974 95 LRAGMIVVNVNPLYTPRELEHQLNDSgakaivivsNFahtlekvvfktpvkHVILTRMGDQL---STAKGT-LVNFVVky 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 662 ----VEQWqDLPGdqppAIP--------RHAQ---------QLAQVIYTSGSTGLPKGVMIEHGSLI-NLLD-------- 711
Cdd:PRK08974 171 ikrlVPKY-HLPD----AISfrsalhkgRRMQyvkpelvpeDLAFLQYTGGTTGVAKGAMLTHRNMLaNLEQakaaygpl 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 712 -DHRDRIDFTPQStMFNCMSLSfdagnMTTLLPLSSGGT-LAFGEPNDRAIMQAEQA--------GATHLIlpTALMSIL 781
Cdd:PRK08974 246 lHPGKELVVTALP-LYHIFALT-----VNCLLFIELGGQnLLITNPRDIPGFVKELKkypftaitGVNTLF--NALLNNE 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 782 DPEQVNGIQ---AIGmGGEACPNAVVENWAD--KVALYNMYGPTECT--VTALSTRLrKGQPVTIGKPLIHIQALILDTA 854
Cdd:PRK08974 318 EFQELDFSSlklSVG-GGMAVQQAVAERWVKltGQYLLEGYGLTECSplVSVNPYDL-DYYSGSIGLPVPSTEIKLVDDD 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 855 GQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfehitlnDVNNAGQGAatlriyrTGDKARLLNNGDYEYCGRIDEQIK 934
Cdd:PRK08974 396 GNEVPPGEPGELWVKGPQVMLGYWQRPEATD---------EVIKDGWLA-------TGDIAVMDEEGFLRIVDRKKDMIL 459
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 935 LRGYRIEPGEIEAQLAAvcpslkQIKVI-VAQVG----SRPALVAYATVKADSS-TPEpaAVLIDVAKYLPEYMVPFRLM 1008
Cdd:PRK08974 460 VSGFNVYPNEIEDVVML------HPKVLeVAAVGvpseVSGEAVKIFVVKKDPSlTEE--ELITHCRRHLTGYKVPKLVE 531
|
570
....*....|....*...
gi 499404635 1009 LLEDMPLTPNGKLDMKQL 1026
Cdd:PRK08974 532 FRDELPKSNVGKILRREL 549
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
532-1026 |
2.97e-13 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 75.03 E-value: 2.97e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAvaQRDPQQLAIaFDGEPRtdtLTYAELNRQANQLAHWLHRQGL--GEQSLV--GVLAKrdryFVIALLAIW 607
Cdd:PRK10946 25 LPLTDILTR--HAASDAIAV-ICGERQ---FSYRELNQASDNLACSLRRQGIkpGDTALVqlGNVAE----FYITFFALL 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 608 KAGAAyvPLDPDYPPERL-----------RHIITDANLSviLGGDGQQLAQWSAEQR-----IDLTDPA--VVEQWQDLP 669
Cdd:PRK10946 95 KLGVA--PVNALFSHQRSelnayasqiepALLIADRQHA--LFSDDDFLNTLVAEHSslrvvLLLNDDGehSLDDAINHP 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 670 GDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHgslinllDDHRDRI-------DFTPQsTMFNC-------MSLS--- 732
Cdd:PRK10946 171 AEDFTATPSPADEVAFFQLSGGSTGTPKLIPRTH-------NDYYYSVrrsveicGFTPQ-TRYLCalpaahnYPMSspg 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 733 ----FDAGNMTTLLPlSSGGTLAFgepndrAIMQAEQAGATHLILPTA---LMSILDP---EQVNGIQAIGMGGEACPNA 802
Cdd:PRK10946 243 algvFLAGGTVVLAP-DPSATLCF------PLIEKHQVNVTALVPPAVslwLQAIAEGgsrAQLASLKLLQVGGARLSET 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 803 VvenwADKVA------LYNMYGPTECTVTalSTRLRKGQPVTI---GKPLIHIQAL-ILDTAGQLCPVGVPGELCLAGLG 872
Cdd:PRK10946 316 L----ARRIPaelgcqLQQVFGMAEGLVN--YTRLDDSDERIFttqGRPMSPDDEVwVADADGNPLPQGEVGRLMTRGPY 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 873 LARGYLNQPQMTASRFehitlnDVNNagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLaav 952
Cdd:PRK10946 390 TFRGYYKSPQHNASAF------DANG---------FYCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLL--- 451
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 953 cpsLKQIKVIVAqvgsrpALV------------AYATVKadssTPEPAAVLidvAKYL-----PEYMVPFRLMLLEDMPL 1015
Cdd:PRK10946 452 ---LRHPAVIHA------ALVsmedelmgekscAFLVVK----EPLKAVQL---RRFLreqgiAEFKLPDRVECVDSLPL 515
|
570
....*....|.
gi 499404635 1016 TPNGKLDMKQL 1026
Cdd:PRK10946 516 TAVGKVDKKQL 526
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
524-1026 |
4.69e-13 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 74.41 E-value: 4.69e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 524 PRSYPqpqlTVTDVIEAVAQRDPQQLAIAFDGEprtdTLTYAELNRQANQLAHWL-HRQGLGEQSLVGVLAKRDRYFVIA 602
Cdd:PRK05677 20 PDEYP----NIQAVLKQSCQRFADKPAFSNLGK----TLTYGELYKLSGAFAAWLqQHTDLKPGDRIAVQLPNVLQYPVA 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 603 LLAIWKAGAAYVPLDPDYPPERLRHIITD--ANLSVILGGDGQQLAQWSAEQRI---------DLTDP-------AVVEQ 664
Cdd:PRK05677 92 VFGAMRAGLIVVNTNPLYTAREMEHQFNDsgAKALVCLANMAHLAEKVLPKTGVkhvivtevaDMLPPlkrllinAVVKH 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 665 WQ------DLPG------------DQP--PAIPrHAQQLAQVIYTSGSTGLPKGVMIEHGSLI-----------NLLDDH 713
Cdd:PRK05677 172 VKkmvpayHLPQavkfndalakgaGQPvtEANP-QADDVAVLQYTGGTTGVAKGAMLTHRNLVanmlqcralmgSNLNEG 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 714 RDRIdFTP------QSTMFNCMSLsFDAGNMTTLLPlssggtlafgEPNDRAIMQAE---QAGATHLILPTALMSILDPE 784
Cdd:PRK05677 251 CEIL-IAPlplyhiYAFTFHCMAM-MLIGNHNILIS----------NPRDLPAMVKElgkWKFSGFVGLNTLFVALCNNE 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 785 QV-----NGIQAIGMGGEACPNAVVENWAD--KVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQL 857
Cdd:PRK05677 319 AFrkldfSALKLTLSGGMALQLATAERWKEvtGCAICEGYGMTETSPVVSVNPSQAIQVGTIGIPVPSTLCKVIDDDGNE 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 858 CPVGVPGELCLAGLGLARGYLNQPQMTASrfehiTLNDvnnagQGaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRG 937
Cdd:PRK05677 399 LPLGEVGELCVKGPQVMKGYWQRPEATDE-----ILDS-----DG-----WLKTGDIALIQEDGYMRIVDRKKDMILVSG 463
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 938 YRIEPGEIEAQLAAVcPSLKQIKVI-VAQVGSRPALVAYATVKADSSTPEpAAVLIDVAKYLPEYMVPFRLMLLEDMPLT 1016
Cdd:PRK05677 464 FNVYPNELEDVLAAL-PGVLQCAAIgVPDEKSGEAIKVFVVVKPGETLTK-EQVMEHMRANLTGYKVPKAVEFRDELPTT 541
|
570
....*....|
gi 499404635 1017 PNGKLDMKQL 1026
Cdd:PRK05677 542 NVGKILRREL 551
|
|
| PRK08180 |
PRK08180 |
feruloyl-CoA synthase; Reviewed |
524-706 |
5.57e-13 |
|
feruloyl-CoA synthase; Reviewed
Pssm-ID: 236175 [Multi-domain] Cd Length: 614 Bit Score: 74.14 E-value: 5.57e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 524 PRSYPQpqlTVTDVIEAVAQRDPQQLAIA---FDGEPRTdtLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRD-RYF 599
Cdd:PRK08180 34 LGDYPR---RLTDRLVHWAQEAPDRVFLAergADGGWRR--LTYAEALERVRAIAQALLDRGLSAERPLMILSGNSiEHA 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 600 VIALLAIWkAGAAYVPLDPDY-----PPERLRHIITDANLSVILGGDGQQLAqwSAEQRIDLTDPAVVEQ---------- 664
Cdd:PRK08180 109 LLALAAMY-AGVPYAPVSPAYslvsqDFGKLRHVLELLTPGLVFADDGAAFA--RALAAVVPADVEVVAVrgavpgraat 185
|
170 180 190 200
....*....|....*....|....*....|....*....|....*....
gi 499404635 665 -WQDLPGDQPPAI--PRHAQ----QLAQVIYTSGSTGLPKGVMIEHGSL 706
Cdd:PRK08180 186 pFAALLATPPTAAvdAAHAAvgpdTIAKFLFTSGSTGLPKAVINTHRML 234
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
536-1020 |
1.51e-12 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 72.60 E-value: 1.51e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 536 DVIEAvAQRDPQQLAIAFDGeprTDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVP 615
Cdd:PRK07514 7 DALRA-AFADRDAPFIETPD---GLRYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 616 LDPDYPPERLRHIITDANLSVILGGDGQQ-----LAQWSAEQRIDLTDPAVVEQWQDLPGDQPPA---IPRHAQQLAQVI 687
Cdd:PRK07514 83 LNTAYTLAELDYFIGDAEPALVVCDPANFawlskIAAAAGAPHVETLDADGTGSLLEAAAAAPDDfetVPRGADDLAAIL 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 688 YTSGSTGLPKGVMIEHGsliNLLDDH---RDRIDFTPQSTM------FNCMSLsFDAGNmTTLLplsSGGTLAFGEPNDR 758
Cdd:PRK07514 163 YTSGTTGRSKGAMLSHG---NLLSNAltlVDYWRFTPDDVLihalpiFHTHGL-FVATN-VALL---AGASMIFLPKFDP 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 759 AIMQAEQAGATHLI-LPTALMSILDPEQVNGIQAIGM----GGEA--CPNAVVEnWADKV--ALYNMYGPTEctvTALST 829
Cdd:PRK07514 235 DAVLALMPRATVMMgVPTFYTRLLQEPRLTREAAAHMrlfiSGSAplLAETHRE-FQERTghAILERYGMTE---TNMNT 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 830 -------RLrkgqPVTIGKPLIHIQALILD-TAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndvNNAGq 901
Cdd:PRK07514 311 snpydgeRR----AGTVGFPLPGVSLRVTDpETGAELPPGEIGMIEVKGPNVFKGYWRMPEKTAEEF--------RADG- 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 902 gaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI-VAQVGSRPALVAyATVKA 980
Cdd:PRK07514 378 ------FFITGDLGKIDERGYVHIVGRGKDLIISGGYNVYPKEVEGEIDEL-PGVVESAVIgVPHPDFGEGVTA-VVVPK 449
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 499404635 981 DSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGK 1020
Cdd:PRK07514 450 PGAALDEAAILAALKGRLARFKQPKRVFFVDELPRNTMGK 489
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
686-1026 |
2.28e-12 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 72.11 E-value: 2.28e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 VIYTSGSTGLPKGVMIEHGSL-INLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLL-PLSSGGT-----LAFGEPNdr 758
Cdd:cd05928 179 IYFTSGTTGSPKMAEHSHSSLgLGLKVNGRYWLDLTASDIMWNTSDTGWIKSAWSSLFePWIQGACvfvhhLPRFDPL-- 256
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 759 AIMQA-EQAGATHLI-LPTALMSILDPE----QVNGIQAIGMGGEACPNAVVENWADKVAL--YNMYGPTECTVTALSTR 830
Cdd:cd05928 257 VILKTlSSYPITTFCgAPTVYRMLVQQDlssyKFPSLQHCVTGGEPLNPEVLEKWKAQTGLdiYEGYGQTETGLICANFK 336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 831 LRKGQPVTIGKPLIHIQALILDTAGQLCPVGVPGELCL-----AGLGLARGYLNQPQMTAsrfehitlndvnnagqgaAT 905
Cdd:cd05928 337 GMKIKPGSMGKASPPYDVQIIDDNGNVLPPGTEGDIGIrvkpiRPFGLFSGYVDNPEKTA------------------AT 398
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 906 LR--IYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLA---AVCPSlkqikvivAQVGS----RPALV-AY 975
Cdd:cd05928 399 IRgdFYLTGDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIehpAVVES--------AVVSSpdpiRGEVVkAF 470
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 976 ATVKADSSTPEPAAVLID----VAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:cd05928 471 VVLAPQFLSHDPEQLTKElqqhVKSVTAPYKYPRKVEFVQELPKTVTGKIQRNEL 525
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
529-923 |
3.48e-12 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 71.68 E-value: 3.48e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 529 QPQLTVTDVIEAVAQRDPQQLAIAF-------DGEPRTdtLTYAELNRQANQLAHWLhrQGLGEQ-SLVGVLAKRDRYFV 600
Cdd:PRK07769 18 PPNTNLVRHVERWAKVRGDKLAYRFldfsterDGVARD--LTWSQFGARNRAVGARL--QQVTKPgDRVAILAPQNLDYL 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 601 IALLAIWKAGAAYVPL-DPDYP--PERLRHIITDANLSVILGGDG------QQLAQWSAEQR-----IDLTDPAVVEQWQ 666
Cdd:PRK07769 94 IAFFGALYAGRIAVPLfDPAEPghVGRLHAVLDDCTPSAILTTTDsaegvrKFFRARPAKERprviaVDAVPDEVGATWV 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 667 dlpgdqPPAIprHAQQLAQVIYTSGSTGLPKGVMIEHGSL-------INLLD-DHRDR-IDFTPqstMFNCMSLsfdagn 737
Cdd:PRK07769 174 ------PPEA--NEDTIAYLQYTSGSTRIPAGVQITHLNLptnvlqvIDALEgQEGDRgVSWLP---FFHDMGL------ 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 738 MTTLLPLSSGGTLAFGEPN------DRAI--MQAEQAGATHLI---------------LPTALMSILDPEQVNGIQAigm 794
Cdd:PRK07769 237 ITVLLPALLGHYITFMSPAafvrrpGRWIreLARKPGGTGGTFsaapnfafehaaargLPKDGEPPLDLSNVKGLLN--- 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 GGEACPNAVVENWADKVALYNM--------YGPTECTVTALSTR--------------LRKGQPVTI------------- 839
Cdd:PRK07769 314 GSEPVSPASMRKFNEAFAPYGLpptaikpsYGMAEATLFVSTTPmdeeptviyvdrdeLNAGRFVEVpadapnavaqvsa 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 840 GKPLIHIQALILD--TAGQLcPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITLNDVNNA-GQGAAtlriyrtgDKAR 916
Cdd:PRK07769 394 GKVGVSEWAVIVDpeTASEL-PDGQIGEIWLHGNNIGTGYWGKPEETAATFQNILKSRLSEShAEGAP--------DDAL 464
|
....*..
gi 499404635 917 LLNNGDY 923
Cdd:PRK07769 465 WVRTGDY 471
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
672-1022 |
3.71e-12 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 71.92 E-value: 3.71e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 672 QPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGsliNLLDDHRD---RIDFTPQSTMFNCMSL--SF--DAGnmtTLLPL 744
Cdd:PRK06814 784 LVYFCNRDPDDPAVILFTSGSEGTPKGVVLSHR---NLLANRAQvaaRIDFSPEDKVFNALPVfhSFglTGG---LVLPL 857
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 745 SSG-GTLAFGEP-NDRAIMQ-AEQAGATHLI-LPTALMS---ILDPEQVNGIQAIGMGGEACPNAVVENWADK--VALYN 815
Cdd:PRK06814 858 LSGvKVFLYPSPlHYRIIPElIYDTNATILFgTDTFLNGyarYAHPYDFRSLRYVFAGAEKVKEETRQTWMEKfgIRILE 937
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 816 MYGPTECT-VTALSTRLRKgQPVTIGKPLIHIQAlildtagQLCPV-GVP--GELCLAGLGLARGYLnqpqmtasrfehi 891
Cdd:PRK06814 938 GYGVTETApVIALNTPMHN-KAGTVGRLLPGIEY-------RLEPVpGIDegGRLFVRGPNVMLGYL------------- 996
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 892 tlnDVNNAGqgaaTLRI-----YRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIKVIV--A 964
Cdd:PRK06814 997 ---RAENPG----VLEPpadgwYDTGDIVTIDEEGFITIKGRAKRFAKIAGEMISLAAVEELAAELWPDALHAAVSIpdA 1069
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 965 QVGSRPALVayaTVKADSStpepAAVLIDVAKY--LPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:PRK06814 1070 RKGERIILL---TTASDAT----RAAFLAHAKAagASELMVPAEIITIDEIPLLGTGKID 1122
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
560-1046 |
3.71e-12 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 71.60 E-value: 3.71e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 560 DTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDP-----DYP-PERlrhiITDAN 633
Cdd:PRK06060 29 DVVTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVMAFLANPelhrdDHAlAAR----NTEPA 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 634 LSVILGGDGQQLAQWSAEQRIDL-TDPAVVEqwqdlPGDQPPAiprHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDD 712
Cdd:PRK06060 105 LVVTSDALRDRFQPSRVAEAAELmSEAARVA-----PGGYEPM---GGDALAYATYTSGTTGPPKAAIHRHADPLTFVDA 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 713 H-RDRIDFTPQSTMFNC--MSLSFDAGNmTTLLPLSSGGTLAFGE----PNDRAIMQAEQAGATHLILPTALMSILD--- 782
Cdd:PRK06060 177 McRKALRLTPEDTGLCSarMYFAYGLGN-SVWFPLATGGSAVINSapvtPEAAAILSARFGPSVLYGVPNFFARVIDscs 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 783 PEQVNGIQAIGMGGEACPNAVVENWAD---KVALYNMYGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCP 859
Cdd:PRK06060 256 PDSFRSLRCVVSAGEALELGLAERLMEffgGIPILDGIGSTEVGQTFVSNRVDEWRLGTLGRVLPPYEIRVVAPDGTTAG 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 860 VGVPGELCLAGLGLARGYLNQPQMTasrfehitlndVNNAGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYR 939
Cdd:PRK06060 336 PGVEGDLWVRGPAIAKGYWNRPDSP-----------VANEGW-------LDTRDRVCIDSDGWVTYRCRADDTEVIGGVN 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 940 IEPGEIEaQLAAVCPSLKQIKVI-VAQVGSRPALVAYATVKADSSTPEpaAVLIDVAK----YLPEYMVPFRLMLLEDMP 1014
Cdd:PRK06060 398 VDPREVE-RLIIEDEAVAEAAVVaVRESTGASTLQAFLVATSGATIDG--SVMRDLHRgllnRLSAFKVPHRFAVVDRLP 474
|
490 500 510
....*....|....*....|....*....|....*...
gi 499404635 1015 LTPNGKLDMK----QLP--PVLEANESDGEADNPLEAD 1046
Cdd:PRK06060 475 RTPNGKLVRGalrkQSPtkPIWELSLTEPGSGVRAQRD 512
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
533-950 |
6.89e-12 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 70.48 E-value: 6.89e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDpqQLAIAFDGEprtdTLTYAELNRQANQLAHWLH-RQGLGEQSLVGVLAKRDRYFVIALLAIWKAGA 611
Cdd:PRK07867 6 TVAELLLPLAEDD--DRGLYFEDS----FTSWREHIRGSAARAAALRaRLDPTRPPHVGVLLDNTPEFSLLLGAAALSGI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 612 AYVPLDPDYPPERLRHIITDANLSVILGGDGQQ--LAQWSAEQRIDLTDPAvveQWQDL----PGDQPPAIPRHAQQLAQ 685
Cdd:PRK07867 80 VPVGLNPTRRGAALARDIAHADCQLVLTESAHAelLDGLDPGVRVINVDSP---AWADElaahRDAEPPFRVADPDDLFM 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 VIYTSGSTGLPKGVMIEHGSLI---NLLDDHRdriDFTPQSTMFNCMSLSFDAGNMTTLLP-LSSGGTLAFgepndRAIM 761
Cdd:PRK07867 157 LIFTSGTSGDPKAVRCTHRKVAsagVMLAQRF---GLGPDDVCYVSMPLFHSNAVMAGWAVaLAAGASIAL-----RRKF 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 762 QAEQ-------AGATHL---------ILPTALMsildPEQVNGIQAIGMGGEACPNAvVENWADK--VALYNMYGPTECT 823
Cdd:PRK07867 229 SASGflpdvrrYGATYAnyvgkplsyVLATPER----PDDADNPLRIVYGNEGAPGD-IARFARRfgCVVVDGFGSTEGG 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 824 VTAlsTRLRKGQPVTIGKPLIHIQALILDTaGQLCPVGVP------------GELC-LAGLGLARGYLNQPQMTASRFEH 890
Cdd:PRK07867 304 VAI--TRTPDTPPGALGPLPPGVAIVDPDT-GTECPPAEDadgrllnadeaiGELVnTAGPGGFEGYYNDPEADAERMRG 380
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 891 itlndvnnagqgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLA 950
Cdd:PRK07867 381 ----------------GVYWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILL 424
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
68-496 |
7.68e-12 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 71.35 E-value: 7.68e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 68 NATSGPLSSsQSGL-----WFIEQYEEQSHLYNMPVYFRLTGPLDVAALEFAFDALAQRHASLRTRFV-VNEQGKGEQRI 141
Cdd:PRK05691 2782 QAEQGPLQG-ASGLtpiqhWFFDSPVPQPQHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRFSqADGRWQAEYRA 2860
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 142 DAYQPFVIQHDDFSLlpeAERegrlqQQVKAEISRPFDLTAGDLTRVRLVKMSERTHVLMITQHHIISDGWSVKNLFADF 221
Cdd:PRK05691 2861 VTAQELLWQVTVADF---AEC-----AALFADAQRSLDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSWRVLLEDL 2932
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 222 KPAF--LACQNCQPYPVETTQLNyiDYAHWFNSDSFLDYHNEFKPFWVERLTGIPevHSLPLDKPRPAHQNSGGEVIfsA 299
Cdd:PRK05691 2933 QALYrqLSAGAEPALPAKTSAFR--DWAARLQAYAGSESLREELGWWQAQLGGPR--AELPCDRPQGGNLNRHAQTV--S 3006
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 300 INNDLwDKFKRLCQR----YNTSNFIGLHAVFSLMLARISGEKDIVIGSPLAYRERP----DIEDVVGFFVNTIVLRTQ- 370
Cdd:PRK05691 3007 VRLDA-ERTRQLLQQapaaYRTQVNDLLLTALARVLCRWSGQPSVLVQLEGHGREALfddiDLTRSVGWFTSAYPLRLTp 3085
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 371 -LQDSQNFVDYLQYCREQdLSAFDHQLYRFEALSE-AIGSDRTT-AINPIFQVMLVYQAKVD--------FNDLIPGCDA 439
Cdd:PRK05691 3086 aPGDDAARGESIKAIKEQ-LRAVPHKGLGYGVLRYlADAAVREAmAALPQAPITFNYLGQFDqsfasdalFRPLDEPAGP 3164
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*..
gi 499404635 440 AEETSPVLPakTDISVKVTELMGEVRLDWLFATALFERQTIQYYADRFIRLIEAVVE 496
Cdd:PRK05691 3165 AHDPDAPLP--NELSVDGQVYGGELVLRWTYSAERYDEQTIAELAEAYLAELQALIA 3219
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
546-951 |
8.49e-12 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 70.42 E-value: 8.49e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 546 PQQLAIAFDG--EPRTDTLTYAELNRQANQLAHWLHRQGLgeqslvgvlAKRDR---YF------VIALLAIWKAGAAYV 614
Cdd:cd05967 65 GDQIALIYDSpvTGTERTYTYAELLDEVSRLAGVLRKLGV---------VKGDRviiYMpmipeaAIAMLACARIGAIHS 135
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 615 PLDPDYPPERLRHIITDANLSVILGGD-----GQ------------QLAQWSAE-----QR----IDLTDPAVVEQWQDL 668
Cdd:cd05967 136 VVFGGFAAKELASRIDDAKPKLIVTAScgiepGKvvpykplldkalELSGHKPHhvlvlNRpqvpADLTKPGRDLDWSEL 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 669 PGDQPPA--IPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSlsfDAG-----NMTTL 741
Cdd:cd05967 216 LAKAEPVdcVPVAATDPLYILYTSGTTGKPKGVVRDNGGHAVALNWSMRNIYGIKPGDVWWAAS---DVGwvvghSYIVY 292
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 742 LPLSSGGTLAF--GEPND--------RAImqaEQAGATHLI-LPTALMSI--LDPE-------QVNGIQAIGMGGEACPN 801
Cdd:cd05967 293 GPLLHGATTVLyeGKPVGtpdpgafwRVI---EKYQVNALFtAPTAIRAIrkEDPDgkyikkyDLSSLRTLFLAGERLDP 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 802 AVVEnWADK---VALYNMYGPTE------CTVTALSTR-LRKGQPvtiGKPLIHIQALILDTAGQLCPVGVPGELCLaGL 871
Cdd:cd05967 370 PTLE-WAENtlgVPVIDHWWQTEtgwpitANPVGLEPLpIKAGSP---GKPVPGYQVQVLDEDGEPVGPNELGNIVI-KL 444
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 872 GLARGYLNQPQMTASRFEHITLNDVNNagqgaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAA 951
Cdd:cd05967 445 PLPPGCLLTLWKNDERFKKLYLSKFPG---------YYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLS 515
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
1566-1985 |
1.05e-11 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 69.60 E-value: 1.05e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSMLY-HRLRCPQDdAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIV--KQADLPF 1641
Cdd:cd19538 2 IPLSFAQRRLWFlHQLEGPSA-TYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFpEEDGVPYQLILeeDEATPKL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1642 YyqdlMQDADPLAVIERYRQQdLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQTLMQG 1721
Cdd:cd19538 81 E----IKEVDEEELESEINEA-VRYPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARCKG 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 QvlMHGDAP-AIQvdraYVDYA-------RHAVAQQSAVD---AFW-QQRQSLLAQTN---DVsmlfaaagKRADLSQHl 1786
Cdd:cd19538 156 E--APELAPlPVQ----YADYAlwqqellGDESDPDSLIArqlAYWkKQLAGLPDEIElptDY--------PRPAESSY- 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1787 tqiEPQVTSVSLNEKDQATLTAFAREVGITPSIIAQYAWHRLLARsTGDAVSIV-GNVLSGRESpvEDVASSVGLYINSL 1865
Cdd:cd19538 221 ---EGGTLTFEIDSELHQQLLQLAKDNNVTLFMVLQAGFAALLTR-LGAGTDIPiGSPVAGRND--DSLEDLVGFFVNTL 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1866 PLALSWQQPVSLQQHL--VQLQNeLMAM-NQHATQSLI--ALTAGRSR----LFNSLFIYENYPDAKAEQGQRADDPhRL 1936
Cdd:cd19538 295 VLRTDTSGNPSFRELLerVKETN-LEAYeHQDIPFERLveALNPTRSRsrhpLFQIMLALQNTPQPSLDLPGLEAKL-EL 372
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 499404635 1937 YPEFSAAYEkvempLNLVVREQSGC-----MLLRFEFDADALDSAQARRVLMRW 1985
Cdd:cd19538 373 RTVGSAKFD-----LTFELREQYNDgtpngIEGFIEYRTDLFDHETIEALAQRY 421
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
1566-1867 |
1.08e-11 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 69.37 E-value: 1.08e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1566 LPLSSLQQSM-LYHRLRcPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIV--KQADLPF 1641
Cdd:cd19540 2 IPLSFAQQRLwFLNRLD-GPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFpEDDGGPYQVVLpaAEARPDL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1642 YYQDLMQDADPLAVIERyrqqdLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLgavhRDyqtlmqg 1721
Cdd:cd19540 81 TVVDVTEDELAARLAEA-----ARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLA----RD------- 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1722 qvLM-------HGDAP-----AIQvdraYVDYA--RHAV-----------AQQSavdAFWQQRqslLAQTNDVSML---- 1772
Cdd:cd19540 145 --LAtayaarrAGRAPdwaplPVQ----YADYAlwQRELlgdeddpdslaARQL---AYWRET---LAGLPEELELptdr 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1773 --FAAAGKRADlsQHLTQIEPQVTsvslnekdqATLTAFAREVGITPSIIAQYAWHRLLAR-STGDAVSIvGNVLSGR-E 1848
Cdd:cd19540 213 prPAVASYRGG--TVEFTIDAELH---------ARLAALAREHGATLFMVLHAALAVLLSRlGAGDDIPI-GTPVAGRgD 280
|
330
....*....|....*....
gi 499404635 1849 SPVEDVassVGLYINSLPL 1867
Cdd:cd19540 281 EALDDL---VGMFVNTLVL 296
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
542-1021 |
1.36e-11 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 69.27 E-value: 1.36e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 542 AQRDPQQLAI--AFDGEprtdTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPD 619
Cdd:PRK13390 7 AQIAPDRPAVivAETGE----QVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHH 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 620 YPPERLRHIITDANLSVILGG---DGQqLAQWSAEQRIDLTDPAVVEQWQDLPGDQPPAIPRHAQQL--AQVIYTSGSTG 694
Cdd:PRK13390 83 LTAPEADYIVGDSGARVLVASaalDGL-AAKVGADLPLRLSFGGEIDGFGSFEAALAGAGPRLTEQPcgAVMLYSSGTTG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 695 LPKGVMIE-HGSLINLLDD-----HRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLAFGEPNDRAI----MQAE 764
Cdd:PRK13390 162 FPKGIQPDlPGRDVDAPGDpivaiARAFYDISESDIYYSSAPIYHAAPLRWCSMVHALGGTVVLAKRFDAQAtlghVERY 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 765 QAGATHLIlPTALMSI--LDPE-----QVNGIQAIGMGGEACPNAVVENWADKVA--LYNMYGPTEC-TVTALSTRLRKG 834
Cdd:PRK13390 242 RITVTQMV-PTMFVRLlkLDADvrtryDVSSLRAVIHAAAPCPVDVKHAMIDWLGpiVYEYYSSTEAhGMTFIDSPDWLA 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 835 QPVTIGKPL---IHiqalILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTAsrfehitlndvnnAGQGAATLRIYRT 911
Cdd:PRK13390 321 HPGSVGRSVlgdLH----ICDDDGNELPAGRIGTVYFERDRLPFRYLNDPEKTA-------------AAQHPAHPFWTTV 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 912 GDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLaAVCPSLKQIKVIVA---QVGSRPALVAYATVKADSSTpEPA 988
Cdd:PRK13390 384 GDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENAL-TMHPAVHDVAVIGVpdpEMGEQVKAVIQLVEGIRGSD-ELA 461
|
490 500 510
....*....|....*....|....*....|....
gi 499404635 989 AVLIDVAK-YLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:PRK13390 462 RELIDYTRsRIAHYKAPRSVEFVDELPRTPTGKL 495
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
533-888 |
8.74e-11 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 66.89 E-value: 8.74e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 533 TVTDVIEAVAQRDPQQLAIAF-----DGEPRTDTLTYAELNRQANQLAHWLHRQGL-GEQSLVgvLAKRDRYFVIALLAI 606
Cdd:PRK05850 2 SVPSLLRERASLQPDDAAFTFidyeqDPAGVAETLTWSQLYRRTLNVAEELRRHGStGDRAVI--LAPQGLEYIVAFLGA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 607 WKAGAAYVPLDPDYP---PERLRHIITDANLSVIL--GGDGQQLAQWSAEQRIDlTDPAVVE-QWQDLPGDQPPAIPRH- 679
Cdd:PRK05850 80 LQAGLIAVPLSVPQGgahDERVSAVLRDTSPSVVLttSAVVDDVTEYVAPQPGQ-SAPPVIEvDLLDLDSPRGSDARPRd 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 680 AQQLAQVIYTSGSTGLPKGVMIEHGSLI----NLLDD---HRDRIdFTPQSTMFNCMSLSFDAGNMTTL-LPLSSGGT-- 749
Cdd:PRK05850 159 LPSTAYLQYTSGSTRTPAGVMVSHRNVIanfeQLMSDyfgDTGGV-PPPDTTVVSWLPFYHDMGLVLGVcAPILGGCPav 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 750 ----LAFGEPNDRAImqaeQAGATHLILPTAL----------------MSILDPEQVNGIQAigmGGEACPNAVVENWAD 809
Cdd:PRK05850 238 ltspVAFLQRPARWM----QLLASNPHAFSAApnfafelavrktsdddMAGLDLGGVLGIIS---GSERVHPATLKRFAD 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 810 KVALYNM--------YGPTECTVTALSTrlRKGQPVTI--------------------GKPLIHIQA------LILDT-A 854
Cdd:PRK05850 311 RFAPFNLretairpsYGLAEATVYVATR--EPGQPPESvrfdyeklsaghakrcetggGTPLVSYGSprsptvRIVDPdT 388
|
410 420 430
....*....|....*....|....*....|....
gi 499404635 855 GQLCPVGVPGELCLAGLGLARGYLNQPQMTASRF 888
Cdd:PRK05850 389 CIECPAGTVGEIWVHGDNVAAGYWQKPEETERTF 422
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
534-1021 |
8.90e-11 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 67.07 E-value: 8.90e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 534 VTDVIEAVAQRdpqQLAIAFDGEPRTDTLTYAELNRQANQLAHWLHR-QGLGEQslVGVLAKRDRYFVIALLAIWKAGAA 612
Cdd:PRK12476 44 IANVGDTVAYR---YLDHSHSAAGCAVELTWTQLGVRLRAVGARLQQvAGPGDR--VAILAPQGIDYVAGFFAAIKAGTI 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 613 YVPL-DPDYP--PERLRHIITDANLSVILGgdgQQLAQWSAEQRID----LTDPAV--VEQWQDLPGDQPPAIPRHAQQL 683
Cdd:PRK12476 119 AVPLfAPELPghAERLDTALRDAEPTVVLT---TTAAAEAVEGFLRnlprLRRPRViaIDAIPDSAGESFVPVELDTDDV 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 684 AQVIYTSGSTGLPKGVMIEHGSL----------INLLDDHRDRIDFTPqstMFNCMSLS---FDA---GNMTTLLPlssg 747
Cdd:PRK12476 196 SHLQYTSGSTRPPVGVEITHRAVgtnlvqmilsIDLLDRNTHGVSWLP---LYHDMGLSmigFPAvygGHSTLMSP---- 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 748 gtLAFGEPNDRAImQAEQAGATHLILPTALMSILD--------PEQVNGIQ----AIGMGGEACPNAVVENWADKVALYN 815
Cdd:PRK12476 269 --TAFVRRPQRWI-KALSEGSRTGRVVTAAPNFAYewaaqrglPAEGDDIDlsnvVLIIGSEPVSIDAVTTFNKAFAPYG 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 816 M--------YGPTECT-------------VTAL---------STRLRKGQP-----VTIGKPLIHIQALILD-TAGQLCP 859
Cdd:PRK12476 346 LprtafkpsYGIAEATlfvatiapdaepsVVYLdreqlgagrAVRVAADAPnavahVSCGQVARSQWAVIVDpDTGAELP 425
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 860 VGVPGELCLAGLGLARGYLNQPQMTASRFE---HITLNDVNNAGQGAATLRIYRTGDKARLLnNGDYEYCGRIDEQIKLR 936
Cdd:PRK12476 426 DGEVGEIWLHGDNIGRGYWGRPEETERTFGaklQSRLAEGSHADGAADDGTWLRTGDLGVYL-DGELYITGRIADLIVID 504
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 937 GYRIEPGEIEAQLAAVCPSLKQIKV----IVAQVGSRPALVAYATVKADSSTPEPA--AVLIDVAKylpEYMVP---FRL 1007
Cdd:PRK12476 505 GRNHYPQDIEATVAEASPMVRRGYVtaftVPAEDNERLVIVAERAAGTSRADPAPAidAIRAAVSR---RHGLAvadVRL 581
|
570
....*....|....
gi 499404635 1008 MLLEDMPLTPNGKL 1021
Cdd:PRK12476 582 VPAGAIPRTTSGKL 595
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
683-1024 |
1.17e-10 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 65.21 E-value: 1.17e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 683 LAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQST------MFNcmSLSFDAGNMTTLLplsSGGTLAFGEPN 756
Cdd:cd17638 2 VSDIMFTSGTTGRSKGVMCAHRQTLRAAAAWADCADLTEDDRyliinpFFH--TFGYKAGIVACLL---TGATVVPVAVF 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 757 D-RAIMQAEqagATHLIL-----PTALMSILD-PEQVNG----IQAIGMGGEACPNAVVENWADKVALYNM---YGPTEC 822
Cdd:cd17638 77 DvDAILEAI---ERERITvlpgpPTLFQSLLDhPGRKKFdlssLRAAVTGAATVPVELVRRMRSELGFETVltaYGLTEA 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 823 TVTALStrlRKGQPVTigkplihiqaLILDTAGQLCP-----VGVPGELCLAGLGLARGYLNQPQMTASRfehitlndVN 897
Cdd:cd17638 154 GVATMC---RPGDDAE----------TVATTCGRACPgfevrIADDGEVLVRGYNVMQGYLDDPEATAEA--------ID 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 898 NAGQgaatlriYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI------VAQVGSrpA 971
Cdd:cd17638 213 ADGW-------LHTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEH-PGVAQVAVIgvpderMGEVGK--A 282
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|...
gi 499404635 972 LVayatVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLdMK 1024
Cdd:cd17638 283 FV----VARPGVTLTEEDVIAWCRERLANYKVPRFVRFLDELPRNASGKV-MK 330
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
561-1020 |
1.42e-10 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 65.92 E-value: 1.42e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQ-GLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIItdaNLSvilg 639
Cdd:cd05937 5 TWTYSETYDLVLRYAHWLHDDlGVQAGDFVAIDLTNSPEFVFLWLGLWSIGAAPAFINYNLSGDPLIHCL---KLS---- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 gdgqqlaqwsaEQRIDLTDPAVVeqwqdlpgdqppaiprhaqqlAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDF 719
Cdd:cd05937 78 -----------GSRFVIVDPDDP---------------------AILIYTSGTTGLPKAAAISWRRTLVTSNLLSHDLNL 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 720 TPQSTMFNCMSLSFDAGNMTTLLP-LSSGGTLAFGE--PNDRAIMQAEQAGATHLI--------LPTALMSILDpeQVNG 788
Cdd:cd05937 126 KNGDRTYTCMPLYHGTAAFLGACNcLMSGGTLALSRkfSASQFWKDVRDSGATIIQyvgelcryLLSTPPSPYD--RDHK 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 789 IQAI---GMGGEacpnaVVENWADKVA---LYNMYGPTECTVTalSTRLRKGqPVTIGK-----PLIHI-----QALI-L 851
Cdd:cd05937 204 VRVAwgnGLRPD-----IWERFRERFNvpeIGEFYAATEGVFA--LTNHNVG-DFGAGAighhgLIRRWkfenqVVLVkM 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 852 DTAGQL------------CPVGVPGELCLA----GLGLARGYLNQPQMTASRFehitLNDVNNAGQGaatlrIYRTGDKA 915
Cdd:cd05937 276 DPETDDpirdpktgfcvrAPVGEPGEMLGRvpfkNREAFQGYLHNEDATESKL----VRDVFRKGDI-----YFRTGDLL 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 916 RLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVIVAQVGSRPALVAYATVK-ADSSTPEPAAVLIDV 994
Cdd:cd05937 347 RQDADGRWYFLDRLGDTFRWKSENVSTTEVADVLGAH-PDIAEANVYGVKVPGHDGRAGCAAITlEESSAVPTEFTKSLL 425
|
490 500 510
....*....|....*....|....*....|
gi 499404635 995 AKY----LPEYMVPFRLMLLEDMPLTPNGK 1020
Cdd:cd05937 426 ASLarknLPSYAVPLFLRLTEEVATTDNHK 455
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
1133-1305 |
1.61e-10 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 65.45 E-value: 1.61e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1133 QR-WFMEQSLARPEHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLGCDAEG----QRYLADVPCPaLSTLDYRQLG 1206
Cdd:cd19531 9 QRlWFLDQLEPGSAAYNIPGALRLRgPLDVAALERALNELVARHEALRTTFVEVDgepvQVILPPLPLP-LPVVDLSGLP 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1207 DDGLQQAFTALQSE-----FDPAQGRTMACALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERLYLGE------PLL 1275
Cdd:cd19531 88 EAEREAEAQRLAREearrpFDLARGPLLRATLLRLGED-EHVLLLTMHHIVSDGWSMGVLLRELAALYAAFlagrpsPLP 166
|
170 180 190
....*....|....*....|....*....|....*....
gi 499404635 1276 PKTSSY-------RQW--GAALQhyatqhaEQLTYWQAQ 1305
Cdd:cd19531 167 PLPIQYadyavwqREWlqGEVLE-------RQLAYWREQ 198
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
678-946 |
2.14e-10 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 65.59 E-value: 2.14e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 678 RHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTT-LLPLSSGG------TL 750
Cdd:cd05908 103 ELADELAFIQFSSGSTGDPKGVMLTHENLVHNMFAILNSTEWKTKDRILSWMPLTHDMGLIAFhLAPLIAGMnqylmpTR 182
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 751 AFGEPNDRAIMQAEQAGATHLILPT----ALMSILDPEQVN-----GIQAIGMGGEACPNAVVENWADKVALYNM----- 816
Cdd:cd05908 183 LFIRRPILWLKKASEHKATIVSSPNfgykYFLKTLKPEKANdwdlsSIRMILNGAEPIDYELCHEFLDHMSKYGLkrnai 262
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 817 ---YGPTECTVTALSTRLRK--------------GQP--------------VTIGKPLIHIQALILDTAGQLCPVGVPGE 865
Cdd:cd05908 263 lpvYGLAEASVGASLPKAQSpfktitlgrrhvthGEPepevdkkdsecltfVEVGKPIDETDIRICDEDNKILPDGYIGH 342
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 866 LCLAGLGLARGYLNQPQMTASRFehitlndvnnAGQGAatlriYRTGDKArLLNNGDYEYCGRIDEQIKLRGYRIEPGEI 945
Cdd:cd05908 343 IQIRGKNVTPGYYNNPEATAKVF----------TDDGW-----LKTGDLG-FIRNGRLVITGREKDIIFVNGQNVYPHDI 406
|
.
gi 499404635 946 E 946
Cdd:cd05908 407 E 407
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
562-761 |
2.62e-10 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 65.31 E-value: 2.62e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGL--GEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILG 639
Cdd:cd05927 6 ISYKEVAERADNIGSALRSLGGkpAPASFVGIYSINRPEWIISELACYAYSLVTVPLYDTLGPEAIEYILNHAEISIVFC 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 640 GDGQQLaqWSAEQRIDLTDpavveqwqdlpGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLIN----LLDDHRD 715
Cdd:cd05927 86 DAGVKV--YSLEEFEKLGK-----------KNKVPPPPPKPEDLATICYTSGTTGNPKGVMLTHGNIVSnvagVFKILEI 152
|
170 180 190 200
....*....|....*....|....*....|....*....|....*...
gi 499404635 716 RIDFTPQSTMFNCMSLS--FDAgnMTTLLPLSSGGTLAFGEPNDRAIM 761
Cdd:cd05927 153 LNKINPTDVYISYLPLAhiFER--VVEALFLYHGAKIGFYSGDIRLLL 198
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
1161-1471 |
3.68e-10 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 64.39 E-value: 3.68e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1161 ERLVTMLQALMAQHDALRLGCDAEGQRYLADVPCPALStLDYRQLGDDGLQQAFTALQSEFDPAQGRT--------MACA 1232
Cdd:cd19536 39 DLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVHRQAQ-VPVTELDLTPLEEQLDPLRAYKEETKIRRfdlgraplVRAA 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1233 LVRHHPQADTALFLAFHHLVIDAVSWRILVDDLERLYLGEP-----LLPKTSSYRQWgAALQHYATQHAEQLTYWQAQED 1307
Cdd:cd19536 118 LVRKDERERFLLVISDHHSILDGWSLYLLVKEILAVYNQLLeykplSLPPAQPYRDF-VAHERASIQQAASERYWREYLA 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1308 GVDLTAL----LAAKDPQGHASAAILTLDAKTTGQlvsEANRAFNTDVSDLLLSALTRTLNDLGWGDKARIMLEGHGREA 1383
Cdd:cd19536 197 GATLATLpalsEAVGGGPEQDSELLVSVPLPVRSR---SLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSE 273
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1384 idPTLDVSRTVGWFTSTYP--VCLQDKPdWASLIQSSKEQLRQVPDKGVGfnPLRYHHPQGNSLTLSPIVFNYLGLSVQA 1461
Cdd:cd19536 274 --ETTGAERLLGLFLNTLPlrVTLSEET-VEDLLKRAQEQELESLSHEQV--PLADIQRCSEGEPLFDSIVNFRHFDLDF 348
|
330
....*....|
gi 499404635 1462 AGTWRPVDVA 1471
Cdd:cd19536 349 GLPEWGSDEG 358
|
|
| ACSBG_like |
cd05933 |
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very ... |
561-987 |
4.03e-10 |
|
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very long-chain fatty acid CoA synthetase is named bubblegum because Drosophila melanogaster mutant bubblegum (BGM) has elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene of this family. The human homolog (hsBG) has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. VL-FACS is involved in the first reaction step of very long chain fatty acid degradation. It catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341256 [Multi-domain] Cd Length: 596 Bit Score: 65.07 E-value: 4.03e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVILGG 640
Cdd:cd05933 8 TLTYKEYYEACRQAAKAFLKLGLERFHGVGILGFNSPEWFIAAVGAIFAGGIAVGIYTTNSPEACQYVAETSEANILVVE 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 DGQQLAQWSAEQR--------IDLTDP-----AVVEQWQDLPgDQPPAIPRH----------AQQLAQVIYTSGSTGLPK 697
Cdd:cd05933 88 NQKQLQKILQIQDklphlkaiIQYKEPlkekePNLYSWDEFM-ELGRSIPDEqldaiissqkPNQCCTLIYTSGTTGMPK 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 698 GVMIEHgslinllddhrDRIDFTP----QSTMFNC-----------MSLSFDAGNMTTL-LPLSSGGTLAFGEPN----D 757
Cdd:cd05933 167 GVMLSH-----------DNITWTAkaasQHMDLRPatvgqesvvsyLPLSHIAAQILDIwLPIKVGGQVYFAQPDalkgT 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 758 RAIMQAEQAGATHLILPTALMSILDPEQVNGIQAIG--------------------MGGEAcPNAVVENWADK------- 810
Cdd:cd05933 236 LVKTLREVRPTAFMGVPRVWEKIQEKMKAVGAKSGTlkrkiaswakgvgletnlklMGGES-PSPLFYRLAKKlvfkkvr 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 811 ------------------------------VALYNMYGPTECTvtalstrlrkgQPVTIGKPlihiQALILDTAGQLCPv 860
Cdd:cd05933 315 kalgldrcqkfftgaapisretlefflslnIPIMELYGMSETS-----------GPHTISNP----QAYRLLSCGKALP- 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 861 GVP-----------GELCLAGLGLARGYLNQPQMTASRF-EHITLndvnnagqgaatlriyRTGDKARLLNNGDYEYCGR 928
Cdd:cd05933 379 GCKtkihnpdadgiGEICFWGRHVFMGYLNMEDKTEEAIdEDGWL----------------HSGDLGKLDEDGFLYITGR 442
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 499404635 929 IDEQIKLR-GYRIEPGEIEAQLAAVCPSLKQIKVIVAQvgsRPALVAYATVKA--DSSTPEP 987
Cdd:cd05933 443 IKELIITAgGENVPPVPIEDAVKKELPIISNAMLIGDK---RKFLSMLLTLKCevNPETGEP 501
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
589-1026 |
4.44e-10 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 64.66 E-value: 4.44e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 589 VGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERL----RH-----IITDANLSVILggDGQQLaqwSAEQRIDLTDP 659
Cdd:PRK13388 55 VGVLLGNTPEMLFWLAAAALGGYVLVGLNTTRRGAALaadiRRadcqlLVTDAEHRPLL--DGLDL---PGVRVLDVDTP 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 660 AvveqWQDL---PGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAG 736
Cdd:PRK13388 130 A----YAELvaaAGALTPHREVDAMDPFMLIFTSGTTGAPKAVRCSHGRLAFAGRALTERFGLTRDDVCYVSMPLFHSNA 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 737 NMTTLLP-LSSGGTLAFgepndRAIMQA-------EQAGATHL-ILPTALMSIL-DPEQVNGIQ---AIGMGGEACPNAV 803
Cdd:PRK13388 206 VMAGWAPaVASGAAVAL-----PAKFSAsgflddvRRYGATYFnYVGKPLAYILaTPERPDDADnplRVAFGNEASPRDI 280
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 804 VEnWADK--VALYNMYGPTECTVTAlsTRLRKGQPVTIGKPLIHIQALILDTaGQLCPVGV-------------PGELC- 867
Cdd:PRK13388 281 AE-FSRRfgCQVEDGYGSSEGAVIV--VREPGTPPGSIGRGAPGVAIYNPET-LTECAVARfdahgallnadeaIGELVn 356
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 868 LAGLGLARGYLNQPQMTASRFEHitlndvnnagqgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEA 947
Cdd:PRK13388 357 TAGAGFFEGYYNNPEATAERMRH----------------GMYWSGDLAYRDADGWIYFAGRTADWMRVDGENLSAAPIER 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 948 QLAavcpslKQIKVIVAQVGSRP-----ALVAYATVKADSSTPEPA--AVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGK 1020
Cdd:PRK13388 421 ILL------RHPAINRVAVYAVPdervgDQVMAALVLRDGATFDPDafAAFLAAQPDLGTKAWPRYVRIAADLPSTATNK 494
|
....*.
gi 499404635 1021 LDMKQL 1026
Cdd:PRK13388 495 VLKREL 500
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
686-1024 |
8.99e-10 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 62.78 E-value: 8.99e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 VIYTSGSTGLPKGVMIEHGSLINLLDDHRD--RIDFTPQ------------STMFNCMSLSFDAGNMTTLLPLSSGGTLA 751
Cdd:cd05924 8 ILYTGGTTGMPKGVMWRQEDIFRMLMGGADfgTGEFTPSedahkaaaaaagTVMFPAPPLMHGTGSWTAFGGLLGGQTVV 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 752 FgePNDR-----AIMQAEQAGATHLILPTALMS--ILD------PEQVNGIQAIGMGG------------EACPNAVven 806
Cdd:cd05924 88 L--PDDRfdpeeVWRTIEKHKVTSMTIVGDAMArpLIDalrdagPYDLSSLFAISSGGallspevkqgllELVPNIT--- 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 807 wadkvaLYNMYGPTEctVTALSTRLRKGQPVTIGkPLIHIQ--ALILDTAGQLCPVGVPGELCLAGLGL-ARGYLNQPQM 883
Cdd:cd05924 163 ------LVDAFGSSE--TGFTGSGHSAGSGPETG-PFTRANpdTVVLDDDGRVVPPGSGGVGWIARRGHiPLGYYGDEAK 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 884 TASRFehITLNDVnnagqgaatlRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQikVIV 963
Cdd:cd05924 234 TAETF--PEVDGV----------RYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKS-HPAVYD--VLV 298
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 964 AQV-----GSRPALVAYAtvkADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMK 1024
Cdd:cd05924 299 VGRpderwGQEVVAVVQL---REGAGVDLEELREHCRTRIARYKLPKQVVFVDEIERSPAGKADYR 361
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
686-1022 |
1.33e-09 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 61.90 E-value: 1.33e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 VIYTSGSTGLPKGVMIEHGSLI--NL-------LDDHRDRIDFTPqstMFNCMSLS-----FDAGNMTTLLPlssggtlA 751
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHGNLIaaNLqlihamgLTEADVYLNMLP---LFHIAGLNlalatFHAGGANVVME-------K 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 752 FGEPNDRAIMQAEqaGATHLI-LPTALMSILDPEQVNGIQAIGM---GGEACPnAVVENWADKVA--LYNMYGPTE--CT 823
Cdd:cd17637 75 FDPAEALELIEEE--KVTLMGsFPPILSNLLDAAEKSGVDLSSLrhvLGLDAP-ETIQRFEETTGatFWSLYGQTEtsGL 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 824 VTALSTRLRKGqpvTIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFE---Hitlndvnnag 900
Cdd:cd17637 152 VTLSPYRERPG---SAGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTFRngwH---------- 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 901 qgaatlriyRTGDKARLLNNGDYEYCGRIDEQ--IKLRGYRIEPGEIEAQLAAVcPSLKQIKVI-VAQVGSRPALVAYAT 977
Cdd:cd17637 219 ---------HTGDLGRFDEDGYLWYAGRKPEKelIKPGGENVYPAEVEKVILEH-PAIAEVCVIgVPDPKWGEGIKAVCV 288
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 499404635 978 VKAdSSTPEPAAvLID-VAKYLPEYMVPFRLMLLEDMPLTPNGKLD 1022
Cdd:cd17637 289 LKP-GATLTADE-LIEfVGSRIARYKKPRYVVFVEALPKTADGSID 332
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1560-1914 |
1.98e-09 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 63.14 E-value: 1.98e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1560 YDIDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAAL-ESECASIQVIVKQAD 1638
Cdd:PRK10252 2 EPMSQHLPLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFtEDNGEVWQWVDPALT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1639 LPFY-YQDLMQDADPLAVIERYRQQDLRTGFDLSQ-PPLLRIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLGAVHRDYQ 1716
Cdd:PRK10252 82 FPLPeIIDLRTQPDPHAAAQALMQADLQQDLRVDSgKPLVFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYC 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1717 TLMQGQvlmhgDAPAIQ-VDRAYV--DYARHAVAQQSAVD-AFW-QQRQSLLAQTNDVSMLFAAAGKRADLsqhltqiep 1791
Cdd:PRK10252 162 AWLRGE-----PTPASPfTPFADVveEYQRYRASEAWQRDaAFWaEQRRQLPPPASLSPAPLPGRSASADI--------- 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1792 qvtsvsLNEKDQATLTAFAREVGITPSI---------IAQYawhrlLARSTGDAVSIVGNVLSGRESPVedVASSVGLYI 1862
Cdd:PRK10252 228 ------LRLKLEFTDGAFRQLAAQASGVqrpdlalalVALW-----LGRLCGRMDYAAGFIFMRRLGSA--ALTATGPVL 294
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*...
gi 499404635 1863 NSLPLALSWQQPVSLQQHLVQLQNELMAMNQH----ATQSL--IALTAGRSRLFNSLF 1914
Cdd:PRK10252 295 NVLPLRVHIAAQETLPELATRLAAQLKKMRRHqrydAEQIVrdSGRAAGDEPLFGPVL 352
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1559-1703 |
6.06e-09 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 61.72 E-value: 6.06e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1559 RYDIDTLLPLSSLQQSMLYHRLRCPQDDAYHLQTPIRYAHVLDVEGYRQAWQRQIQRFPALRAALES-ECASIQVIVKQA 1637
Cdd:PRK05691 1722 RVDRSQPVPLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSvDGVPVQQVAEDS 1801
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1638 DLPFYYQDLmqDADPLAVIERYRQQ----DLRTGFDLSQPPLLRIACFRLGEQDYRVLLSCHHSVIDGWS 1703
Cdd:PRK05691 1802 GLRMDWQDF--SALPADARQQRLQQladsEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWA 1869
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
559-1021 |
6.18e-09 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 60.90 E-value: 6.18e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 559 TDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLDPDYPPERLRHIITDANLSVIL 638
Cdd:cd05939 1 DRHWTFRELNEYSNKVANFFQAQGYRSGDVVALFMENRLEFVALWLGLAKIGVETALINSNLRLESLLHCITVSKAKALI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 639 ggdgqqlaqwsaeqrIDLTDPAVveqwQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRID 718
Cdd:cd05939 81 ---------------FNLLDPLL----TQSSTEPPSQDDVNFRDKLFYIYTSGTTGLPKAAVIVHSRYYRIAAGAYYAFG 141
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 719 FTPQSTMFNCMSLSFDAGNMttllpLSSGGTLAFgepndraimqaeqaGATHLILP--TALMSILDPEQVNG--IQAIgm 794
Cdd:cd05939 142 MRPEDVVYDCLPLYHSAGGI-----MGVGQALLH--------------GSTVVIRKkfSASNFWDDCVKYNCtiVQYI-- 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 795 gGEAC------PNAVVEN----------------WADKVALYNM------YGPTECT---------VTA---LSTRLRKG 834
Cdd:cd05939 201 -GEICryllaqPPSEEEQkhnvrlavgnglrpqiWEQFVRRFGIpqigefYGATEGNsslvnidnhVGAcgfNSRILPSV 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 835 QPVTIGKPLIHIQALILDTAGqLCPVGVPGElclAGLGLARGYLNQPqmtASRFEhitlndvNNAGQGAATLRIYR---- 910
Cdd:cd05939 280 YPIRLIKVDEDTGELIRDSDG-LCIPCQPGE---PGLLVGKIIQNDP---LRRFD-------GYVNEGATNKKIARdvfk 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 911 TGDKArlLNNGD--------YEYC-GRIDEQIKLRGYRIEPGEIEAQLAAvCPSLKQIKVIVAQVGSRPALVAYATVKAD 981
Cdd:cd05939 346 KGDSA--FLSGDvlvmdelgYLYFkDRTGDTFRWKGENVSTTEVEGILSN-VLGLEDVVVYGVEVPGVEGRAGMAAIVDP 422
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 499404635 982 SSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKL 1021
Cdd:cd05939 423 ERKVDLDRFSAVLAKSLPPYARPQFIRLLPEVDKTGTFKL 462
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
673-1026 |
1.26e-08 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 59.29 E-value: 1.26e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 673 PPAIPRHAQQL--------------AQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTM---------FNCM 729
Cdd:PRK07824 13 PAQDERRAALLrdalrvgepidddvALVVATSGTTGTPKGAMLTAAALTASADATHDRLGGPGQWLLalpahhiagLQVL 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 730 SLSFDAGNMTTLLPLSSGgtlaFGEPNDRAIMQAEQAGATHLIL-PTALMSIL-DPEQVNGIQ---AIGMGGEACPNAVV 804
Cdd:PRK07824 93 VRSVIAGSEPVELDVSAG----FDPTALPRAVAELGGGRRYTSLvPMQLAKALdDPAATAALAeldAVLVGGGPAPAPVL 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 805 ENWAD-KVALYNMYGPTEctvTAlstrlrkGQPVTIGKPLIHIQALILDtagqlcpvgvpGELCLAGLGLARGYLNQPqm 883
Cdd:PRK07824 169 DAAAAaGINVVRTYGMSE---TS-------GGCVYDGVPLDGVRVRVED-----------GRIALGGPTLAKGYRNPV-- 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 884 tasrfEHitlNDVNNAGQgaatlriYRTGDkARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI- 962
Cdd:PRK07824 226 -----DP---DPFAEPGW-------FRTDD-LGALDDGVLTVLGRADDAISTGGLTVLPQVVEAALATH-PAVADCAVFg 288
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 963 VA--QVGSRpalVAYATVKADSSTPEPAAVLIDVAKYLPEYMVPFRLMLLEDMPLTPNGKLDMKQL 1026
Cdd:PRK07824 289 LPddRLGQR---VVAAVVGDGGPAPTLEALRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
686-962 |
1.48e-08 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 58.85 E-value: 1.48e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 686 VIYTSGSTGLPKGVMIEHGSLI----NLLDDHrdriDFTPQSTMFNCMSLsFDAGN-MTTLLPLSSGGTLAFGEPND--- 757
Cdd:cd17636 5 AIYTAAFSGRPNGALLSHQALLaqalVLAVLQ----AIDEGTVFLNSGPL-FHIGTlMFTLATFHAGGTNVFVRRVDaee 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 758 -RAIMQAEQAGATHLILPTaLMSIL-----DPEQVNGIQAIGMGGEACPNAVVENWADKVALYNmYGPTEctVTALSTRL 831
Cdd:cd17636 80 vLELIEAERCTHAFLLPPT-IDQIVelnadGLYDLSSLRSSPAAPEWNDMATVDTSPWGRKPGG-YGQTE--VMGLATFA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 832 RKGQPV--TIGKPLIHIQALILDTAGQLCPVGVPGELCLAGLGLARGYLNQPQMTASRFehitlndvnnAGQGaatlriY 909
Cdd:cd17636 156 ALGGGAigGAGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRT----------RGGW------H 219
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 499404635 910 RTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLAAVcPSLKQIKVI 962
Cdd:cd17636 220 HTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQH-PAVADAAVI 271
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1600-1867 |
1.49e-08 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 59.39 E-value: 1.49e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1600 LDVEGYRQAWQRQIQRFPALRAALESECAS---IQVIVKQADLPFYYQDLMQDADPLAVIERYRQQDlrtgFDLSQPPLL 1676
Cdd:cd19532 36 LDVARLERAVRAVGQRHEALRTCFFTDPEDgepMQGVLASSPLRLEHVQISDEAEVEEEFERLKNHV----YDLESGETM 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1677 RIACFRLGEQDYRVLLSCHHSVIDGWSGPQLLgavhRDYQTLMQGQVLMHgdaPAIQvdraYVDYARHavaQQSAVD--- 1753
Cdd:cd19532 112 RIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFL----RDLERAYNGQPLLP---PPLQ----YLDFAAR---QRQDYEsga 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1754 -----AFWQqrqSLLAQTNDVSML--FAAAGKRADLSQHLTQIepqvTSVSLNEKDQATLTAFAREVGITPSIIaqY--A 1824
Cdd:cd19532 178 ldedlAYWK---SEFSTLPEPLPLlpFAKVKSRPPLTRYDTHT----AERRLDAALAARIKEASRKLRVTPFHF--YlaA 248
|
250 260 270 280
....*....|....*....|....*....|....*....|....
gi 499404635 1825 WHRLLARSTG-DAVSIvGNVLSGRESpvEDVASSVGLYINSLPL 1867
Cdd:cd19532 249 LQVLLARLLDvDDICI-GIADANRTD--EDFMETIGFFLNLLPL 289
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
1047-1101 |
4.54e-08 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 51.41 E-value: 4.54e-08
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 1047 VLAIWRSVLNTP---LGVEDDFFRLGGDSILSIQLTTRLRSA-GYACTVKDVFEAKSVR 1101
Cdd:pfam00550 3 LRELLAEVLGVPaeeIDPDTDLFDLGLDSLLAVELIARLEEEfGVEIPPSDLFEHPTLA 61
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
559-721 |
4.56e-08 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 58.09 E-value: 4.56e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 559 TDTLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGAAYVPLdpdypP------------ERLR 626
Cdd:PRK09192 47 EEALPYQTLRARAEAGARRLLALGLKPGDRVALIAETDGDFVEAFFACQYAGLVPVPL-----PlpmgfggresyiAQLR 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 627 HIITDANLSVILGGDGqqLAQWSAEQRIDLTDPAVVE-QWQDLPGDQPPAIPR-HAQQLAQVIYTSGSTGLPKGVMIEHG 704
Cdd:PRK09192 122 GMLASAQPAAIITPDE--LLPWVNEATHGNPLLHVLShAWFKALPEADVALPRpTPDDIAYLQYSSGSTRFPRGVIITHR 199
|
170
....*....|....*...
gi 499404635 705 SLINLLDDH-RDRIDFTP 721
Cdd:PRK09192 200 ALMANLRAIsHDGLKVRP 217
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
561-973 |
2.35e-07 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 55.68 E-value: 2.35e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 561 TLTYAELNRQANQLAHWLHRQGLGEQSLVGVLAKRDRYFVIALLAIWKAGaayvpldpdypperlrhiITDANLSVILGG 640
Cdd:cd17639 5 YMSYAEVWERVLNFGRGLVELGLKPGDKVAIFAETRAEWLITALGCWSQN------------------IPIVTVYATLGE 66
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 641 DGQQLAQWSAEQRIDLTDPAvveqwqdlPGDqppaiprhaqqLAQVIYTSGSTGLPKGVMIEHGSLI--------NLLDD 712
Cdd:cd17639 67 DALIHSLNETECSAIFTDGK--------PDD-----------LACIMYTSGSTGNPKGVMLTHGNLVagiaglgdRVPEL 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 713 HR--DR-IDFTPQSTMFncmSLSFdagnmtTLLPLSSGGTLAFGEPndRAIMQAEQAGaTHLIL----PTaLMS----IL 781
Cdd:cd17639 128 LGpdDRyLAYLPLAHIF---ELAA------ENVCLYRGGTIGYGSP--RTLTDKSKRG-CKGDLtefkPT-LMVgvpaIW 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 782 DP---------EQVNGIQ-------------AIGMGGEACP-NAVVENwadKVA------LYNM---------------- 816
Cdd:cd17639 195 DTirkgvlaklNPMGGLKrtlfwtayqsklkALKEGPGTPLlDELVFK---KVRaalggrLRYMlsggaplsadtqefln 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 817 ---------YGPTECTVTALSTRLRKGQPVTIGKPLIHIQALILDT--AGQLCPVGVP-GELCLAGLGLARGYLNQPQMT 884
Cdd:cd17639 272 ivlcpviqgYGLTETCAGGTVQDPGDLETGRVGPPLPCCEIKLVDWeeGGYSTDKPPPrGEILIRGPNVFKGYYKNPEKT 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 885 ASRFehitlndvnnAGQGaatlrIYRTGDKARLLNNGDYEYCGRIDEQIKLR-GYRIEPGEIEAQLAAvCPSLKQIKVIV 963
Cdd:cd17639 352 KEAF----------DGDG-----WFHTGDIGEFHPDGTLKIIDRKKDLVKLQnGEYIALEKLESIYRS-NPLVNNICVYA 415
|
490
....*....|.
gi 499404635 964 AQVGSRP-ALV 973
Cdd:cd17639 416 DPDKSYPvAIV 426
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
1041-1110 |
6.11e-07 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 49.08 E-value: 6.11e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 1041 NPLEADVLAIWRSVLNTP---LGVEDDFFR-LGGDSILSIQLTTRLRSA-GYACTVKDVFEAKSVRRLCRVLAQN 1110
Cdd:COG0236 4 EELEERLAEIIAEVLGVDpeeITPDDSFFEdLGLDSLDAVELIAALEEEfGIELPDTELFEYPTVADLADYLEEK 78
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
1131-1425 |
6.78e-07 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 53.85 E-value: 6.78e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1131 PIQRWFMEQSLARPEHWNQAAMIQL-PEVDTERLVTMLQALMAQHDALR---LGCDAEGQRY---LADVPCPALSTldyr 1203
Cdd:cd19542 6 PMQEGMLLSQLRSPGLYFNHFVFDLdSSVDVERLRNAWRQLVQRHDILRtvfVESSAEGTFLqvvLKSLDPPIEEV---- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1204 QLGDDGLQQAFTALQSEFDPAQGRTMACALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERLYLGEPLLPKTSSYRQ 1283
Cdd:cd19542 82 ETDEDSLDALTRDLLDDPTLFGQPPHRLTLLETSSG-EVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLPPAPPFSDY 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1284 wgaALQHYATQHAEQLTYWQAQEDGVDLTAL-----LAAKDPQGHASAAIL-TLDA--KTTGqlVSEANrAFNTDVSdLL 1355
Cdd:cd19542 161 ---ISYLQSQSQEESLQYWRKYLQGASPCAFpslspKRPAERSLSSTRRSLaKLEAfcASLG--VTLAS-LFQAAWA-LV 233
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1356 LSALTRTlNDLGWGDkariMLegHGREAIDPTLDvsRTVGWFTSTYPVCLQDKPDWasliqSSKEQLRQV 1425
Cdd:cd19542 234 LARYTGS-RDVVFGY----VV--SGRDLPVPGID--DIVGPCINTLPVRVKLDPDW-----TVLDLLRQL 289
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1133-1469 |
7.76e-07 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 53.80 E-value: 7.76e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1133 QR--WFMEQSLARPEHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLGC---DAEGQRYLADVPCPALSTLDYRQLG 1206
Cdd:cd20483 8 QRrlWFLHNFLEDKTFLNLLLVCHIKgKPDVNLLQKALSELVRRHEVLRTAYfegDDFGEQQVLDDPSFHLIVIDLSEAA 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1207 D--DGLQQAFTALQS-EFDPAQGRTMACALVRHHPqADTALFLAFHHLVIDAVSWRILVDDLERLY----LGEPL---LP 1276
Cdd:cd20483 88 DpeAALDQLVRNLRRqELDIEEGEVIRGWLVKLPD-EEFALVLASHHIAWDRGSSKSIFEQFTALYdalrAGRDLatvPP 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1277 KTSSYRQ---WGAALQHYATQHAEqLTYWQAQEDGV-DLTALL----AAKDP--QGHASAAILTLDAKTTGQLVSEANRA 1346
Cdd:cd20483 167 PPVQYIDftlWHNALLQSPLVQPL-LDFWKEKLEGIpDASKLLpfakAERPPvkDYERSTVEATLDKELLARMKRICAQH 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1347 FNTDVSdLLLSALTRTLNDLGwGDKARIMLEGHGREaidPTLDVSRTVGWFTSTYPVCLQDKPDWA--SLIQSSKEQL-- 1422
Cdd:cd20483 246 AVTPFM-FLLAAFRAFLYRYT-EDEDLTIGMVDGDR---PHPDFDDLVGFFVNMLPIRCRMDCDMSfdDLLESTKTTCle 320
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 1423 ----RQVP-----DKgVGFNPLRYHHPqgnsltLSPIVFNYlglsvQAAGTWRPVD 1469
Cdd:cd20483 321 ayehSAVPfdyivDA-LDVPRSTSHFP------IGQIAVNY-----QVHGKFPEYD 364
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
676-1035 |
7.97e-07 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 54.33 E-value: 7.97e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 676 IPRHAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLsFDAGNMTT--LLPLSSggtlafg 753
Cdd:PRK08043 360 VKQQPEDAALILFTSGSEGHPKGVVHSHKSLLANVEQIKTIADFTPNDRFMSALPL-FHSFGLTVglFTPLLT------- 431
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 754 epndraimqaeqaGATHLILPTALMSILDPEQV---NGIQAIGM------------------------GGEACPNAVVEN 806
Cdd:PRK08043 432 -------------GAEVFLYPSPLHYRIVPELVydrNCTVLFGTstflgnyarfanpydfarlryvvaGAEKLQESTKQL 498
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 807 WADKVALYNM--YGPTECT-VTALSTRLrKGQPVTIGKPLIHIQALILDTAGqlcpVGVPGELCLAGLGLARGYLnqpqm 883
Cdd:PRK08043 499 WQDKFGLRILegYGVTECApVVSINVPM-AAKPGTVGRILPGMDARLLSVPG----IEQGGRLQLKGPNIMNGYL----- 568
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 884 tasRFEHITLNDVNNA--GQGAATLRIYRTGDKARLLNNGdyeYCgrideQIKLRGYRIepgeieAQLAAVCPSLKQIKV 961
Cdd:PRK08043 569 ---RVEKPGVLEVPTAenARGEMERGWYDTGDIVRFDEQG---FV-----QIQGRAKRF------AKIAGEMVSLEMVEQ 631
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 962 IVAQVGsrPALVAYATVKADSSTPEpAAVLIDVAKYL--------------PEYMVPFRLMLLEDMPLTPNGKLDMKQLP 1027
Cdd:PRK08043 632 LALGVS--PDKQHATAIKSDASKGE-ALVLFTTDSELtreklqqyarehgvPELAVPRDIRYLKQLPLLGSGKPDFVTLK 708
|
....*...
gi 499404635 1028 PVLEANES 1035
Cdd:PRK08043 709 SMVDEPEQ 716
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
1135-1422 |
1.12e-06 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 53.54 E-value: 1.12e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1135 WFMEQSLARPEHWNQAAMIQLPE-VDTERLVTMLQALMAQHDALRLGCDAEGQrylaDVPCPALST-----LDYRQLGDD 1208
Cdd:cd19539 12 WFIDQGEDGGPAYNIPGAWRLTGpLDVEALREALRDVVARHEALRTLLVRDDG----GVPRQEILPpgpapLEVRDLSDP 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1209 G--LQQAFTALQSE-----FDPAQGRTMACALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERLYLG-----EPLLP 1276
Cdd:cd19539 88 DsdRERRLEELLREresrgFDLDEEPPIRAVLGRFDPD-DHVLVLVAHHTAFDAWSLDVFARDLAALYAArrkgpAAPLP 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1277 KT-SSYRQWGAALQHYAT--QHAEQLTYWQAQEDGVDLTALLAA--KDPQGHASAAILT--LDAKTTGQLVSEANRAFNT 1349
Cdd:cd19539 167 ELrQQYKEYAAWQREALAapRAAELLDFWRRRLRGAEPTALPTDrpRPAGFPYPGADLRfeLDAELVAALRELAKRARSS 246
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 499404635 1350 DVSdLLLSALTRTLNDlgWGDKARIML----EGHGREAIDptldvsRTVGWFTSTYPVCLQ--DKPDWASLIQSSKEQL 1422
Cdd:cd19539 247 LFM-VLLAAYCVLLRR--YTGQTDIVVgtpvAGRNHPRFE------STVGFFVNLLPLRVDvsDCATFRDLIARVRKAL 316
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1600-1703 |
4.42e-06 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 51.48 E-value: 4.42e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1600 LDVEGYRQAWQRQIQRFPALRAALESECASIQVIVK---QADLPFYYQDLMQDADPLAVieRYRQQDLRTGFDLSQPPLL 1676
Cdd:cd19534 34 LDPDALRQALRALVEHHDALRMRFRREDGGWQQRIRgdvEELFRLEVVDLSSLAQAAAI--EALAAEAQSSLDLEEGPLL 111
|
90 100
....*....|....*....|....*..
gi 499404635 1677 RIACFRLGEQDYRVLLSCHHSVIDGWS 1703
Cdd:cd19534 112 AAALFDGTDGGDRLLLVIHHLVVDGVS 138
|
|
| PTZ00216 |
PTZ00216 |
acyl-CoA synthetase; Provisional |
661-712 |
5.50e-06 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240316 [Multi-domain] Cd Length: 700 Bit Score: 51.52 E-value: 5.50e-06
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*
gi 499404635 661 VVEQWQDLPGDQPPAIPRHAQQLAQVIYTSGSTGLPKGVMIEHGSL---INLLDD 712
Cdd:PTZ00216 244 VVAKGHSAGSHHPLNIPENNDDLALIMYTSGTTGDPKGVMHTHGSLtagILALED 298
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
670-707 |
6.05e-06 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 51.66 E-value: 6.05e-06
10 20 30 40
....*....|....*....|....*....|....*....|
gi 499404635 670 GDQPPAIPR--HAQQLAQVIYTSGSTGLPKGVMIEHGSLI 707
Cdd:PLN02387 237 GKENPVDPDlpSPNDIAVIMYTSGSTGLPKGVMMTHGNIV 276
|
|
| TubC_N |
pfam18563 |
TubC N-terminal docking domain; This is the N-terminal docking domain found in TubC proteins ... |
4-54 |
1.28e-05 |
|
TubC N-terminal docking domain; This is the N-terminal docking domain found in TubC proteins from the tubulysin polyketide synthase and nonribosomal polypeptide synthetase (PKS-NRPS) system, which binds to C-terminal docking domain of TubB.
Pssm-ID: 436580 [Multi-domain] Cd Length: 52 Bit Score: 44.43 E-value: 1.28e-05
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|.
gi 499404635 4 IVTLLKQLERQGVRLALNaQGQLISQSNKEAITAEIGRTIKENKDAIVRCL 54
Cdd:pfam18563 1 IVELLAELYALGIKLWLE-GGRLRFRAPKGVLTPELREKLKERKAEIIAFL 50
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
688-1032 |
1.72e-05 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 50.02 E-value: 1.72e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 688 YTSGSTGLPKGVMIEH-GSLINLLDDHRD-RIDFTP----QSTMFNCMSLSFDAGNMttllplSSGGT-LAFGEPNDRAI 760
Cdd:PLN03102 193 YTSGTTADPKGVVISHrGAYLSTLSAIIGwEMGTCPvylwTLPMFHCNGWTFTWGTA------ARGGTsVCMRHVTAPEI 266
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 761 MQ-AEQAGATHL-ILPTALMSILDPEQVN-----GIQAIGMGGEACPNAVVENwADKVALYNM--YGPTECTVTALS--- 828
Cdd:PLN03102 267 YKnIEMHNVTHMcCVPTVFNILLKGNSLDlsprsGPVHVLTGGSPPPAALVKK-VQRLGFQVMhaYGLTEATGPVLFcew 345
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 829 ----TRLRKGQPVTIG--KPLIHIQALILDTAGQLCPVGVP------GELCLAGLGLARGYLNQPQMTASRFEHITLNdv 896
Cdd:PLN03102 346 qdewNRLPENQQMELKarQGVSILGLADVDVKNKETQESVPrdgktmGEIVIKGSSIMKGYLKNPKATSEAFKHGWLN-- 423
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 897 nnagqgaatlriyrTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIEAQLaavcpsLKQIKVIVAQVGSRP------ 970
Cdd:PLN03102 424 --------------TGDVGVIHPDGHVEIKDRSKDIIISGGENISSVEVENVL------YKYPKVLETAVVAMPhptwge 483
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 499404635 971 ALVAYATVKADSSTPEPAAVLI-----DVAKY----LPEYMVPFRLMLLEDMPLTPNGKLDMKQLPPVLEA 1032
Cdd:PLN03102 484 TPCAFVVLEKGETTKEDRVDKLvtrerDLIEYcrenLPHFMCPRKVVFLQELPKNGNGKILKPKLRDIAKG 554
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
2033-2098 |
2.53e-05 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 43.71 E-value: 2.53e-05
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 499404635 2033 QTLLRAWAQTLHLGEPGLGESDlwsrTLCESGVDSLQRIALAQALSRTLAHPVSVALLQHYPSPQA 2098
Cdd:pfam00550 1 ERLRELLAEVLGVPAEEIDPDT----DLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
2035-2105 |
4.25e-05 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 43.78 E-value: 4.25e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 499404635 2035 LLRAWAQTLHLGEPGLGESDlwsRTLCESGVDSLQRIALAQALSRTLAHPVSVALLQHYPSPQALSGHLAQ 2105
Cdd:smart00823 17 VREQVAAVLGHAAAEAIDPD---RPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALAEHLAA 84
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
1156-1312 |
4.96e-05 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 47.95 E-value: 4.96e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1156 PEVDTERLVTMLQALMAQHDALR---LGCDAEGQRYLADVPcP---ALSTLDYRqlgddglqqafTALQSEFDPAQGrtm 1229
Cdd:cd19537 34 GDVDRDRLASAWNTVLARHRILRsryVPRDGGLRRSYSSSP-PrvqRVDTLDVW-----------KEINRPFDLERE--- 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1230 acALVRHHPQADTaLFLAFHHLVIDAVSWRILVDDLERLYLGEPLLPKTSSYRQWgAALQHYATQhaEQLTYWQAQEDGV 1309
Cdd:cd19537 99 --DPIRVFISPDT-LLVVMSHIICDLTTLQLLLREVSAAYNGKLLPPVRREYLDS-TAWSRPASP--EDLDFWSEYLSGL 172
|
...
gi 499404635 1310 DLT 1312
Cdd:cd19537 173 PLL 175
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
1131-1310 |
5.46e-05 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 48.06 E-value: 5.46e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1131 PIQRWFMEQSLARPEHWNQAAMIQLPE-VDTERLVTMLQALMAQHDALRlgcdaegqryladvpcpalSTLDyrQLGDDG 1209
Cdd:cd19545 6 PLQEGLMALTARQPGAYVGQRVFELPPdIDLARLQAAWEQVVQANPILR-------------------TRIV--QSDSGG 64
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1210 LQQA-----------FTALQS--EFDPAQG-----RTMACALVRHhPQADTALFLAFHHLVIDAVSWRILVDDLERLYLG 1271
Cdd:cd19545 65 LLQVvvkespiswteSTSLDEylEEDRAAPmglggPLVRLALVED-PDTERYFVWTIHHALYDGWSLPLILRQVLAAYQG 143
|
170 180 190
....*....|....*....|....*....|....*....
gi 499404635 1272 EPlLPKTSSYRQWGAALQHyaTQHAEQLTYWQAQEDGVD 1310
Cdd:cd19545 144 EP-VPQPPPFSRFVKYLRQ--LDDEAAAEFWRSYLAGLD 179
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
532-823 |
6.01e-05 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 48.24 E-value: 6.01e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 532 LTVTDVIEAVAQRDPQQLAIAFDGEPRTDTlTYAELNRQANQLAHWLHRQ-GLGEQSLVGVLAKRDRYFVIALLAIWKAG 610
Cdd:PRK05620 10 LSLTRILEYGSTVHGDTTVTTWGGAEQEQT-TFAAIGARAAALAHALHDElGITGDQRVGSMMYNCAEHLEVLFAVACMG 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 611 AAYVPLDPDYPPERLRHIITDANLSVILGG--DGQQLAQWSAE----------QRIDLTDPAV----------------- 661
Cdd:PRK05620 89 AVFNPLNKQLMNDQIVHIINHAEDEVIVADprLAEQLGEILKEcpcvravvfiGPSDADSAAAhmpegikvysyealldg 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 662 ---VEQWQDLPGDQPPAIprhaqqlaqvIYTSGSTGLPKGVMIEHGSLinllddhrdridftpqstMFNCMSL----SFD 734
Cdd:PRK05620 169 rstVYDWPELDETTAAAI----------CYSTGTTGAPKGVVYSHRSL------------------YLQSLSLrttdSLA 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 735 AGNMTTLL---P----LSSGGTLAF---GEPndrAIMQAEQAGATHLI-------------LPTALMSIL------DPEQ 785
Cdd:PRK05620 221 VTHGESFLccvPiyhvLSWGVPLAAfmsGTP---LVFPGPDLSAPTLAkiiatamprvahgVPTLWIQLMvhylknPPER 297
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 499404635 786 VNgIQAIGMGGEACPNAVVENWADK--VALYNMYGPTECT 823
Cdd:PRK05620 298 MS-LQEIYVGGSAVPPILIKAWEERygVDVVHVWGMTETS 336
|
|
| PLN02736 |
PLN02736 |
long-chain acyl-CoA synthetase |
562-721 |
7.50e-05 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 178337 [Multi-domain] Cd Length: 651 Bit Score: 47.79 E-value: 7.50e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 562 LTYAELNRQANQLAHWLHRQGLGEQSLVGVlakrdrYFV--IALLAIWKAGAAY----VPLDPDYPPERLRHIITDANLS 635
Cdd:PLN02736 79 MTYGEAGTARTAIGSGLVQHGIPKGACVGL------YFInrPEWLIVDHACSAYsyvsVPLYDTLGPDAVKFIVNHAEVA 152
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 636 -------------------------VILGGDGQQLAQWSAEQRIDLTDPAVVEQwQDLPGDQPPAIPRhAQQLAQVIYTS 690
Cdd:PLN02736 153 aifcvpqtlntllsclseipsvrliVVVGGADEPLPSLPSGTGVEIVTYSKLLA-QGRSSPQPFRPPK-PEDVATICYTS 230
|
170 180 190
....*....|....*....|....*....|.
gi 499404635 691 GSTGLPKGVMIEHGSLINLLDDHRDRIDFTP 721
Cdd:PLN02736 231 GTTGTPKGVVLTHGNLIANVAGSSLSTKFYP 261
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
684-935 |
7.85e-05 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 47.50 E-value: 7.85e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 684 AQVIYTSGSTGLPKGVMIEHGsliNLLDDHRDRIDFTPQSTMFNCMSL--SFDAG--NMTTLLPLSSGGTLAFGEPNDRA 759
Cdd:PRK06334 186 AVILFTSGTEKLPKGVPLTHA---NLLANQRACLKFFSPKEDDVMMSFlpPFHAYgfNSCTLFPLLSGVPVVFAYNPLYP 262
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 760 IMQAEQAGATHLIL----PTALMSILDPEQ-----VNGIQAIGMGGEACPNAV---VENWADKVALYNMYGPTECT-VTA 826
Cdd:PRK06334 263 KKIVEMIDEAKVTFlgstPVFFDYILKTAKkqescLPSLRFVVIGGDAFKDSLyqeALKTFPHIQLRQGYGTTECSpVIT 342
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 827 LSTRLRKGQPVTIGKPLIHIQALILDTAGQLcPV--GVPGELCLAGLGLARGYLNqpqmtasrfehitlndvNNAGQGAA 904
Cdd:PRK06334 343 INTVNSPKHESCVGMPIRGMDVLIVSEETKV-PVssGETGLVLTRGTSLFSGYLG-----------------EDFGQGFV 404
|
250 260 270
....*....|....*....|....*....|....
gi 499404635 905 TL---RIYRTGDKARLLNNGDYEYCGRIDEQIKL 935
Cdd:PRK06334 405 ELggeTWYVTGDLGYVDRHGELFLKGRLSRFVKI 438
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
944-1020 |
1.43e-04 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 42.15 E-value: 1.43e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 944 EIEAQLAAvCPSLKQIKVI---VAQVGSRPalVAYATVKADssTPEPAAVLID-VAKYLPEYMVPFRLMLLEDMPLTPNG 1019
Cdd:pfam13193 1 EVESALVS-HPAVAEAAVVgvpDELKGEAP--VAFVVLKPG--VELLEEELVAhVREELGPYAVPKEVVFVDELPKTRSG 75
|
.
gi 499404635 1020 K 1020
Cdd:pfam13193 76 K 76
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
1035-1109 |
1.56e-04 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 42.24 E-value: 1.56e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1035 SDGEADNPLEADVLAIWRSVLNTP----LGVEDDFFRLGGDSILSIQLTTRLRSA-GYACTVKDVFEAKSVRRLCRVLAQ 1109
Cdd:smart00823 5 PPAERRRLLLDLVREQVAAVLGHAaaeaIDPDRPFRDLGLDSLMAVELRNRLEAAtGLRLPATLVFDHPTPAALAEHLAA 84
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
1129-1359 |
2.25e-04 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 45.82 E-value: 2.25e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1129 LLPIQR--WFMEQSLARPEHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLG-CDAEG---QRYLADVPCPaLSTLD 1201
Cdd:cd19533 4 LTSAQRgvWFAEQLDPEGSIYNLAEYLEITgPVDLAVLERALRQVIAEAETLRLRfTEEEGepyQWIDPYTPVP-IRHID 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1202 YRQLGD-DGLQQAF--TALQSEFDPAQGRTMACALVRHHPQAdTALFLAFHHLVIDAVSWRILVDDLERLYL----GEPL 1274
Cdd:cd19533 83 LSGDPDpEGAAQQWmqEDLRKPLPLDNDPLFRHALFTLGDNR-HFWYQRVHHIVMDGFSFALFGQRVAEIYTallkGRPA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1275 LPKTS-SYRQWGAALQHYAT--QHAEQLTYWQAQEDGVDLTALLAAKDPQGHASAAILTLD-AKTTGQLVSEANRAFNTD 1350
Cdd:cd19533 162 PPAPFgSFLDLVEEEQAYRQseRFERDRAFWTEQFEDLPEPVSLARRAPGRSLAFLRRTAElPPELTRTLLEAAEAHGAS 241
|
....*....
gi 499404635 1351 VSDLLLSAL 1359
Cdd:cd19533 242 WPSFFIALV 250
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
1161-1339 |
2.89e-04 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 45.51 E-value: 2.89e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1161 ERLVTMLQALMAQHDALRLGCDAEG-----QRYLADVPCPaLSTLDYRQlGDDGLQQaftaLQSEFDPAQGRT------- 1228
Cdd:cd19544 39 DAFLAALQQVIDRHDILRTAILWEGlsepvQVVWRQAELP-VEELTLDP-GDDALAQ----LRARFDPRRYRLdlrqapl 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1229 MACALVRHHPQADTALFLAFHHLVIDAVSWRILVDDLERLYLGEP-LLPKTSSYRQWGAALQHyATQHAEQLTYWQAQED 1307
Cdd:cd19544 113 LRAHVAEDPANGRWLLLLLFHHLISDHTSLELLLEEIQAILAGRAaALPPPVPYRNFVAQARL-GASQAEHEAFFREMLG 191
|
170 180 190
....*....|....*....|....*....|....*.
gi 499404635 1308 GVD-LTALLAAKDPQGHASA---AILTLDAKTTGQL 1339
Cdd:cd19544 192 DVDePTAPFGLLDVQGDGSDiteARLALDAELAQRL 227
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1121-1359 |
3.23e-04 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 46.19 E-value: 3.23e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1121 GTLEGEFALLPIQR--WFMEQSLARPEHWNQAAMIQLP-EVDTERLVTMLQALMAQHDALRLG-CDAEG---QRYLADVP 1193
Cdd:PRK10252 2 EPMSQHLPLVAAQPgiWMAEKLSPLPSAWSVAHYVELTgELDAPLLARAVVAGLAEADTLRMRfTEDNGevwQWVDPALT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1194 CPALSTLDYRQlGDDGLQQAFTA----LQSEFDPAQGRTMAC-ALVRHHPQaDTALFLAFHHLVIDAVSWRILVDDLERL 1268
Cdd:PRK10252 82 FPLPEIIDLRT-QPDPHAAAQALmqadLQQDLRVDSGKPLVFhQLIQLGDN-RWYWYQRYHHLLVDGFSFPAITRRIAAI 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 1269 Y----LGEPllPKTSSYRQWGAAL---QHYATQHAEQL--TYWQAQEDGVDLTALLAAKDPQGHASAA-----ILTLDAK 1334
Cdd:PRK10252 160 YcawlRGEP--TPASPFTPFADVVeeyQRYRASEAWQRdaAFWAEQRRQLPPPASLSPAPLPGRSASAdilrlKLEFTDG 237
|
250 260
....*....|....*....|....*
gi 499404635 1335 TTGQLVSEANRAFNTDVSdLLLSAL 1359
Cdd:PRK10252 238 AFRQLAAQASGVQRPDLA-LALVAL 261
|
|
| PLN03051 |
PLN03051 |
acyl-activating enzyme; Provisional |
672-973 |
5.34e-04 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215552 [Multi-domain] Cd Length: 499 Bit Score: 44.81 E-value: 5.34e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 672 QPPAIPrhAQQLAQVIYTSGSTGLPKGVMIEHGSLINLLDDHRDRIDFTPQSTMFNCMSLSFDAGNMTTLLPLSSGGTLA 751
Cdd:PLN03051 112 SPVYAP--VESVTNILFSSGTTGEPKAIPWTHLSPLRCASDGWAHMDIQPGDVVCWPTNLGWMMGPWLLYSAFLNGATLA 189
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 752 F--GEPNDRAIMQ-AEQAGATHL-ILPT----------ALMSILDpeqVNGIQAIGMGGEAcpnAVVENWADKVALYNMY 817
Cdd:PLN03051 190 LygGAPLGRGFGKfVQDAGVTVLgLVPSivkawrhtgaFAMEGLD---WSKLRVFASTGEA---SAVDDVLWLSSVRGYY 263
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 818 GPT-EC-------TVTALSTRLRKGQPVTIGKPLIHIQALILDTAGQLCPVGVP--GELCLAG--LGLARGYLNQPQmTA 885
Cdd:PLN03051 264 KPViEYcggtelaSGYISSTLLQPQAPGAFSTASLGTRFVLLNDNGVPYPDDQPcvGEVALAPpmLGASDRLLNADH-DK 342
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 886 SRFEHITLNDVNNagqgaatLRIYRTGDKARLLNNGDYEYCGRIDEQIKLRGYRIEPGEIE-AQLAAVCPSLKQIKVIVA 964
Cdd:PLN03051 343 VYYKGMPMYGSKG-------MPLRRHGDIMKRTPGGYFCVQGRADDTMNLGGIKTSSVEIErACDRAVAGIAETAAVGVA 415
|
....*....
gi 499404635 965 QVGSRPALV 973
Cdd:PLN03051 416 PPDGGPELL 424
|
|
| Dip2 |
cd05905 |
Disco-interacting protein 2 (Dip2); Dip2 proteins show sequence similarity to other members of ... |
857-974 |
6.70e-04 |
|
Disco-interacting protein 2 (Dip2); Dip2 proteins show sequence similarity to other members of the adenylate forming enzyme family, including insect luciferase, acetyl CoA ligases and the adenylation domain of nonribosomal peptide synthetases (NRPS). However, its function may have diverged from other members of the superfamily. In mouse embryo, Dip2 homolog A plays an important role in the development of both vertebrate and invertebrate nervous systems. Dip2A appears to regulate cell growth and the arrangement of cells in organs. Biochemically, Dip2A functions as a receptor of FSTL1, an extracellular glycoprotein, and may play a role as a cardiovascular protective agent.
Pssm-ID: 341231 [Multi-domain] Cd Length: 571 Bit Score: 44.65 E-value: 6.70e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 857 LCPVGVPGELCLAGLGLARGYLNQPQMTASRFEHITlndVNNAGQGAATLRIYRTGDKA-----RLLNNGDYEY-----C 926
Cdd:cd05905 382 LCKDGEIGEIWVNSPANASGYFLLDGETNDTFKVFP---STRLSTGITNNSYARTGLLGflrptKCTDLNVEEHdllfvV 458
|
90 100 110 120
....*....|....*....|....*....|....*....|....*...
gi 499404635 927 GRIDEQIKLRGYRIEPGEIEAQLAAVCPSLKQIkvIVAQVGSRPALVA 974
Cdd:cd05905 459 GSIDETLEVRGLRHHPSDIEATVMRVHPYRGRC--AVFSITGLVVVVA 504
|
|
| PRK09294 |
PRK09294 |
phthiocerol/phthiodiolone dimycocerosyl transferase; |
101-211 |
6.50e-03 |
|
phthiocerol/phthiodiolone dimycocerosyl transferase;
Pssm-ID: 181765 [Multi-domain] Cd Length: 416 Bit Score: 41.23 E-value: 6.50e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 499404635 101 RLTGPLDVAALEFAFDALAQRHASLRTRFvvneqgkgEQRIDAYQPFVIQHDdfsLLPEAEregrlqqQVKAEISRP--- 177
Cdd:PRK09294 29 HLRGVLDIDALSDAFDALLRAHPVLAAHL--------EQDSDGGWELVADDL---LHPGIV-------VVDGDAARPlpe 90
|
90 100 110
....*....|....*....|....*....|....*
gi 499404635 178 FDLTAGD-LTRVRLVKMSERTHVLMITqHHIISDG 211
Cdd:PRK09294 91 LQLDQGVsLLALDVVPDDGGARVTLYI-HHSIADA 124
|
|
|